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ABSTRACT 
In this study the human embryonal carcinoma cell line TERA2.cl.sp 12 (TERA2.sp 12) was 
utilised as an in vitro model in which to study mechanisms governing neural versus non-
neural transitions in the human ectoderm. TERA2.sp12 cells have been previously reported to 
differentiate under adherent culture conditions into both neural and non neural derivatives of 
the ectoderm in response to treatment with retinoic acid (RA). In this investigation an 
alternative culture method was also characterised, which markedly modulated the 
differentiation fate of TERA2.sp 12 cells in response to RA. Dissociated cells cultured in the 
presence of RA under suspension conditions generated aggregates which differentiated 
rapidly, and as detected by immuno-staining and Western blot analyses, exhibited marked up-
regulation of neural markers without evidence of non neural differentiation. Previous work in 
cultured Xenopus animal cap explants show that suspension cultures of dissociated ectoderm 
differentiate into neural instead of epidermal tissue as a result of the inhibition of Bone 
morphogenetic protein (BMP) pathway activity. Polymerase chain reaction (PCR) and 
Western blot analyses demonstrated that RA treated adherent cultures of TERA2.spl2 cells 
exhibited up-regulated expression of BMP regulated genes in comparison to cultures treated in 
parallel and cultured under suspension conditions. Correspondingly, addition of the BMP 
inhibitor Noggin to adherent cultures increased the expression of neural markers (as detected 
by Western blot analyses) towards that observed in suspension cultures. Both BMP and FGF 
mediated pathways were also manipulated in the absence of RA exposure; BMP pathway 
activation or FGF receptor inhibition induced similar differentiation responses, yielding a 
differentiated heterogeneous population. Correspondingly, FGF receptor inhibitor and BMP 
treatments were detected to up-regulate the expression of BMP regulated genes by Western 
blot analysis, supporting the hypothesis that in both treatments differentiation was driven by 
an up-regulation of BMP pathway activity. Treated cultures displayed positive immuno-
staining for trophoblast, smooth muscle and simple epithelial endoderm derivatives, 
demonstrating for the first time that TERA2.sp 12 cells are capable of forming non-ectodermal 
lineages. To further investigate the full differentiation potential of TERA2.sp 12 cells, the 
differentiation of tumour explants derived from TERA2.sp 12 cell injection into immuno-
compromised mice was characterised. Although tumours exhibited markedly restricted 
differentiation complexity when compared with tumours derived from human embryonic stem 
(ES) cell lines, immuno-staining assays demonstrated that TERA2.sp 12 cells formed multiple 
germ layer derivatives in vivo. In conclusion, neural differentiation of TERA2.sp 12 cells can 
be modulated by active manipulation of the BMP signalling pathway, and TERA2.sp 12 cells 
provide a suitable model in which to further investigate the effects of BMP signalling on 
11 
Abstract Ill 
neural induction. However, although TERA2.sp 12 cells exhibit a marked propensity for 
ectodermal differentiation, their differentiation potential is not restricted to ectoderm 
derivatives and is therefore more similar to human ES cells. 
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1.1 Stem cells- an overview 2 
1.1 STEM CELLS-AN OVERVIEW 
Over recent years the rapidly expanding field of stem cell research has gained prominence in 
both scientific and non-scientific circles, reflecting advances towards the much heralded 
potential of stem cells as sources for transplantation therapies (Loveii-Badge 2001 ). A stem 
cell is classically defined as a cell that has the ability to choose between prolonged self-
renewal and differentiation, and under this definition populations exist in both the adult and in 
the embryo. In adult mammalian tissues such as in epithelia and blood, stem cells function to 
replace cells lost from normal cellular senescence or damage. Previously unidentified small 
populations of stem cells have also been characterised in other organs such as the brain 
(Reynolds & Weiss 1992a), for review (Frisen et al. 1998). However, these cells are difficult to 
isolate and typically undergo limited cellular regeneration or turnover (Andrews 2002). Such 
adult stem cell populations are defined as multipotent - capable of differentiating into a 
restricted range of cell types (typically within a specific germ layer). Although recent reports 
indicate that adult stem cell populations may have more plasticity than originally thought 
(Brazelton et al. 2000, Mezey et al. 2000, Panchision et al. 1998), they typically form a limited 
number of cell types. In contrast, stem cells of the early mammalian embryo, as the 
progenitors of the entire range of adult tissues, are termed pluripotent - because they retain 
the remarkable potential to differentiate into any cell type of the body (Smith 200 I). An 
outline of the early germ layers and derivatives in relation to pluripotent embryonic stem cells 
and multipotent adult stem cells is depicted in Figure 1.1. 
A key difference between adult multipotent stem cells and embryonic pluripotent stem 
cells is manifested in the transient nature of pluripotent stem cells in the embryo. Under steady 
state conditions adult stem cells typically undergo asymmetric cell division, in which a stem 
cell produces one daughter cell with a stem cell fate and another daughter cell with a 
differentiated fate, maintaining a stable and self-renewing source of differentiated cells 
throughout life. In contrast, the pluripotent stem cells in the inner cell mass of a developing 
blastocyst and early progenitors in embryonic development undergo symmetric cell division to 
generate identical daughter stem cells, effectively and rapidly increasing the size of the stem 
cell population (for review see Morrison & Kimble 2006). However, these stem cell 
populations exist only transiently, becoming progressively restricted in their differentiation 
potential during embryonic development. Pluripotent stem cells in the inner cell mass of the 
blastocyst promptly differentiate into cells of the primitive ectoderm, which in turn 
differentiate during gastrulation into cells with increasingly restricted differentiation potentials 
to form the three embryonic germ layers. This loss of pluripotency is reflected in the 
Figure 1.1 
Scheme Of Early Development Depicting Relationship Between Early Cell Populations, The 
Primary Germ Layers and pluripotent versus multipotent stem cells 
Pluripotent stem cells 
Germ cells 
Ectoderm 
Multi potent 
stem cells 
0 d ~. 
d ~. 
Figure 1.1 . Scheme of early development in the mouse, depicting relationship between early cell populations and 
germ layers. The inner cell mass of the developing blastocyst contains a population of pluripotent stem cells, which 
have the potential to form derivatives of all germ layers and proliferate by dividing asymmetrically to produce 
identical daughter cells. This pluripotent population rapidly differentiates into the primitive ectoderm, which in turn 
will generates the epiblast. The epiblast which will generate all the tissues of the body, including germ cells and the 
three germ layers - definitive endoderm, mesoderm and ectoderm. Multipotent populations reside in the developing 
germ layer tissues, which under steady state conditions divide asymmetrically to generate both an identical daughter 
stem cell and a differentiated precursor cell. In the adult, stem cell populations function to replace differentiated 
cells lost during injury or normal senescence. Flow chart schematic of germ layers adapted from Keller et al. 2005. 
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expression of the pluripotency associated transcription factor Octamer binding protein 4 
(Oct4), which is first expressed in the developing oocyte and early cleavage embryos, before 
becoming restricted to the cells of the inner cell mass, such that after gastrulation it is solely 
expressed by the primordial germ cells, which maintain Oct4 expression until the initiation of 
sexual differentiation of the gametes (Palmieri et al. 1994, for review see Scholer & Pesce 
2001). An outline of the events leading to the formation of the murine blastocyst and the 
corresponding expression pattern of0ct4 is presented in Figure 1.2. 
In contrast to the transient nature of pluripotent stem cells in embryonic development, 
their counterparts in vitro- either in the malignant form of embryonal carcinoma cells or as 
feeder dependent embryonic stem cells- can be maintained under specific culture conditions 
to self renew through symmetric division, retaining their pluripotency and Oct4 expression 
(for reviews see Chambers & Smith 2004, Andrews 2002, Scholer & Pesce 2001). As cultured 
pluripotent embryonic stem cells are capable of forming virtually any cell type, they have 
been viewed with much excitement as potential sources of cell therapy: In theory, muscle cells 
could be produced to treat muscular dystrophies and heart disease, insulin producing 
pancreatic cells could be generated to treat diabetes, haemopoietic cells could be produced to 
treat leukaemia and there are promising reports in these fields (Donovan & Gearhart 2001, 
Klug et al. 1996, Soria et al. 2000). Much research has been directed towards the use of 
embryonic stem cells as potential sources for neural tissue transplants, partly because of the 
current limited regenerative potential in traumatised brain tissue, and as a potential therapy for 
neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. In this 
respect there are some remarkable demonstrations of the therapeutic potential of embryonic 
stem cell derivatives in mouse models: Mouse embryonic cell derived glial precursors 
transplanted into a rat with myelin disease have been demonstrated to interact with host 
neurons to produce myelin in the brain and spinal cord (Brustle et al. 1999), and McDonald et 
al. (1999) report that RA treated mouse embryonic stem cells transplanted into a rat spinal 
cord after traumatic injury differentiated into astrocytes, oligodendrocytes and neurons, 
promoting motor recovery. More recently, differentiated dopamine-producing neurons were 
found to incorporate into the striatum and improve performance in behavioural tests after 
being grafted into mice that phenotypically model Parkinson's disease (Kim et al. 2002, 
Nishimura et al. 2003). Although their potential as sources of cells for transplantation 
therapies has been the focus of public interest, there is a wide range of potential applications 
of embryonic stem cells. This includes their use as sources of large amounts of human tissue 
for drug testing and development, and importantly human ES cells also provide a human 
experimental model in which to study early development and aspects of embryogenesis in 
humans (for review Pera & Trounson 2004). 
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Figure 1.2. Outline of events leading to the formation of the mouse blastocyst with respect to Oct4 
expression levels. A. The fertilized zygote expresses Oct4 (blue), and this is maintained in the blastomeres 
prior to compaction (A,B). The formation of trophoblast tissue in the compacted morula is accompanied 
by a down-regulation of Oct4 in the outer cells (pale blue). Differentiation of the primitive endoderm in 
the blastocyst is preceded by a transient up-regulation of Oct4 (dark blue) followed by a subsequent 
shutdown in Oct4 expression. The primitive endoderm and trophoectoderm lineages will contribute 
towards the formation of the placenta, whereas the remaining Oct4 positive cells of the inner cell mass 
will form the tissues of the embryo proper, including the three germ layers (definitive endoderm, 
ectoderm and mesoderm) and the germ line. Oct4 is down-regulated in these cells during gastrulation such 
that Oct4 expression becomes restricted to the primordial germ cells, which maintain Oct4 expression 
until the initiation of sexual differentiation of the gametes. Figure adapted from Figure I in Scholer & 
Pesce 2001. 
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The first isolation of human embryonic stem cells by Thompson et al. ( 1998) marked 
a significant advance in human embryonic stem cell research and was consequently accorded 
with public acclaim. However, this important step was founded on decades of study that began 
with the characterisation of a class of tumours - the teratomas. 
1.2 FROM TERATOMAS TO EMBRYONIC STEM CELLS 
The term teratoma is coined from a greek name, roughly translating as 'monster tumour', 
which reflects the properties of these tumours that have fascinated historians, clinicians and 
biologists since their first observation hundreds of years ago (Andrews et al. 2001 ). Teratomas 
and teratocarcinomas occur in a range of manifestations and comprise of a variety of 
differentiated tissues - mimicking normal development but in a grossly disorganised context, 
such that they present caricatures of embryogenesis. Teratomas typically arise in the gonads as 
a form of germ cell tumour (Andrews et al. 2001 ), although they are also rarely detected in 
other sites such as in the spinal chord in adults (Sloof et al. 1964) or at the base of the spine in 
infants (reviewed in Isaacs 2004 ). In these cases it has been hypothesised that these tumours 
are generated from multipotential germinal cells that are misplaced in early embryonic 
development (Bucy et al. 1935). The relative proportion of teratomas among the germ cell 
tumours is quite different in the male and female gonads, with about 95% of ovarian germ cell 
tumours represented by pure teratoma (Katsube et al. 1979, Koonings et al. 1989) but only 
about 4% of testicular germ cell tumours (von Hochstetter & Hedinger 1982). The 
histopathology and classification of germ cell tumours is complex and controversial, however 
a simple schematic representation of a commonly held view of germ cell tumour histogenesis 
in parallel with normal development is presented in Figure 1.3. 
The most common teratomas are ovarian dermoid cysts, which form from oocytes that 
are parthogenetically activated and begin development, but eventually become disorganised to 
form a mass of embryonic tissue as depicted in plate A of Figure 1.3. These tumours are 
generally benign, although they can grow to very large sizes. In contrast, germ cell tumours in 
the adult male account for almost all testicular cancers and are always malignant, 
demonstrating a peak incidence in 30-40 year olds (Moller 1993). Testicular germ cell 
tumours appear to arise from abnormal gonocytes within the seminiferous tubules and as 
shown in Figure 1.3, invasive testicular germ-cell tumours undergo an initial carcinoma in situ 
phase (Giwercman et al. 1991, Jacobsen et al. 1981, Daugaard et al. 1987), lasting for a 
median period of approximately five years (Skakkebaek et al. 1982). Testicular germ cell 
tumours are categorised as either seminomas (which comprise 35% to 50% of all germ cell 
tumours), or non-seminomas (Damajanov 1993). Seminomas consist of relatively uniform 
cells that resemble primordial germ cells, whereas as depicted in plate B of Figure 1.3, non-
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Figure 1.3. Schematic representation of a common view of germ cell tumour histogenesis and its parallel with 
normal development. The solid arrows represent the progression of events in normal development, whereas the 
dashed arrows represent the transitions towards tumour formation. In females the most common form of 
teratoma is generated when an oocyte begins parthogenesis but becomes disorganised, forming a teratoma or 
dermoid cyst ofthe ovary. Plate A depicts an example of a mature human teratoma derived from a dermoid cyst 
of the ovary, showing extensive somatic differentiation including hair and tooth. A malignant germ cell tumour 
resembling a seminoma can also occur, termed Dysgerminoma, in which the tumour cells resemble primordial 
germ cells. In the male, testicular germ cell tumours are always malignant, and can occur in the form of 
seminomas, in which the tumour component resembles primordial germ cells, or in the form of 
teratocarcinomas. Teratocarinomas are formed from embryonal carcinoma cells, the stem cell component of 
this tumour, which generate differentiated somatic tissues (teratoma component), and also can generate 
extraembryonic cells (yolk sac carcinoma or trophoblast). Plate B depicts a histologically stained section 
through a well differentiated mouse teratocarcinoma, note extensive differentiation including keratin pearls and 
cartilage. In rare cases spermatocytic seminomas occur, a low malignancy tumour which resembles a caricature 
of spermatogenesis. Figure adapted from Figure 1 in Andrews (2002) and Figure 2 in Andrews et al. (2001). 
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seminoma germ cell tumours are histologically heterogeneous and frequently contain somatic 
tissues such as nerve, bone, tooth and muscle (termed the teratoma component), although they 
can also contain elements of seminoma (Uibright, 1993, Bosl & Motzer 1997). They also 
contain histologically undifferentiated cells, termed embryonal carcinoma (EC) cells, which 
are the key malignant component of these tumours (Damjanov 1990, 1993). The term 
teratocarcinoma is used to refer to germ cell tumours containing both embryonal carcinoma 
and teratoma components. Other elements of non-seminoma germ cell tumours include highly 
malignant cells corresponding to extra embryonic tissues such as the yolk sac (yolk sac 
carcinoma) and trophoblast (choriocarcinoma), (Ulbright 1993, Mostofi & Sesterhenn 1997). 
The first experimental studies of teratomas began with the observation that in the 
mouse 129 strain teratomas occurred spontaneously in the testes of approximately 1% of 
males (Stevens & Little 1954 ). These teratomas could be observed by 15 days of embryonic 
development, as structures described as embryoid bodies within the seminiferous tubules of 
the fetal gonad. Stevens (1964) subsequently demonstrated that the incidence ofthese tumours 
could be increased by transplanting the genital ridges of early embryos to the testis capsule of 
adult mice, and furthermore demonstrated that teratomas could successfully be produced using 
genital ridges transplanted from the embryos of another mouse strain ( l970b ). Some of these 
tumours were clearly malignant teratocarcinomas, and could be re-transplanted to successive 
hosts (Stevens & Hummel 1957). The histologically undifferentiated cells within these 
tumours - EC cells, had long been hypothesised to comprise the stem cell component of the 
tumour, acting as the progenitors of all the cell types observed within the teratocarcinoma. 
This was confirmed by Kliensmith and Pierce (1964), who demonstrated that single EC cells 
transferred to a new host could reform complex teratocarcinomas with the full range of 
differentiated derivatives observed in the parental tumour, that could again be re-transplanted 
to another host (for reviews Andrews 2002, Andrews et al. 2001 ). 
1.2.1 Murine embryonal carcinoma cell lines and their relationship to cells of 
the early embryo 
Although testicular tumours could only be induced in a limited number of strains, teratomas 
could be formed from many strains of mice if early embryos (notably at about 7 days of 
development) were transplanted to ectopic sites (Salter et al. 1970, Stevens l970a). As in 
ovarian parthogenetic tumours, these embryos became disorganised and formed teratomas, or 
in some cases, retransplantable teratocarcinomas containing EC cells, strengthening a long 
held hypothesis that EC cells resembled stem cells of the early embryo (for review Andrews et 
al. 2001). 
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Murine embryonal carcinoma cell lines were first established in culture during the 
1970's, allowing these stem cells to be extensively characterised (Evans 1972, Kahn & 
Ephrussi 1970, Martin & Evans 1974, Nicolas et al. 1975). Many of these lines remained 
pluripotent in vitro, exhibiting undifferentiated characteristics and retaining the key ability to 
form teratocarcinomas when transplanted back into an appropriate mouse host. Numerous 
murine EC cell lines could also differentiate in culture, although different cell lines required 
particular culture conditions to do so: Some cells differentiated spontaneously if maintained as 
confluent cultures for several days (Nicolas et al. 1975), whereas others required feeder layers 
of transformed mouse fibroblasts to maintain an EC phenotype and would differentiate in 
response to removal from the feeder layer (Martin & Evans 1974). Under suspension 
conditions these cells frequently formed floating highly differentiated aggregations of cells 
termed 'embryoid bodies' (Martin & Evans 1975). 
On the basis that EC cells resembled early cells of the embryo, antibodies were 
generated from immunising adult mice of the 129 strain with mouse EC cells (of 129 strain 
origin) in order to identify specific embryonic cell surface antigens (Artzt et al. 1973). To this 
effect an antigen detected by Anti-F9 sera was demonstrated to be present on EC cells and 
absent on a range of differentiated cells. Significantly, anti-F9 sera and a subsequently derived 
monoclonal antibody to stage specific embryonic (SSEA I) antigen were demonstrated to be 
expressed on both murine EC cells and by the embryonic cells of the blastocyst inner cell 
mass (ICM), (Artzt 1973, Salter & Knowles 1978). Taken together with a similar expression 
of other markers such as alkaline phosphatase and their comparable capacity for 
differentiation, this led to widespread acceptance that EC cells were a malignant counterpart 
of ICM embryonic cells (Andrews 200 I). Further evidence for the close relationship of 
murine EC cells to the ICM was generated when implanted EC cells were demonstrated to 
contribute to almost all tissues of the host embryo, and moreover, their malignant character 
was suppressed (Papaioannou et al. 1975), although suppression of malignancy was not 
always complete (Papaioannou & Rossant 1983). Figure 1.4 depicts an outline of the 
experimental similarities between murine EC cells and embryonic cells of the blastocyst ICM. 
1.2.2 Human embryonal carcinoma cell lines 
Human embryonal carcinoma cell lines have also been established in vitro. Unlike murine EC 
cell lines, many human EC cell lines exhibit little capacity for differentiation (termed 
nu/lipotent), with the exception of a sub-group of human EC cell lines. This may be 
manifested by the fact that unlike murine EC cells, human EC cells are highly aneuploid (for 
review Andrews 2001). Cell lines capable of differentiation include GCT27- a cell line that 
requires maintenance on fibroblast feeder layers and differentiates upon removal from feeders 
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Figure 1.4. Outline of the relationships between teratocarcinoma stem cells and cells in the 
developing blastocyst of the mouse. A fertilized zygote will form a blastocyst consisting of an 
outer layer of cells that form trophoectoderm derivatives and an inner cell mass that will generate 
all the tissues of the embryo. In rare cases a germ cell tumour will arise in the adult male mouse, 
which can form a teratocarcinoma. The stem cell or embryonal carcinoma (EC) component of 
teratocarcinomas can be isolated and cultured in vitro, where they can be differentiated into many 
cell types. They retain their ability to form teratocarcinomas when injected into immuno-
compromised adult mice, and can also contribute to the formation of multiple tissues in normal 
development (except the germ cells) when injected into a developing blastocyst. Conversely, 
embryonic stem (ES) cells isolated from the inner cell mass of the developing blastocyst can be 
differentiated in vitro, and can also form teratomas when injected into an adult irnmuno-
compromised mouse, whereas if they are injected back into a developing blastocyst they 
contribute to all tissues, including the germ cells of the developing embryo. Adapted from Figure 
1 in Thompson et al. (1998) and Figure 2 in Andrews et al. (2001}. 
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(Pera et al. 1989, Pera & Herszfeld 1998, Roach et al. 1993), NCCIT (Damjanov 1993, 
Teshima et al. 1988) and TERA2 (Andrews et al. 1980, Andrews et al. 1984b, Fogh & 
Trempe 1975). All ofthe human EC cell lines generated were characterised by the expression 
of a distinct set of surface antigens - the globuloseries glycolipid antigens stage specific 
embryonic antigen 3 (SSEA3), stage specific embryonic antigen 4 (SSEA4), and the keratan 
sulphate related antigens TRA 160 and TRA 181, and these were down-regulated during 
differentiation (Andrews 1984a, 1984b, Andrews et al. 1984c, Andrews 1980, Andrews et al. 
1996, Badcock et al. 1999). 
One of the most established teratocarcinoma cell lines, the TERA2 cell line, was 
initially derived by Fogh and Trempe ( 1975) from a lung metastasis in a patient suffering from 
testicular teratocarcinoma. However, it's identity as an EC cell line and pluripotent nature was 
not recognised until subsequent characterisation by Andrews et al. (Andrews 1980, Andrews 
1984b) as the specific culture conditions required to maintain pluripotent undifferentiated 
human EC cells were previously not fully appreciated. In contrast to many mouse EC cell 
lines, it is necessary to maintain human EC cells at high densities, and TERA2 cells require 
passaging by scraping rather than using Trypsin. Cultures of TERA2 are frequently 
heterogeneous, but contain cells that closely resemble the phenotype of EC cells and can form 
well differentiated teratocarcinomas containing multiple cell types when grown as xenografts 
in immuno-suppressed mice (Andrews 1980). 
Andrews et al. (1984b) subsequently demonstrated the stem cell nature of these cells 
by the isolation of single cell clones from a robust NTERA2 sub-line, generated from a 
xenograft tumour of the TERA2 explant culture transplanted into an immune-deficient murine 
host. These clones such as the widely used sub-line NTERA2.ci.DI (NT2/D1), expressed 
characteristics common to other human EC cells, such as the expression of SSEA3, SSEA4, 
TRA 160 and high levels of alkaline phosphatase and produced similar teratocarcinomas to the 
TERA2 cell line upon transplantation into an immune-deficient murine host (Andrews 1984b). 
Unlike many other EC cell lines; these TERA2 derived lines showed no evidence of 
trophoblastic differentiation when cultured at low density, although induction of both SSEA 1 
and Fibronectin occurred (see review Andrews 2001). In 2001 Przyborski established another 
clonal EC cell line, TERA2.ci.SP 12 (TERA2.sp 12), derived directly from the earliest 
available passage (passage 15) of the TERA2 explant culture using immuno-magnetic sorting 
(Przyborski 200 I). Przyborski selected cells that were immuno-positive for the EC stem cell 
specific antigen SSEA3, by labelling an individualised culture ofTERA2 cells with a primary 
antibody to SSEA3, followed by a secondary antibody that was covalently attached to 
magnetic particles. As a consequence, cells exhibiting an EC stem cell phenotype and 
expressing high levels of SSEA3 were bound by high levels of the anti-SSEA3 antibody, and 
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upon subsequent binding of the secondary antibody acquired a strong magnetic charge. These 
SSEA3 positive cells could then be isolated from the remaining cells using a direct magnetic 
separator, and selected single cells cultured in isolation on fibroblast feeder layers to establish 
clonal EC colonies, one of which was the TERA2.spl2 cell line. Figure 1.5 outlines the 
method by which SSEA3 immuno-positive cells were isolated from an early culture of 
TERA2 cells and clonally propagated to form the TERA2.spl2 EC cell line. 
1.2.3 Retinoic acid induced differentiation of EC cells 
Initial studies of EC cell differentiation focused on their ability to differentiate spontaneously 
under a variety of circumstances (as previously described). However, the range of cell types 
produced and the uncontrolled nature of differentiation made study of the underlying 
processes difficult. A significant advance was made when certain murine EC cell lines were 
induced to differentiate by exposure to retinoic acid (RA) along specific lineages: An 
apparently nullipotent murine EC cell line, F9, was the first EC line discovered to differentiate 
upon RA exposure, generating cells that closely resembled parietal endoderm (Strickland et 
al. 1980). RA was later shown to be capable of inducing the differentiation of a number of 
murine EC cell lines (for reviews see Alonso et al. 1991, McBurney 1993). In particular, the P19 
EC cell line differentiates into predominantly neural cells when exposed to RA (Pfeiffer et al. 
1981 ). 
Although many human EC cell lines did not respond to RA exposure, a number of 
lines that do differentiate extensively in response to RA have been described: GCT27 EC cells 
respond to RA by differentiating into cells resembling extra-embryonic endoderm (Roach et 
al. 1994). In contrast RA treated NTERA2 EC cells differentiate towards a predominantly 
ectodermal lineage: After exposure to 1-1 Of! M retinoic acid, these cells rapidly lose their EC 
phenotype, extinguishing expression of EC markers such as SSEA3, SSEA4 and TRA 160 
over a two week period and expressing markers of neural differentiation (Andrews 1984a, 
Fenderson et al. 1987). The differentiation of NTERA2 cells into neurons appears in many 
ways to recapitulate the steps and molecular events that occur during neural embryonic 
development: The expression of the proliferating neural progenitor marker Nestin peaks after 
3 days of exposure to RA, followed by a peak in expression ofNeuro D 1 as neural progenitors 
exit the cell cycle and embark on neuronal differentiation. Transcripts typical of maturing 
neurons such as neural specific enolase (NSE) appear after 2 weeks of treatment, 
corresponding with the observation of morphologically distinct neurons, which comprise 2-
5% of the population (Przyborski et al. 2000). Figure 1.6 outlines the expression pattern of 
these genes in developing CNS neurons of the vertebrate embryo, and the corresponding 
expression pattern ofNTERA2 cells after treatment with RA. 
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Figure 1.5 Schematic outline of method used for the derivation of the clonal human embryonal carcinoma 
(EC) cell line TERA2.sp 12 from an early culture of TERA2 cells. To isolate cells with an EC phenotype 
from the heterogeneous population of TERA2 cells, a culture of passage 15 TERA2 cells was dissociated 
using Trypsin and then incubated with an antibody to the human EC stem cell antigen SSEA3. After 
subsequent washes in antibody diluent the cells were then incubated with an appropriate secondary 
antibody that had been covalently bound to magnetic particles. Further washes ensured that SSEA3 
expressing EC cells within the TERA2 cultures were the only cells to have acquired a magnetic charge. 
These cells could then be separated from the remaining solution of cells using a magnetic separator, in 
which the magnetically charged SSEA3 positive cells would bind to the sides of the tube wall while the 
remaining cells were flushed away. The SSEA3 positive cells could then be collected and single cells 
transferred using a micropipette to each well of a tissue culture plate containing irradiated mouse feeder 
cells. The antibody complexes subsequently fell off the cell surface due to antigen turn over and after 3 
passages the single EC cells had established sufficiently large colonies to be cultured in the absence of 
feeder layers. 
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Figure 1.6 Gene expression patterns in the developing CNS neurons of the vertebrate embryo, compared 
with the expression profile in NTERA2 EC cells after treatment with retinoic acid. (A) Neuronal precursors 
proliferate in the ventricular zone of the neural tube. As these cells repeatedly divide and pass through the 
cell cycle, the position of their perikarya oscillates within this geminal epithelium as indicated (G I, S, G2, 
mitosis). Cells leave the mitotic cell cycle, migrate out of the ventricular zone, and commence 
differentiation. The levels of previously characterised neural genes change markedly during this process 
and can be used as indicators of neuronal development. (B) Schematic illustrating the regulated expression 
of Nestin, NeuroDl, Neuron-specific enolase (NSE) and Synaptophysin in proliferating, postmitotic and 
maturing embryonic neurons respectively, during the formation of the vertebrate CNS. (C) Depicts a highly 
representative graph presenting the changes in expression levels of these genes in NTERA2 cells in 
response to retinoic acid (RA). Nestin expression is rapidly up-regulated, reaching peak levels after 3 days, 
followed by a peak in NeuroD expression and then the expression of Synaptophysin after 14 days, which 
corresponds with the observation of neurons in the culture. Adapted from Figure 7 in Andrews et al. (200 1) 
and Figure 2 in Przyborski et al. (2000). 
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TERA2.sp 12 cells have been demonstrated to follow simi Jar developmentally 
regulated neural differentiation upon RA treatment (Stewart 2003), and can form 
physiologically active neurons (Stewart et al. 2004). They also appear to be able to generate a 
wider range of neural sub-types compared to NTERA2 cell lines, as they are also capable of 
differentiating into cells that express astrocytic markers (Przyborski 2001, Stewart et al. 
2003). 
1.2.4 The derivation of embryonic stem cell lines 
The recognition of EC cells as the malignant counterparts to cells from the inner cell mass of 
the blastocyst led to a series of experiments that eventually culminated in the isolation of 
pluripotent stem cells from very early mouse embryos: In 1981, Evans & Kaufman and Martin 
derived permanent lines of cells directly from mouse blastocysts, which they termed 
embryonic stem cells (Evans & Kaufman 1981, Martin 1981) . These closely resembled murine 
EC cells in their expression of SSEA I and high phosphatase activity, and their ability to form 
highly differentiated teratomas upon transplantation into immune-deficient murine hosts (for 
review Andrews 2001). Like some EC lines, these murine embryonic stem (ES) cell lines required 
feeder layers of mouse fibroblast cells to maintain an undifferentiated phenotype. Additionally 
they frequently and easily underwent spontaneous differentiation into a range of cell types (Martin 
1981 ). This is consistent with the transience of the corresponding stem cell phenotype in the inner 
cell mass of the developing embryo, such that the apparent ability of ES cells to grow 
indefinitely and exhibit an immortal characteristic seems to be a consequence of their removal 
from the embryo and maintenance in tissue culture (Smith 200 I). Conover et al. (1993) have 
since demonstrated that murine ES cells remain undifferentiated and proliferate in the absence 
of fibroblasts if the cytokine Leukaemia inhibitory factor (LIF) is added to the culture media, 
and Ying et al. (2003) have demonstrated that in the absence of serum, bone morphogenetic 
proteins (BMPs) are able to act in concert with LIF to maintain self renewal and pluripotency 
in murine ES cells. 
Fourteen years later Thompson et al. successfully derived primate ES cells and 
established their growth on feeder layers of mouse fibroblasts, first establishing ES cells from 
the embryos of rhesus monkeys, marmosets and finally in 1998 from human embryos 
(Thompson et al. 1998, Thompson et al. 1995, Thompson et al. 1996, Thompson & Marshall 
1998). To summarise, human blastocysts were grown from cleavage-stage embryos produced 
by in vitro fertilization, inner cell mass cells were separated from the trophectoderm by 
immunosurgery, plated onto a mouse fibroblast feeder layer in the presence of foetal calf 
serum and colonies sequentially expanded and cloned (Thompson 1998). 
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1.3 UTILISING EMBRYONIC STEM CELLS TO STUDY EMBRYOGENESIS 
Besides being potential sources of differentiated tissues for transplantation therapies, 
embryonic stem cells provide accessible in vitro models in which to study aspects of 
embryogenesis: To this extent mouse embryonic stem cells have been demonstrated to closely 
model early developmental events in the embryo (for review see Loebel et al. 2003). 
1.3.1 Murine ES cells- models of murine embryogenesis 
As previously described (see Figure 1.1 ), after fertilisation a murine zygote undergoes 
proliferation to form a morula or ball of totipotent cells. This is followed by differentiation 
events associated with changes in the expression of the pluripotent transcription factor Oct4; 
such that at the time of implantation, the mouse embryo is composed of three distinct cell 
types, the trophoectoderm, the primitive endoderm and the inner cell mass. Manipulations of 
Oct4 expression in murine ES cells have demonstrated that Oct4 regulates these 
differentiation events, such that repression of Oct4 in murine ES cells generates 
trophoectoderm differentiation, up-regulation induces primitive endoderm differentiation and 
sustained Oct4 expression at intermediate levels is required to maintain a pluripotent state 
(Niwa et al. 2000). 
As development progresses, the primitive endoderm and trophoectoderm will 
contribute towards the formation of the placenta, whereas the inner cell mass is organised into 
a pluripotent epithelial layer (the epiblast), from which the embryonic tissues are derived 
(Gardner & Beddington 1988). In early post implantation development, gastrulation occurs, a 
massive migration event involving complex inductive interactions between tissues in which 
pluripotent epiblast cells are allocated to the three primary germ layers of the embryo; 
ectoderm, mesoderm and definitive endoderm. In this process, cells ingress from the surface 
ectoderm into the interior of the embryo to give rise to the mesodermal and endodermal germ 
layers. In vertebrates, this occurs through a blastopore (in amphibians) or through a primitive 
streak (as in amniotes such as birds and mammals). These primary germ layers are the 
progenitors of all foetal tissue lineages; the endoderm will develop into the digestive tract, the 
ectoderm (consisting of the cells on the outside of the gastrula that played little part in 
gastrulation) will develop into the skin and CNS, and the mesoderm will form all the other 
internal organs (as described in Stern 2005). 
As previously described, murine ES cells can be differentiated by removal of LIF or 
feeder layers such that they form a range of differentiated derivatives of all three germ layers 
in vitro (Conover 1993, Martin 1981 ). This is particularly effective when mouse ES cells are 
cultured in suspension where they form embryoid bodies. Such murine embryoid bodies first 
1.3 Utilising embryonic stem cells to study embryogenesis 11 
form a bilayered structure with extraembryonic endoderm on the outside and primitive 
ectoderm on the inside, and then differentiate into a range of early endoderm, mesoderm, and 
ectoderm derived progenitors, recapitulating in vitro the formation of tissues from all three 
germ layers - albeit in a physically disorganised fashion (Doetschman et al. 1985, for review 
Loebel 2003). During embryogenesis the processes of germ layer formation and specification 
of tissue lineages are accompanied by a restriction of developmental potency and the 
activation of lineage specific gene expression, requiring complex cell-cell interactions that are 
influenced by the cell surroundings and mediated by the key WNT, Fibroblast growth factor 
(FGF) and transforming growth factor (TGF) signalling pathways (for review Loebel 2003). A 
schematic depicting the differentiation of the cells of the murine blastocyst into extra-
embryonic and embryonic tissues of the early embryo, accompanied by a depiction of key 
signals involved in regulating germ layer specification is presented in Figure I. 7. Exposing 
cultured ES cells to these signals has enabled the differentiation of murine ES cells to be 
promoted towards particular lineages, thus mimicking inductive interactions of the murine 
embryo in an in vitro model, as described in the following examples: 
As part of the TGFP signalling pathway, BMP signalling 1s essential for the 
determination of mesoderm and ectoderm cell fates; BMP signalling is required to induce 
mesoderm differentiation in vivo, such that mouse knock out models of BMP4 fail to 
gastrulate and produce mesoderm (Winnier et al. 1995). Correspondingly BMP4 treatment of 
murine ES cells cultured as embryoid bodies inhibits neural differentiation and up-regulates 
the expression of mesoderm genes such as Brachyury in a concentration-dependent manner, 
independent of cell survival or proliferation (Finley et al. 1999). BMP4 has also been 
demonstrated to induce differentiation of murine ES cells towards derivatives resembling 
posterior-ventral embryonic mesoderm, whereas dorsal-anterior mesodermal cell types are 
induced by another TGFP related molecule, Activin A (Johansson & Wiles 1995). BMP4 
treatment can also promote the differentiation of murine ES cells that would normally be 
directed towards a neural lineage (such as in the presence of stromal derived inducing factor) 
to surface ectoderm at the expense of neuroectoderm, underlining the properties of BMP4 as a 
suppressor of neurectodermal differentiation (Kawasaki et al. 2000). WNT3A signalling 
induces cells from the epiblast to adopt a paraxial mesodermal rather than neuroectodermal 
fate after gastrulation (Yoshikawa et al. 1997). Correspondingly, antagonism of WNT 
signalling has been demonstrated to promote neural differentiation in cultured murine ES 
cells: Transfection of the WNT antagonist Sfrp2 into murine ES cells enhances neuronal 
differentiation in embryoid bodies (Aubert et al. 2002). 
For correct patteming and differentiation of the embryo, the influence of BMP 
signalling must be modulated by antagonistic molecules. In brief, BMP antagonists (such as 
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Figure 1.7. (A). The differentiation of trophectoderm (grey), ICM (blue), and primitive endoderm 
(brown) ofthe murine E4.75 embryo to the extraembryonic and embryonic tissues of the E7.5 embryo 
(germ layer tissues are color-coded, see key). In response to complex signalling interactions the cells 
of the developing epiblast become specified into the progenitors of the three germ layers, the 
ectoderm (blue), mesoderm (red) and endoderm (yellow). Key signalling pathways regulating these 
inductive events are Wnt signalling and BMP signalling pathways, who's activity is regulated along a 
proximaVdistal gradient. (8). Proximal and distal polarity of tissue compartments: In the epiblast, 
progenitor populations are color-coded as previously described. Mesoderm progenitors are generated 
in proximal regions of high BMP signalling, whereas in the presence of WNT and BMP signalling 
inhibitors in distal regions ectoderm derivatives are formed . Red arrows and bar, BMP signals and 
antagonists; blue arrow and bar, WNT3A signals and antagonists. Figures taken from Figure I, 
Loebel (2003). 
Figure 1.7 
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Chordin and Noggin) are expressed in the mouse organizer and are required for anterior neural 
differentiation in the embryo (Bachiller 2000). Correspondingly, BMP antagonists promote 
the acquisition of an ectodermal fate by murine ES cells: Exposure of murine ES cells to 
recombinant Noggin counteracts the effects of BMP4 treatment in embryoid bodies (Finley 
1999), and transfection of ES cells with a noggin-encoding plasmid promotes the 
differentiation ofneurectodermal cells (Gratsch & O'Shea 2002). 
Together these studies suggest that murine ES cells follow similarly regulated 
pathways of development to that of the pre-implantation embryo, and can be used as a highly 
accessible experimental model in which to study aspects of murine embryonic development. 
1.3.2 A gross comparison of murine and primate embryogenesis 
In comparison to murine embryogenesis and embryogenesis in other vertebrates, very little is 
known about early stages of human development because of limited access to these 
developmental stages. Primate studies have demonstrated that there are some key differences 
between basic stages of murine and primate development, which are extensively reviewed by 
Pera & Trounson (2004). The main differences between murine and primate embryogenesis 
(extracted from Box 1 in this review) are listed below: 
• Different time scales for development 
• High levels of blastomere fragmentation and chromosomal abnormalities m human 
compared with mouse 
• Later transition in human embryos from maternal to zygotic gene expression (this occurs at 
the 4- to 8-cell stage in humans and at the 2-cell stage in mice). 
• Differences in the temporal and spatial patterns of gene expression in the early embryo. 
• The mouse blastocyst forms one cleavage stage later than the human. 
• Human embryos have two phases of extraembryonic endoderm formation and limited 
reliance on yolk sac placentation. Mice have one phase of extraembryonic endoderm 
generation and more reliance on yolk sac placentation. 
• The human epiblast is shaped into a disc rather than as a cup, as in the mouse. 
• Interstitial implantation occurs in human embryogenesis but not in the mouse. 
• Precocious formation of amnion and extraembryonic mesoderm in human embryos 
compared with in the mouse. 
Two key developmental differences between primate and mouse embryos are evident in the 
formation of extra-embryonic layers and the mode of implantation. The primate embryo 
devotes its first two weeks almost exclusively to the formation of extraembryonic membranes 
(Enders & Schlafke 1981, Enders et al. 1986, Luckett 1978). Thus, in the time it takes the 
mouse embryo to develop past midgestation, the primate embryo has just begun germ layer 
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formation (Pera & Trounson 2004). The formation of a secondary yolk sac between the 
embryonic disk and the primary yolk sac is a characteristic feature of primate embryos, and 
undergoes considerable expansion; only near the end of the third week of development is yolk 
sac hematopoeisis underway (Pera & Trounson 2004 ). 
The mode of implantation as the blastocyst becomes attached to the uterus is another 
key distinction between murine and human development. A primate blastocyst undergoes 
interstitial implantation, becoming entirely surrounded by endometrial tissue and eroding into 
the subepithelial connective tissue, whereas a mouse blastocyst undergoes eccentric 
implantation, eroding partway into the endometrium on the side of the uterus. Thus the 
surrounding environment for the blastocyst is markedly different between murine and primate 
blastocysts. 
There is very little information about gene expression patterns and the molecular 
controls of development during post-implantation development in primates, which makes 
comparison with the extensive data from the mouse very difficult. However, a study 
comparing gene expression patterns in rhesus monkey and mouse embryos revealed 
differences in the abundance of certain transcripts between these species in the oocyte, at the 
cleavage, morula and blastocyst stages of development (Zheng et al. 2004). Unlike the mouse, 
there is little information on gene expression in the immediate post-implantation period in 
human development. However, some studies have found differences in the timing and 
expression patterns of certain developmental regulatory genes between the two species at later 
stages of development (Bibb et al. 2001, Fougerousse et al. 2000, Hanley et al. 2000). For 
example the spatial expression of the key genes Wnt7a and CAPN3 was detected by 
Fougerousse et al. (2000) to be markedly different between murine and human development: 
Wnt7a, a highly conserved gene known to be important in early development, showed 
significant differences in spatial and temporal expression patterns in the developing brain 
(midbrain, telencephalon) of man and mice. A human gene encoding for calpain, (CAPN3, the 
locus for LGMD2A limb girdle muscular dystrophy) and its mouse orthologue also differed 
extensively in expression in embryonic heart, lens and smooth muscle. 
Other molecular studies have also highlighted unexpected species differences, 
questioning the extent to which molecular regulation of human development can be 
confidently extrapolated from the mouse model: For some human disease genes, rodent 
models are not available because orthologues have not been identified despite extensive 
investigation in different rodent lineages, whereas the same approaches have identified clear 
orthologues in other vertebrates, for example the gene which is responsible for Kallman 
syndrome whose expression has been studied in human and chick (Lutz et al. 1994). In 
addition, for many human disease genes where rodent orthologues have been found, attempts 
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to generate mouse models by gene targeting have often produced phenotypes that do not 
closely resemble the human disorder (Wynshaw-Boris 1996). 
1.3.3 A comparison of human and murine ES/EC stem cells 
Human and mouse embryonal carcinoma cells share common features, for example their 
growth patterns and morphology are similar (both tend to grow in clusters of tightly packed 
cells with relatively little cytoplasm and prominent nucleoli) and both express high levels of 
alkaline phosphatase (Andrews 2001, Benham et al. 1981, Bernstine et al. 1973). However, from 
the first establishment of human EC cells differences between mouse ESIEC cells and human 
EC cells became evident, such as the expression of a different range of embryonic surface 
antigens and the ability of human EC cells to differentiate into trophoblast lineages in vitro 
and in vivo (Andrews 1980, Andrews et al. 1996). These differences could not be confidently 
attributed to either a distinction between murine and primate species or to the highly 
aneuploid nature of human EC cells, until the derivation of primate and finally human 
embryonic stem cells in 1998 (Thompson 1998, Thompson 1995, Thompson 1996, Thompson 
& Marshall 1998). The subsequent characterisation of human ES cells demonstrated that many 
of the features of human EC cells which are distinct from those of murine ES and EC cells are 
maintained in human ES cells: 
As previously discussed, the carbohydrate antigen SSEA 1 is strongly expressed by 
murine EC, ES cells and the corresponding inner cell mass (I CM) of the murine developing 
blastocyst. Two other glycolipid antigens - SSEA3 and SSEA4 - are expressed in early 
cleavage murine embryos but disappear by the blastocyst stage and are not expressed by cells 
of the ICM. Correspondingly, they are not expressed by murine EC or ES cells (see review 
Andrews 200 I). This pattern of expression is in marked contrast to that observed initially in 
human EC cells and also in human ES cells, which do not express SSEA 1 and highly express 
SSEA3 and SSEA4 (Andrews 1996, Damjanov et al. 1982, Thompson 1998). Recently, 
Henderson et al. also reported that this pattern of positive SSEA3, SSEA4 and absent SSEA 1 
expression corresponds with that of cells in the human blastocyst (Henderson et al. 2002). 
Another important distinction between murine and human ES cells is evidence 
suggesting that human ES cells require different signalling cues for self renewal. Although 
both human ES cells and murine ES cells are maintained on fibroblast feeder layers, unlike 
murine ES cells, the addition of LIF does not prevent human ES cells from differentiating or 
dying when removed from a fibroblast feeder layer (Reubinoff et al. 2000, Thompson & 
Marshall 1998). This behaviour is reflected in human EC cell lines which are also feeder 
dependent, as LIF is unable to prevent their differentiation upon removal from feeder layers 
(Roach 1993 ). 
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In addition, human ES cell lines will spontaneously differentiate in vitro to extra-
embryonic endoderm and trophoblast, evidenced by the secretion of a feto protein (AFP) and 
Human chorionic gonadotrophin (HCG) (Reubinoff 2000, Thompson 1998, Thompson & 
Marshall 1998). In contrast, mouse ES cells do not spontaneously differentiate into 
trophoblast lineages in vitro, and rarely contribute to trophoblast in chimeras. It is also unclear 
whether the rare ES derived cells that integrate into the trophoblast are functional (Martin 
1981, Beddington 1989). However, mouse ES cells are capable of forming trophoblast in 
vitro, as recently demonstrated by Niwa et al. (2000) who showed that repression of Oct4 
induces differentiation into trophoectoderm. 
In a recent study a direct comparison of the gene expression profiles for human and 
mouse ES cells under stem cell maintenance and differentiation inducing conditions revealed 
distinctly different profiles for the expression of the differentiation markers vimentin, pm 
tubu1in, alpha-fetoprotein, eomesodermin, HEB, ARNT, the stem cell marker FoxD3 as well 
as the expression of the LIF receptor complex LIFRIIL6ST (Ginis et al. 2004). Using focused 
microarray analyses they also identified profound differences in cell cycle regulation, control 
of apoptosis and cytokine expression, with the overall repertoire of cytokines expressed in 
mouse ES cells detected as much richer than in human ES cells. Together with the fact that the 
expression profiles were analysed in multiple independently derived stem cell lines, this 
provides supporting evidence that marked species-specific differences in gene expression 
profiles exist between human and mouse ES cells (and that these differences do not arise from 
differences in culture conditions alone). 
These disparate patterns of embryonic antigen expression, gene expression profiles 
and behavioural differences between human and mouse embryonic stem cells may reflect 
inherent differences in human and mouse embryogenesis, correlating with differences 
observed in the gross comparisons of primate and murine early development. Taken together 
with the evidence from the few molecular studies of human development this suggests that 
although human embryogenesis resembles that of other mammalian species, there are key 
differences at not only the morphological level but at cellular and molecular levels. This 
makes a compelling case for using a human experimental model in which to study human 
embryogenesis. 
1.4 USING TERA2.SP12 CULTURES AS A MODEL OF HUMAN ECTODERM 
The characterisation of human ES cells has validated the presumption that human EC cells 
relate to pluripotent cells of the early embryo, as in the mouse model. Shared patterns of 
surface antigen expression support the close relationship of human ES and EC cells. However, 
1.5 The early stages of neural development in vertebrates -an overview 16 
some key differences between certain human EC lines and ES cells are also readily apparent: 
Until recently human ES cells required propagation on an embryonic fibroblast feeder layer or 
in fibroblast conditioned medium (Thompson 1998, Xu et al. 2001, Xu et al. 2005) and 
frequently and easily embarked on spontaneous differentiation into a range of cell types of all 
germ layers. As a consequence this culture system typically generates a heterogeneous 
population of cells that has been difficult to consistently characterise and manipulate 
exclusively towards particular phenotypes. In contrast, certain EC cell lines such as the clonal 
TERA2.sp 12 cell line can be stably and robustly propagated to maintain a stem cell phenotype 
in the absence of feeder cells, and NTERA2 and TERA2.spl2 cell lines have been 
demonstrated to undergo regulated differentiation into neural derivatives in response to RA 
treatment (Przyborski 2001, Stewart 2003). 
Another key difference is evident in the remarkable differentiation capacity of human 
ES cells compared to human EC cells: Upon transplantation into an immune-deficient murine 
host, human ES cells form highly differentiated tumours containing derivatives of all three 
embryonic germ layers, including smooth and striated muscle, bone, cartilage, gut and 
respiratory epithelium, keratinising squamous epithelium, neurons and ganglia (Heins et al. 
2004, Reubinoff 2000, Stojkovic et al. 2004, Thompson 1998). In contrast, histological 
analysis of tumours generated from transplantation of TERA2.sp 12 cells into immuno-
compromised hosts reveals a markedly reduced range and complexity of differentiation, and 
solely ectodermal derivatives have been observed (Przyborski et al. 2004, Stewart 2004). 
Together with in vitro studies this suggests that like certain other human EC cell lines, 
TERA2.sp 12 cells may have a more restricted differentiation potential than ES cells, such that 
TERA2.spl2 cells appear to capable of generating solely neural and non-neural derivatives of 
the embryonic ectoderm (Przyborski 2004). This may reflect an inherent difference between 
TERA2.spl2 cells and human ES cell lines, such that TERA2.spl2 cells correspond more 
closely to the embryonic ectoderm in their behaviour than to cells of the inner cell mass. 
Correspondingly, the differentiation of TERA2.sp 12 cells in vitro has been proposed to 
provide a suitable experimental system in which to study aspects of development in the human 
ectoderm, in particular the early stages of neural development (Przyborski 2004 ). 
1.5 THE EARLY STAGES OF NEURAL DEVELOPMENT IN 
VERTEBRATES- AN OVERVIEW 
The central nervous system (CNS) is arguably one of the most complex structures to form 
during embryogenesis, involving the formation and diversification of a wide array of cell 
types. In describing the early phases of neural development this review has been sub-divided 
into the following sections, although temporally these are not necessarily distinct: 
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1.5.1 Neural induction and neurulation 
The first step for the formation of the CNS is neural induction, whereby neural epithelium is 
specified from the ectoderm to form the neural plate. In the vertebrate embryo, ectodermal 
cells acquire a neural cell fate in response to signals provided by the organizer region, while 
the remaining ectodermal cells are specified into non-neural progenitors and will form the 
epidermal cells ofthe skin (Spemann & Mangold 1924, Beddington 1994, Storey et al. 1992). 
The signalling events regulating this neural induction step in vertebrates have been the subject 
of intense study and will be reviewed in the introduction to Chapter 4. In brief, experiments in 
animal models (particularly in Xenopus laevis) have demonstrated that the Bone 
Morphogenetic Protein (BMP) signalling pathway plays a key role in determining whether 
cells of the nai've ectoderm are specified into neural or epidermal progenitors (Hemmati-
Brivanlou & Melton 1994b), although other signalling pathways have also been implicated in 
neural induction, including the Fibroblast Growth Factor (FGF) signalling and Wnt pathways 
(reviewed in Wilson & Edlund 2001, Stern 2005). 
Subsequent to neural plate formation the neural tube is formed during neurulation, 
whereby the neural plate folds to produce a neural groove, the folds elevate from the dorsal 
side of embryo, approach each other medially and initiate fusion to form the a tube. The 
neuroepithelial cells of the neural tube are the progenitors for all the cell types of the CNS, 
initially producing neurons in neurogenesis, and glia (including astrocytes and myelin-forming 
oligodendrocytes) at later stages. As demonstrated in Figure 1.6, during neurogenesis 
proliferating neuroepithelial cells adjacent to the lumen of the neural tube exit the cell cycle, 
delaminating out of the epithelium and activating the expression of a large panel of genes 
indicative of generic neuronal differentiation. Neurons originate from almost all regions of the 
neuroepithelium, although the onset and period of neurogenesis varies greatly among 
neuroepithelial cells depending on their location along the neuraxis (Kintner 2002). This 
reflects the extensive patterning of the neural tube whereby the developing CNS is highly 
regionalised along both its anteroposterior (AP) and dorsoventral (DV) axes. 
1.5.2 Patterning of the neural tube 
Anteroposterior regionalisation in the CNS is clearly evident from the localization of the 
cerebral cortex and eyes at the anterior end and the spinal cord at the posterior end. Similarly, 
different neurons and neural structures form at specific dorsal ventral positions of the neural 
tube; for example, motor and sensory neurons form in the ventral and dorsal spinal cord 
respectively. Studies of anterior-posterior patterning indicate that after neural induction, the 
cells of the neural plate are anterior in character: In the frog neural induction generates neural 
tissue with anterior properties, then further posteriorizing signals, including FGFs, Wnts and 
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retinoic acid, induce midbrain hind brain and spinal chord (Harland 2000). Similarly, early 
chick neural plate has anterior identity and requires further signals that are provided by both 
axial and paraxial mesoderm to acquire posterior characteristics (Muhr et al. 1999, Dale et al. 
1999). Dorsal ventral patteming of the CNS has been extensively studied in the spinal chord, 
where the opposing activities of gradients of the diffusible molecules Sonic Hedgehog (which 
emanates from the floor plate and notochord), BMPs and Wnts (which originate in the roof 
plate and adjacent nonneural tissue) activate the expression of several patteming genes in 
different, partially overlapping domains in a concentration dependent manner (as reviewed in 
Gomez-Skarmeta et al. 2003). These patteming genes encode homeodomain transcription 
factors, and specific combinations of these patteming genes will define the different 
progenitor domains in which specific neurons will arise (Lee & Pfaff2001). 
To summarise, this complex organization of the CNS is anticipated by the 
regionalised expression of specific combinations of patteming transcription factors (Lumsden 
& Krumlauf 1996) generated in the neural tube in response to dorsoventral and anteroposterior 
cues from diffusible signalling molecules, such that a unique combination of transcription 
factors is expressed over time in each progenitor domain (Briscoe et al. 2000, Shirasaki & 
Pfaff 2002). However, regardless of where and when neurons are formed, a genetic program 
involving a cascade of pro-neural basic helix-loop-helix (bHLH) transcription factors is 
thought to govern the differentiation of neural epithelial cells, mediating both neuronal 
determination and differentiation. The regionalisation in different points of the neuroaxes is 
generated through the means by which these bHLH proteins are activated within 
neuroepithelial cells by different patteming genes (for review Kintner 2002). 
1.5.3 p Helix-loop-helix proteins and neurogenesis 
Vertebrate pro-neural bHLH genes are categorised into two families based on their homology 
to pro-neural bHLH genes in Drosophila; those related to the Drosophila Achaete-Scute genes 
such as Mash 1, and those related to Drosophila atonal, such as the neurogen ins, the NeuroD-
Iike, and the A TH genes (Brunet & Ghysen, 1999). As transcriptional activators, these 
proteins hetero or homo-dimerise and bind to E-box promoters of target genes to induce the 
expression of both generic neuronal proteins such as pm tubulin and subtype specific proteins 
(Diez del Corral & Storey 200 1 ). 
At the point where cells in the neuroepithelium embark on neurogenesis to form a 
postmitotic neuron, they express a cascade of transcription factors that is triggered by one or 
several proneural bHLH genes, and the exact range of genes expressed varies depending on 
time and place (Kintner 2002). When ectopically expressed, proneural bHLH proteins are 
potent inducers of neuronal differentiation (Lee et al. 1995), activating the expression of a 
generic set of neuronal genes, and they are key in promoting cell cycle exit as neurons embark 
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on terminal differentiation (Farah et al. 2000). Thus proneural bHLH proteins are thought to 
be responsible for promoting neuronal differentiation, regardless of when and where a neuron 
forms in the CNS. Experiments show that when their activity is sufficiently high in 
neuroepithelial cells, these bHLH proteins activate the expression of a cascade of downstream 
differentiation bHLH genes, which then act to promote exit from the cell cycle and neuronal 
differentiation. For example an up-regulation in the expression of bHLH protein Neurogenin 
precedes the expression of the bHLH protein NeuroD in both the frog and mouse, which is 
necessary for cell cycle exit and neuronal differentiation (Ma et al. 1996). Conversely, other 
experiments show that when the activity and expression of the determinative bHLH genes is 
inhibited, neuroepithelial cells exhibit a 'ground state' whereby they can continue to divide 
and become a neuron at a later time, or serve as the source of progenitor cells for various glia 
(Nieto et al. 2001). Thus the balance of proneural bHLH proteins allows for protracted 
neurogenesis and the proliferation of neuronal progenitor cells, such that the time of neuron 
formation is a mechanism of determining neuronal subtype specification (Perron & Harris 
2000). 
1.6 AIM OF THIS STUDY 
As described in Section 1.4, the TERA2.sp 12 cell line has been proposed to provide a suitable 
model in which to study aspects of development in the human ectoderm, particularly the early 
stages of neural development. In the first stage of neural development, the na"ive ectoderm is 
specified into neural as opposed to epidermal progenitors (termed neural induction). The aim 
of this study is to investigate whether the signalling mechanisms governing the transition of 
na"ive ectoderm into neural as opposed to non-neural progenitors of the ectoderm are 
conserved in human development, specifically focussing on the role of the BMP pathway. 
1. 7 OBJECTIVES 
The central objective of the investigations in this study was to determine the role of BMP 
signalling in neural versus non-neural transitions of TERA2.sp 12 cells, as an experimental 
model of human ectoderm. 
1) The objective of the first experimental chapter (Chapter 3) was to characterise the 
differentiation of TERA2.spl2 cells in response to RA under two alternative culture 
conditions. These alternative methods had been previously reported to generate different 
proportions of neurons (Stewart 2003), and the aim of this investigation was to determine if 
this observation was based on a difference in the specification of neural as opposed to non-
neural ectoderm fates. Culture of dissociated TERA2.sp 12 cells under suspension conditions 
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as opposed to adherent conditions was observed to markedly and more rapidly up-regulate RA 
induced markers of neural differentiation and inhibit the up-regulation of epidermal marker 
expression. 
2) The first objective of the second experimental chapter (Chapter 4 Section A) was to utilise 
these two systems in which neural versus non-neural ectoderm transitions were differentially 
regulated, to study the role ofthe BMP pathway on the specification ofTERA2.sp12 cells into 
neural versus epidermal fates. The activity of the BMP signalling pathway and also the FGF 
mediated MAPK pathway was compared in these two culture systems, by monitoring the 
phosphorylation state of selected down-stream signalling proteins which are phosphorylated in 
response to receptor activation. In the case of the BMP pathway, pathway activity was also 
monitored by detecting the expression of genes transcriptionally regulated by BMP signalling. 
The effect of active manipulation of these pathways on neural as opposed to non-neural 
ectoderm marker expression in these two culture systems was also investigated, through 
treatments with recombinant activators and inhibitors. The objective of the remaining section 
of this chapter was to investigate the effect of active manipulation of these pathways on 
TERA2.sp12 cells in the absence of stimulation by RA, in order to more closely model the 
signalling events in the development of early neural or non-neural ectoderm progenitors in 
vivo. 
4) Since during the course of this study TERA2.spl2 cells were observed under certain 
conditions to differentiate into non-ectodermal lineages in vitro, the objective of the last 
experimental chapter was to more closely investigate the differentiation potential of 
TERA2.sp 12 cells in an in vivo system. Tumours derived from injection of TERA2.sp 12 cells 
into immune-deficient hosts were analysed for the expression of a range of markers associated 
with lineages of different germ layers and extraembryonic lineages, and compared with a 
tumour derived from human ES cells. 
CHAPTlER2 
MATERIALS AND METHODS 
21 
2.1 Cell culture 22 
2.1 CELL CULTURE 
2.1.1 TERA2.sp12 cells 
The human caucasion embryonal carcinoma stem cell line TERA2.sp 12 is a subclone derived 
by Stephan Przyborski (Department of Biological science, University of Durham) from 
passage 15 of TERA-2 embryonal carcinoma cells (Przyborski 200 l ), which were originally 
isolated from a lung metastasis of a 22 year old patient with primary embryonal carcinoma of 
the testis (Fogh & Trempe 1975). 
Maintenance and passaging of TERA2.sp12 cells 
TERA2.spl2 cells were cultured in Dulbecco's modified Eagle's medium (DMEM, high 
glucose formulation, Sigma) supplemented with l 0% foetal calf serum (FCS, Sigma), 2mM L-
glutamine (VWR) and 1 J.1M penicillin/streptomycin solution (pen/strep, Invitrogen) in NUNC 
80cm2 T75 filter cap culture flasks (VWR). Cultures were incubated at 37°C under a 
humidified atmosphere of 3% carbon dioxide in air, with media replacement every 2-3 days. 
Cultures were passaged when they were over 95% confluent using the following method. The 
media was removed and l ml of media was added to the flask, followed by l 0-15 small acid 
washed glass beads (Fisher). The flask was gently rocked such that the rolling beads dislodged 
the cells, then 8mls of media used to gently re-suspend the cells, which were re-seeded in 
fresh T75 culture flasks with fresh media at a ratio of l :3. Cultures were passaged 
approximately every 6-7 days. 
Preparation of TERA2.sp12 cell cultures for storage 
Confluent cultures of TERA2.sp 12 cells were washed m phospho-buffered saline (PBS, 
Sigma) then individualised by the addition of 2mls of 1 X Trypsin-EDTA, (0.05% Trypsin, 
0.53mM EDTA.4Na, GIBCO, Invitrogen) diluted to 0.5X in PBS supplemented with 0.02% 
EDTA (Sigma), 0.1 5% phenol red (Sigma) and incubated for l-2 minutes at 37°C followed by 
gentle tapping, until the cell layer had dispersed. Individualised cells were then re-suspended 
and gently titurated in fresh media, then centrifuged at 129g, 4°C for 2 minutes to pellet cells. 
The media was subsequently removed and cells re-suspended in 3mls of ice-cold 10% 
dimethyl sulfoxide (DMSO, Sigma) and 90% FCS, transferred to 2ml cryogenic vials, 
(Nalgene, VWR) and placed in the -80°C freezer overnight, prior to long-term storage at -
l20°C. 
Thawing and culture of TERA2.sp12 cells 
Individual vials ofTERA2.sp12 at low passage numbers that had been stored at -120°C in 1ml 
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of 10% DMSO (Sigma) in FCS were rapidly defrosted in a water-bath at 37°C and the 
contents transferred to a 15 ml centrifuge tube (VWR) containing 9mls of DMEM with 10% 
FCS, 2mM L-glutamine and lf.!M penicillin/streptomycin solution. To pellet the cells the tube 
was centrifuged at 129g for 2 minutes at 4°C, the supematant removed and replaced with 
I Omls of fresh media. The cells were re-suspended in this media by gentle pipetting and then 
transferred to a NUNC 30cm2 T25 filter cap culture flask (VWR), and incubated at 37°C 
under a humidified atmosphere of 3% carbon dioxide in air. 
After 1-2 days, when the culture was over 95% confluent, the cells were passaged 
using the following procedure: The media was removed and I ml of media and I O-I5 small 
acid washed glass beads (Fisher) added to the flask, which was then gently rocked such that 
the rolling beads dislodged the cells. The cells were gently re-suspended in 9mls of media and 
transferred into a NUNC 80cm2 T75 filter cap culture flask (VWR) containing I Omls of 
media. 
RA Differentiation as adherent monolayers 
TERA2.spi2 cells were seeded at a differentiation density of 20 000 cells/cm2 into electro-
statically coated T75 filter cap culture flasks and cultured in DMEM media with 10% FCS, 
2mM L-glutamine and If.!M pen/strep. After 24 hours cells the media was removed and 
replaced with the same media supplemented with lf.!l/ml of I OmM all-trans RA (Sigma) 
reconstituted in dimethyl sulfoxide (DMSO, Sigma) such that the final concentration was 
l Of.!M. In experimental controls the media was replaced with the same media with no 
supplement or vehicle treated with media supplemented with lf.!llml of DMSO. Media 
supplemented with 10f.!M RA (or with the specified media for experimental controls) was 
replaced every 2-3 days, and RA treated cultures were maintained for up to 28 days. 
RA Differentiation as suspension aggregates 
TERA2.sp 12 cells were seeded at a differentiation density of 20 000 cells/cm2 into uncoated 
90mm triple vent bacteriological dishes (VWR) and cultured in DMEM media with I 0% FCS, 
2mM L-glutamine and lf.!M pen/strep. After 24 hours, media containing suspended cells was 
transferred to individual 15ml centrifuge tubes (VWR) and centrifuged at 129g for 2 minutes 
at 4°C to pellet the cells at the base of the tubes. The media was then removed and replaced 
with the same media supplemented If.!l/ml of I OmM all-trans RA reconstituted in DMSO such 
that the final concentration was I Of.! M. Cultures were maintained in media with I Of.! M RA for 
up to I4 days, with media and bacteriological dishes replaced every 3 days using the 
following procedure: Media containing suspended cells was transferred to 15 ml centrifuge 
tubes, tubes were centrifuged at 129g for 2 minutes at 4°C when up to 3 days old, and 64g for 
2 minutes at 4°C after 3 days of culture. The supematant was then removed and cells re-
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suspended in fresh media before being transferred to new bacteriological dishes. 
Culture as suspension aggregates without RA 
As an experimental control for suspension culture conditions TERA2.sp12 cells were seeded 
at a differentiation density of 20 000cells/cm2 into uncoated 90mm triple vent bacteriological 
dishes and cultured in DMEM media with 10% FCS, 2mM L-glutamine and 1 f.! M pen/strep. 
After 24 hours, media containing suspended cells was transferred to individual 15ml 
centrifuge tubes and centrifuged at 129g for 2 minutes at 4 oc to pellet the cells at the base of 
the tubes. The media was then removed and replaced with the fresh media. Cultures were 
maintained for up to I4 days, with media and bacteriological dishes replaced every 3 days as 
follows: Media containing suspended cells was transferred to 15 ml centrifuge tubes, tubes 
were centrifuged at 129g for 2 minutes at 4°C when up to 3 days old, and 64g for 2 minutes at 
4°C after 3 days of culture. The supernatant was then removed and cells re-suspended in fresh 
media before being transferred to new bacteriological dishes. 
Manipulation ofBMP signalling in adherent cultures 
Individualised TERA2.sp12 cells were seeded at a differentiation density of20 000 cells/cm2 
into electro-statically coated NUNC tissue culture flasks and cultured in DMEM media with 
I 0% FCS, 2mM L-glutamine and 1 f.! M penlstrep supplemented with either 25nglml BMP2, 
25nglml BMP4, 1 OOnglml Noggin, 1 Of.! M RA or mock treated with no additional supplement. 
Media was replaced every 2-3 days. 
Inhibition of FGF signalling in adherent cultures 
To investigate the effect of continuous inhibition of FGF mediated signalling in TERA2.spi2 
cells, individualised cells were seeded at a differentiation density of 20 000 cells/cm2 into a 
NUNC I2 well dish and cultured in DMEM media with I 0% FCS, 2mM L-glutamine and 
I f.!M pen/strep supplemented with either 20f.1M of the pharmacological inhibitor of FGF 
receptor kinases, SU5402 which specifically interacts with intracellular catalytic domain of 
FGF receptors (Mohammadi et al. 1997), or vehicle treated with DMSO. Media was 
replenished every 3-4 days, (or every 1-3 days as required for vehicle treated cultures). 
TERA2.sp12.GFP cells 
TERA2.sp 12.GFP cells, TERA2.sp 12 cells which have been transfected with the GFP (green 
fluorescent protein) expression vector pTP6 and selected for their resistance to puromycin, 
consitutively express GFP (Stewart et al. 2004). These cells were cultured as described for 
TERA2.sp I2 cells. 
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2.1.2 Cell lines used as positive controls 
The phayrinx carcinoma derived cell line FADU 
FaDU cells were used as a positive control for the detection of simple epithelial keratins and 
the epidermal stem cell transcription factor tumour protein 63 (Tp63) in both immuno-staining 
and Western Blot analyses. They were also used as a negative control for markers of neural 
differentiation. 
A frozen vial of FaDU cells was obtained from the ATCC bank, (code HTB-43, lot 
3 81 6051 ), and handled according to instructions in the accompanying data sheet as described 
briefly below. The vial of cells was thawed for 2 minutes at 37°C in a water-bath and then the 
contents transferred directly into a T75 flask containing llmls of Eagles minimal essential 
medium with Earle's BSS (MEM from Sigma), 2mM L-glutamine and 10% FCS media at 
37°C. Media was replaced every 2-3 days, and when over 90% confluent, cells were sub-
cultured at a ratio of 1 :6 using the following procedure. The media was removed, and cells 
washed in Smls of PBS. Then cells were incubated for 5-1 0 minutes with Trypsin at 37°C 
with minimal agitation and observed under the microscope until the cell layer had dispersed. 
Then 8mls of growth medium was added and gentle pipetting used to aspirate cells, before 
transfer into fresh T75 flasks. After an initial 2 passages, 1 flask of FaDU cells was 
maintained and the cells from superfluous flasks trypsinised and stored as frozen cell pellets at 
-120°C. 
The neuroblastoma derived cell line IMR 32 
IMR 32 cells were used as a positive control for the detection of neuronal markers in both 
immuno-staining and Western Blot analyses, and also used as a negative control for the 
detection of endoderm and non-neural ectoderm markers. 
The human Caucasian neuroblastoma cell line IMR 32 was obtained from ECACC 
(number 86041809) and cultured in EMEM with 2mM L-glutamine, 1% non essential amino 
acids and 10% FCS. Sub-confluent cultures (70-80%) were split using 0.25% Trypsin, and 
reseeded at a ratio of I :3 in fresh T75 culture flasks (extra care was taken as cells have a low 
plating efficiency and easily detach). 
The hepatocarcinoma derived cell line Hep G2 
HepG2 cells were used as a positive control for the detection of endoderm expressed markers 
hepatic nuclear factor~ (HNF3~) and alpha-1-fetoprotein (AFP) in both immuno-staining and 
Western Blot analyses, and as a negative control for the detection of neural markers. 
A confluent flask of the human Caucasian hepatocyte carcinoma cell line HepG2 was obtained 
from Or Maria Bakari (sourced from ECACC, number 85011430) and cultured in EMEM, 
(EBSS) with 2mM Glutamine, 1% non essential amino acids (Sigma) supplemented with 10 
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% FCS and 1 ml pen/strep. Media was replaced every 6 days and cells were sub-cultured at a 
ratio of 1 :4 using the following method. The media was removed, and cells washed in Smls of 
PBS prior to incubation for 5-10 minutes with Trypsin/EDTA and observation under the 
microscope until the cell layer had dispersed. Then 8mls of growth medium was added and 
gentle pipetting used to aspirate cells, before transfer into fresh T75 flasks. In the first few 
days after sub-culture the cells grew as islands, which formed a confluent monolayer after 6-7 
days of culture. 
The human embryonic stem cell line H7 
As an additional positive control for markers of germ layer differentiation, spontaneously 
differentiated human H7 embryonic stem cells were kindly donated by Linda Lako in 
Newcastle. In summary, cells were cultured on mouse embryonic feeder layers with 
embryonic stem cell medium containing knock-out DMEM (Invitrogen), 1 OOJ!M ~­
mercaptoethanol (Sigma), I mM L-glutamine (Invitrogen), 1 OOmM non-essential amino acids, 
10% serum replacement (SR, Invitrogen), I% penicillin-streptomycin (Invitrogen) and 4ng/ml 
bFGF (Invitrogen). Colonies were passaged by incubation in 1 mg/ml collagenase IV 
(Invitrogen) for 5-8 minutes at 37°C and then grown in feeder-free conditions in ES medium. 
2.2 CELL COUNT ASSAY 
Individualisation of cultures using Trvpsin 
At the specified time-points the selected adherent cultures were washed gently in PBS and 
incubated at 37°C for 2-3 minutes with 2mls of O.SX Trypsin in EDTA with gentle tapping 
used until the cell layer had dispersed. Once cells had individualised 9mls of media was added 
to inactivate the Trypsin, and the cells gently aspirated with a pipette. 
For non-adherent (suspension) cultures, the contents of each dish was transferred to 
individual 15ml centrifuge tubes and centrifuged for 2 minutes at 64g, 4°C. The media was 
removed and to was the aggregates they were re-suspended in I Omls of PBS, pelleted by 
centrifugation as previously described, and the PBS removed. To dissociate the aggregates 
into individual cells 1 ml of O.SX Trypsin in EDT A was added to the centrifuge tubes and 
these were incubated at 37°C, for 3-5 minutes, with periodic gentle aspiration using a pipette. 
When the aggregates were no longer visible and a suspension of single cells was formed, the 
Trypsin was inactivated by adding 9mls of media. 
Cell counts 
To count the individualised cells in each sample, 1 OJ!I of solution was loaded onto a 
haemocytometer, and cell counts performed using a phase contrast light microscope (Nikon 
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eclipse TS I 00). Three different replicates of each sample were assayed using this method, and 
if any unusual cell counts were collected the counts were repeated. These counts were then 
used to estimate the concentration of cells in each sample (count multiplied by 1 0,000), and 
the total cell number estimated by multiplying this value by the total volume of solution 
(10mls). These counts were also compared to the size of the pellets when centrifuged at 129g, 
to ensure as much as possible that they were representative. 
2.3 FLOW CYTOME'fRY 
The remaining cells from the cell count assay were analysed using live flow cytometry to 
determine the level of expression of surface antigens associated with the stem cell phenotype 
(TRA I60, SSEA 3) or with the neural phenotype (VINIS 53, A2BS). In each experiment 
confluent flasks of undifferentiated TERA2.sp 12 were used for the EC samples. Three 
replicates of cells from the same passage number were used for each treatment, and processed 
in parallel. For the duration of the following procedure cells were stored on ice and re-
suspended in solutions maintained at 4°C to ensure cell viability. 
Cell samples suspended in media were centrifuged for 2mins at 129g, 4°C and the 
media removed. To wash off any remaining media the pelleted cells were re-suspended in 
PBS, centrifuged for 2mins at 129g, 4°C and the PBS removed. The remaining pelleted cells 
were then re-suspended in ice-cold flow cytometry buffer consisting of PBS supplemented 
with I% normal goat serum (lnvitrogen) and 0.1% sodium azide (Sigma) at an appropriate 
volume such that the concentration was (I 000 cells/JJI). The cell solutions were then dispensed 
in 200J.1l volumes into the appropriate number of wells in a 96 m! round-bottomed plate with 
lid (VWR), according to the well plate plan outlined in Figure 2.1. Each plate was then 
centrifuged at I29g, 4°C for 2mins to pellet the cells, and the supernatant removed by quickly 
and briefly turning the plates upside down. Cell pellets were then re-suspended in 2SJ.1l of the 
appropriate primary antibody diluted in flow cytometry buffer, as detailed in Table 2.1 and 
following the well plate plan outlined in Figure 2.1. 
Table 2.1. Antibodies utilised in flow cytometry, listing antigen, antibody sub-type, source, 
and dilution factor. 
ANTIGEN ANTIBODY SUB-TYPE SOURCE DILUTION FACTOR 
SSEA3 Mouse lgM Hybridoma bank 1:5 
TRA 160 Mouse lgM Hybridoma bank 1:5 
A2B5 Mouse lgM Chemicon 1:100 
VINIS 53 Mouse lgG Hybridoma bank 1:5 
VINIS 56 Mouse lgM Hybridoma bank 1:2 
Mouse P3X Negative control antibody to mouse Hybridoma bank 1:5 
antigen 
Mouse lgM (IJChain) Fluorescein-conjugated goat lgG Cappel 1:100 fraction 
Mouse lgG Fluorescein-conjugated goat lgG Cappel 1:100 fraction 
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Schematic Of Well Plate Plan For Flow Cytometry Experiments 
I gM lgG 
1 2 3 4 5 6 7 8 9 10 11 12 
P3x SSEA TRA A2B5 P3X VINIS 
3 160 53 
P3x SSEA TRA A2B5 P3X VINIS 
3 160 53 
P3x SSEA TRA A2B5 P3X VINIS 
3 160 53 
P3x SSEA TRA A2B5 P3X VINIS 
3 160 53 
P3x SSEA TRA A2B5 P3X VINIS 
3 160 53 
P3x SSEA TRA A2B5 P3X VINIS 
3 160 53 
Figure 2.1 Outline of well plate plan for flow cytometry showing locations for each antibody tested. 
Treatment I and treatment 11 represent different cell culture treatments (for example RA treated adherent 
cultures and RA treated suspension cultures at 14 days), and within each culture treatment each row (i.e. 
row A) was loaded with cells from one of the three replicate cultures at the same passage number. Separate 
pipette tips were used during washes between each treatment, and the well spacer between each antibody 
minimised transfer during washes. 
Figure 2.1 
= 
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Following 30 minutes of incubation on ice, cells were washed 4 times with buffer to remove 
unbound antibody using the following method. One hundred and fifty microlitres of buffer 
was added to each well and the cells suspended using a multi-pipette, then the plate 
centrifuged at 129g, 4°C for 2mins, and the supernatant removed as previously described. 
Cells were then re-suspended in 251JI of the appropriate secondary antibody diluted in flow 
cytometry buffer, as described in Table 2.1 and Figure 2.1 and incubated for 30 minutes in the 
dark. To remove unbound secondary antibody cells in each well were then washed 3 times 
with buffer as described previously, and finally re-suspended in 2001JI buffer. The suspended 
cells of each well were then transferred to individual Sml glass test-tubes (Invitrogen). To 
maximise cell collection the wells were washed with a further 2001JI of buffer and this was 
also transferred to the corresponding test-tubes such that each tube contained 4001JI of buffer 
and suspended cells. 
Immediately prior to loading a sample into the flow cytometer (EPICS XL from 
Beckmann and Coulter), 11JI of propidium iodine (Sigma) was added to each sample. All flow 
cytometry data was processed using WINMIDI 2.8, and statistics analysed using Windows 
Excel software. 
2.4 WESTERN BLOT ANALYSIS 
The recipes for the solutions in the following protocol are listed in Section 7.2 of the 
appendix. 
Collection of samples as cell pellets 
The cells in each culture treatment were individualised with Trypsin in EDT A and collected in 
centrifuge tubes with 1 Omls of media as described within Section 2.2. Following 
centrifugation for 2mins at 64g, 4°C the media was removed and the pelleted cells re-
suspended in PBS. To remove any remaining media the cells were pelleted by centrifugation 
as described, the PBS removed and replaced with 3-4mls of fresh PBS, depending on the size 
of the cell pellet. For each sample, 1 ml of re-suspended cells in PBS was then transferred to 
l.Sml PCR clean eppendorf tubes (VWR), such that approximately three eppendorf tubes 
were used to collect cells from each flask. The eppendorf tubes were then centrifuged for 5 
minutes at 1 SOOg and the supernatant removed. To maximise supernatant removal the 
eppendorf tubes were centrifuged for a further I 0 seconds at 1 SOOg, and any remaining 
supernatant removed using a fine pipette tip. Pelleted cells were then rapidly frozen by placing 
in liquid nitrogen, before storage at -80°C, or used immediately in the following procedure. 
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Lysis and extraction of protein from cell pellets 
In the following procedure the eppendorf tubes containing the pellets of cells and the solutions 
used were all maintained on ice. To lyse the cells in each sample I 00-200~1 of freshly 
prepared protein lysis buffer was added to each tube of pelleted cells and agitated using a 
vortex every 5 minutes for 30 minutes. To isolate the protein fraction the samples were then 
centrifuged at 15,000rpm in a microcentrifuge for 5 minutes at room temperature, and the 
supernatant containing the protein suspension transferred to a fresh eppendorftube. 
Measurement of protein concentration 
To measure the protein concentration of each sample solution, disposable semi micro cuvettes 
suitable for absorbance at 595 nm (Fisher) were loaded with the following: 
I. 798~1 distilled water 
2. 200~1 BIO-RAD protein assay dye reagent (BIO-RAD laboratories) 
3. 2~1 sample solution 
As a loading control an additional cuvette was prepared with the above except 2~1 of lysis 
buffer was loaded instead of 2~1 of sample solution, and categorised as a blank control using 
Vision software. 
A calibration curve was previously prepared by measuring the absorbance at 595nm of known 
concentrations of protein (BSA standards) with a Helios B mass spectrometer and then saved 
using Vision software. The absorbance of the sample solutions at 595nm was then measured 
with the mass spectrometer and the corresponding protein concentration calculated from the 
calibration curve using Vision software. The measured concentration of the loaded samples 
was then used to calculate the concentration of the corresponding protein solutions. 
Preparation of protein samples for electrophoresis 
For each sample, a solution of protein in loading buffer was prepared such that each sample 
contained IO~g of protein, with the following composition, (where a= calculated volume of 
protein solution required for I Oug). 
3 ul 5X loading dye 
a ~I sample 
I5-a ~I H20 
Each loading sample was then boiled at 90°C for 3 minutes to denature the proteins within 
these samples. 
Electrophoresis of protein samples and transfer to PVDF membrane 
Protein electrophoresis gel kits (BIO RAD) were used following the manufacturers 
instructions. To summarise, I 0% agarose gel was freshly prepared and loaded into casts of 
glass plates clamped into position, followed by a small quantity of isopropanol (Fisher) to 
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level the top of the gel, and allowed to set for 20 minutes. The isopropanol was then washed 
off with distilled water, excess water removed carefully with filter paper, and 4% agarose gel 
loaded above the I 0% gel. The well mould was subsequently added and the gel allowed to set 
for 20 minutes. 
Once the gels had set, the glass moulds were removed from the clamps, and placed in 
the electrophoresis box with running buffer. SOS was flushed out of wells using a syringe; the 
protein samples in loading dye were loaded into the wells. To separate the proteins within 
each loaded sample according to their size the samples were then electrophoresed at 200v for 
approximately I hour, or until the dye reached the base of the gel. 
The gels containing electrophoresed protein were washed in ice cold transfer buffer at 
4°C for I Ominutes to remove any remaining SOS. The separated proteins on each gel were 
then transferred to a PVDF membrane using the following procedure.Pieces of PVDF 
membrane, (Amersham biosciences) cut to the corresponding gel size were activated by 
placing in methanol for I 0 seconds, followed by subsequent I 0 minute washes in water and 
transfer buffer. The gel and membrane were then placed in the transfer cassette, sandwiched 
by suitably sized filter paper and fibropads following the order listed: 
I. fibropad 
2. 2mm X 3mm filter paper 
3. PVDF membrane 
4. gel 
5. 2mm X 3mm filter paper 
6. fibropad 
The cassette was then placed in an electrophoresis box with ice cold transfer buffer and 
subjected to 1 OOv for 1 hour and 20 minutes at 4°C, or for 30v overnight at 4°C. 
Using molecular markers to map protein size to distance travelled. 
During Western blot analysis protein standards were used as a reference to determine the 
molecular weight of proteins identified by antibody probes. Electrophoresis gels were loaded 
with precision plus all blue pre-stained standards (Bio Rad) and the protein bands detected 
through subsequent immuno-blotting mapped to the corresponding ladder of molecular 
standards to estimate the molecular weight of the protein. The expected molecular weight of 
each protein detected is listed in Table 2.2. This method was used for the detection of novel 
proteins. For proteins in which detection was standard in the lab, molecular markers were only 
used initially. 
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Ponceau staining of protein bound PVDF membrane 
To determine that equal levels of total protein were present for each sample on the PVDF 
membrane, the membrane was washed once in Tris-buffered saline (TBS) for 1 0 minutes, and 
then washed in Ponceau stain for two minutes, followed by three five minute washes in 5% 
acetic acid, and a final wash in TBS. 
Immuno-detection ofPVDF bound protein 
To detect specific proteins on the protein bound PVDF membranes, the Amersham 
biosciences protocol was used unless otherwise specified. To summarise, protein bound PVDF 
membranes were treated with blocking buffer overnight at 4°C in a rolling 50ml centrifuge 
tube (VWR), and subsequently incubated with primary antibody diluted in 4mls of blocking 
buffer to the specified concentration (see Table 2.2) for 1hr in a rolling 50ml centrifuge tube at 
room temperature. 
Table 2.2 Details of primary and secondary antibodies used in Western blot analyses. 
ANTIGEN MOLECULAR ANTIBODY ISOTYPE SOURCE DILUTION CATEGORY WEIGHT (KDa) 
13 actin 42 Mouse lgG Sigma 1:4000 Constitutively expressed 
Nestin 220-240 Mouse lgG Chemicon 1:200 Ectoderm- neural 
13111 Tubulin 50-54 Rabbit lgG Covance 1:4000 . 
13111 Tubulin 50-54 Mouse lgG Sigma 1:1000 . 
NF200 or NFH 200 Rabbit lgG Chemicon 1:1000 . 
MAP2 280, 70 Mouse lgG Sigma 1:400 . 
Vimentin 58 Mouse lgG Sigma 1:400 . 
TP63/TP73L 73 Goat lgG R&D 1:200 Ectoderm-systems epidermis I 
Keratin 8 55,45 Mouse lgG Sigma 1:400 . 
Keratin 8 55,45 Rabbit lgG Abeam 1:400 . 
a smooth muscle 42 Mouse lgG Sigma 1:400 Smooth muscle 
actin 
HCG 40 Mouse lgG Abeam 1:200 Trophoblast 
P-Smad 1 60 Rabbit lgG Chemicon 1:100 BMP pathway 
Smad 1 60 Rabbit lgG Santa Cruz 1:100 . 
ID2 15 Rabbit lgG Santa Cruz 1:200 . 
ID3 15 Mouse lgG Santa Cruz 1:200 . 
ERK 1/2 43,41 Rabbit lgG Santa Cruz 1:500 MAPK pathway 
PERK 1/2 43,41 Mouse lgG Santa Cruz 1:500 . 
horse radish Secondary Mouse lgG 
-
peroxidase conjugate Amersham 1:1000 
(from sheep) antibodies 
horse radish 
Rabbit lgG - peroxidase conjugate Amersham 1:1000 . 
(from donkey) 
Goat lgG horse radish Sigma 1:1000 . - peroxidase conjugate 
Unbound primary antibody was subsequently removed by washing the blots three times for 10 
minutes in blocking buffer, and then the blots were incubated with the corresponding 
secondary antibody conjugated to horse radish peroxidase diluted in blocking buffer at a 
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concentration of I: 1000 (unless specified otherwise) for I hour at room temperature. Details 
of the secondary antibodies used are listed in Table 2.2. To remove unbound secondary 
antibody the blots were then washed 3 times for I 0 minutes in TBS. To visualise the bound 
secondary antibody each blot was then exposed to freshly mixed developing solutions 1 and 2 
in the dark, placed in a photo-casette, exposed to hyperfilm (Amersham) and the film 
developed using an X-ograph imaging system compact X-4 automatic X-ray film processor 
developer or manually. 
2.5 IMMUNO-CYTOCHEMISTRY 
2.5.1 Adherent cultures 
TERA2.sp12 cells were seeded into electrostatically coated NUNC 12 well dishes (VWR) and 
treated as specifically described in each experiment. At the selected time-points, the media 
was removed and cultures were fixed in 4% para formaldehyde, PF A (Sigma) in PBS for 20 
minutes at room temperature (unless specified otherwise), then washed three times in PBS for 
I 0 minutes. To reduce non-specific antibody interactions the cells were then incubated for 30 
minutes with blocking buffer consisting of 5% goat serum (lnvitrogen) or 5% horse serum 
(lnvitrogen), 0.2% triton X 100, (Sigma) and 0.1% bovine serum albumin (BSA, Sigma). 
After this blocking step the buffer solution was then removed and the cells incubated with 
200J.1l of primary antibody diluted in antibody diluent (1% goat or horse serum, 0.2% triton 
X lOO, 0.01% BSA) for 1 hour at room temperature or in specified cases at 4°C overnight in a 
sealed chamber. Table 2.3 lists the details and concentrations at which the primary antibodies 
were used, and Table 2.4 lists the details and concentrations at which the secondary antibodies 
were used. In blocking and antibody diluent solutions, goat serum was used except when 
using antibodies which had been raised in goat, whereupon horse serum was substituted. After 
the primary antibody incubation step, to remove unbound primary antibodies cells were 
washed three times in PBS for 10 minutes, and then incubated for I hour in the dark at room 
temperature with 200J.1l of the appropriate secondary antibody diluted in antibody diluent (to 
the concentration described in Table 2.4). After incubation with the secondary antibody, 
unbound secondary antibody was removed with four sets of 1 0 minute washes in PBS and the 
stained cells were mounted under 16mm diameter round glass coverslips (Fisher) in 
Vectashield mounting medium (Vector laboratories) with 0.1% of the nuclear stain Hoescht 
33342 (Molecular probes). 
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Table 2.3 Details of primary antibodies used for immuno-staining analyses 
ANTIGEN ANTIBODY SOURCE DILUTION FIXATIVE CATEGORY REFERENCE 
(Niwa eta/. 
R&D 2000, Okamoto Oct4 Rat lgG 
systems 1:40 PFA Stem cell et al. 1990, Scholer et al. 
1990) 
Nanog Goat lgG R&D 1:50 PFA . (Mitsui et al. 
systems 2003) 
PFAno (Andrews et al. Tra 160 Mouse lgM Hybridoma 1:5 . 1984, Badcock TX100 
et al. 1999) 
SSEA4 Mouse Hybridoma 1:5 PFAno . (Shevinsky et al. TX100 1982) 
BrDu Mouse lgG Hybridoma 1:40 PFA then treat Dividing cell 
with 4MHCL 
Ectoderm- (Lendahl et al. 
Nestin MouselgG Chemicon 1:400 PFA neural 1990) 
progenitor 
Musashi Rat lgG GIFT 1:200 PFA . (Kaneko et al. 2000) 
13111 Tubulin Rabbit lgG Covance 1:400 PFA Ectoderm-(TUJ1) neuronal 
13111 Tubulin MouselgG Sigma 1:200 PFA . 
NF160 or MouselgG Chemicon 1:100 PFA . NFM 
NF200 or NFH Rabbit lgG Chemicon 1:400 PFA . 
NF68 or NFL MouselgG sigma 1:100 PFA . 
MAP2 MouselgG Sigma 1:200 PFA . 
GFAP MouselgG Sigma 1:100 Methanol Ectoderm-glial 
S100 Rabbit lgG Abeam 1:200 PFA Ectoderm-
astrocytes 
TP63/TP73L GoatlgG R&D 1:50 PFA Ectoderm- (Pellegrini et al. 
systems epidermis 2001) 
Keratin 8 MouselgG Sigma 1:200 PFA . 
Keratin 8 Rabbit lgG Abeam 1:100 PFA . 
Keratin MouselgG Chemicon 1:400 PFA . 
epithelial 
Fibronectin MouselgG Sigma 1:100 PFA . 
Gala 4 Goat lgG R&D 1:50 PFA Endoderm (Arceci et al. 
systems 1993) 
PFA then treat 
AFP MouselgG Sigma 1:100 for 1 minute . 
with ethanol 
R&D (Ang et al. 1993, HNF313 Goat lgG 1:50 PFA . Heins eta/. 
systems 2004) 
Brachyrury Goat lgG R&D 1:50 PFA Mesoderm (Herrmann et al. 
systems 1990) 
Alpha smooth 
mouse lgG Sigma 1:100 Methanol with developing 
muscle actin acetic acid muscle 
BMP 2/4 Goat lgG R&D 1:50 PFA 
systems 
(Muyan & Boime 
HCG mouse lgG Abeam 1:50 PFA Trophoblast 1997, Xu et al. 
2002) 
Keratin 8 Rabbit lgG Abeam 1:100 PFA . 
To control for non-specific binding of the secondary antibodies, some culture wells were 
incubated in antibody diluent without a primary antibody, and subsequently incubated with 
secondary antibodies as described above. In the case of antibodies that were not routinely 
used, to control for non-specific binding of the primary antibody cultures of other human cell 
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lines such as FaDU, HepG2 and IMR32 cells were immuno-stained in parallel, with HepG2 
and FaDU cells used as a negative control for neural antibodies, IMR32 cells used as a 
negative control for non-neural ectoderm associated antibodies and so on. Positive controls for 
each antibody are described in specific experiments. Stained cultures were examined under a 
Nikon diaphot 30 flourescence microscope with filters suitable for the detection of 
fluorescence of fluorescein thiocyanate (FITC), Alexa flour 488, Cy3 and hoescht dyes. 
Pictures were taken with a Nikon digital camera DXM1200 using ACT-I software and 
overlay images created and processed using Adobe Photoshop software. 
Table 2.4 Details of secondary antibodies used for immuno-staining analyses 
ANTIGEN ANTIBODY SOURCE DILUTION 
Rat lgG Rabbit conjugated to Fluorescein Sigma 1:100 isothiocyanate (green) 
Goat lgG Rabbit conjugated to Fluorescein Sigma 1:100 isothiocyanate (green) 
Mouse lgG Donkey Conjugated to Cy3 (red) Jackson lmmuno-Research 1:600 Labs 
Rabbit lgG Goat Conjugated to Cy3 (red) Jackson lmmuno-Research 1:600 Labs 
Mouse lgG Donkey conjugated to Alexa flourophore Molecular probes 1:600 488 (green) 
Methanol based fixation methods 
Where indicated, instead of PF A fixation, the following methods of methanol based fixation 
were used: 
1. Methanol fixation: Cells were rinsed in PBS and then fixed m ice-cold methanol, 
(Fisher) for 1 0 minutes. 
2. Methanol-acetic acid fixation: Cells were rinsed in PBS and then fixed in ice-cold 
methanol with 5% acetic acid (Fisher) for 10 minutes. 
3. Methanol-acetone fixation: Cells were rinsed in PBS, then fixed in 50:50 cold 
Methanol/ Acetone (Fisher) for I 0-15 minutes, then allowed to air-dry for 10 minutes. 
(Cells could then be stored at -20°C and hydrated with PBS 5 minutes prior to 
staining). 
2.5.2 Suspension cultures 
Fixing and sectioning aggregates 
TERA2.sp12 cells were seeded into uncoated 90mm triple vent Bacteriological Petri dishes, 
(VWR) at a density of 20 000 cells/cm2 and treated as specifically described in each 
experiment. At the specified time points, the contents of the Petri dish for each treatment was 
transferred into individual 15ml centrifuge tubes and centrifuged for 2 minutes at 64g, 4°C to 
pellet the aggregates. The supernatant was then removed, and the cells re-suspended in PBS, 
before being centrifuged once more as above. To fix the aggregates the PBS was removed, the 
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aggregates re-suspended in 4% PFA and incubated with gentle rolling for 20-30 minutes at 
room temperature. After fixation, aggregates were washed 3 times for 10 minutes in PBS by 
consecutive centrifuging, supernatant removal and re-suspension steps, before being cryo-
protected by incubation in 30% sucrose (lnvitrogen) solution in PBS on a roller at 4°C 
overnight. After centrifugation for 2mins at 64g, 4°C, the sucrose solution was removed and 
replaced with OCT embedding medium (RA lamb), and incubated at room temperature on a 
roller. After 20 minutes aggregates were transferred to a small mould made from aluminium 
foil and frozen slowly at -20°C, before being transferred to -80°C. Ten micrometer sections 
were made on a Leica CM3050 S cryostat, using DBSOL disposable microtome blades 
(Leica), collected on histobond glass slides (RA Lamb) and stored at -80°C. 
Immuno-staining of sections 
Immuno-staining of slides of aggregate sections was carried out as described for adherent 
cultures, except prior to processing slides were air dried for up to 30 minutes, and to contain 
the antibody solutions on the slides a wax PAP pen was used to outline the cryostat sections 
on each slide. Each slide was then gently washed in PBS before being incubated in blocking 
buffer, and in all cases slides were incubated with primary antibodies overnight in a 
humidified chamber. Stained sections were mounted under 24mm X 50mm glass coverslips 
(VWR) in Vectashield mounting medium with 0.1% Hoescht, and the edges sealed with clear 
nail varnish. 
To control for non-specific binding of the secondary antibodies some slides were 
incubated in antibody diluent without primary antibody, and subsequently incubated with 
secondary antibodies as described above. 
2.5.3 Tissues 
Tissues were either perfusion fixed in PF A prior to extraction and placed in PBS in a 50ml 
centrifuge tube, or transferred into a 50ml centrifuge tube, washed in PBS and then fixed in 
4% PFA for 40 minutes or overnight at 4°C depending on the specific tissue (as described for 
each experiment). 
OCT embedding and sectioning 
The solution of 4% PF A was carefully removed, replaced with PBS and the tissue incubated 
on a roller for 30 minutes, with the PBS replaced with fresh PBS every 1 0 minutes. The tissue 
was then cryo-protected by incubation in 30% sucrose solution in PBS on a roller at 4°C 
overnight. Fifty percent of the sucrose solution was then removed and replaced with OCT 
embedding medium, and incubated on a roller for 20 minutes. Then the solution was replaced 
with I 00% OCT embedding medium, and the tissue incubated for 20 minutes on a roller. The 
2.5 Immuno-cytochemistry 36 
tissues were then transferred to a small aluminium foil mould filled with fresh OCT medium 
and frozen at -20°C, before being transferred to -80°C. Ten micrometer sections were made on 
a Leica CM3050 S cryostat using disposable microtome blades, collected on histobond glass 
slides and stored at -80°C. 
Paraffin wax embedding and sectioning 
The solution of 4% PF A was carefully removed, replaced with PBS and the tissue incubated 
on a roller for 30 minutes, with the PBS replaced with fresh PBS every I 0 minutes. Tissues 
were incubated for 30-50 minutes in the following dehydration series, 25%, 50%, 75% and 
I 00% ethanol, (depending on the size of the tissue). The ethanol was subsequently replaced 
with histoclear (National diagnostics). After approximately I hour (depending on the size of 
the tissue) the histoclear was removed and replaced with fresh histoclear, and the tubes 
transferred to an oven at 55°C. 
After 30 minutes 50% of the histoclear was removed and replaced with filtered molten 
wax (55°C) and after an hour the supematant was removed and replaced with fresh filtered 
molten wax. This step was repeated after another hour, (or longer depending on the size of the 
tissue) and then the tissue was transferred into a mould containing fresh molten wax, allowed 
to cool and stored at 4°C. Eight micrometer sections of aggregates were cut on an RM2125 
microtome (Leica), using disposable microtome blades. Paraffin ribbons of sections were then 
floated on 40-43°C water to smooth out and eliminate folds and wrinkles, mounted on 
histobond slides and allowed to air dry overnight or for up to 8 hours at 40°C. 
Immmuno-staining of tissue sections 
OCT embedded tissue sections were immuno-stained using the same protocol described for 
aggregate sections. Paraffin wax embedded tissue sections were first processed for antigen 
retrieval prior to immune-staining as described in the following protocol. 
Rehydration and antigen retrieval of wax embedded sections 
The slides were placed in the specified solutions for the specified times as listed below. 
I. Histoclear- 4 minutes 
2. Histoclear- 4 minutes 
3. 100% ethanol- I minute 
4. 95% ethanol - I minute 
5. 70% ethanol- I minute 
6. Distilled water- 5 minutes 
7. Distilled water- 5 minutes 
Following rehydration, the slides were placed in I OmM citrate buffer (pH 6), boiled for 5 
minutes in a microwave oven, allowed to rest for 30 seconds, then boiled for a further 5 
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minutes, and allowed to cool for 20 minutes. The slides were then washed three times in PBS 
for 10 minutes, prior to proceeding with the immuno-staining protocol described for aggregate 
sections in Section 2.5.2. 
2.5.4 Double Immuno-labelling 
To further characterise cell phenotypes, many cell cultures and tissue sections were double 
immuno-labelled. In this case the slides or well plates were treated following the described 
immuno-staining method except both primary antibodies were added at the recommended 
dilutions to the same antibody diluent prior to staining. Secondary antibodies conjugated to 
either green or red fluorescence emitting constructs (a combination of Cy3-conjugated 
secondary and either FITC or Alexitlour conjugated secondary antibodies) were also mixed in 
the same antibody diluent prior to application. Care was taken to only use combinations of 
primary antibodies that were raised in different hosts, and also to ensure that the secondary 
antibodies were not raised in the same host as either of the primary antibodies. In effect only 
mouse-rabbit or mouse-goat double immuno-labelling was possible with the antibodies 
available. All antibodies were previously used alone to control for changes in antibody 
staining behaviour in double-immunolabelling preparations. To control for non-specific 
binding of the secondary antibodies, cells were processed in parallel but with no antibodies 
used in the primary incubation step. 
2.6 HISTOLOGICAL STAINING 
Haematoxylin and eosin staining was used to investigate the structure of aggregates formed 
under suspension conditions or the structure of tumours derived from injection of 
TERA2.sp 12 cells or HNCL-1 human ES cells into immune deficient mice. Haematoxylin is a 
basic dye that stains acidic structures, (RNNDNA containing nuclei, ribosomes and rough 
endoplasmic reticulum). Eosin is an acidic dye that stains basic structures red or pink (as most 
cytoplasmic proteins are basic the cytoplasm stains pink). Aggregates were collected, fixed in 
4% PFA and embedded in OCT embedding medium as described in Section 2.5.2, or 
embedded in filtered wax, (RA lamb) using the method described below. Tissues were fixed 
in 4% PFA, embedded in paraffin wax and sectioned as described previously in Section 2.5.3. 
2.6.1 Preparation ofwax embedded sections 
Aggregates were transferred to 15 ml centrifuge tubes and washed m PBS as previously 
described, then centrifuged for 2mins at 64g, 4°C and the PBS removed, and incubated for 20 
minutes in with the following dehydration series, 25%, 50%, 75% and I 00% ethanol, (Fisher) 
using consecutive centrifugation and supernatant replacement. The ethanol was subsequently 
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replaced with histoclear, (National diagnostics). After 20 minutes the histoclear was removed 
and replaced with fresh histoclear, and the tubes transferred to an oven at 55°C. 
After a further 20 minutes 50% of the histoclear was removed and replaced with 
filtered molten wax (55°C) and after 30 minutes the supernatant was removed and replaced 
with fresh filtered molten wax. After another 30 minutes the aggregates in wax were 
transferred into a pre-warmed glass embryo dish and the wax allowed to cool, before being 
stored at 4°C. The wax was then trimmed to fit a mounting block and 8f.!m sections of 
aggregates were cut on an RM2125 microtome (Leica), using disposable microtome blades. 
Paraffin ribbons of sections were then floated on 40-43°C water to smooth out and eliminate 
folds and wrinkles, mounted on histobond slides and allowed to air dry overnight or for up to 
8 hours at 40°C. 
2.6.2 Staining of sections with Haematoxylin and Eosin 
Wax embedded sections 
Prior to haematoxylin and eosin staining, the paraffin was removed from sections and the 
slides re-hydrated following by placing the slides in following solutions for the specified times 
listed below: 
I. Histoclear- 5 minutes 
2. Histoclear- 5 minutes 
3. IOO% ethanol- I minute 
4. 95% ethanol- 1 minute 
5. 70% ethanol - 1 minute 
OCT embedded sections 
OCT sections were rapidly removed from -80°C storage and without allowing the section to 
dry or thaw, immersed in 70% ethanol for 30 seconds. Then the slides were processed 
following the standard haematoxylin and eosin staining protocol below. 
Staining protocol 
The slides containing sections were placed in the following solutions for the specified times 
listed below: 
I. Distilled water- 1 minute 
2. Mayer's Haematoxylin -Ehrlich- naturally ripened, (RA lamb)- I 0 seconds 
3. Distilled water- 30 seconds 
4. Blueing reagent (alkaline alcohol)- 5-10 seconds 
5. 70% ethanol- 30 seconds 
6. I% aqueous eosin (RA lamb) - 1 0 seconds 
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7. 95% ethanol - 30 seconds 
8. 95% ethanol - 30 seconds 
9. 100% ethanol- 30 seconds 
10. I 00% ethanol- 30 seconds 
11. Histoclear- 4 minutes 
Stained sections were mounted under 24mm X 50mm glass coverslips using high viscosity 
formula DPX (RA lamb) and viewed with phase contrast microscopy using a Nikon diaphot 
30 microscope. Pictures were taken with a Nikon DXM1200 digital camera using ACT-I 
software. 
2. 7 GENE EXPRESSION ANALYSIS 
Polymerase chain reaction (PCR) analysis was used to determine the expression of specific 
genes in TERA2.sp12 cultures. Culture samples were collected as pellets as for Western blot 
analysis in Section 2.4 except gloves, RNAse free filter barrier pipette tips (Thistle) and PCR 
clean eppendorftubes were used at all times. 
Isolation of RNA 
RNA was isolated from cell pellets following the manufacturer's instructions for isolation of 
RNA with Tri-reagent (Sigma), as outlined in the steps below. 
1. I ml ofTri-Reagent added to each pellet (approximately I million cells). 
2. Contents pipetted repeatedly to lyse pellet. 
3. Allowed to stand for 5mins (room temperature). 
4. 200ul Chloroform (Fisher) per ml ofTri-Reagent added to each tube. 
5. Tubes shaken vigorously for 15 seconds. 
6. Allowed to stand for 15mins at room temperature. 
7. Tubes centrifuged at 12,000g, 4°C for 15 minutes to separate the solution into 3 
phases: A red base layer (the organic phase - containing mainly proteins), a white 
inter-phase layer (containing DNA), and the uppermost phase- a colourless aqueous 
layer (containing RNA). 
8. The aqueous uppermost layer was transferred into a fresh 1.5ml eppendorf tube. 
To remove DNA contaminants, the following additional steps were carried out 
9. Mixed with one tenth of the total volume of isopropanol to be added to the aqueous 
RNA solution (SO!ll). 
10. Allowed to stand for 5 minutes at room temperature. 
11. Samples centrifuged 12,000g for 10 minutes at 4°C to precipitate any contaminating 
DNA at the base of the eppendorftube. 
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12. The supematant was transferred to a fresh tube. 
13. For each tube the remaining amount of isopropanol (500!-11 minus S11l= 450!-11) was 
added to precipitate the RNA, and the tubes allowed to stand for 5-10 minutes at 
room temperature or overnight at -20°C. 
14. To pellet the RNA samples were centrifuged at 12,000g, 4°C for 10 minutes. 
15. The supematant was removed and the pellet washed by adding approximately 1ml of 
75% RNAse free ethanol and vortexing. 
16. The samples centrifuged at 7,500g, 4°C for 5 minutes, and the supematant removed. 
17. An additional brief centrifuge ( 1 0 seconds) used to allow the collection of any 
remaining supematant that had collected on the sides of the tube. 
18. The pellet was allowed to dry by allowing the tube to stand for 5 minutes (depending 
on the size of the pellet) at room temperature with an open lid (care was taken not to 
over-dry the pellet) 
19. Approximately 50!-11 of RNAse free water was added to each pellet (depending on the 
pellet size), and the solution stored at -20°C. 
Determining the concentration of sample RNA solutions and assaying for RNA 
degradation 
For each sample disposable semi micro-cuvettes suitable for wavelength absorbance at 260-
280nm (Fisher) were loaded with 995!-11 water and 5!-11 sample. As a blank an additional 
cuvette was loaded with 10001-11 of water. Sample absorbance was then measured at 260nm 
using a Helios B mass spectrometer and the sample concentration calculated on the basis that 
40Jlg of RNA/ml will have an absorbance at 260nm of one. (For each cuvette sample the 
absorbance reading was multiplied by 40 and by the dilution factor to calculate original RNA 
concentration in the corresponding sample). To assay for RNA degradation, S11g of each 
sample was loaded with blue juice loading buffer (Promega) into a 1% agarose gel prepared 
following the recipe listed in the appendix, and electrophoresed for 40 minutes at 80 volts. To 
visualise the bands of RNA the agarose gel was then viewed under UV light. 
Reverse transcription and PCR analysis 
To convert the RNA to DNA and detect selected gene transcripts by primer specific 
amplification the access quick RT-PCR system (Promega) was used according to the 
manufacturer's instructions, as described in the following list. 
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I. For each SOul reverse transcription reaction, combine: 
a. 25J.1l Master mix. 
b. I OJ.1M upstream primer. 
c. I OJ.1M downstream primer. 
d. RNA template, (0.1-1 J.lg) 
e. Nuclease free water to a final volume of 50J.1l. 
2. Vortex samples. 
3. Add I J.ll AMY Reverse Transcriptase as the final component and mix by gentle 
vortexing. 
4. Incubate tubes at 45°C for 40-45 minutes. 
5. Proceed with PCR cycling as below: 
6. Initial denaturation at 95°C, (2mins) 
7. Then 30 cycles of annealing, (55-65°C as detailed for each primer), Imin for 
extension at 70°C, I min for denaturation at 95°C. 
8. Soak at 4°C overnight. 
Primer sequences were obtained from published papers or designed using the Primer DNAstar 
package, and primers were ordered from MWG-Biotech. Details of primers and the annealing 
temperature used are specified in each experiment. 
To detect the PCR products I J.ll of blue juice dye was added to I5J.1l of each sample 
and the mixture subsequently loaded onto a I % agarose gel and electrophoresed at 80 volts 
for 40-60 minutes, according to the predicted size of the PCR product. The PCR products in 
the agarose gel were subsequently visualised using a transilluminator (Gel Doe 2000, Bio 
Rad). 
2.8 GENERATION OF TUMOURS IN IMMUNE-DEFICIENT MICE 
Preparation of TERA2.sp12 cells for injection 
For each batch of injections, a confluent flask generated from TERA2.sp I2 cells cultured 
under maintenance conditions was used and cells prepared for injection using the following 
procedure: A confluent T75 flask of TERA2.spl2 cells was washed in PBS then 
individualised using Trypsin, and counted using a haemocytometer as described in Section 
2.3. In summary, cells were incubated at 37°C for 2-3 minutes with 2mls of 0.5X Trypsin in 
EDT A, and gentle tapping used until the cell layer had dispersed. Once cells were 
individualised 9mls of media was added to inactivate the Trypsin, and gentle pipetting used to 
aspirate cells. Ten micro-litres of solution was then loaded onto a haemocytometer, and cell 
counts performed using a phase contrast light microscope (Nikon eclipse TS I 00). The cells 
were counted twice, and if any unusual cell counts were collected the counts were repeated. 
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Haemocytometer counts were then used to estimate the concentration of cells in each sample 
(count multiplied by I 0,000), and the total cell number estimated by multiplying this value by 
the total volume of solution (10mls). 
The suspension of cells was then centrifuged at 129g 4°C for 2 minutes, the supernatant 
removed, the cells gently re-suspended in PBS and then this step was repeated. Care was taken 
to ensure the cells were thoroughly washed as it is essential that no media is injected into the 
mouse host. After the final wash the cells were suspended in a defined amount of PBS such 
that 1ml was added for every million cells. The cells were gently aspirated to ensure an even 
distribution and then SOfll samples of cell suspension (for each mouse to be injected) were 
pipetted to form individual drops in a sterile bacteriological dish, such that each formed a 
meniscus of cell suspension with 50,000 cells in SOfll. Then for each meniscus, using a sterile 
1 ml disposable syringe (VWR) and sterile gauge 21 syringe needle (Fisher), the solution of 
cells was taken up into the syringe, the sterile needle cap replaced and the syringe placed 
upright in ice ready for injection. 
Subcutaneous injection of TERA2.sp12 cells into immune-deficient mice 
All procedures involving mice were carried out in accordance with institution guidelines and 
institution permission, using licensed procedures and according to Home Office guidelines. 
The cells were injected subcutaneously on the left flank into nude (C57BLI6J-Hfhl lnu) adult 
male mice. Injections were performed by Stefan Przyborski or Alison Ritchie (manager of the 
Biological Sciences animal unit). 
2.9 TISSUES USED AS POSITIVE CONTROLS 
Human placental tissue 
As a positive control for trophoblast markers, day 19 human placenta villous tissue was kindly 
donated by Dr Lisgo from University ofNewcastle. Pieces of villous tissue were dissected and 
rapidly frozen in liquid nitrogen prior to storage at -80°C for use in Western blot analysis. The 
remaining placental villous tissue was washed in PBS before being fixed in 4% PF A for 40 
minutes. After fixation, the placental tissue was washed 3 times for 1 0 minutes in PBS and 
then cryo-protected in 30% sucrose at 4°C overnight. The sucrose solution was then removed 
and replaced in stages with OCT embedding medium from RA lamb. After 30 minutes the 
tissue was transferred to a small mould made from aluminium foil, frozen slowly at -20°C, 
and transferred to -80°C. Ten micrometer sections were made on a Leika cryostat, collected 
on Histobond slides and stored at -80°C. 
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3.1 INTRODUCTION 
The following introduction reviews the retinoic acid (RA) signalling pathway, discussing the 
key roles of RA in early development and also its use as a potent inducer of stem cell 
differentiation. Subsequently RA induced differentiation in the context ofTERA2.spl2 cells is 
described, and two alternative culture methods of RA induced differentiation are introduced 
which are reported to generate markedly different proportions of neurons from TERA2.sp 12 
cells. Finally the objective of the investigations in this chapter is proposed, namely to 
compare and characterise the differentiation ofTERA2.sp12 cells under these alternate culture 
conditions. 
3.1.1 Retinoic acid- a key morphogen in vitro and in vivo 
Retinol (vitamin A) and its retinoid derivative retinoic acid (RA) play a fundamental role in 
the development of mammalian embryos as well as other chordate embryos: Mouse and quail 
retinoid knockout models have linked vitamin A function to the development ofthe heart, the 
embryonal circulation and to the central nervous system (Maden et al. 1996, for review Ross 
et al. 2000), and most remarkably, in the absence of sufficient vitamin A the embryo is 
eventually reabsorbed (Wellik & Deluca 1995). 
Retinol is obtained by cells of the embryo or adult from the blood, where it circulates 
bound to retinol binding protein (Maden 2002). Upon entering the cell, retinol is bound to 
cellular retinol binding protein (CRBP) and then metabolised into RA in two oxidation steps, 
as described in Figure 3.1.A. Retinol is converted initially by retinol dehydrogenases into 
retinal, and subsequently by the retinal dehydrogenases (RALDHs) into RA. There are several 
members of each of these enzyme classes, and the most important ones for the embryo are 
RALDHl, RALDH2 and RALDH3. Cells that require RA also contain cellular RA-binding 
proteins (CRAB I and CRAB2), which bind to RA in the cytoplasm (for review see Maden 
2002). Upon entering the nucleus RA serves as a ligand that controls the action of nuclear RA 
receptors (Mangelsdorf et al. 1994) either in the cells where it is generated or in neighbouring 
cells via paracrine signalling (Mic et al. 2002). These nuclear receptors are heterodimers and 
function as RA activated transcription factors, recognising consensus sequences termed 
retinoic acid response elements (RAREs) in the control elements of RA responsive genes. A 
summary of the cellular mechanism of retinoid action is depicted in Figure 3.1.B. 
Alternatively, RA can be further metabolised into inactive products by two cytochrome p450 
enzymes (CYP261 A CYP261 B) as shown in Figure 3.1.A, although there is evidence that 
some of these retinoids are also bioactive modulators of development (Pijnappel et al. 1993). 
RA can exist in two isoforms, as either all-trans RA or 9-cis RA, which act through 
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Figure 3.1 
A. The metabolic pathway that converts vitamin A (retinol) into various isoforms of retinoic acid 
(RA), which involves three classes of enzymes, the retinol dehydrogenases, the retinaldehyde 
dehydrogenases and the cytochrome p450 enzymes CYP26A 1 and CYP26B 1. 
B. The cellular mechanism of retinoid action. Retinol is taken up from the blood and bound to 
CRBP (cellular retinol-binding protein) in the cytoplasm. The retinol dehydrogenase enzymes 
(RoDH) metabolise retinol to retinal then retinal is metabolised to RA by the retinaldehyde 
dehydrogenases (RALDHs). RA is bound in the cytoplasm by CRABP (cellular RA-binding 
protein). RA enters the nucleus and binds to the RA receptors (RARs) and the retinoid X receptors 
(RXRs), which themselves heterodimerise and bind to a sequence of DNA known as the retinoic 
acid response element (RARE). This activates transcription of the target genes. Figure and legend 
copied from Figure 1 in (Maden 2002). 
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different nuclear receptors. In human, rat and mouse, there are two classes of these RA 
receptors, the retinoic acid receptors (RARs) RARa, RARP RARy, which are activated by all-
trans RA and 9-cis RA, and the retinoid X receptors (RXRs) RXRa, RXRP RXRy which are 
only activated by 9-cis RA (Heyman et al. 1992, Levin et al. 1992, for review Maden 2000). 
All trans-RA has been reported to be the main biologically active retinoid occurring during 
embryogenesis in zebra fish (Costaridis et al. 1996), and most studies to date use the readily 
available all-trans RA isoform. Correspondingly an embryonic lethal mutation in which RA 
synthesis is inhibited can be rescued by retinoid activation of RARs but not RXRs (Mic et al. 
2003). 
In early studies, ectopic addition of RA was demonstrated to have a marked 
teratogenic effect on normal embryonic development, with embryos presenting abnormalities 
remarkably similar to that of vitamin A deprivation (Fantel et al. 1977, Kochhar 1973, 
Shenfelt 1972). This is an important demonstration that although RA is necessary for normal 
embryogenesis to occur, it is required at precisely controlled levels within the developing 
embryo. Correspondingly, the pathway of retinol metabolism and mechanism of RA mediated 
gene regulation as summarised in Figure 3.1, presents several points at which a cells response 
to retinol can be regulated: Through the regulation of retinol uptake from the blood, the 
presence of enzymes to convert retinol to RA or to degrade RA, the presence of RARs and 
RXRs and the presence of further eo-activators and repressors that interact with the retinoic 
acid nuclear receptors (Maden 2002). 
Retinoic acid - a universal differentiation agent? 
RA promotes the differentiation of a variety of progenitor cell lines (Mogi et al. 2005, 
Takahashi 1999) and in vitro studies demonstrate that RA can induce an inordinate number of 
genes (reviewed in Sporn et al. 1995). To this effect it has been described as a universal 
differentiation agent (McCafferya & Draeger 2000). However, the extensive range of genes 
induced by RA is typically a result of secondary or even tertiary transcriptional responses, and 
the number of genes containing retinoic acid response elements in their promoters and that can 
be directly transcriptionally regulated by RA is much lower. Table 3.1 lists some of the genes 
reported to contain RARE in their promoters. 
In the embryo, genes directly regulated by RA include key transcription factors (such 
as the homeobox hox genes), signalling molecules (Sonic hedge hog) and enzymes (Protein 
kinase C), each of which can activate multiple pathways of development (for review 
McCafferya & Draeger 2000). This contributes to the powerful morphogenetic effects of RA 
and its attributes as a key trigger of differentiation. The range of genes activated directly and 
indirectly by RA also depends on the transcriptional eo-activators and inhibitors present in 
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each cell, and the concentration of RA (McCafferya & Draeger 2000). As a consequence, the 
response of a cell to RA is highly dependent on the context of the cell type and the level of 
exposure to RA. 
Table 3.1 List of genes with functional RAREs (Taken from Table 1 of McCafferya & 
Draeger 2000) 
RARa2 
RA SIGNALLING COMPONENTS RAR 132 CRBPII 
CRABP 11 
Hepatocyte Nuclear Factor -3alpha 
TRANSCRIPTION FACTORS AND Hox genes a1 ,b1 ,b4,d4 
CO-FACTORS Oct3/4 (repression) 
Stat1 
Cholesteryl ester transfer 
Phosphoenolpyruvate carboxykinase 
ENZYMES Protein kinase C 17 beta-hydroxysteroid dehydrogenase type 1 
Tissue-type plasminogen activator 
Medium chain acyl-coenzyme A dehydrogenase 
NEUROTRANSMITTER Beta 1-adrenergic receptor 
RECEPTORS Dopamine D2 receptor 
Gonadotropin-releasing hormone 
HORMONE Thyroid stimulating hormone-beta 
RELATED/SIGNALLING FACTORS Oxytocin 
Sonic hedgehog 
Intercellular adhesion molecule-1 
ADHESION PROTEINS Laminin 81 Intercellular adhesion molecule-1 
Laminin 81 
OTHER a fetoprotein 
Retinoic acid in embryonic development- patterning the CNS system 
In the developing mouse and chick embryo all the main regions of the embryo were detected 
to contain endogenous RA, but at varying levels (Horton & Maden 1995, Maden et al. 1998). 
In both cases the highest levels of RA were detectable in the neural tube, with decreasing 
levels found in the somites, eye, tail bud, fronto-nasal mass, branchial aches, limb buds and 
heart (see review Maden 2000). Within the neural tube, the levels of RA detected were not 
uniform - the region which would form the spinal chord had the highest levels, whereas the 
forebrain and midbrain had virtually undetectable levels, and the hindbrain intermediate levels 
of RA. 
RA has since been demonstrated to play key roles in neurogenesis and the patteming 
of both the anterior posterior and dorsal-ventral axes of the neural tube (for review Maden 
2002). Proneural genes that control the process of primary neurogenesis have been found to be 
controlled by RA in vertebrates, including prepattem genes (X-ngnr-1, X-MyTl ), neurogenic 
genes (X-delta-1) and RA is also responsible for down-regulating genes that inhibit 
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neurogenesis (Zic2, X-shh) (Franco et al. 1999, Papalopulu & Kintner 1996, Sharpe & 
Goldstone 2000, Sharpe & Goldstone 1997). Correspondingly manipulations in the level of 
RA in Xenopus embryos regulate the number of primary neurons formed (for review Maden 
2002). 
The potent effect of a RA gradient on the anterior-posterior patterning of the neural 
tube is demonstrated by the concentration dependent effect of RA on the expression of 
different classes of Hox genes, each of which activates a different sub-set of cell-type specific 
genes. Hox homeobox genes exhibit segmental expression in the developing hindbrain and are 
intimately involved in the formation and identity of the eight rhombomeres that constitute the 
mouse hindbrain (Krumlauf 1993, Wilkinson 1993), and several members of the mammalian 
Hox gene family are direct targets of RA signaling during hindbrain development, including 
Hox bl (Simeone et al. 1990). Complexes of homeobox hox genes respond differently to RA, 
following a trend whereby Hox genes positioned at the 3' end of the complex are activated 
more rapidly and to lower doses of RA than genes positioned more 5' within the complex (for 
reviews Lutldn 1996, 2006). 
Retinoic acid induced differentiation in embryonic stem cells 
The differentiation of pluripotent stem cells has proved an invaluable tool in characterising 
early lineage decisions in mammalian embryonic development, and neural induction by RA in 
embryonal carcinoma cell lines and mouse embryonic stem cells has been extensively studied, 
(as previously discussed in chapter I). To re-capitulate, RA was one of the first chemicals 
discovered to induce differentiation in embryonal carcinoma cell lines in vitro. When treated 
with RA, a subset of responsive embryonal carcinoma cells rapidly lost their malignant stem 
cell phenotype (Mummery et al. 1987, Rayner & Graham 1982). This applied to mouse 
embryonal carcinoma cells such as P19, F9 and the human embryonal carcinoma cell line 
NTERA2 (Alonso et al. 1991, Andrews 1998, McBurney 1993 ). Human EC cell lines NT2D I, 
TERA2.sp12 and the mouse EC line Pl9 have all been reported to respond to RA by 
differentiating along neural lineages (Andrews 1984, McBurney 1993, Przyborski 2001 ). 
Correspondingly, in mouse embryonic stem cells, the low levels of neural differentiation 
observed upon removal from feeder layers and culture to form embryoid bodies are markedly 
up-regulated if aggregated cells are treated with high concentrations of RA, and mesodermal 
gene expression is actively repressed (Bain et al. 1995, Bain et al. 1996, Fraichard 1995, 
Strubing et al. 1995). 
As discussed in Chapter I, TERA2.sp 12 cells are presented a suitable model in which 
to study aspects of ectoderm development, as their differentiation behaviour suggests that 
unlike human ES cells, they more closely resemble cells of the ectoderm than cells of the 
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inner cell mass. Currently there are two alternative culture methods of differentiating 
TERA2.sp12 cells with RA, which generate markedly different responses. 
3.1.2 Alternative methods of culturing retinoic acid treated TERA2.sp12 cells 
TERA2.sp12 cells are routinely cultured on adherent electrostatically-coated plastic-ware, and 
upon differentiation with RA under these conditions, a small proportion of the population 
differentiates into maturing neurons. However, after 6 weeks of treatment with RA, aggregate-
like formations are observed and these frequently detach from the culture surface and float in 
the media. When isolated and re-plated, cells growing out of these aggregate structures 
demonstrate marked morphological evidence of neural differentiation. 
In an effort to promote neural differentiation, TERA2.spl2 cells were differentiated 
with RA while cultured in non-adherent conditions to form aggregates in suspension. Figure 
3.2, published in (Horrocks et al. 2003) summarises the two alternative methods of 
TERA2.spl2 culture and differentiation with RA. These initial studies indicated that 
TERA2.sp 12 cells cultured as aggregates and treated with RA prior to plating on an adherent 
surface generated markedly increased numbers of morphologically identifiable neurons 
compared to adherent cultures grown in parallel (Stewart et al. 2003). One possible 
explanation for the increased numbers of neurons observed in RA treated suspension cultures 
is that in these cultures an increased proportion of cells are differentiating into a neural fate. If 
this is indeed the case, comparison of these two culture systems would provide a simple basis 
from which to investigate mechanisms regulating neural induction in TERA2.spl2 cells, as a 
model of human ectoderm development. Accordingly, the central aim of the experiments in 
this chapter is to characterise and systematically compare the early stages of differentiation of 
TERA2.sp12 cells when induced to differentiate with RA under suspension conditions versus 
adherent conditions, in order to address the following questions: 
1. Is neural differentiation indeed enhanced in RA treated TERA2.sp 12 cells 
dissociated and cultured in suspension to form aggregates? 
2. Is this up-regulation of neural differentiation associated with a reduction of 
differentiation into non-neural (putative epidermis) cell types? 
3. What markers are expressed by the non-neural population of cells induced by RA 
treatment - can this population be definitively characterised as epithelial cells of the 
prospective epidermis? 
A summary of the aims, objectives and experiments carried out is presented as a strategy flow 
chart in Figure 3.3. 
Retinoic Acid Induced Neural Differentiation And The Formation Of Aggregates In 
TERA2.sp 12 Cells Cultured Using Two Different Methods. 
METHOD 1: METHOD 11 : 
Suspension culture Adherent culture 
r 
+ 
Figure 3.2. Formation of aggregate structures in retinoic acid differentiated TERA2.sp12 cells. 
Phase contrast images show live cultures taken at various stages of differentiation. 
TERA2.sp12 stem cells were grown and maintained as confluent monolayers (A). Cells 
exposed to 10 ~M retinoic acid were cultured either in suspension (B) and then plated onto an 
adherent surface (D) or cultured as adherent monolayers (C). Cultures of adherent cells 
produced large, dense accumulations of cells that form many well-developed neurites after 6 
weeks of differentiation {C, arrows). A background of non-neuronal cell types surrounded 
these aggregates (C). Both methods ultimately result in the production of populations of 
aggregate structures that radiate large numbers of neurites (D,E). Scale bars: (A) 50:lm; (B) 
750:lm; (C) 1500:lm; (D) 600:lm; and (E) 150:lm. Adapted from (Horrocks 2003) Figure l. 
Figure 3.2 
Figure 3.3 
Strategy Flow Chart For Investigating The Differentiation Of RA Treated TERA2.sp12 Cells 
Under Adherent Versus Non-adherent Conditions 
Compare two alternative methods of 
culturing TERA2.sp12 cells, as either 
suspension (aggregate forming) or 
adherent cultures. 
~ Assess changes in morphology Are there any obvious changes in cell behaviour? Assess changes in proliferation 
using cell count assays 
K 
Compare changes in surface 
Compare the differentiation of TERA2.sp12 antigen expression using flow cytometry 
cells under these alternate treatments 
Compare the expression of neural 
and non-neural ectoderm proteins over 4 -
14 days using Western blot analysis 
Further characterise the cultures 
generated 
under these different conditions: Immune-label with markers of various stages 
k 
of neural differentiation to characterise the 
neural population 
RA treated adherent cultures 
Characterise the large-celled population 
Characterise the neural and non-neural that does not express neural markers by 
population screening with markers of non neural 
ectoderm and of other germ layers. 
Immune-label with markers of various stages 
RA treated aggregate cultures K of neural differentiation to characterise neural population Characterise the neural population . Are RA treated aggregates similar Assess whether, like neurospheres, to neurospheres? aggregates are clonal using 
TERA2.sp12.GFP mixing experiment. 
Aggregate cultures grown without RA 
K 
Immune-stain aggregate sections with stem 
Further characterise the down-regulation cell markers Oct 4, Nanog and TRA 160 
of stem cell marker expression. 
What differentiated markers do these Immune-stain aggregate sections with 
aggregates express -are they similar to markers of derivatives from all three germ 
ES derived embryoid bodies? layers. 
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3.2 RESULTS 
3.2.1 General observations 
TERA2.sp 12 cells cultured under adherent conditions and treated with 1 OJ.1M RA lost their 
characteristic stem cell morphology of a high nucleus to cytoplasm ratio with pale nuclei and 
prominent nucleoli, and developed into two morphologically distinct populations, depicted in 
Figure 3 .4. The majority of the culture consisted of densely packed small cells which typically 
formed rosette-like structures (arrow) after 14 days of culture. A distinctive sub-population of 
cells was observed, consisting of large diameter cells with sizeable nuclei and prominent 
nucleoli, which formed small sheets of cells that grew in distinct patches and were easily 
distinguishable after 7 days of culture. These were given the term 'large cell plaques' (panels 
F and H). These 'large cell plaques' were observed at a consistent density over multiple 
experiments and appeared to increase in size over 7-14 days of culture. This phenotype was 
not observed in TERA2.sp 12 cells grown as adherent cultures at differentiation density or in 
cultures vehicle treated with DMSO, indicating that the observed changes in RA treated 
cultures were indeed a result of RA exposure. 
Cultures differentiated under non-adherent conditions formed small clusters of cells in 
suspension after 24 hours, and these clusters grew to form large floating aggregates of cells 
(Figure 3.5). These aggregates were usually variable in size, with smaller aggregates present 
even in cultures over 2 weeks old. However, the majority of aggregates reached a substantial 
size (1-2 mm) by 14 days in culture (panels D and G). Aggregates formed from cells cultured 
under non-adherent conditions and exposed to 1 OJ.1M RA were initially more ragged in 
appearance than cultures grown without RA (panels B and E). However, by 7-14 days RA 
treated cells typically formed aggregates that were more regular and smaller than those grown 
without RA. TERA2.sp 12 cells cultured in suspension without RA formed large and irregular 
aggregates after 14 days, and bud-like formations were frequently observed on aggregates 
between 7-14 days of culture. 
3.2.2 Cell count assay 
To compare the proliferation of TERA2.sp12 cells cultured under adherent versus non-
adherent conditions, cultures were differentiated under either adherent or suspension 
conditions as described in Section 2.1.1 with three replicates set up for each time-point of 5, 7 
and 14 days. At each time-point the selected cultures were individualised using Trypsin and 
counted using a haemocytometer as described in Methods Section 2.2. 
Three different replicates of each sample were assayed using this method, and if any unusual 
cell counts were collected the counts were repeated. Cell counts were then used to estimate the 
Changes In Morphology Of Adherent Cultures OfTERA2.sp12 Cells Treated With 
Retinoic Acid. 
Figure 3.4 
Figure 3.4. Phase contrast images of TERA2.sp 12 cells grown as (A) a confluent adherent stem cell 
culture or seeded at a density of20,000 cells/cm2 and treated after 24 hours (B) with I OJ.lM RA for 14 
days. Representative images at 2 days (C), 5 days (D), 7 days (E, F) and 14 days (G,H) of culture 
demonstrate several changes in morphology. Undifferentiated TERA2.sp 12 cells displayed a 
characteristic stem cell morphology of a high nucleus to cytoplasmic ratio, with prominent nucleoli, 
(A). Over time RA treated TERA2.spl2 cultures changed in morphology, forming more densely 
packed small cells after 7 to 14 days (E, G) with small rosette-like structures visible after 14 days of 
culture, as shown by the arrow in (G). By 7 days of treatment with RA, clusters of large-diameter cells 
with prominent nuclei and distinct boundaries (F) were visible, and these clusters had increased in size 
after 14 days (H). Scale bars= 50J.lm 
Aggregate Formation OfTERA2.sp12 Cells Cultured Under Suspension Conditions 
And Treated With Or Without Retinoic Acid 
I DAY 
2 DAYS 
7 DAYS 
14 DAYS 
Figure 3.5 Representative phase contrast images of TERA2.sp 12 cells cultured under suspension 
conditions to form aggregates. TERA2.sp 12 cells were seeded at a density of 20,000 cells/cm2 into non-
adherent petri dishes and treated after 24 hours (A) with I 0 ~M RA (B-D) or cultured without RA (E-G) 
for 14 days. Representative images at 2 days, 7 days and 14 days of culture depict aggregate development. 
TERA2.sp 12 cells had formed small aggregates of cells after 24 hours of culture under non-adherent 
conditions (A). Cells cultured without RA rapidly formed larger, regular spheres (E), which then 
increased in size to form large irregular aggregates at 14 days (G). Initially, RA treated cultures formed 
small more irregular aggregates (B). These became more regular over time to form tightly packed spheres 
(D). Scale bars= I OO~m 
Figure 3.5 
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concentration of cells in each sample (count multiplied by I 0,000) and the total cell number 
estimated by multiplying this value by the total volume of solution (IOmls). These counts 
were also compared to the size of the pellets when centrifuged at 129g, to check that they 
were representative. The results are summarised in Table 3.2. Trypan blue exclusion was 
never more than 5% in all treatments, indicating that cell number was not markedly affected 
by cell death. 
Table 3.2 Mean number of cells (per million) in adherent or suspension cultures of 
TERA2.spl2 cells treated with (+RA) or without RA over 14 days. 
Days Adherent Adherent +RA Suspension Suspension +RA 
0 1.50 1.50 1.20 1.20 
5 8.85 10.93 3.23 3.83 
7 24.87 28.33 8.13 5.57 
10 33.10 22.40 5.27 3.50 
14 - 35.80 11.47 8.83 
As indicated in the graph in Figure 3.6, the increase in cell number over time was reduced by 
RA treatment under both suspension and adherent conditions. However, the most marked 
difference in rate of increase in cell number was between adherent and suspension cultures. 
Cells grown under suspension conditions and treated with RA ceased to increase in number by 
day 5, whereas cells grown under adherent conditions and treated with RA continued to 
increase in cell number, albeit at a slower rate by day 14. This suggests that proliferation in 
RA treated TERA2.sp12 cells is markedly inhibited under suspension conditions compared to 
adherent conditions, which may correspond to more a rapid departure from the stem cell 
phenotype. Despite a generally fast rate of increase, a distinct intermediate phase of slowed 
growth was observed between 7-10 days in adherent cultures treated with RA. This 'Jag 
phase' was consistently observed over repeated experiments. This could be a result of growth 
inhibition as a result of increased cell-cell contacts as the population grows. This would 
prevent further growth in cultures of genetically normal cells but as observed here, contact-
induced growth inhibition is overcome- a hallmark oftumourogenic cells. 
Adherent cultures of TERA2.sp 12 cells grown without RA initially demonstrated a 
similar rate of increase to adherent cultures treated with RA. However after 7 days the cell 
number escalated, such that cultures became so overgrown that they were no longer viable. 
After 7 days of culture, adherent cultures without RA were split and reseeded at 1 :3, and the 
total count of three re-seeded flasks used to estimate the total population at 10 days. This rapid 
increase in cell proliferation after an initial Jag-phase was observed over multiple repeated 
experiments. This was in contrast to cells grown in suspension culture conditions without RA 
- the rate of increase in cell number remained relatively steady, indicating that suspension 
conditions alone encouraged reduced proliferation and possibly differentiation. One source of 
Cell Count Assay Of Adherent Or Suspension Cultures OfTERA2.spl2 Cells Treated 
Over 14 Days With Or Without Retinoic Acid. 
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Figure 3 .6. Graph presenting changes in mean cell count over 14 days for TERA2.sp 12 cells cultured in 
adherent (MON) or non-adherent conditions (AGG) and treated with 10J.1M RA (+RA) or without RA. 
TERA2.sp12 cells were seeded at a density of 20,000 cells/cm2 into either T75 culture flasks or 
bacteriological petri dishes and after 24 hours treated with either 10J.1M RA or untreated. At 5, 7 and 14 
days 3 replicate cultures of each treatment were harvested and individualised using Trypsin, and samples 
counted with a haemocytometer. Adherent cultures demonstrated a markedly higher rate of increase in 
cell number compared to suspension cultures, with RA treated suspension cultures exhibiting the lowest 
rate of increase. N=3 for each data point and the error bars represent the standard deviation. There is no 
14 day count for adherent cultures grown without RA (MON), because the cultures became too dense 
and were no longer viable. 
Figure 3.6 
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experimental variation encountered was that cells forming aggregates under suspension 
conditions were physically more difficult to individualise with Trypsin treatment, with 
repeated aspiration necessary during this step. However, as a general comparison, the size of 
the pellet formed after centrifuging individualised cells from each culture matched the 
expected size estimated from cell counts. 
3.2.3 Changes in cell surface marker expression 
To compare the levels of expression of surface antigens associated with the stem cell 
phenotype (TRA I60, SSEA 3) or with the neural phenotype (VINIS 53, A2B5) in these 
treatments, at 7 and I4 days the remaining cells from the cell count assay were analysed using 
live flow cytometry following the procedure described in Section 2.3. Three replicates of cells 
from the same passage number were used for each treatment, and processed in parallel. 
Comparisons of cell surface marker regulation in TERA2.sp I2 cells treated with RA 
under adherent and suspension conditions demonstrated a similar pattern of regulation in both 
conditions, except under suspension conditions the down-regulation of stem cell marker 
expression was accelerated: Cells grown under both adherent and suspension conditions 
ceased to express stem cell markers TRA I60 and SSEA3, and up-regulated VINIS 53 and 
A2B5 expression after 2 weeks of treatment with RA (Figure 3.7). This corresponds with the 
results of the cell count assay in demonstrating that RA treated TERA2.spi2 cells cultured 
under suspension conditions more rapidly depart from the stem cell phenotype than those 
cultured under adherent conditions. Stem cell markers SSEA3 and TRA I60 also 
demonstrated variable levels of expression and sensitivity to treatment. In this experiment 
SSEA 3 was expressed in 64% of cells grown under maintenance conditions and down-
regulated rapidly after RA treatment under both culture conditions, with less than I 0% of cells 
positive after 7 days. In contrast, TRA I60 was expressed at a high intensity in I 00% of cells 
grown under maintenance conditions, and after 7 days of RA treatment was still expressed in 
60% of cells in adherent cultures compared to only 20% of cells suspension cultures. 
The neural associated markers A2B5 and VINIS 53 were markedly up-regulated by 
RA treatment, following a similar trend in both culture conditions. A2B5 expression was up-
regulated very rapidly, from less than 5% positive in EC cultures to 80-90% of cells 
expressing A2B5 after 7 days of treatment. VINIS 53 expression was up-regulated more 
gradually, with approximately 50% of cells positive after 7 days and 80-90% positive after I4 
days. Together these data indicate that under both culture conditions, RA treated TERA2.spi2 
cells are differentiating along a neural lineage. 
Cells grown under suspension conditions for I4 days without RA treatment also 
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Figure 3.7 
Comparing The Regulation of Surface Markers During RA Treatment OfTERA2.sp12 Cells 
Cultured Under Adherent Or Suspension Conditions. 
i. Histograms Depicting Percentage Of Cells Positive For Stem Cell Surface Markers SSEA3, TRA 160 Or 
Neural Associated Markers A2B5 And VINIS 53 After 7 Or 14 Days Of Treatment, (Patterned Or Black 
Bars Respectively). 
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ii. Comparison Of Representative Flow Cytometer Traces For TRA 160 Detection After 14 Days In Adherent 
Cultures Treated With (+RA) or Without RA And Suspension Cultures Treated Without RA. 
Adherent culture + RA Adherent culture Suspension culture 
Fluorescence intensity 
Figure 3.7 
Figure 3.7. Detection of surface markers by flow cytometry. TERA2.sp12 cells were seeded at a density of 
20,000 cells/cm2 into either T75 culture flasks or bacteriological petri dishes and after 24 hours either treated 
with lOJ.1M RA or untreated. At 7 and 14 days 3 replicate cultures of each treatment were harvested and 
individualised using Trypsin and immuno-labelled with antibodies to surface antigens SSEA3, TRA 160, 
A2B5, VINIS 53 or with the control antibody P3X. The percentage of immuno-positive cells in each sample 
was detected using a flow cytometer, with the mean percentage for each treatment generated from 3 
replicates. Histograms in plate i depict the mean percentage of positive cells at day 7 (patterned bars) and day 
14 (black bars) after live immuno-staining with either SSEA3, TRA 160, A2B5 or VINIS 53. A confluent 
flask ofTERA2.sp12 cells cultured under maintenance conditions was used to monitor expression in EC cells 
(white bars). The percentage of immuno-positive cells in each sample was detected using a flow cytometer, 
with the mean percentage for each treatment generated from 3 replicates. The error bars represent the 
standard deviation of the mean. Mock treated cultures were split and re-seeded at a ratio of 1 :3 at 7 and 10 
days of culture (only one flask from each original culture was maintained, the remaining cells were discarded). 
(ii) Representative flow cytometry traces of adherent cultures treated with or without RA and suspension 
cultures treated without RA and either immuno-stained with TRA 160 (grey trace) or with the control antibody 
P3X (clear trace). As depicted by the histograms in (i), both adherent and suspension cultures rapidly down-
regulated the expression of stem cell markers SSEA3 and TRA 160, although in suspension cultures TRA 160 
was more rapidly down-regulated such that after 7 days less that 25% of the population were immuno-
positive, compared to over 50% in adherent cultures. Correspondingly, neural differentiation associated cell 
surface markers A2B5 and VINIS 53 were markedly up-regulated by RA treatment in both culture conditions, 
such that after 14 days over 80% and 90% of cells were positive for these markers respectively. Stem cell 
markers were down-regulated to some extent in cultures treated with-out RA, with a more permanent and 
marked down-regulation detected in suspension cultures. Although the percentage of cells positive for TRA 
160 was still relatively high in suspension cultures treated without RA, comparisons of flourescence intensity 
in (ii) demonstrate that the level ofTRA 160 expression was markedly down-regulated in suspension cultures 
compared to adherent cultures treated without RA. 
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down-regulated the expression of stem cell markers TRA 160 and SSEAJ to some extent. This 
is clearly visible in representative traces of TRA 160 expression (plate ii, Figure 3.7). At 14 
days the number of TRA 160 positive cells is still high, but compared to the pattern of 
expression in EC cells, there is a marked spread in fluorescence intensity, with a large 
proportion of cells down-regulating the expression levels of TRA 160. Correspondingly, in 
suspension cultures without RA treatment the number of cells positive for neural associated 
markers A2B5 and VINIS 53 was up-regulated to a certain extent (Figure 3.7), although in 
flow cytometry traces of A2B5 expression the staining intensity in positive cells was still very 
low compared to RA treated cultures. Taken together this suggests that a population of cells in 
aggregates cultured under suspension conditions in the absence of RA are embarking on 
differentiation (including neural differentiation). 
Cells grown at the same density under adherent conditions without exposure to RA 
also showed some variation in cell surface marker expression. The proportion of cells positive 
for SSEA3 decreased after 7 days by approximately 20%, but after 14 days SSEA3 expression 
was once again similar to the expression in cells cultured under maintenance conditions. 
Correspondingly, VINIS 53 expression was up-regulated in these cultures at 7 days, although 
after 14 days the number of positive cells was reduced to levels seen in cells cultured under 
maintenance conditions. This implies that the regulation of expression of these markers is very 
sensitive in TERA2.spl2 cells, and that changes in the expression of these markers may be 
reversible to some extent. 
3.2.4 Comparison of neural and non-neural ectoderm protein expression 
To compare the expression of proteins associated with neural and non-neural ectoderm 
differentiation in TERA2.sp 12 cells cultured with RA under either adherent or suspension 
conditions, the total level of expression of these proteins was monitored over 14 days using 
Western blot analyses. TERA2.sp 12 cells were cultured under adherent or suspension 
conditions with or without RA as described in Section 2.1.1, with three replicate cultures for 
each treatment harvested at 4, 7 and 14 day time-points. At each time-point, cell pellets from 
sample cultures for each condition were collected as described in Methods Section 2.4, and 
cell pellets from IMR32 and FaDU cell lines were collected to use as positive controls for 
neural and non-neural ectoderm differentiation respectively. Protein was extracted from 
pelleted cell samples, electrophoresed in a 1 0% gel and transferred to PVDF membrane 
following the Western blot analysis protocol in Section 2.4. Blots were probed with antibodies 
to the neural progenitor protein Nestin, the neuronal proteins ~Ill tubulin and NSE and 
epithelial keratins 8 and 18, following the protocol in Section 2.4. Equal loading was assessed 
by both Ponceau staining and by probing with an antibody to ~-actin, and immuno-blots were 
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repeated three times with samples from different passage numbers. 
Comparisons of the expression of neural and non-neural ectoderm proteins in RA 
treated cultures by Western blot analysis revealed differing trends in cells grown under 
adherent or suspension conditions, as depicted by Figure 3.8. Neural proteins were 
consistently up-regulated by RA treatment in both cultures (panels i and ii), but the total levels 
of these proteins were up-regulated to a greater extent over the first 14 days in cultures grown 
under suspension conditions. This marked difference was observed in every Western blot 
comparison ofthese cultures undertaken, and was most marked at 7-14 days oftreatment. The 
neural progenitor protein Nestin also demonstrated a similar pattern of regulation, with protein 
expression detected after 4 days of treatment and increasing over 14 days in both RA treated 
cultures, although to a greater extent in cells cultured under non-adherent conditions. In 
adherent conditions, Nestin expression was subsequently steadily down-regulated between 14 
and 28 days. No down-regulation in Nestin expression was observed in cultures grown under 
non-adherent conditions as they were analysed only for the first 14 days of treatment. 
In parallel to the differences between levels of neural protein up-regulation in RA 
treated cultures grown under adherent or suspension conditions, the level of Keratin 8 protein 
as detected by Western blot analysis decreased rapidly in cells cultured to form aggregates, 
reaching almost undetectable levels by 7 days, whereas in cultures grown under adherent 
conditions, Keratin 8 levels increased over time, particularly between 7 and 14 days. These 
observations were made with data from more than 3 repeated experiments using cells grown 
from different passages. Keratin 8 levels in cells cultured under suspension conditions without 
RA also decreased, to a small extent. Neuronal ~Ill tubulin levels were not markedly up-
regulated, although the expression of Neuronal ~Ill tubulin was variable over repeated 
experiments. Nestin expression also demonstrated variable levels of expression in repeated 
analyses, with the blot in panel iii in Figure 3.8 showing strong Nestin expression after 14 
days of culture. Taken together the Western blot data indicate that under both suspension and 
adherent conditions, RA treated TERA2.sp 12 cells are expressing developmentally regulated 
neural proteins as they undergo neuronal differentiation. However, compared to adherent 
cultures the rate of differentiation appears to be faster in suspension cultures and the 
proportion of cells differentiating along a neural lineage appears to be greater. This 
corresponds with evidence of minimal differentiation into non-neural ectoderm (as indicated 
by the expression of Keratin 8) under suspension conditions, compared to considerable levels 
of differentiation in adherent cultures. 
For a more direct comparison between RA treated cultures grown under adherent and 
suspension conditions, protein expression was also compared in samples loaded onto the same 
gel, as depicted in the Western blot in Figure 3.9. Protein from RA treated cells cultured under 
Figure 3.8 
Western Blot Detection OfNeural And Non-neural Ectoderrn Proteins In RA Treated Adherent 
And Suspension Cultures Of TERA2.sp 12 Cells 
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Figure 3.8 Western blot detection of neural and non-neural ectoderm markers from protein extracted at 4, 7 and 
14 days from cells cultured under suspension culture conditions and either treated on day I with IO!!M RA (i) 
or without RA (iii), and detection of the same markers from protein extracted at 4, 7, 14, 21 and 28 day time-
points from TERA2.sp 12 cells cultured under adherent culture conditions and treated on day I with I O!!M RA 
(ii). Positive controls for neural protein (A) and non-neural ectoderm protein (B) were extracted from IMR32 
and FaDU cells respectively, and protein was extracted from confluent cultures of TERA2.spl2 cells grown 
under maintenance conditions for EC samples. TERA2.sp 12 cells grown as suspension cultures with RA 
demonstrated a marked increase in neural proteins ~Ill tubulin and NSE, and the neural progenitor protein 
Nestin. Keratin 8 was down-regulated by 4 days of RA treatment. Note no controls were loaded for NSE and 
Nestin Western blots in panel (i). 
Cells grown with RA as adherent cultures over 4-28 days (ii) demonstrated a gain in protein expression of 
neural markers ~Ill tubulin and NSE, and a transient increase in expression of the neural progenitor protein 
Nestin. The levels of the simple ep ithelial protein Keratin 8 were also up-regulated with RA treatment. Cells 
grown as suspension cultures without RA treatment (iii) demonstrated some transient up-regulation of ~Ill 
tubulin expression, and variable Nestin expression, with maximal levels detected at 14 days. Keratin 8 protein 
was down-regulated to some extent, reaching low levels after 14 days. Note that Keratin 8 protein is detected as 
two bands, at 54KDa and 45KDa (the band at 45KDa represents a degradation product of Keratin 8). 13 actin 
detection demonstrated equal loading in these samples. 
Western Blot Comparison Of Keratin 8 and ~Ill Tubulin Expression In RA Treated 
Adherent and Suspension Cultures Of TERA2.sp12 Cells 
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Figure 3.9. Western Blot detection of Keratin 8, ~Ill tubulin and 13 actin from protein extracted at 5 and 14 
days from TERA2.sp 12 cells seeded either as adherent cultures or suspension cultures and treated after 24 
hours with IO~M of RA. Protein was also extracted from confluent cu ltures of TERA2.sp 12 cells grown 
under maintenance conditions (EC sample). Keratin 8 expression was detected to increase over time in 
cultures grown under adherent conditions, whereas under suspension conditions Keratin 8 expression was 
detected to remain low and decrease to almost undetectable levels by 14 days of culture. Note that Keratin 
8 protein is detected as two bands, at 54KDa and 45KDa (the band at 45KDa represents a degradation 
product of Keratin 8). Neuronal 13111 tubulin protein levels increased in both culture conditions after RA 
treatment, but to a much greater scale in cells cultured under suspension conditions. 13 actin detection 
demonstrated equal loading in these samples. 
Figure 3.9 
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either suspension or adherent conditions for 7 and 14 days was electrophoresed on the same 
gel and transferred to PVDF membrane as previously described. Membranes were then 
immuno-blotted with antibodies to keratin 8 or neuronal ~III tubulin. Equal loading was 
assessed by both Ponceau staining and by probing with an antibody to ~-actin. The magnified 
up-regulation of neuronal ~Ill tubulin in cultures treated with RA under aggregate-forming 
conditions compared to adherent conditions is marked, and correspondingly there is a marked 
down-regulation in Keratin 8 protein expression compared to an up-regulation in cells 
cultured under adherent and non-adherent conditions respectively. This confirmed that marked 
differences in the expression of markers for neural and non-neural ectoderm were generated in 
TERA2.sp 12 cells treated with RA under either adherent or suspension conditions, suggesting 
that under adherent conditions differentiation into both neural and non-neural ectoderm is 
promoted, whereas under suspension conditions solely neural differentiation occurs. 
3.2.5 Characterising the EC phenotype 
To assess the undifferentiated TERA2.sp 12 cell phenotype, cells were seeded at maintenance 
density into 12 well plates, and grown in maintenance media for 2-3 days until approximately 
90% confluent. Cultures were then fixed in 4% PF A for 20 minutes at room temperature, and 
washed 3 times in PBS for 10 minutes. These cultures were then immuno-labelled following 
the protocol in Section 2.5 with antibodies to stem cell antigens TRA 160, SSEA4, Oct4, 
Nanog and with antibodies to the neural progenitor marker Nestin, neuronal markers ~Ill 
tubulin, NF200, NF160, the epithelial keratins 8 and 18, and pan-epithelial keratin. Cultures 
from four different passages were immuno-stained in four repeated experiments. 
Cultures grown under maintenance conditions immuno-stained positive for stem cell 
markers Nanog, Oct4 and TRA 160 in all cells observed (representative images for Oct4 and 
TRA 160 immuno-staining are depicted in Figure 3.1 0). However, these cells also faintly 
expressed Nestin and neuronal ~Ill tubulin (Figure 3.10 plates D-F). Note that Nestin was 
undetectable in EC samples using Western blot analysis, whereas neuronal ~Ill tubulin was 
present at low levels in all protein from EC samples in Western analyses. The expression 
pattern of both Nestin and neuronal ~III tubulin was diffuse and not typical of neural cells, 
and ~Ill tubulin expression was also detected in cells that appeared to be actively dividing 
(arrow). Thus under maintenance conditions TERA2.sp12 cells express the normal panel of 
stem cell markers indicative of a stem cell phenotype, although they also express low levels of 
some neural markers (in a pattern of expression that is not typical of neural cells). 
3.2.6 RA induced differentiation as adherent cultures 
To characterise the neural and putative epidermal differentiation of RA treated adherent 
!mm uno-staining Profile Of TERA2.sp 12 EC Stem Cells 
Figure 3.1 0. Confluent adherent cultures of TERA2.sp 12 cell s grown at maintenance conditions 
were fixed with PFA and immuno-stained with antibod ies to Oct4 (A), TRA 160 (C), Nestin (D), 
Pill tubulin (E) and the nuclei counterstained with hoescht (blue). TERA2.sp 12 EC cells 
expressed stem cell transcription factor Oct 4 (A, with corresponding hoescht stain in B) and 
TRA 160 (overlaid with hoescht stain in C). However, TERA2.sp 12 EC cells also expressed faint 
but significant levels of Nestin (D) and demonstrated weak staining for neuronal specific Pill 
tubulin (E with overlay in F). Neuronal l3 Ill tubulin reactivity was also detected in actively 
dividing cells (arrow). Scale bars = I OOJlm 
Figure 3.10 
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cultures, cells were seeded at 20,000cells/cm2 into NUNC coated 12 well plates and cultured 
in DMEM media with I 0% FCS, 2mM L-glutamine and I J.LM pen/strep. After 24 hours cells 
the media was removed and replaced with the same media supplemented with 1 OJ.LM RA. In 
experimental controls the media was replaced with the same media with no supplement or 
vehicle treated with media supplemented with 1 J.Ll/ml of DMSO. At 7 and 14 day time-points 
selected well plates for each treatment were fixed in 4% PF A for 20 minutes at room 
temperature, or fixed on ice in cold methanol for I 0 minutes, washed three times in PBS for 
10 minutes, and immuno-labelled following the procedure in Section 2.5 with the following 
antibodies: Neural progenitor markers Musashi and Nestin, neural markers MAP2, ~lll 
tubulin, NF160, NF200, and the glial marker GFAP (for GFAP immuno-staining cultures 
were fixed in methanol). To assay for epidermal differentiation cu ltures were immuno-stained 
with pan-epithelial keratin, keratin 8, keratin 18 and Tp63 antibodies. This immuno-labelling 
experiment was repeated twice for 7 day time-points and three times for 14 day time-points 
using TERA2.sp 12 cells at different passages. As positive controls for neural and glial 
differentiation, cultured human IMR 32 cells and PFA fixed cryo-sectioned rat brain were 
immuno-stained in parallel. As a positive control for differentiation into prospective epidermis 
cultured FaDU cells were immuno-stained in parallel. As a negative control for non-specific 
binding of primary antibodies, FaDU cells were immuno-stained with neural antibodies, and 
IMR 32 cells immuno-stained with epithelial keratin and Tp63 antibodies. 
In order to further characterise the expression profile of the neural and non-neural 
populations identified in RA treated adherent cultures, TERA2.sp 12 cells were seeded into 12 
well plates and cultured for 14 days with lOJ.LM RA as described, fixed in 4% PFA, washed 3 
times in PBS and double immuno-labelled following the protocol in Section 2.6.3 using the 
combinations of antibodies listed in Table 3.3 
Table 3.3 Combinations of antibodies used to further characterise neural and non-neural 
ectoderm populations of RA treated TERA2 .sp 12 cells. 
ANTIBODY COMBINATION ANTIBODY TYPE AIM OF IMMUNO-LABELLING 
Nestin + ~Ill tubulin (Covance) Mouse + rabbit To discriminate between neural progenitors and maturing neurons. 
MAP2 +~Ill tubulin (Covance) Mouse + rabbit Characterise maturing neural cells. 
NF160 + NF200 Mouse + rabbit Characterise mature neurons 
NF160 +~Ill tubulin (Covance) Mouse + rabbit . 
Keratin 8 (ABCAM) + ~Ill tubulin Rabbit + mouse Are any neural cells expressing Keratin (Sigma) 8? 
Keratin 8 (ABCAM) + Nestin Rabbit + mouse Are any neural progenitor/ Nestin positive cells expressing Keratin 8? 
Pan epithelial keratin + ~Ill tubulin Discriminate between cells positive for Mouse + rabbit neural and non-neural ectoderm (Covance) 
antigens 
Keratin 8 + 18 Rabbit + mouse Characterise epithelial marker positive population 
Pan epithelial keratin + TP63 Mouse+ goat Characterise prospective epidermis -like population. 
As negative controls for non-specific binding of the secondary antibody, some wells were 
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incubated with no primary antibody, and then incubated with either a combination of mouse 
and rabbit secondary antibodies or mouse and goat secondary antibodies in antibody diluent. 
This immuno-labelling experiment was repeated four times with cultures at different passage 
numbers. 
Neural differentiation 
In accordance with the Western blot analyses, immuno-staining assays detected marked 
evidence of neural differentiation in RA treated adherent cultures: After 14 days a 
heterogeneous population of neural cells was displayed, with the majority of cells staining 
immuno-positive for neural progenitor markers Musashi and Nestin, and substantial 
populations expressing various neural markers including neuronal ~Ill tubulin, MAP2 and 
neurofilaments. No cells stained GF AP positive by 14 days, although some cells expressing 
the astrocytic protein SI 00 were detected. After 14 days, the majority of cells stained brightly 
positive for Nestin or for neuronal ~Ill tubulin, and distinctive rosette or ridge formations 
were observed at high frequencies within all cultures examined, as represented in Figure 3.11. 
These rosette formations were also visible under phase microscopy. Maturing neurons with 
well developed axons and expressing neurofilaments such as NF200 or NF68 were also 
detected (Figure 3.11 ), usually growing in small clusters on top of the other cells. By 21 days 
of culture, Nestin expression was down-regulated such that most cells demonstrated no or 
very low staining intensity for Nestin, and neuronal ~Ill tubulin staining was dominant. 
However, in an exception to this trend, after 21 days some large aggregations of cells had 
formed within these cultures, and these stained positive for Nestin (Figure 3 .12) and 
incorporated BrDU. Aggregate-like structures also showed strong immuno-reactivity to 
MAP2 and NF200 and demonstrated distinct regional staining (Figure 3.13). Some structures 
observed appeared almost tubular, as depicted in Figure 3.13 plate D, where MAP2 immuno-
positive cells surround the outer edge and NF200 positive cells form a ring around the centre 
ofthe structure. 
Non-neural differentiation 
The large plaques of cells observed under phase contrast were negative for all neural and 
neuronal markers tested, including Nestin, Musashi, neuronal ~Ill tubulin, MAP2, 
neurofilaments, GFAP and SlOO. An example of positive ~Ill tubulin immuno-staining in 
surrounding cells is presented in Figure 3.14. However, these large cells showed strong 
immuno-reactivity to pan epithelial keratin, and in larger plaques a proportion of cells were 
faintly positive for the epidermis stem cell marker TP63 (Figure 3.14 ). These 'large-cell 
plaques' were also negative for all stem cell markers tested, although there were a few 
exceptions: In cultures treated for 7 days with RA, a small number of plaques, which were 
Neural Differentiation In RA Treated Adherent Cultures OfTERA2.sp12 Cells 
Figure 3.11. TERA2.spl2 cells were seeded at 20,000 cells/cm2 into 12 well plates and treated with 
IOf.lM RA for 14 days prior to fixation in 4% PFA and immuno-labelling with either Nestin (green) 
and neuronal 13111 tubulin (red), (plates A-D) or with neurofilaments NF200 (red) and NFI60 
(green), (plates E-F). Note that the majority of cells expressed high levels of 13111 tubulin or Nestin . 
Plates A and 8 depict positive 13111 tubulin staining in two different regions within the same culture, 
(with corresponding Nestin staining and overlay for plate 8 in C and D). Note that Nestin and 13111 
tubulin positive regions surrounding weakly Nestin positive and ~Ill tubulin negative cells were 
frequently visible in these cultures. As depicted in 8,C (overlay D), some complex structures were 
also observed. The arrow denotes the edge of a thick ridge of very strong Nestin positive immuno-
staining, bounded by clusters of strongly 13111 tubulin positive cells which were often orientated with 
nuclei at the top of the ridge with axonal like projections leading down or away from the ridge. As 
depicted in E, F, neurons immuno-positive for NFI60 tended to grow on top of other cells and 
exhibited well defined axons. NF200 immuno-reactivity was also detected in cells displaying a less 
mature neuronal morphology, and some developing neurons did not show reactivity to both NF68 
and NF200 (F). Scale bars = I 00f.1m. 
Figure 3.11 
Figure 3.12 
Zones OfProliferation In 21 Day RA Treated Adherent Cultures OfTERA2.Spl2 Cells 
Figure 3.12. TERA2.spl2 cells were seeded at 20,000 cells/cm2 into 12 well plates and treated 
with I OflM RA for 21 days. Twenty four hours prior to fixation in 4% PF A, I OflM of BrDU was 
added to the culture media. Fixed cultures were then immuno-labelled with either Nestin or BrDU 
and the nuclei counterstained with hoescht. Minimal Nestin immuno-staining was observed 
throughout the culture with the exception of aggregate-like structures. Two different examples of 
positive Nestin staining are depicted in A (with hoescht overlay in B) and C (with hoescht overlay 
in D). Note that the stained cells are aligned in a radial orientation within the aggregate-like 
structure (A, overlay with hoescht in B), and that in C, (overlay with hoescht in D) an 
invagination is apparent within the centre of the aggregate-like structure. As depicted by a 
representative image in E (with hoescht overlay in F), BrDU uptake and cell proliferation was 
rare except within these aggregate-like structures. Note that clusters of BrDU positive cells were 
situated predominantly around the edge of these structures. Scale bars = I OOflM 
Figure 3.13 
NF200 And MAP2 Immuno-positive Aggregate-like Structures In 21 Day RA Treated 
Adherent Cultures OfTERA2.sp12 
Figure 3.13 
Figure 3.13 NF200 And MAP2 immuno-positive aggregate-like structures in 21 day RA treated adherent 
cultures. TERA2.spl2 cells were seeded at 20,000 cells/cm2 into 12 well plates and treated with lOJ.lM 
RA for 21 days. Cultures were then fixed in 4% PF A and double immuno-labelled with MAP2 (green), 
and NF200 (red) and the nuclei counterstained with hoescht. Aggregate-like structures demonstrated 
strong reactivity to MAP2 and NF200 with distinct regional staining. Some of these structures appeared 
almost tubular, as depicted in (A-C with magnified image in D). Note that MAP2 immuno-positive cells 
surround the outer edge and NF200 positive cells form a ring around the centre of the structure. As 
presented in E-F (with corresponding hoescht stain in G and overlay in H) distinct regional staining was 
visible within the structure and cells were aligned in a radial orientation. Scale bars = 1 OOJ.lm 
A Distinctive Sub-population Of Retinoic Acid Treated Adherent TERA2.sp 12 
Cells Express Markers OfNon-neural Ectoderm. 
Figure 3. 14. A distinctive sub-population of retinoic acid treated adherent ce lls express epithelial 
markers. TERA2.sp12 cells were seeded at 20,000 ce lls/cm2 into 12 well plates and treated with 
IO~M RA for 14 days prior to fixation in 4% PFA and double immuno-labelled with neuronal ~I l l 
tubulin (red) and pan-epithelial keratin (green), (A-C) or with pan-epithelial keratin (red) and the 
stem cell antigen Tp63 (green), (D-E). Distinctive populations of large diameter cells formed 
plaques negative for neuronal ~Ill tubulin (A) and positive for pan-epithelial keratin (in overlay B), 
creating a marked boundary of differential staining between the edge of the area of large cells and 
densely packed neural cells. Note that this partition is reflected in the contrasting, non overlapping 
morphologies between the two populations in the corresponding phase contrast image (C). Cells 
within these large plaques were detected to eo-express nuc lear localised Tp63 (D) and pan-
epithelial keratin (overlay in E). The expression pattern of TP63 and pan-epithelial keratin was 
similar to that of the positive control population of cultured FaDU cells (F) although the staining 
intensity for both pan-epithelial keratin and Tp63 was much brighter in the positive control 
population. Scale bars = I OO~m 
Figure 3.14 
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smaller in size, displayed some positive Nanog and TRA 160 immuno-staining, and the 
staining intensity was low in both cases. 
In order to further characterise the 'large-celled plaques' adherent cultures of 
TERA2.sp12 treated for 14 days with RA were screened with a panel of differentiation 
markers of other germ layers. Immuno-staining was negative in the large celled population 
within adherent cultures for all of these markers. However the endoderm marker HNF3~ was 
detected in less than 0.5% of the remaining cells, with positive nuclear localised staining 
typically occurring in a group of 2-3 cells. The previously identified marker of early 
mesoderm differentiation, Brachyury, was also detected at low levels in RA treated adherent 
cells. Expression was still very low, detected in less than 1% of the population, with positive 
nuclear localisation typically occurring in small groups of 4-8 cells. In both cases the cells 
were morphologically indistinguishable from the surrounding neural population under phase 
contrast microscopy, and no expression was detected in cells cultured under maintenance 
conditions. To summarise, the immuno-staining experiments identified both a neural and non-
neural population of cells in RA treated adherent cultures. The neural population consisted of 
both neural progenitors and a range of progressively more mature neuronal cells, whereas the 
morphologically distinct 'large cell plaques' expressed markers supporting their 
characterisation as non-neural ectoderm. Screening with markers for non-ectoderm derivatives 
also confirmed that the predominant differentiation in RA treated TERA2.sp12 cells is 
ectoderm derived. 
3.2. 7 RA induced differentiation as suspension cultures 
Assay of aggregate formation -similar to neurospheres? 
To determine whether RA treated aggregates shared characteristics typical of 
neurospheres, such as their formation from a single cell, a simple mixing experiment where 
aggregates were formed from a mixture of normal TERA2.sp12 cells and GFP transfected 
TERA2.sp 12 single cells was performed, and aggregate sections analysed for GFP expression. 
The GFP transfected TERA2.sp12 cell line (with GFP expression promoted by the CAG 
promoter); termed TERA2.spl2.GFP was used in addition to TERA2.sp12 cells. Confluent 
T75 flasks of TERA2.sp12 or TERA2.spl2.GFP were individualised using Trypsin as 
previously described to form a single cell suspension. Then different mixtures of 
TERA2.sp12.GFP and TERA2.sp12 cells were seeded at a density of 20,000cells/cm2 into 
90mm bacteriological dishes as summarised in Table 3.4. Cultures were treated with RA and 
cultured following the protocol in Section 2.11. To assess the effect of cell density on 
aggregation formation, single cells were also seeded following the same ratios as in Table 3.4 
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at half the normal differentiation density, ( 1 0,000cells/cm2). 
After 5 days, aggregate cultures were then fixed in 4% PF A, embedded in OCT 
embedding medium and cryo-sectioned following the procedure in Section 2.5.2. Sections 
were collected on histobond slides and mounted under glass coverslips in vectashield 
mounting medium with 0.1% Hoescht, before being examined under a Nikon diaphot 30 
fluorescence microscope with filters suitable for the detection of GFP fluorescence and 
Hoescht fluorescence. 
Table 3.4 Summary of combinations of individualised TERA2.spi2.GFP and TERA2.sp12 
cells seeded into bacteriological dishes. 
Treatment Percentage of Percentage of AIM TERA2.sp12.GFP cells TERA2.sp12 cells 
1 100 0 Are all cells in aggregates derived from TERA2.sp12.GFP cells detected to express GFP? 
2 0 100 Check that no aggregates derived from TERA2.sp12 cells are detected to express GFP 
Do aggregates derived from a seeding mixture of 
3 50 50 both TERA2.sp12 and TERA2.sp12.GFP cells 
contain either GFP expressing or non-GFP 
exPressing cells (supports clonal Ho) or a mixture? 
Cultures seeded entirely with the TERA2.sp12.GFP cell line formed aggregates in which all 
the cells observed were GFP positive, as shown in a representative aggregate section in panels 
A-C of Figure 3.15, although the level of GFP fluorescence detected was highly variable from 
cell to cell. Control cultures seeded entirely with non-GFP expressing TERA2.sp12 cells 
formed aggregates in which no GFP fluorescence was detected. Cultures seeded from a 50:50 
mixture of normal and GFP expressing cells formed aggregates that all contained both GFP 
positive and GFP negative regions (representative section in panels D-F of Figure 3.15). No 
aggregates containing solely GFP positive or GFP negative cells were observed, even in 
aggregates formed from cells seeded at a lower density - in this case the aggregates formed 
were smaller in size. This experiment indicates that under these conditions aggregates of 
TERA2.sp12 cells are not formed from individual cells, rather from a combination of cells 
aggregating together and proliferating. Therefore they do not exhibit one of the defining 
features of neurospheres, and should not be described as such. 
Histology of aggregates 
To investigate the internal structure of aggregates formed with RA treatment under suspension 
conditions, sections of aggregates formed after RA treated culture under suspension 
conditions were stained with haematoxylin and eosin. To summarise, TERA2.spl2 cells were 
cultured with 1 OJ.I.M RA under suspension conditions for 7 or 14 days as described in Section 
2.1.1, fixed in 4% PFA and either embedded in OCT embedding medium and cryo-sectioned 
following or dehydrated and embedded in paraffin wax and sectioned using a microtome 
Figure 3.15 
TERA2.spl2 Aggregate Formation Assay 
100% TERA2.spi2.GFP 50% TERA2.spi2.GFP 
Figure 3.15. Cryostat sections of aggregates formed from individualised cells seeded at 20,000cells/cm2 into 
bacteriological dishes and treated with IO~tM RA for 4 days prior to fixation in 4% PFA. Cultures were 
either seeded entirely with TERA2.spi2.GFP cells, with a 50:50 mixture ofTERA2.spl2: TERA2.spi2.GFP 
cells, or entirely with TERA2.sp 12 cells. Fixed aggregates were embedded in OCT embedding medium, 
cryostat sections collected on slides counterstained with hoescht (blue), and GFP fluorescence (green) 
detected using a filter suitable for GFP fluorescence under a fluorescence microscope. As depicted in a 
representative aggregate section (overlay in A, hoescht stain in B, GFP fluorescence in C), GFP fluorescence 
was detected in all cells within aggregates generated from cultures seeded with I 00% TERA2.sp 12.GFP 
cells, although levels of GFP expression were variable from cell to cell. However, as depicted by a 
representative aggregate section (overlay in D, hoescht stain in E, GFP fluorescence in C), aggregates grown 
from a seeding mixture of 50% TERA2.sp 12.GFP and 50% TERA2.sp 12 cultures contained distinct regions 
displaying either the presence (arrow i) or complete absence of GFP (arrow ii). This indicates that under 
these conditions aggregates form from multiple cells and are not clonal in origin. Scale bars = I OO~tm 
Haematoxylin And Eosin Stained Sections OfRA Treated Aggregates Formed 
From Suspension Culture OfTERA2.sp12 Cells. 
Figure 3.16. TERA2.spl2 cells were seeded at 20,000 cells/cm2 into bacteriological petri dishes 
and treated with IOJ.!M RA for 14 days to form suspension aggregates. These were fixed in 4% 
PFA, embedded in OCT embedding medium and I 0 JJm cryostat sections collected on slides and 
stained with haematoxylin, eosin, and alkaline alcohol to blue the nuclei. Phase contrast images of 
sections of the same aggregate (A, B) and two different aggregates (C, D) under I Ox and 20x 
magnification demonstrate that the internal structure is not homogeneous. Cells were often 
arranged around distinct tubular formations, (arrow heads) and at least two different cell 
morphologies were visible, with some cells displaying prominent round nuclei and others 
displaying a more angular morphology with a low cytoplasm to nucleus ratio (arrows). Scale 
bars= I OOJ.!m 
Figure 3.16 
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following the protocol in Section 2.6. Sections were then collected on Histobond slides and 
stained with haematoxylin and eosin as described in Section 2.6. 
Sections demonstrated that aggregates were typically solid in structure, and in 
sections of 14 day aggregates some small cavities or tubular formations were observed 
(depicted by arrowheads in Figure 3 .16). Staining also revealed that after 14 days cells within 
these aggregates were not homogeneous, with at least two different cell morphologies visible 
(arrows in Figure 3.16). 
Location of dividing cells within aggregates 
To locate the population of dividing cells within RA treated aggregates and identify any 
patterns of localisation, suspension cultures of RA treated aggregates were pulsed with BrDU 
prior to processing and sectioning at 5, 7 and 14 day time-points. For each time-point, 24 
hours prior to fixation, 3.26 Jll/ml of a 10 mg/ml stock solution of 5-bromo-2'-deoxyuridine, 
BrDU (Sigma) in PBS was added to the cell culture media to make a final concentration of 
lOJlM. Collected aggregates were then fixed in 4% PFA, processed and immuno-stained with 
the G3G4 antibody to BrDU (hybridoma) following the corresponding immuno-labelling 
protocols in Section 2.5, except an additional step was required. Prior to the blocking stage, 
cells were treated for I 0-15 minutes with 4NHCL to denature the double stranded DNA and 
allow penetration ofthe BrDU antibody, and then washed in PBS for 5 minutes. In addition, 
the diluted primary antibody was pre-warmed to 37°C prior to application. As a negative 
control, cultures which had not been pulsed with BrDU prior to fixation were also immuno-
labelled with the antibody to BrDU in parallel. 
As demonstrated by representative sections in Figure 3.17, positive immuno-staining 
for incorporated BrDU was very frequent in 5 day aggregates, with BrDU positive cells 
distributed evenly through-out the aggregate. The frequency of BrDU positive cells decreased 
over time such that 14 day aggregates contained lower numbers of immuno-positive cells, 
although different aggregates demonstrated different levels of positive staining. No distinctive 
regional localisation of dividing cells was observed within the aggregates, although in the 
older and larger aggregates BrDU staining was typically observed less frequently in the 
centre. In general, larger aggregates also appeared to contain fewer cells that had incorporated 
BrDU then smaller aggregates. These data suggest that over time there are fewer dividing cells 
within RA treated aggregates. Although there is no distinct localisation of dividing cells 
within these aggregates after 5 days of culture, after 14 days there may be a trend whereby 
dividing cells are localized to the centre of the aggregates, although this needs to be further 
analysed. 
Figure 3. 17 
Down Regulation Of Stem Cell Marker Expression And Proliferation In RA Treated Aggregates 
Formed From Suspension Culture Of TERA2.sp 12 Cells. 
5 DAYS 7 DAYS 
5DAYS 14 DAYS 
Figure 3.17. TERA2.sp 12 cells were seeded at 20,000 cells/cm2 into bacteriological petri dishes and treated with 
1 O~M RA to form suspension aggregates. After 5 or 7 days aggregates were fixed in 4% PFA, embedded in 
OCT embedding medium and IO~m cryostat sections collected on slides. Sections of day 5 aggregates were 
immuno-labelled with an antibody to Oct4 (A) and the nuclei counterstained with hoescht (overlay in B). 
Sections of 7 day aggregates were immuno-labelled with an antibody to TRA 160 (C) and the nuclei 
counterstained with hoescht (overlay in D). Nuclear expression of the stem cell marker Oct4 was down-regulated 
in the majority of cells within 5 day aggregate sections, with a minority of cells situated towards the edge of the 
aggregate demonstrating positive nuclear expression (B). Note that a substantial proportion of cells within 7 day 
aggregates immuno-stained positive for TRA 160. To detect proliferating cells in aggregates suspension cultures 
were grown as above and fixed at 5 or 14 days, except 24 hours prior to fixation , IO~M of BrDU was added to 
the culture media. After fixation aggregates were embedded and sectioned as above and immuno-labelled with an 
antibody to BrDU (red) and the nuclei counterstained with hoescht (blue). After 5 days of culture the frequency 
of BrdU labelled cells was relatively high in a typical aggregate (E), with positive cells distributed fairly evenly 
throughout the structure. In 14 day aggregates, the frequency of BrDU labelled cells was lower. An aggregate 
section demonstrating relatively high positive staining is depicted in F. Scale bars = 50 ~m 
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Pattern of stem cell marker down-regulation within aggregates 
The flow cytometry analyses demonstrated a rapid down-regulation of stem cell markers 
SSEA3 and TRA 160 in RA treated aggregate cultures, although 20% of the population was 
still immuno-positive for TRA 160 after 7 days of treatment. To confirm flow cytometry data 
and investigate the pattern of expression of other key stem cell markers in RA treated 
aggregates, TERA2.sp12 cells were differentiated with RA under suspension conditions as 
described in Section 2.1.1 for 5, 7 and 14 days, embedded in OCT mounting medium and 
I OJ.lm cryo-sections immuno-labelled with the stem cell markers TRA 160, Oct4 and Nanog 
following the protocol in Section 2.5. 
Immuno-staining for stem cell markers TRA 160 and Oct4 in sectioned aggregates 
revealed markedly different patterns of expression and down-regulation (Figure 3.17). TRA 
160 was expressed in distinct sub-populations through-out the aggregates after 7 days of 
culture, and down-regulated such that no positive cells were detected in aggregates cultured 
for 14 days. In contrast, nuclear localised Oct4 expression was rare in aggregates after only 5 
days of culture, with small pockets of immuno-positive cells typically occurring close to the 
surface of the aggregates, and no positive staining for nuclear localised Oct4 was observed in 
aggregates cultured for 7 days. This indicates that Oct4 and TRA 160 are not always eo-
expressed, and supports the hypothesis that cells that have already down-regulated the stem 
cell transcription factor Oct4 may still be expressing TRA 160. 
Characterising aggregate differentiation 
To characterise the neural differentiation within RA treated aggregates and assay for evidence 
of non-neural ectoderm differentiation, TERA2.sp 12 cells were differentiated with RA under 
suspension conditions as described in Section 2.1.1 for 5, 7 and 14 days, embedded in OCT 
mounting medium and I OJ.lm cryo-sections immuno-labelled using the protocol described in 
Section 2.5.2 with antibodies to the following: Neural progenitor markers Musashi and Nestin, 
neuronal markers MAP2, ~Ill tubulin, NF160, NF200 and glial marker GFAP (note that for 
GFAP immuno-labelling aggregates were fixed in methanol instead of PFA). To screen for 
evidence of non-neural ectoderm differentiation sections were immuno-stained with pan-
epithelial keratin, keratin 8 and keratin 18. To further characterise the neural populations in 
RA treated aggregates, slides were also double immuno-labelled as described in Section 2.5.4 
with the combinations of antibodies listed in rows 1-4 ofTable 3.3. 
As detected by Western blot analyses, immuno-staining demonstrated strong up-
regulation of neural differentiation markers in RA treated suspension cultures. Sections of 
aggregates generated from 7 days of suspension culture stained brightly immuno-positive for 
Nestin and neuronal ~Ill tubulin, and immuno-positive cells for these markers very closely 
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associated. However the staining intensity was greater in sections of aggregates cultured for 
14 days. In a proportion of 14 day aggregates, tubular or rosette-like staining of radially 
arranged Nestin positive and ~Ill tubulin negative cells around a small cavity was observed 
(Figure 3.18). In some cases an aggregate section contained up to three of these rosette-like 
structures, and multiple sections through the same aggregate revealed that some of these 
cavities extended through the aggregate and were tubular in structure. 
Cells expressing neuronal filaments NF200 and NF160 and demonstrating a more 
mature morphology were frequently detected in immuno-labelled sections of 14 day RA 
treated aggregates, usually situated close to the surface of the aggregate (Figure 3.19, F). 
These neurofilaments were not expressed in cells within or close to rosette-like structures 
(arrow head). lmmuno-staining with MAP2 identified immuno-positive cells localised within 
a region close to the surface of the aggregate, such that sections through the middle of the 
aggregate frequently contained a ring of immuno-stained positive cells (Figure 3.19). In 
summary, immuno-staining analyses demonstrated that within RA treated aggregates formed 
from suspension culture, extensive neuronal differentiation was occurring in the absence of 
differentiation into non-neural ectoderm. Complex structures resembling neural tube 
formations were present and aggregates contained a marked level of organisation with neurons 
at different developmental stages regionally localised. 
No markers of other germ layer derivatives were detected by immuno-staining in RA 
treated aggregate sections (in contrast to positive controls), and immuno-staining for epithelial 
keratins was negative in most aggregates. However within one batch of aggregates in rare 
cases a ball of cells close to the centre of the aggregate was detected to express keratin 8 and 
this exhibited corresponding negative staining for neural markers. This indicates that on rare 
occasions some RA treated cells cultured under suspension conditions are able to differentiate 
into aggregates containing non-neural ectoderm, which may be associated with variations in 
the culture conditions. 
3.2.8 Aggregates formed from suspension culture without RA 
Histology of aggregates 
To study the internal structure of aggregates formed from culture under suspension conditions 
in the absence of RA, TERA2.sp 12 cells were cultured under suspension conditions for 7 or 
14 days as described in Section 2.1.1, fixed in 4% PF A and either embedded in OCT 
embedding medium and cryo-sectioned, or dehydrated, embedded in paraffin wax and 
sectioned using a microtome following the protocols in Section 2.6. Aggregate sections were 
collected on Histobond slides and subsequently stained with haematoxylin and eosin 
Figure 3.18 
Formation OfNeural Tube-like Structures Within RA Treated Aggregates Formed From 
Suspension Culture OfTERA2.spl2 Cells. 
Figure 3.18. TERA2.sp 12 cells were seeded at 20 000 cells/cm2 into bacteriological petri dishes and 
treated with IO~M RA to form suspension aggregates. After 14 days aggregates were fixed in 4% PFA, 
embedded in OCT embedding medium, IO~m cryostat sections collected on slides and double immuno-
labelled with antibodies to neuronal ~III tubulin (red) and Nestin (green) and the nuclei counterstained 
with hoescht (blue). Two different sections (A-D and E-F) through the same aggregate present distinct 
rosette (arrow head) and tubular (arrow) formations that appear to form a tube through the aggregate . 
These structures were composed of Nestin immuno-positive cells that orientated radially from the centre 
and were negative for neuronaiJ3111 tubulin. Overlay images (C and with hoescht in D) show that many 
cells within the aggregate stained positive for Nest in or for neuronal 1311 I tubulin (although no cellular eo-
localisation was detected). Scale bars = 50~m 
Regional Staining For Neurofilaments And MAP2 Within RA Treated Aggregates 
Formed From Suspension Culture OfTERA2.sp12 Cells. 
Figure 3.19. TERA2.sp 12 cells were seeded at 20,000 cells/cm2 into bacteriological petri dishes 
and treated with I OJ.!M RA to form suspension aggregates. After 14 days aggregates were fixed 
in 4% PFA, embedded in OCT embedding medium, I OJ.Lm cryostat sections collected on slides 
and double immuno-labelled with antibodies to NF200 (red) and NFI60 (green) in plates A-C and 
plates D-E or with an antibody to MAP2 (green, plate F). Sections depicted by examples of two 
different aggregates (A,B with corresponding overlay D) and (E,F) contained a population of 
cells with a neuronal morphology which eo-expressed the neurofilaments NFI60 and NF200. 
Cells expressing high levels of these neurofilaments were typically situated close to the surface of 
the aggregates (arrows), and neither neurofilament was expressed in cells within or close to 
putative tubular structures (arrow heads). A representative section of an aggregate stained with 
MAP2 as shown in F, contains MAP2 bright cells situated in a ring close to the surface of the 
aggregate (outlined with white dashes) with very strong staining in the cytoplasm around the 
nucleus. As depicted by an asterix, cells within putative tubular structures contained cells that 
were faintly positive for MAP2. Scale bars = 50J.1m 
Figure 3.19 
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following the protocol Section 2.6.2. 
Aggregates formed from culture under non-adherent conditions and without RA were 
usually larger than those formed with RA treatment, and frequently contained cavities as 
indicated by arrow heads in Figure 3.20. Cells usually lined these cavities in an organised 
manner, such that the surface of the cavity was relatively smooth, and immuno-staining of 
these aggregates with the stem cell surface marker TRA 160 stained continuous membranes of 
the cells surrounding these cavities, an indication that these cavities were not formed from 
mechanical stresses during processing. Haematoxylin and eosin staining identified at least 3 
morphologically different cell phenotypes within aggregate sections (arrows), indicating that 
these aggregates were heterogeneous in nature. 
Down-regulation of stem cell marker expression 
To characterise the population of cells within aggregates that had down-regulated surface stem 
cell antigens SSEA3 and TRA 160 as identified by flow cytometry, TERA2.spl2 cells were 
cultured as aggregates in suspension as described in Section 2.1.1 (without the addition of 
RA) for 5, 7 and 14 days. The' following procedures were carried out as detailed in Section 
2.5.2. At the selected time-points the aggregates were collected, fixed in 4% PFA, embedded 
in OCT embedding medium and cryo-sectioned. Ten micrometer sections from 5, 7 and 14 
day aggregates were then immuno-labelled with the stem cell antibodies TRA 160 and Oct4. 
Immuno-staining of sections ofthese aggregates with stem cell markers confirmed the 
flow cytometry results; regions of cells within the aggregates were slowly losing stem cell 
marker expression. After 7 days of culture under non-adherent conditions, small regions of 
adjacent cells within an aggregate (usually close to the surface) were negative for stem cell 
marker TRA 160, whereas marked down-regulation of Oct4 was already present in aggregates 
after 5 days (Figure 3.21 ). After 7 days almost no positive staining for nuclear Oct4 was 
detected, whereas the down-regulation of TRA 160 was more prolonged. After 14 days larger 
areas within the aggregates (typically closer to the centre) had down-regulated TRA 160 
expression, and a corresponding down-regulation in nuclear localised Oct4 staining was also 
observed, with roughly 50% of cells within an aggregate exhibiting negative staining for 
nuclear localised Oct4. These data support the hypothesis whereby an increasing number of 
cells within these aggregates are down-regulating stem cell antigens and differentiating. 
An alternative explanation for this pattern of expression could be that a sub-population of 
stem cell antigen negative cells within the culture has expanded in number and merged with 
aggregates consisting of stem cell antigen positive cells. However, the stem cell antigen 
positive population decreases over time, and no increase in propidium iodide exclusion was 
detected, indicating that this decrease is not due to cell death. 
Haematoxylin And Eosin Stained Sections Of Aggregates Formed From Suspension 
Culture Of TERA2.sp 12 Cells. 
Figure 3.20 
Figure 3.20. TERA2.spl2 cells were seeded at 20,000 cells/cm2 into bacteriological petri dishes 
and cultured for 14 days to form suspension aggregates. These were fixed in 4% PFA, embedded in 
OCT embedding medium and I Of..Lm cryostat sections collected on slides and stained with 
haematoxylin, eosin and alkaline alcoho l to blue the nuc lei. Phase contrast images of sections of 
three different aggregates viewed at I OX magnification {A, B) and 20X magnification (C) reveal 
that the aggregates were heterogeneous in structure, with some cavities present (arrow head), that 
are typically lined with an ordered arrangement of cells. At least 3 different cell morphologies 
were observed, as depicted by arrows in C. Scale bars = I OOf..Lm 
Figure 3.21 
Down-regulation Of Stem Cell Markers Within Aggregates Formed From Suspension 
Culture OfTERA2.sp12 Cells. 
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Figure 3.21. Down-regulation of stem cell markers within aggregates formed from suspension 
culture. TERA2.sp 12 cells were seeded at 20,000 cells/cm2 into bacteriological petri dishes and 
cultured for 7 or 14 days to form suspension aggregates. Aggregates were fixed in 4% PFA, 
embedded in OCT embedding medium, I OJ.Lm cryostat sections collected on slides and immuno-
labelled with an antibody to either the stem cell transcription factor Oct4 (A-B, E-F) or the stem 
cell surface antigen TRA 160 (C-D, G-H) and the nuclei counterstained with hoescht (blue). 
Regions negative for TRA 160 or nuclear localised Oct4 staining are outlined in white dashes. A 
representative section through an aggregate cultured for 7 days contains a small distinct region 
towards the edge of the aggregate exhibiting down-regulation of nuclear localised Oct4 (A with 
hoescht overlay in B). A similar pattern of down-regulation is also observed in a representative 7 
day aggregate section stained with TRA 160 (C with overlay in D). After 14 days of culture, a 
representative aggregate section (G with overlay H) demonstrates more substantial down-
regulation of this stem cell marker, with a large region exhibiting negative staining for TRA 160 
within the centre of the aggregate. Correspondingly at 14 days an aggregate section stained with 
an antibody to Oct4 (E with overlay F) demonstrates that a substantial proportion of cells within 
aggregates had down-regulated the expression of nuclear localised Oct4. Note that cells 
surrounding the cavity (arrow) in this section remained positive for nuclear localised Oct4. Scale 
bars= IOOJ.Lm 
Figure 3.21 
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Characterising differentiation 
To identify the phenotype of the cells that had down-regulated stem cell marker expression 
and determine whether, like ES cell derived embryoid bodies, these aggregates contained 
differentiated derivatives from all three germ layers, cryostat sections of day 7 and 14 
aggregates cultured without RA were immuno-stained with the following panel of markers for 
different germ layer derivatives and with antibodies to extmembryonic tissues. 
Table 3.5 Details of antibodies used in immuno-labelling screen for markers of differentiation 
ANTIGEN ANTIBODY SOURCE DILUTION FIXATIVE CATEGORY 
Nestin MouselgG Chemicon 1:400 PFA Ectoderm- neural progenitor 
13111 Tubulin Rabbit lgG Covance 1:400 PFA Ectoderm -neuronal 
NF160 or NFM MouselgG Chemicon 1:100 PFA . 
NF200 or NFH Rabbit lgG Chemicon 1:400 PFA . 
MAP2 MouselgG Sigma 1:200 PFA . 
TP63/TP73L GoatlgG R&D systems 1:50 PFA Ectoderm-epidermis 
Keratin 8 Rabbit lgG Abeam 1:100 PFA . 
Keratin epithelial MouselgG Chemicon 1:400 PFA . 
Gata 4 Goat lgG R&D systems 1:50 PFA Endoderm 
AFP MouselgG Sigma 1:100 PFA then 1 min Endoderm and 
with ethanol primitive endoderm 
HNF3j3 Goat lgG R&D systems 1:50 PFA Endoderm 
Brachyrury Goat lgG R&D systems 1:50 PFA Mesoderm 
a smooth muscle 
mouse lgG Sigma 1:100 PFA smooth muscle 
actin 
HCG mouse lgG Abeam 1:50 PFA Trophoblast -trophoectoderm 
Nuclear localised 
Keratin 8 Rabbit lgG Abeam 1:100 PFA marker of 
troohoblast cells 
No mature neurons were observed at 14 days in the sections sampled, although most 
aggregates contained Nestin and pm tubulin positive cells. However, the pattern of staining 
for both Nestin and pm tubulin was diffuse and very similar to that observed in 
undifferentiated TERA2.sp 12 cells. In contrast, large regions within the aggregates frequently 
stained immuno-stained positive for pan epithelial keratin (Figure 3.22), and cells within these 
regions were morphologically different under phase microscopy. Many cells within aggregate 
sections also exhibited positive nuclear staining for the early endoderm transcription factor 
Gata4 and mesoderm transcription factor Brachyury, as depicted by representative sections in 
Figure 3.22, whereas no positive immuno-staining for the endoderm transcription factor 
HNF3p, the smooth muscle protein a-smooth muscle actin or the trophoblast hormone HCG 
was detected. In rare cases (less than 5% of aggregates screened), 2-3 cells within a sectioned 
aggregate stained positive for the primitive endoderm protein AFP. These immuno-staining 
analyses provide supporting evidence that TERA2.sp12 cells within aggregates formed from 
culture under suspension conditions in the absence of RA are differentiating into non-neural 
ectoderm, mesoderm and endoderm progenitors. This draws comparisons to the formation of 
Figure 3.21 
Down-regulation Of Stem Cell Markers Within Aggregates Formed From Suspension 
Culture OfTERA2.spl2 Cells. 
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Figure 3.22. TERA2.sp 12 ce lls were seeded at 20,000 cells/cm2 into bacterio logical petri dishes and 
cultured for 14 days to form suspension aggregates. Aggregates were fixed in 4% PFA, embedded in 
OCT embedding medium, IOf.lm cryostat sections collected on slides and immuno-labelled with an 
antibody to the mesoderm transcription factor Brachyury (A), the endoderm transcription factor Gata4 
(C), or the ectoderm expressed pan epithelial keratin (E) and the nuclei counterstained with hoescht 
(blue). A representative aggregate section in A (with hoescht overlay in B) shows variable staining 
intensities for nuclear localised Brachyury, although a substantial number of cells display bright nuclear 
staining. In representative aggregate section C (with hoescht overlay in D), Gata4 positive cells 
demonstrate bright nuclear staining and occur in distinct patches throughout the aggregate. The Keratin 
immuno-stained section in E (with hoescht overlay in F) contains distinct regions that are immuno-
positive for pan-epithelial keratins. Scale bars = I 00f.1m 
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Embryoid bodies from ES cells, which contain derivatives of all three germ layers. 
3.2.9 Summary of results 
A summary ofthe results generated from comparisons between TERA2.sp12 cells treated with 
RA under adherent or suspension conditions is depicted in Table 3.6. TERA2.spl2 cells 
cultured under suspension conditions without RA treatment also down-regulated stem cell 
antigens (to a slower extent), and after 14 days of culture the aggregates formed were detected 
by immuno-staining to express early markers indicative of all three germ layers. 
Table 3.6 Summary comparison of RA induced differentiation in TERA2.sp12 cells cultured 
under adherent versus non-adherent conditions. 
FORM OF ANALYSIS ADHERENT CONDITIONS NON-ADHERENT CONDITIONS 
Adherent aggregate- like structures Small clusters of cells fonned after Aggregate fonnation 24 hours, free floating aggregates fonned after more than 21 days fonned after 2-3 days. 
Estimated mean rate of proliferation 
over 0-14 days (increase in cell 2.45 cells/24 hours 0.545/24 hours 
number per 24 hours). 
Both SSEA3 and TRA 160 down- Both SSEA3 and TRA 160 down-
Loss of surface carbohydrate stem regulated to less than 4% by 14 regulated to less than 4% by 14 
cell markers days. 56.35% of cells immuno- days. 17.7% of cells immuno-
positive for TRA 160 at 7 days. positive for TRA 160 at 7 days. 
Both antigens up-regulated. 75% of Both antigens up-regulated. 82% of 
Gain of surface glycolipid antigens cells immuno-positive fOr A2B5 and cells immuno-positive for A2B5 and 
VINIS 53 and A2B5 96% immuno-positive for VINIS 53 89% immuno-positive for VINIS 53 
after 14 days. after 14 days. 
Up-regulation of neuronal ~Ill 
tubulin after 7 days(+), levels Strong up-regulation of neuronal ~Ill 
maintained for 28 days. NSE tubulin after 7 days(++), and NSE 
Western blot detection of neural detected after 14 days, reaching detected at low levels after 4 days, 
markers maximum levels after 28 days(++). increasing to high levels after 14 Levels of Nestin protein increased days(+++). Nestin expression up-
from 7-14 days (maximum++), then regulated after 4 days, reaching 
decreased gradually to low levels at high levels after 14 days, (+++). 
28 days. 
Keratin 8 levels up-regulated over 
Western blot and immuno-staining 14 days, and decreased slightly Keratin 8 rapidly down-regulated to 
detection of simple epithelial protein after 28 days. TP63 was not very low levels after 7 days. TP63 
Keratin 8 and epidennal stem cell detected in Western blot analyses, was not detected in Western blot or 
transcription factor Tp63 although it was detected by immuno-staining analyses. immuno-staining in plaques of large 
cells. 
A large proportion of cells had taken 
up BrDU after 5 days of culture, but 
after 14 days only scattered cells At 5 days scattered cells within the 
had taken up BrDU, and after 21 aggregate had taken up BrDU, and 
BrDU up-take days BrDU up-take was rare. An at 14 days the frequency was even 
exception was observed within lower. BrDU immuno-staining 
aggregate-like growths of cells in tended not to be localised in the 
the culture, which contained a high centre of the aggregate. 
frequency of BrDU incorporating 
cells. 
------------------------------
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3.3 DISCUSSION 
3.3.1 Summary 
The aim of this investigation was to compare and characterise the RA induced differentiation 
of TERA2.sp 12 cells cultured under either adherent conditions or suspension conditions (in 
which floating aggregates form), and determine whether neural differentiation was indeed up-
regulated as a result of suspension culture. Stem cell marker expression and proliferation rate 
were both more rapidly down-regulated in RA treated cells cultured under suspension 
conditions compared to adherent conditions, indicating that suspension cultures more rapidly 
embarked on differentiation. Correspondingly, the expression of neuronal proteins was more 
rapidly up-regulated and to higher levels as detected by Western blot analysis, and the 
increase in epithelial Keratin 8 expression observed in adherent cultures was reversed, 
supporting the hypothesis that increased neural differentiation and decreased non-neural 
ectoderm-like differentiation was occurring in suspension cultures. However, Keratin 8 was 
subsequently demonstrated to be expressed in two different populations within adherent 
cultures; in a non-neural morphologically distinct population that also expressed the epidermal 
stem cell marker TP63, and also in a proliferative Nestin positive population. 
Aggregates generated from RA treatment under suspension conditions were also 
further characterised and although solely neural sub-types were identified, they did not 
resemble neurospheres in their structure or in other key characteristics. However, it was of 
interest to observe that distinct zones of proliferation and neuronal differentiation were 
displayed within these aggregates (and also to some extent in adherent cultures), with 
organised structures consisting of aligned proliferative neural progenitors and maturing 
neurons present after 14 days of RA treatment. These structures frequently resembled neural 
tube structures and could potentially provide useful models in which to study neural tube 
formation and patterning. 
Culture under suspension conditions in the absence of RA treatment also induced 
stem cell marker down-regulation and a decrease in proliferation in TERA2.sp 12 cells, 
although the time course of stem cell marker down-regulation was much longer than in RA 
treated cultures. Early markers of all three germ layers were detected in immuno-stained 
sections of aggregates after 14 days of culture (neural differentiation was not observed in the 
sections sampled), implying that these aggregates are similar to simple embryoid bodies 
formed from human ES cells and suggesting that TERA2.sp 12 cells are not limited in their 
differentiation potential to solely ectodermal derivatives. 
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3.3.2 The stem cell phenotype 
TERA2.sp12 cells have previously been reported to express stem cell surface markers 
TRA 160 and SSEA3 which are down-regulated upon RA treatment (Przyborski 2001) and in 
this study we demonstrated that TERA2.sp 12 cells also show nuclear localised immuno-
staining for Oct4 and Nanog; two key homeodomain transcription factors reported to be 
essential to the pluripotent and self-renewing phenotypes of embryonic stem cells (Chambers 
et al. 2003, Mitsui et al. 2003, Pesce & Scholer 2001). Oct4 is described as a key gate keeper 
in the beginnings of mammalian development and synergises with Sox2 in pluripotent cells to 
promote the transcription of target genes (Ben-Shushan et al. 1998, Chew et al. 2005, 
Nishimoto et al. 2005) including the sox2 and Oct4 encoding genes and the pluripotent 
marker Nanog (Rodda et al. 2005). In an initial study, the stem cell markers TRA 160, 
SSEA3, Oct4 and Nanog were utilised to compare the effect of RA treatment on the loss of 
stem cell phenotype in TERA2.sp12 cells cultured in either suspension or adherent culture 
conditions. 
The effect of suspension culture - accelerated departure from the stem cell phenotype 
Initial comparisons of stem cell marker expression and changes in proliferation rate indicate 
that RA treated cells cultured under suspension conditions departed from the stem cell 
phenotype more mpidly than cells cultured in adherent conditions: Cells grown under 
suspension conditions down-regulated the expression of the cell surface antigen TRA 160 to 
low levels in approximately half the time of cells treated in adherent conditions, and nuclear 
expression of the transcription factor Oct4 was absent in cells after 5 days of RA treatment in 
cultures grown under non-adherent conditions. 
However, this trend was not observed for all stem cell markers. SSEA3 was observed 
to be down-regulated at relatively the same rate at the time-points tested in both culture 
conditions. This could be due to differential regulation of these stem cell markers, (the 
pathways controlling the expression of cell surface markers such as SSEA3 and TRA 160 
have not yet been elucidated). However, it is more likely to be due to the limitations of this 
experiment. SSEA3 appears to be lost very early in TERA2.sp 12 differentiation and was 
already down-regulated to low levels after 7 days of RA treatments in both sets of cultures. 
Rapid down-regulation of SSEA3 upon differentiation has been reported in both human 
embryonal carcinoma and embryonal stem cells (Draper et al. 2002, Fenderson et al. 1987). 
Hence it is likely that SSEA3 was down-regulated during the first few days of culture, and any 
difference in the speed of down-regulation was not detected because the first time-point of 
detection was too late. Live surface staining analyses indicated that by 4 days of culture 
SSEA3 expression was down-regulated to minimal levels in aggregate cultures compared to 
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significant expression in monolayer cultures. However in this experiment whole aggregates 
were immuno-stained, and as a result SSEA3 expression was only monitored on the surface of 
aggregates. 
Oct4 protein levels were down-regulated in both sets of RA treated cultures after 14 
days of treatment. This corresponds with previous studies that report that Oct4 expression can 
be regulated through the binding of nuclear receptors (including the RA receptors RAR/RXR) 
to its proximal promoter (Bamea & Bergman 2000, Ben-Shushan et al. 1995), and reports that 
Oct4 expression is down-regulated by RA treatment (Okamoto et al. 1990). It was also 
interesting to note that in these immuno-staining experiments - where Oct4 staining was 
absent from the nucleus, there was still low level staining in the surrounding cytoplasm of 
these cells. This could simply represent non-specific background staining. However, controls 
using secondary antibodies alone did not yield a similar background effect, and although this 
staining could represent non-specific interactions between the primary antibody and the 
stained cells, there is a possibility that the staining represents Oct4 protein in the cytoplasm. In 
the latter case this could reflect a post-translational means of regulating Oct4 activity, through 
translocation from the nucleus. However, there are no reports to date of regulation of Oct4 
through this mechanism. 
Stained sections of aggregates cultured with RA indicate that Oct4 was rapidly down-
regulated in these aggregates, whereas it is interesting to note after 7 days of culture, sectioned 
aggregates still exhibited substantial TRA 160 expression - when Oct4 expression is almost 
entirely absent. Again this reflects the differing sensitivities and kinetics of regulation for the 
range of stem cell markers tested. As Oct4 is considered to be the key 'gate keeper' for stem 
cell maintenance, this also implies that cells that have begun to depart from the stem cell 
phenotype may still express some stem cell antigens (such as TRA 160), an indication that 
caution should be used when identifying stem cells with only a limited number of antigens. It 
would be interesting to determine whether TRA 160 is directly regulated by Oct4. One 
approach would be to use transfection or RNAi to directly inhibit Oct4 activity, and determine 
whether TRA 160 is also down-regulated. It would also be interesting to determine whether 
any other stem cell markers are also expressed in cells which remain positive for TRA 160, 
and to generate an overview of the kinetics of down-regulation of a range of stem cell 
markers. This would lead to a better characterisation of the kinetics of stem cell marker 
expression and a better understanding of the process by which cells depart from the stem cell 
phenotype. 
As discussed later, negative staining for nuclear localised Oct4 was also detected in a 
proportion of cells within aggregates cultured without RA, indicating that the more rapid loss 
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of stem cell markers in RA treated cultures grown under non-adherent versus adherent 
conditions may be due in part to signalling events resulting from aggregate formation alone. 
Cell confluency and the maintenance of stem cell phenotype 
TERA2.sp 12 cells are routinely seeded at a lower density (20,000cells/cm2) than maintenance 
culture density prior to RA treatment, so that the cultures do not overgrow during the 
experiment. In both adherent and non-adherent conditions, cells were seeded at this density 
prior to treatment with RA. However, cell-confluence is known to inhibit differentiation in 
embryonal carcinoma cells (for review Andrews 2002). Thus there is the possibility that some 
of the differentiation observed could be due to the initial low seeding density. To control for 
this possibility, cells were cultured in parallel at the same density and cultured without RA. In 
adherent cultures, cell growth initially slowed, and the percentage of cells expressing SSEA3 
had decreased by roughly 15% after 7 days, although TRA 160 expression remained high. 
However, cells began to rapidly proliferate after 5 days such that the culture became over-
confluent and the cells expired within 24 hours if they were not split and reseeded at 
maintenance density. After 14 days the proportion of cells expressing SSEA3 was equivalent 
to that of maintenance cells at 60 %. This raises an important point. Either SSEA3 expression 
had been up-regulated to original levels in these cells, or in a more likely scenario, the 
remaining SSEA3 positive cells had proliferated rapidly such that the increased number of 
SSEA3 negative cells had become insignificant after 14 days. It is interesting to note that TRA 
160 was not down-regulated by seeding at low-density, in contrast to the sensitivity of SSEA3 
expression. This may support the theory that stem cells can occupy various stages of 'stern-
ness' where they have not yet committed to differentiate but have down-regulated some stem 
cell markers. Variable SSEA3 expression has been reported within populations of human 
embryonic stem cell cultures, for example approximately 65% of the culture of the H7 cell 
line express SSEA3 (Draper 2002) and indeed SSEA3 expression is not ubiquitous in 
maintenance cultures of TERA2.sp 12. This raises the question of whether SSEA3 loss of 
expression in culture is reversible, and also whether down-regulated SSEA3 expression 
actually confers a restricted differentiation capability and reduced pluripotency. Fluorescence 
activated cell sorting of SSEA3 positive and negative cells is one technique that could be used 
to separate these populations and compare their differentiation profiles. It would also be useful 
to determine the expression of a wider range of stem cell markers (including Oct4 and Nanog) 
in cells seeded at this lower density. However, due to time constraints this was not carried out 
in the course of this study. 
It is important to note that cells cultured without RA and seeded at the same density 
under adherent or suspension conditions behaved markedly differently. In adherent conditions, 
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as discussed previously, a transient down-regulation in cell proliferation and the proportion of 
SSEA3 positive cells were observed. In suspension conditions, levels of SSEA3 expression 
and the proportion of cells expressing SSEA3 were steadily down-regulated and this was 
permanent. In addition, other stem cell markers such as TRA 160 and nuclear localised Oct4 
were also down-regulated. 
Undifferentiated TERA2.sp12 cells express neuronal 8111 tubulin and Nestin 
Both Western blot and immuno-staining analyses demonstrated positive expression of 
neuronal ~Ill tubulin in undifferentiated cultures of TERA2.spl2 cells that were uniformly 
positive for Oct4, Nanog and TRA 160. This was the case with two different anti-~III tubulin 
antibodies, raised in different hosts, and control cultures of the human squamous carcinoma 
FaDU cell line were negative. Hoescht eo-staining of cell nuclei indicated that ~Ill tubulin 
expression was also present in cells that were actively dividing. Cells in undifferentiated 
cultures also immuno-stained positive for Nestin. Importantly, the expression of these markers 
was not only unusual in context, but also in phenotype; in both cases the immuno-staining was 
more diffuse and the cells did not display a neural morphology. 
This aberrant expression could be a result of the abnormal genetic phenotype of 
TERA2.sp12. These embryonal carcinoma cells exhibit marked trisomy, and one could argue 
that these cells are inherently genetically instable. Another possibility is that this aberrant 
expression is an artefact from prolonged cell culture. Although this phenotype was observed 
in many different passages of TERA2.sp 12, including those cultured from very early passage 
numbers, TERA2.sp 12 cells are derived from passage 15 of TERA2 cells, and therefore even 
the earliest passages have undergone substantial cell culture. 
The intermediate filament protein Nestin was originally categorised as a neural 
progenitor marker (Fuchs & Weber 1994), but recently this has been questioned in several 
reports documenting the expression in various non-neural lineages, including mesenchymal 
stem cells, angiogenic endothelial cells and pancreatic islets of langerhans (Hunziker & Stein 
2000, Lardon et al. 2002, Woodbury et al. 2002). Nestin is also expressed in at least some 
human ES cell lines (Linda Lako, personal communication). Neuronal ~Ill tubulin expression 
has also been reported in non-neuronal lineages including mesenchymal stem cells (Tondreau 
et al. 2004), and there have been some reports of neuronal ~Ill tubulin expression in 
undifferentiated cultures of both mouse and human ES cell lines (Ginis et al. 2004). In one 
study where undifferentiated HI cell cultures were reported to stain positive for ~Ill tubulin, 
this staining displayed filamentous localisation in cells that eo-stained positive for the stem 
cell marker TRA 181 (Carpenter et al. 200 I). However, Neuronal ~Ill tubulin is also 
expressed in non-neuronal tumours and is associated with de-differentiation and an ascending 
3 .3 Discussion 70 
histological grade of malignancy in gliomas and lung cancer (Katsetos et al. 2003). As non-
neural ~Ill tubulin expression is associated with 'de-differentiation' in cancer, it may be 
expressed in TERA.sp12 cells as a consequence of selection for an undifferentiated 
phenotype. In addition, recent investigations have highlighted the genetic instability of human 
stem cell lines cultured for prolonged periods (Draper et al. 2004). Thus low levels of ~Ill 
tubulin expression in undifferentiated cell cultures of human stem cell and embryonic 
carcinoma cells could be an aberrant phenotype acquired during prolonged culture, in 
association with strong selection for the stem cell phenotype. It would be of interest to test 
very early passages of human embryonic stem cells, and discern whether ~Ill tubulin 
expression in undifferentiated cells is acquired after subsequent passaging. 
The aberrant expression of Nestin and neuronal ~Ill tubulin underscores the 
importance of using multiple markers to characterise a phenotype, and in determining whether 
marker localisation is typical. To distinguish between undifferentiated neuronal ~Ill tubulin 
and Nestin expression in this study, in all cases immuno-staining was carried out in addition to 
the Western blot analyses. 
3.3.3 Neural differentiation in RA treated TERA2.sp12 cells 
RA treatment induced neural differentiation in both suspension and adherent culture 
conditions: TERA2.sp 12 cells gained neural marker expression in a regulated series of 
molecular events that appeared to mimic neuronal differentiation during embryogenesis. 
Similar to previously published studies with NTERA2 and TERA2.sp 12 (Przyborski 2001, 
Przyborski et al. 2000), cells initially increased expression of the neural progenitor marker 
Nestin, followed by an increase in NeuroD 1, expressed when cells exit the cell cycle and 
begin to differentiate, and the up-regulation of ~Ill tubulin, NSE and neurofilament expression 
typical of maturing neurons. However, in aggregate cultures, the up-regulation of Nestin, 
NeuroD1, and maturing neuronal marker proteins started 2-3 days earlier, and peak expression 
levels (especially for ~Ill tubulin) were generally higher. This indicates that induction of 
neuronal differentiation is occurring earlier, and neural differentiation may be occurring to a 
greater extent in aggregate cultures compared to monolayer cultures. 
lmmuno-staining analyses in adherent cultures demonstrated that by 14 days the 
majority of the cell culture consisted of proliferating Nestin positive cells, closely associated 
with ~Ill tubulin and MAP2 positive cells that were distinctly neuronal in morphology. The 
expression of neuronal filaments was detected in a small proportion of neuronal cells 
exhibiting long axons that were detected in clusters on the top of the remaining cells, and 
increased numbers of these cells were observed with longer culture periods. Distinct rosette 
like structures of Nestin positive cells were observed between 7-14 days of RA treatment, 
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consisting of columnar, Nestin negative cells within the centre, and occasionally distinct 
ridges of orientated Nestin positive progenitor cells closely associated with pm tubulin 
positive neural cells were detected. Nestin positive cells invaginating to form a tubular 
structure were also observed, and after 21 days larger tubular structures had developed, 
consisting of distinct zones of neural cells expressing MAP2 and more mature neurofilaments. 
These structures demonstrated a marked similarity to various stages of neural tube formation, 
and similar observations have recently been reported in human embryonic stem cell cultures 
that have been differentiated towards the dopaminergic lineage with FGF treatment (Li et al. 
2005, Yan et al. 2005). In parallel, neural tube like structures consisting of radially aligned 
Nestin positive cells surrounded by pm tubulin positive cells were also generated within 
aggregates formed from RA treated TERA2.sp12 cells cultured in suspension. These tube-like 
structures extended through several consecutive sections of aggregates, and had formed after 
14 days of culture mther than 21 days in adherent conditions. 
Further investigation to chamcterise these neuml tube-like structures would be 
valuable, as these could be potentially useful models in which to study human neuml tube 
formation and differentiation in vitro. In particular the neural tube-like structures formed 
within aggregates may re-capitulate the in vivo situation more closely as these cells are within 
a three-dimensional context. Immuno-staining for markers of various stages of neural tube 
formation, known patteming markers such as Sonic hedgehog (Shh) and Fibroblast growth 
factors (FGFs), and markers for positional identity in the neural tube would help to establish 
whether these structures could be useful models in which to study aspects of neural tube 
development. 
As previously discussed, neural markers such as NSE, pm tubulin and Nestin were 
up-regulated more rapidly in cells cultured under non-adherent conditions, and this could be 
closely linked to the rapid loss of stem cell marker expression. However, another possibility is 
that neural differentiation was up-regulated in TERA2.sp12 cells cultured as aggregates in 
suspension as a result of neural differentiation being promoted over other forms of 
differentiation, such as non-neural ectoderm differentiation. This is supported by early 
observations of divergent Keratin 8 expression detected by Western blot analysis in 
differentiating adherent versus suspension cultures. Keratin 8 expression increased over 14 
days in cells cultured under adherent conditions, and decreased in cells cultured in suspension. 
Keratin 8 is a type I acidic intermediate filament and together with Keratin 18 forms the major 
components of simple epithelia (Moll et al. 1982). Taken together with the observation that 
large-diameter cells similar in morphology to simple epithelia were observed in RA treated 
adherent cultures and not in suspension cultures of TERA2.sp 12, this supports the hypothesis 
that neural and non-neural ectoderm differentiation is occurring in RA treated adherent 
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cultures, whereas neural differentiation alone occurs in suspension cultures, which could 
account for the enhanced levels of neural proteins detected by Western blot analysis in non-
adherent cultures. 
3.3.4 Non-neural differentiation in RA treated TERA2.sp12 cells 
Keratin expression- indicative of differentiation into non-neural ectoderm? 
Keratin 8, 18 and pan-epithelial keratin were detected by immuno-staining in the plaques of 
large-diameter cells observed in adherent cultures, supporting evidence that these cells were 
non-neural ectoderm in character, and immuno-staining analyses demonstrated that pan-
epithelial Keratin and Keratin 8 expression was almost non-existent in aggregate cultures 
compared to adherent cultures. 
However, the monoclonal anti Keratin 8 antibody (Sigma) also immuno-stained cells 
which were not within these 'large-celled plaques', in this case eo-staining Nestin positive 
cells. This was in contrast to pan-epithelial keratin and Keratin 18 antibodies. A polyclonal 
anti-Keratin 8 antibody raised in a different host (ABCAM) solely immuno-stained large 
diameter-cells. One explanation for the different staining specificity is that the ABCAM 
sourced antibody recognises more restricted isoforms of Keratin 8 compared to the Sigma 
antibody. Westerns repeated with the ABCAM sourced antibody to Keratin 8 demonstrated no 
difference in expression to the antibody sourced from Sigma. This suggests that preparation of 
the samples for Western blot analyses enabled all forms of Keratin 8 to be detected by the 
ABCAM antibody. As a consequence, Keratin 8 expression detected in Western blot analyses 
is likely to represent at least two different populations of Keratin 8 expressing cells. Indeed, 
Western blot analyses indicate that undifferentiated TERA2.sp12 cells express Keratin 8. 
Although typical of simple epithelia, Keratin 8 expression is not confined to cells of 
the non-neural ectoderm, and demonstrates a varied expression pattern during development. 
Keratin 8 and 18 are the first intermediate filaments to be expressed in embryogenesis, at the 8 
cell stage of mouse blastomeres (Jackson et al. 1980). Keratin 8 expression has also been 
identified in the foetal heart (Markl 1991 ), and in astrocytic progenitor cells in the developing 
or repairing CNS of vertebrates (Groff et al. 1997, Heatley 1996). This correlates to some 
extent with the observed expression in undifferentiated cells, and the population ofNestin and 
Keratin 8 positive cells in differentiating RA treated cultures could represent neural stem cells 
or astrocytic progenitors. Therefore the up-regulation of total Keratin 8 protein detected by 
Western analysis in adherent cultures may reflect both an up-regulation in the proportion of 
neural progenitors and the presence of non-neural cell plaques in adherent cultures. 
Correspondingly, the observed down-regulation of Keratin 8 protein in TERA2.sp 12 cultures 
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is likely to reflect the rapid departure of these cells from the stem cell phenotype and earlier 
neural differentiation. 
Non-ectodermal differentiation of RA treated TERA2.sp12 cells? 
In order to characterise these keratin positive 'large-celled plaques', and determine whether 
these cells were non-neural ectoderm precursors or another germ layer derivative, adherent 
cultures were immuno-stained with further markers of ectoderm derivatives and also markers 
of endoderm, mesoderm and tropho-ectoderm derivatives. These cells were negative for all 
markers tested, with one exception: Some cells within the larger cell plaques immuno-stained 
positive for TP63, a marker of epidermis progenitor cells (Koster & Roop 2004, McKeon 
2004, Pellegrini et al. 200 I), which has recently been reported to be temporally expressed in 
human embryonic stem cells differentiating into keratinocytes (Green et al. 2003). 
During this screen, the endoderm transcription factor Gata4, mesoderm transcription 
factor Brachyury, and in very rare cases endoderm transcription factor HNF3~ was detected in 
small populations of cells within the culture that were morphologically indistinct under phase 
microscopy. This questions the supposition that TERA2.spl2 cells are limited to ectodermal 
differentiation. However, these markers are early markers of differentiation, and markers of 
later stage differentiation, (such as a smooth muscle actin and AFP) were not detected. In 
addition, Brachyury expression is reported to occur with no other evidence of mesoderm 
differentiation in NTERA2 cells (Gokhale et al. 2000) implying that the Brachyury expression 
detected may not be indicative of true mesoderm differentiation. 
3.3.5 Characterisation of aggregates formed from suspension culture 
Aggregation has been used in many cell systems to derive differentiated cells: Embryoid 
bodies are generated from mouse and human embryonic stem cells to form differentiated 
derivatives of all three germ layers, and neurospheres are routinely cultured from dissociated 
embryonic or adult CNS tissue exposed to growth factors (Campos 2004, Reynolds & Weiss 
1992, Reynolds & Weiss 1996). The aggregates formed from culture of TERA2.spl2 cells 
under suspension conditions either with or without RA treatment displayed distinctive 
characteristics in both structure and protein expression. 
Aggregates formed from RA treated suspension cultures 
As previously discussed, TERA2.spl2 cells cultured as aggregates in suspension and treated 
with RA demonstrated accelerated down-regulation of stem cell marker expression and 
enhanced neural marker expression, with immuno-staining of aggregate sections suggesting 
that these aggregates were entirely neural in characteristics. 
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The neural characteristics of these aggregates raised the question of whether RA 
induced aggregates were comparable to neurospheres. Neurospheres are formed from 
dissociated embryonic or adult CNS tissue exposed to growth factors and consist of both 
neural progenitors and more differentiated progeny. One key feature used to classifY 
neurospheres is that they are clonal in origin, meaning each neurosphere is derived from a 
single cell (Campos 2004, Reynolds & Weiss 1996). 
To investigate whether RA treated aggregates formed from TERA2.sp212 cells were 
clonal in origin, aggregates were cultured from single cells of either TERA2.sp 12 or GFP 
expressing TERA2.sp12.GFP cells at various cell densities. These aggregates consistently 
contained populations of both GFP positive and negative cells, indicating that under these 
conditions aggregate formation was literally due to 'aggregation' of single cells and 
proliferation. In addition, the pattern of neural marker expression within differentiating cells 
differed markedly from that of neurospheres, which are described to have a core of 
differentiating pm tubulin and GF AP positive cells surrounded by Nest in positive progenitor 
cells (Reynolds & Weiss 1996). In contrast, aggregate sections showed no immuno-reactivity 
to GFAP. This indicated that although the aggregates shared some properties with 
neurospheres, they did not satisfY all of the key characteristics for neurosphere formation. 
Another essential difference between neurospheres and TERA2.sp 12 aggregates is their 
proliferative capacity. Neurosphere formation is a routine method to isolate and propagate 
neural stem cells, whereas TERA2.sp 12 cells are being treated with a differentiation agent, 
and ultimately demonstrate very low proliferation rates. It would be interesting to try to 
promote neural differentiation and then proliferation with FGF and EGF to more closely 
mimic neurosphere generation from TERA2.sp 12 cells. 
Aggregates formed from RA treatment under non-adherent conditions frequently 
displayed radial zones of neural marker expression, with more immature markers (such as 
MAP2) coinciding with Nestin in the centre of the aggregate, and then maturing neurons 
expressing neurofilaments situated closer to the outer edge of the aggregate. This indicates 
some organisation in neural development was occurring in these aggregates. It is possible that 
cells within the aggregates were exerting differential effects through paracrine signals in order 
to achieve this level of organisation, and further characterisation of these signals could prove 
useful. 
Aggregates formed from suspension culture without RA 
Aggregates cultured without retinoic acid formed large irregular aggregates which were often 
more tubular in shape and frequently contained small cavities. Cells within these aggregates 
slowly down-regulated stem cell marker expression, such that the proportion of cells immuno-
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positive to SSEA3 and TRA 160 had dropped to 30% and 80% respectively, and TRA 160 
expression was also markedly lower in intensity in the remaining positive cells after 14 days 
of culture. Immuno-stained sections of aggregate cultures identified regions within the 
aggregate down-regulating TRA 160 expression, and also distinct regions were evident where 
nuclear staining of Oct4 was negative, which had expanded to dominate aggregate sections 
after 14 days. Negative staining for nuclear localised Oct4 was always detected in a patch of 
adjacent cells - not in scattered cells throughout the aggregate, suggestive that stem cell 
marker down-regulation was occurring through a localised community effect. 
Immuno-staining identified frequent keratin positive regions within these aggregates, 
and also positive regions of expression for the endoderm marker Gata4 and for the mesoderm 
marker Brachyury, suggestive that epithelial, endodermal and mesododermal differentiation 
was occurring. As previously discussed, a report based on a NTERA2 EC cells indicates that 
Brachyury expression can occur in the absence of mesoderm differentiation (Gokhale 2000). 
However, the up-regulation of Brachyury under these conditions was marked, and much 
higher than in other treatments. Although markers of more mature derivatives such as smooth 
muscle were not detected, strong up-regulation of Brachyury does suggest the presence of an 
early mesoderm derivative. 
The use of suspension culture and the detection of early markers from all three germ 
layers in these aggregates closely resemble the method of generation and key characteristics of 
embryoid bodies. Embryoid bodies (EBs) were first grown to form differentiated derivatives 
of all three germ layers in vitro from mouse embryonic stem cells in 1985 (Doetschman et al. 
1985). There are two main methods of creating embryoid bodies with mouse ES cells in vitro, 
in both cases cells are either removed from their feeder layers or cultured without LIF to 
remove stem cell maintenance factors, and cultured under conditions which prevent the cells 
from adhering to a surface: Cells can be cultured as hanging drops in suspension in an 
inverted Petri dish and then transferred to an un-coated Petri dish for further differentiation in 
suspension, or cultured as single cells in an uncoated non-adherent Petri dish. In these 
structures, the developmental program of ICM/epiblast cells is thought to be re-activated in 
the ES cells (Smith 2001 ). Cellular differentiation is described to proceed on a schedule 
similar to that in the embryo but in the absence of proper axial organization or elaboration of a 
body plan. A basic description of the formation of EBS from mouse ES cells (extracted from 
Doetschman 1985) is as follows: Within the first few days of differentiation, EBs generate 
populations of cells that express genes indicative of primitive endoderm and mesoderm. While 
first simply appearing as a ball of cells, the embryoid body takes on an increasingly more 
complex appearance, becoming more cavitated, then forming a hollow or cystic embryoid 
body which can eventually form internal structures such as a yolk sac, and actively beating 
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cardiomyocytes. 
As with murine ES cells, when human ES cells are cultured in suspension they can 
spontaneously create EBs, including cystic EBs. However, embryoid bodies are reportedly 
more difficult to derive from human ES cells partly due to the difficulties associated with 
culturing them as single cells (Ng et al. 2005) and not all human ES cell lines appear to be 
capable of forming EBS (Reubinoff et al. 2000). Human EBs are typically generated by 
roughly chopping large clumps of cells and culturing these in petri dishes or culturing cells as 
hanging drops at high densities. The H9 human ES cell line was reported to successfully form 
embryoid bodies containing derivatives of all three embryonic germ layers when cultured in 
non-adherent Petri dishes at high densities, although they were less organised than in mouse 
ES cells, as no pattern formation or organogenesis was observed (Itskovitz-Eldor et al. 2000). 
As a basis from which to determine whether human embryoid bodies are similar to 
the aggregates formed from TERA2.spl2 cells, the reported characteristics of EBs derived 
from the human ES cell line H9 are directly compared with aggregates derived from 
TERA2.spl2 cells in Table 3.7. 
Table 3. 7 List of typical characteristics of embryoid bodies derived from the human ES cell 
line H9 and TERA2.spl2 aggregates formed under similar suspension conditions. 
CHARACTERISTIC EMBRYOID BODIES FORMED FROM AGGREGATES FORMED FROM H9 ESCELLS TERA2.sp12 CELLS. 
Culture conditions for formation Cultured in non-adherent Petri dishes in Culture in non-adherent Petri dishes. the absence of feeder layers 
Initially form compact simple embryoid Cavities observed at 14 days, highly General morphology in culture bodies, cavitated and cystic EBs 
under phase contrast observed under phase microscopy cystic structures not observed under 
between 7 and 14 days. phase microscopy. 
Can contain extra-embryonic tissues 
such as blood islands, highly cystic, At least 3 different cell morphologies 
Morphology of haematoxylin and and multiple cell morphologies visible, cavities are less distinctly 
eosin stained sections observed. Cavities observed that are defined, and no distinct layers of 
lined with two layers of epithelial and cells surrounding cavities observed. 
endoderm-like cells. 
ECTODERM: NF68 ECTODERM: No neurofilament 
expression, pan-epithelial keratin, 
ENDODERM: 
ENDODERM:AFP Gata4, in very rare cases AFP. 
Markers of different germ layers Negative for gut endoderm marker 
detected HNF313 
MESODERM: Brachyury 
MESODERM: a globin, a cardiac actin. Negative for smooth muscle marker 
a-smooth muscle actin. 
Some embryoid bodies reported to 
Other features pulse synchronously and express the 
myocardium marker a cardiac actin. 
Comparisons in Table 3.7 suggest that TERA2.spl2 aggregates formed from culture under 
suspension conditions do share several similarities with embryoid bodies derived from human 
ES cells. However, they appear to contain fewer organised structures than HES derived 
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embryoid bodies and were not observed to gain a highly cystic morphology. In addition, taken 
together with reports linking expression of the mesoderm marker Brachyury with an absence 
of mesoderm differentiation, this study does not yet provide convincing evidence that 
aggregates derived from TERA2.sp 12 can form derivatives of all three germ layers. 
A key difference between ES derived embryoid bodies and TERA2.sp 12 derived 
aggregates is that embryoid bodies are formed in culture conditions where stem cell 
maintenance factors have been removed, such as LIF in mouse ES cultures or fibroblast feeder 
layers in human ES cultures. TERA2.pl2 cells do not require feeder layers or additives to 
retain their stem cell phenotype, and thus the differentiation in TERA2.sp 12 cells is entirely 
due to culture in non-adherent conditions and aggregate formation. This demonstrates that 
aggregation alone is enough to induce differentiation, and as discussed, patterns in stem cell 
marker down-regulation present strong evidence of a community-effect occurring within 
aggregates. The capacity for aggregation alone to induce differentiation is addressed 
somewhat in mouse ES cells, as when aggregates of mouse ES cells are cultured in suspension 
in the presence of LIF, the outer layer of cells down-regulate Nanog expression and express 
markers of visceral endoderm (Hamazaki et al. 2004). However, differentiation is restricted to 
the outer layer of cells, and shows no comparable trend in the regional down-regulation of 
Nanog expression in TERA2.sp 12 aggregates. An investigation into the effect of aggregation 
on human ES cells that are cultured in stem cell maintenance conditions has only recently 
been possible, with the development of feeder free culture systems (Xu et al. 2001 ), and 
would be of interest here. 
In summary, these results demonstrate the powerful effect of aggregation on 
differentiation of TERA2.sp 12 cells, which reflects the increasing complexity of cell-cell 
interactions gained from cells cultured as aggregates. Evidence suggestive of a community 
effect within these aggregates, with regions of cells adjacent to each other embarking on 
proliferation, could be due to local changes in cell signalling that polarise neighbouring cells 
towards differentiation and may be mediated through cell-contact derived signalling or 
through local paracrine signalling events. A future investigation to elucidate the signalling 
events which are inducing differentiation in these aggregates could prove highly relevant to 
the signalling events that induce differentiation in the developing epiblast, as the 3-
dimensional cell-cell contacts and close interactions generated in an aggregate are more 
similar to the environment experienced by embryonic cells in vivo. The mechanisms for 
down-regulation of Oct4 in the compacted morula and trophoectoderm differentiation have 
not yet been determined, although it has been proposed that Oct4 may be repressed as a 
consequence of specific cell-cell adhesion (Pesce & Scholer 2001 ), which would correspond 
with the observations in this study. 
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3.3.6 Synopsis 
• RA induced neural differentiation of TERA2.sp12 cells reflected many aspects of 
neural differentiation in early development, with structures similar to the neural tube 
observed in both adherent and non-adherent cultures. 
• RA treated cells grown under adherent conditions 
o Display many neural characteristics, with regionally organised expression of 
neural markers of different stages. 
o Also differentiate into large-diameter cells which were solely detected to 
express markers of non-neural ectoderm. 
• Ra treated cells grown under non-adherent conditions to form aggregates 
o Demonstrate accelerated loss of stem cell markers and both accelerated and 
up-regulated gain of neural markers compared to adherent cultures. 
o Share some characteristics with neurospheres, although they are unique in 
many aspects and should not be described as neurospheres. 
• Cells cultured under non-adherent conditions to form aggregates (without RA) 
o Contain marked regions of stem cell marker down-regulation and 
differentiation in neighbouring cells that is suggestive of a community effect. 
o Share similarities with embryoid bodies derived from HES cells, although key 
differences exist - the reduced complexity, absence of evidence of mature 
derivatives from all three germ layers and the method whereby in ES cells 
maintenance factors are removed from the culture. 
3.3. 7 Conclusions 
As well as more comprehensively characterising the RA induced differentiation of 
TERA2.sp12 cells under aggregate conditions, and demonstrating that aggregation alone can 
induce differentiation in TERA2.sp 12 cells, this study demonstrates that RA treatment of 
TERA2.sp12 cells under non-adherent conditions does indeed up-regulate neural 
differentiation compared to adherent cultures, and two possible explanations for this 
difference are apparent: 
One possible explanation is based on the accelerated loss of stem cell markers and 
reduction in proliferation in TERA2.sp 12 cells cultured with RA under suspension conditions 
as opposed to adherent conditions. The accelerated neural differentiation observed could be 
due to a more rapid departure from the stem cell phenotype and differentiation in aggregates. 
However, this does not explain the marked up-regulation in neural marker expression, as 
theoretically the maximum expression level of neural markers would eventually be the same, 
and this is not the case. Another possible explanation is that as adherent cultures exhibit 
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evidence of both neural and non-neural ectoderm differentiation (in contrast to solely neural 
differentiation in suspension cultures), the lower level of neural differentiation is a direct 
consequence of a proportion of TERA2.spl2 EC cells differentiating along a non-neural 
instead of neural fate. 
It is likely that the accelerated and up-regulated neural differentiation observed in RA 
treated cells cultured as suspension as opposed to adherent cultures is generated by a 
combination of the above. This raises an important question: Why is an up-regulation of 
neural differentiation and inhibition of non-neural ectoderm differentiation manifested m 
suspension cultures- and do key differences in signalling levels underlie these differences? 
As reviewed in the next chapter, in the vertebrate ectoderm BMP signalling plays a 
key role in determining whether cells are specified towards prospective neural or epidermal 
lineages, and early dissociation experiments with Xenopus ectoderm explants were central to 
generating the generally accepted model of 'default' neural induction and BMP mediated 
inhibition of this process. This draws several parallels to the work in this chapter, suggesting 
that BMP signalling may be playing a similar role in neural induction decisions in 
TERA2.spl2 cells. In the following chapter I attempt to determine whether underlying 
changes in BMP signalling induced by these alternate culture methods are indeed the cause of 
these marked differences in neural and non-neural ectoderm differentiation, as a means to 
investigate neural induction events in TERA2.spl2 cells as a model of human ectoderm. 
CHAPTER4 
BMP SIGNALLING AND CELL FATE DETERMINATION IN 
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4.1 INTRODUCTION 
The following introduction discusses neural versus non-neural ectoderm specification during 
vertebrate development and current theories for neural induction in vertebrates. BMP 
signalling is presented as a key regulator of neural versus non-neural fate determination in the 
ectoderm, and subsequently the BMP signalling pathway and its regulatory components are 
outlined. The roles of other signalling proteins such as fibroblast growth factor (FGF) and Wnt 
in neural induction are also discussed in relation to recent work in chick embryos, focussing 
on their potent regulatory effects on BMP pathway activity. Finally, the current work on BMP 
signalling and neural induction in human and mouse embryonal carcinoma cells is surveyed 
and TERA2.spl2 cells are presented as a suitable model in which to study this key 
developmental process. 
4.1.1 Neural versus non-neural fate specification in the ectoderm 
In vertebrates, the dorsal ectoderm will give rise to the entire nervous system, while the 
ventral side will generate the epidermis. The developmental signals controlling the 
specification of naive ectoderm along neural as opposed to non-neural fates (termed neural 
induction) has been a subject of intense interest since the first clues emerged in an experiment 
in the 1920s by Spemann and Mangold. Using differentially pigmented newts they observed 
that transplantation of the most dorsal lip of the blastopore (prospective mesoderm) to the 
ventral side of another embryo which would normally generate epidermis (prospective 
epidermis) at gastrula stage, generated a second axis with a central nervous system almost 
entirely derived from the host prospective epidermis (Spemann & Man gold 1924, 200 I) (see 
reviews (Hemmati-Brivanlou & Melton 1997, Stern 2005, Weinstein & Hemmati-Brivanlou 
1999). This region in the dorsal lip was termed the 'organiser' and similar regions were 
identified in the prospective mesoderm of other species such as Xenopus and chick that were 
able to induce neural tissue upon transplantation, (Spemann & Mango Id 1923 (200 I)) and see 
reviews (Hemmati-Brivanlou & Melton 1997, Stern 2005, Weinstein & Hemmati-Brivanlou 
1999). This established the concept of neural induction as an instructive interaction between 
the dorsal lip of the blastopore, (the 'organiser') and the neighbouring ectoderm. Consistent 
with this idea, studies identified secreted neural inducers Follistatin, Noggin and Chordin 
expressed in the organizer region of Xenopus embryos that could induce neural markers in 
blastula stage animal cap explants (Hemmati-Brivanlou et al. l994a, Lamb et al. 1993, Sasai 
et al. 1995). 
However, subsequent studies generated an accumulating body of contradictory 
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evidence, including key observations from the culture of animal cap explants (naive ectoderm) 
from the pre-gastrula stage of Xenopus embryos. Although intact cultured explants of pre-
gastrula ectoderm formed epidermis, temporary dissociation of these explants led to neural 
differentiation, in the absence of any interaction with the organiser (for review Stem 2005). 
One suggested explanation for this effect was that signalling between early ectodermal cells 
(possibly mediated by a secreted protein) normally suppressed neural differentiation, and 
dissociation disrupted this suppression through a dilution effect of the secreted protein. 
Furthermore, whilst studying the effect of Activin on mesoderm formation in 
Xenopus, Hemmati-Brivanlou and Melton ( 1992) observed that treatment of cultured animal 
cap explants with a broad range inhibitor of Activin receptors, that actually inhibits a range of 
Transforming growth factor P (TGFP) ligands, namely Activin, mature Vgl and Bone 
morphogenetic protein 4, inhibited mesoderm formation, but also generated neural tissue 
(Hemmati-Brivanlou & Melton 1994b ). Taken together with the reports of neural 
differentiation in dissociated Xenopus explants, this led them to propose a default model of 
induction, namely that cells would become neural in the absence of other signals, and actually 
required instructive signals to form epidermis. They subsequently supported this model and 
identified Bone morphogenetic protein 4 (BMP4) as one such instructive signal using a series 
of classic dissociation experiments with Xenopus cultured animal caps, outlined in Figure 
4.l.a. In summary, they demonstrated that BMP4 treatment could 'rescue' the neuralising 
effect of dissociation in cultured Xenopus gastrula ectoderm explants, preventing these cells 
from forming neural tissue and instead inducing differentiation into epidermis (Wilson & 
Hemmati-Brivanlou 1995). 
Taken together with the finding that Noggin, Chordin, Follistatin and other neural fate 
inducing molecules such as Cerebrus inhibited BMP signalling in the extracellular space 
(Fainsod et al. 1997, Piccolo et al. 1996, 1999, Zimmerman et al. 1996), this led to more 
widespread acceptance of a 'default model' of neural induction in Xenopus. In essence, the 
default model proposes that neural induction occurs as a result of the inhibition of BMP 
signalling in the embryonic ectoderm, and that in the absence of external signalling cues, 
ectodermal cells will adopt a neural fate. BMP2 and BMP7 are also expressed in the ectoderm 
at this time and Suzuki et al. subsequently reported that BMP2 and BMP7 could also inhibit 
neuralisation and mediate epidermis formation in developing Xenopus (Suzuki et al. 1997a). 
In addition, transcription of BMP RNA is maintained by the activity of BMP protein (Biehs et 
al. 1996) which explains the disappearance of BMP4 and 7 expression from the vicinity of the 
organizer (which secretes BMP inhibitors) at the gastrula stage (Fainsod et al. 1994, Hawley 
et al. 1995). 
To summarise, signalling through BMP2, 4 and 7 1s thought to inhibit neural 
Figure 4.1 
The Default Model Of Neural Induction In Developing Xenopus /aevis 
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Figure 4.1 Key Dissociation experiments carried out by Hemmati-Brivanlou et al. that support the default 
model of neural induction (A), an outline ofthe inductive interactions in the default model of neural induction 
(B) and a rough fate map of the blastula-stage embryo (C). 
(A) In key dissociation experiments by Hemmati-Brivanlou et al. ( 1995) on explanted pre-gastrula animal 
caps, they demonstrated that the addition of BMP4 could rescue the neuralising effect of dissociation. Excised 
animal caps matured in vitro differentiate into epidermal tissue. However, if the animal caps are dissociated 
for more than 5 hours, re-associated tissue will differentiate into neural cells. This effect is rescued if the 
dissociated cells are exposed to BMP4 protein, when neural differentiation is suppressed and epidermal tissue 
forms. 
(B) A diagram of the inductive interactions proposed by the model: Ectoderm cells have an autonomous 
tendency to differentiate into neural tissue, but are prevented from doing this and are directed instead to 
epidermis by BMP4, which is expressed ubiquitously. Near the organizer, BMP antagonists block BMP4 
signalling, allowing neighbouring ectoderm cells to develop according to their 'default' neural fate. 
(C) A rough fate map of a blastula-stage embryo. Prospective territories are the organizer in red, ventral 
mesoderm in pink, neural tissue in blue, epidermis in yellow and yolky endoderm in green. The red lines 
represent BMP antagonist activity emanating from the organizer. V (ventral), D (Dorsal). 
(Figures B and C adapted from Stern 2005 Figure l) 
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induction and promote the generation of epidermis in the Xenopus developing ectoderm, and 
neural induction is proposed to occur as a result of suppression of the activity of these BMPs, 
mediated by BMP inhibitors secreted from the organizer region of the underlying mesoderm. 
This is outlined in sections B and C of Figure 4.1. 
4.1.2 Bone morphogenetic proteins 
BMPs form a sub-group of the TGF~ family of secreted proteins that were originally isolated 
from their ability to induce bone and cartilage formation when implanted at ectopic sites in 
rats (Wozney et al. 1988). Subsequent studies have demonstrated that BMPs are 
multifunctional signalling molecules that regulate a vast array of cellular processes including 
differentiation, apoptosis and proliferation and play powerful roles in multiple aspects of 
development, such as mesoderm ventralisation, limb patteming, haematopoiesis and neural 
induction, see reviews (Dale & Jones 1999, GrafT 1997, Hogan 1996a, Hogan 1996b, Mehler 
et al. 1997). It is also important to note that signalling mediated through the Nodal/ Activin 
branch of the TGF~ pathway induces mesodermal gene expression in ectodermal cells, 
reflecting the powerful roles ofTGF~ signalling in fate determination. 
As a subgroup of the TGF~ (transforming growth factor) family, these proteins are 
initially synthesised as large precursors that form homo- or hetero-dimers, and the active 
dimers are released by proteolytic cleavage. These active dimers bind to pairs of 
serine/threonine membrane receptor kinases, (types I and ll), mediating the formation of a 
hetero-tetrameric receptor complex which initiates signalling transduction through Smad 
proteins. An outline of the TFF~ signalling pathway is depicted in Figure 4.2. 
In summary, the Type II receptors are constitutively active kinases, and trans-
phosphorylate Type I receptors upon ligand binding and hetero-tetrameric receptor complex 
formation. The activated kinases of Type I receptors are subsequently able to phosphorylate 
and activate various intracellular Receptor smads (R smads), and thus determine the 
specificity of intracellular signals. Specific receptors for BMPs have been identified 
(BMPRIA, BMPRIB, and BMPRII), but some BMPs also interact with receptors with high 
affinity for Activins (ActRI, ActRII, ActRIIB). Phosphorylated Receptor smads are then able 
to complex with Common smad 4, (Co smad 4) and accumulate in the nucleus, where the 
hetero-complex binds to DNA and complexes with a range of DNA binding eo-factors to 
induce transcriptional activation or repression of a host of genes. Subsequent Receptor smad 
de-phosphorylation then causes their return to the cytoplasm. For reviews see (Balemans & 
Van Hul 2002, Hill 200 I, Itoh et al. 2000, Kawabata et al. 1998, Massague et al. 2005, 
Massague & Wotton 2000, Shi & Massague 2003). 
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Figure 4.2. A basic outline of the TGF beta signalling pathway. 
Upon ligand-induced heteromeric complex formation and activation of type I and type 11 receptors, R-
Smads are phosphorylated and form heteromeric complexes with Co-Smads that translocate to the 
nucleus, where in cooperation with DNA binding eo-factors and eo-activators or repressors they control 
the expression of target genes in a cell type specific manner 
Figure 4.2 
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Smads - the mediators of BMP signalling 
The name smad is derived from a fusion of the terms sma and mothers agains dpp (Mad), after 
the homologues identified in C. elegans and Drosophila respectively (Derynck et al. 1998, 
Savage et al. 1996), and as outlined above, there are three distinct subgroups of smads, the 
receptor smads (R smads), Common smad 4, and inhibitory smads. All of these smads have 
been identified in humans and these well characterised transduction proteins are extensively 
reviewed by Massague et al (Massague 2005, Shi & Massague 2003). Smads 1, 5 and 8 are 
activated by the principle type I BMP receptors BMPR-IA or BMPR-18, (whereas receptor 
Smads 2 and 3 mediate Activin, TGFb and Nodal receptor signalling), and Smad4 serves as a 
common partner for all R Smads. Smad6 and Smad7 are inhibitory Smads that interfere with 
Smad-receptor or Smad-Smad interactions. 
All smad proteins consist oftwo globular domains, mad-homology 1 (MH1) and mad-
homology 2 (MH2) coupled by a linker region: The N-terminal domain, or "Mad-homology 
I" (MH I) domain, is highly conserved in all R Smads and Smad4 but not in the inhibitory 
Smads, and mediates DNA binding. The MH2 domain is conserved in all Smad proteins, and 
mediates interactions with cytoplasmic retention proteins, nucleoporins of nuclear pore 
complexes, and with DNA-binding cofactors. R-Smads also have a conserved C-terminal 
motif, Ser-X-Ser, that is phosphorylated by the activated receptor. The linker region is quite 
divergent between the various subgroups, and a region overlapping the linker and MH2 
regions (the Smad4 activation domain) also mediates interactions with transcriptional 
activators and repressors. 
To summarise, the structural analysis of smad proteins has revealed multiple sites for 
protein and DNA binding and for phosphorylation, which manifests the complexity of 
interactions mediated by these multi-functional signalling proteins and generates an insight 
into the level of sophistication ofthis apparently simple signalling pathway. 
Regulation of BMP pathway activity 
Finely tuned signals between cells are necessary to coordinate all aspects of development, and 
as a key signalling pathway BMP signalling is tightly controlled by a web of regulatory 
proteins acting at multiple levels, particularly at the stages of receptor activation and receptor 
smad activity. These participate in negative feedback loops and also as a mechanism of 
integration with other signalling pathways: Figure 4.3 outlines the key modulators of BMP 
pathway activity in the embryo. 
In summary, extracellular proteins prevent receptor activation by binding to 
extracellular BMPs and preventing their interaction with receptors. Noggin (Zimmerman 
1996) and Chordin (Piccolo 1996) both bind to BMP2 and BMP4 with high affinity (Noggin 
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Figure 4.3. An outline of Modulation ofBMP pathway activity in the embryo. 
NUCLEUS 
In the embryo, BMP pathway activity is modulated at several levels. Extracellularly, various secreted 
inhibitors such as Noggin, Chordin and Follistatin bind and inhibit BMP ligands. At the extracellular 
membrane, a pseudo-receptor (BAMBI) competes with Type 11 receptors for Type I receptors and 
forms an inactive complex. In the cytosol, the inhibitory Smad 6 competes with Smad 4 for binding to 
activated Smad 1, whereas Smad 7 is thought to exert part of its inhibitory activities by preventing the 
activation of Smad 1. In addition, Smurfl and 2 target Smad 1 and the TGF receptors for degradation 
by the proteosome. Additional phosphorylation of Smad 1 mediated by ERK 1/2 in the MAPK pathway 
leads to inhibition of nuclear accumulation, and finally, within the nucleus transcriptional repressors 
recruited by the Ski protein can disrupt smad mediated transcriptional activation of a variety of target 
genes. 
Figure 4.3 
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also binds with lower affinity to BMP7), and Follistatin binds BMP 4 and BMP7, (although it 
also binds activin with high affinity) (Fainsod 1997). Other secreted proteins have been shown 
to antagonise BMP signalling in Xenopus embryos, such as Cerberus, DAN and Gremlin (for 
review (Balemans & Van Hul 2002) ). In addition, the pseudo-receptor BAMBI (BMP and 
activin membrane bound inhibitor) competes with Type 11 receptors to form stable inactive 
complexes with type I receptors, preventing the formation of active receptor complexes upon 
ligand binding (Onichtchouck et al. 1999). 
The first mediators of intracellular modulation are via the inhibitory smads, which are 
reviewed extensively in Derynk et al. ( 1998) and Massague et al. (2005). In brief, Smad6 
competes with Smad4 to interact with receptor-activated Smad 1, forming inactive Smad 1-
Smad6 complexes. Smad 7 competes with R-Smads in binding to activated TGF~ and BMP 
receptors, preventing R-smad phosphorylation and activation. The expression of Smad 6 and 7 
is induced by multiple stimuli, such as EGF and various TGF~ family members that include 
BMP 7, suggesting the existence of a feedback signal. Two Smurfs (Smad ubiquitination 
regulatory factors) Smurf I and 2, modulate signalling by selectively targeting the activated 
type I receptors for degradation, and Smurfl also regulates basal levels of Smad 1, for review 
see (Massague 2005). 
A recently discovered means of pathway modulation that is discussed in more detail 
later links the MAPK pathway to BMP signalling via the R-Smad I. The R-Smad tinker 
region contains multiple serine and threonine consensus sites for ERK MAP kinases, and 
ERK 112 mediated phosphorylation of Smad 1 has been demonstrated to inhibit nuclear 
accumulation in vitro (Kretzschmar et al. 1997). 
Mechanisms ofBMP mediated inhibition of neural induction and promotion of 
differentiation into non-neural ectoderm 
Activated receptor smads mediate the transcriptional regulation of a plethora of genes in 
response to BMP signalling in a cell type specific manner, depending on the eo-factors and 
transcriptional activators and repressors. Most of the BMP target genes identified to date 
encode homeobox transcription factors. Transcription factors that can mediate BMP responses 
identified in developing Xenopus include Msx 1 (muscle segment homeobox I), (Suzuki et al. 
1997b), Msx2, Vent2 (or Xom) and Dlx5 (Miyama et al. 1999), see review by Chang and 
Hemmati-Brivanlou and references therein ( 1998). Msx 1 and Vent2 are reported to be directly 
regulated by BMP signalling in the absence of protein synthesis in Xenopus, and injection of 
Msx1 is able to counteract the neuralizing activity of a truncated BMP receptor to restore 
epidermal fate in intact animal caps (Ladher et al. 1996, Suzuki 1997b ). 
Homeobox genes Msx 1 and Msx2 and Ids (inhibitors of differentiation) 1-3 have also 
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been reported by Hollnagel et al. ( 1999) to be direct targets of BMP signalling in the 
developing mouse, demonstrating transcriptional up-regulation in BMP treated mouse ES 
cells. Members 1-3 of the Id family function as negative regulators of pro-neural helix loop 
helix factors, (such as neurogenin), thus mediating a direct link between BMP signalling and 
inhibition of neural induction (Ho linage I et al. 1999). In addition, studies by Pera et al. ( 1999) 
in the developing chick also demonstrate that the homebox gene dlx5, (that is expressed in 
prospective epidermis) is induced by BMP signalling, suggesting that these homeobox genes 
play an evolutionarily conserved role in mediating BMP induced inhibition of neural 
induction and promotion of epidermal fates. 
4.1.3 Neural induction- simply a matter of BMP signalling inhibition? 
Although the BMP default neural induction model has generally received support in Xenopus, 
work in other systems, particularly the chick, has revealed a key role for FGF and Wnt signals 
and questioned the importance of BMP signalling inhibition in neural induction, as reviewed 
in Wilson & Edlund (2001) and Stem (2005). They discuss key evidence that includes the 
observations that FGF could initiate ectopic expression of neural markers but Chordin and 
Noggin could not. In addition, intact lateral chick epiblast explants formed epidermis and did 
not neuralise in response to FGF or BMP antagonists. However, if Wnt signaling levels were 
lowered by treatment with Wnt antagonists, then both FGFs and BMP antagonists were able to 
induce neural differentiation in lateral epiblast cells. 
Correspondingly, in Xenopus animal cap explants, Wnt antagonists are able to 
transiently induce neural markers and FGFs can function as neural inducers. Taken together, 
the available evidence implies that the 'default model' of neural induction is over-simplified 
and that multiple signalling pathways including Wnts and FGFs are involved in neural 
induction in vertebmtes. However, there is also evidence that at least one means of the neural 
inducing effects of FGF and Wnt may be through antagonising BMP pathway activity: For 
example, during pre-gastrulation in the chick, neural fate choice is thought to involve FGF-
mediated suppression of BMP transcription (Wilson et al. 2000). FGF expression in the 
epiblast leads to the downregulation of BMP tmnscripts, whereas in the presence of the FGF 
receptor inhibitor SU5402, this down-regulation is prevented and epidermal fate is restored. 
FGF mediated suppression of BMP tmnscription at this stage has also been demonstrated to 
require the inhibition ofthe Wnt pathway (Wilson et al. 2001). 
Recently, Pem et al. (2003) reported another mechanism by which FGF signalling 
may mediate the inhibition of BMP pathway activity during development, through ERK 112 
mediated phosphorylation of Smad 1. Positively acting neural inducers such as FGF signal 
through Tyrosine kinase (RTK) tmns-membrane receptors, and Pera et al. reported that both 
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FGF and IGF induce mitogen-activated protein kinase (MAPK) mediated phosphorylation of 
Smad 1 in the tinker region at four conserved PXSP sites. This phosphorylation prevents 
nuclear translocation despite previous phosphorylation events on the C-terminal by activated 
receptors, thus inhibiting the action of Smad 1 independent of BMP receptor activation. Figure 
4.4 outlines the pathway by which FGF signalling can mediate an inhibition of BMP pathway 
activity regardless of BMP signalling. In support of this mechanism of MAPK mediated BMP 
pathway inhibition, over-expression of Smad 1 in Xenopus embryos has little ventralizing (pro-
BMP) effect except in the case of mutant proteins that cannot be phosphorylated by MAPK 
(Pera et al. 2003, Sater et al. 2003). This indicates that MAPK signals are active in the 
developing embryo and this mechanism of inhibiting BMP pathway activity is important in 
dorsalising the Xenopus embryo. 
In summary, studies in the chick have demonstrated the role of multiple pathways 
including Wnts and FGFs in neural induction, and although mechanisms may vary between 
species, the inhibition of BMP pathway activity remains a central event that precedes the 
acquisition of neural fates in developing vertebrates such as Xenopus and chick. This leads to 
the question of whether the BMP mediated inhibition of neural induction during patteming of 
the ectoderm is conserved in human development. 
4.1.4 Using ES cells as in vitro models for the study of neural induction 
As discussed previously, embryonic stem cells provide valuable tools in which to study 
multiple aspects of embryonic development, although for human embryonic stem cells the 
conditions for feeder free maintenance and propagation are still being established. As a cell 
line that shares key characteristics of human embryonic stem cells, and has been demonstrated 
to preferentially differentiate into ectodermal cell fates, TERA2.sp 12 cells provide a useful 
model in which to address this question. Previous studies have demonstrated that human EC 
cells do respond and differentiate in response to BMP 4 treatment: Andrews first reported that 
BMP7 treatment induced differentiation in human EC NTERA2 cells distinct from that of RA 
treatment in 1994, and in more recent studies with the human EC lines GCT 27X-l and 
NT2D 1, Pera & Herszfeld ( 1998) and Caricasole et al. (2000) further reported that BMP 
treatment induced differentiation into endoderm or epithelial non-neural ectoderm lineages 
respectively. However no studies have yet evaluated the effect of BMP signalling on neural 
induction in either human EC or ES cells, although in mouse ES cells BMP treatment has been 
reported to inhibit neural differentiation in embryoid bodies (Finley et al. 1999). 
The effect of dissociation and subsequent culture in suspension of TERA2.sp 12 cells 
drew several parallels to the dissociation experiments with Xenopus animal cap explants 
(discussed previously), suggesting that the increased neural differentiation observed in RA 
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Figure 4.4 An Outline depicting FGF mediated inhibition of BMP pathway activity. 
Ligands such as FGFs bind to the extracellular domains of Transmembrane receptor tyrosine kinases 
(RTKs) causing receptor dimerization, autophosphorylation and activation of the intracellular tyrosine 
kinase domains. This in turn leads to the activation of a number of intracellular signalling cascades, 
including the RAS-MAPK pathway. RTK activation leads to RAS activation which, in turn, induces 
sequential phosphorylation of the protein kinases RAF, MEK and ERK (MAPK). Activated ERK 
induces a variety of downstream responses including gene transcription, translation and cyto-skeletal 
rearrangement. Inhibitory phosphorylation ofSmadl in the tinker region by RTK signals such as FGF, 
IGF, HGF, and EGF is mediated by activation ofMAPK. MHI and MH2 are evolutionarily conserved 
globular Mad-homology domains; MH 1 contains the ON A-binding domain and MH2 multiple protein 
interaction sites. Phosphorylation of Smad 1 by MAPK prevents nuclear accumulation, regardless of 
activating phosphorylation events in the MH2 domain by activated BMP receptors. Figure adapted 
from Figure 5 in Pera et al. (2003). 
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treated aggregate cultures could be the consequence of a disruption in BMP signalling. In the 
following first section (Section A), I investigated whether a disruption in BMP signalling 
activity was causing the up-regulation in neural differentiation in RA treated suspension 
cultures and also whether this was linked to changes in FGF mediated signalling. Figure 4.5 
presents an outline of the aims, objectives and experiments carried out in Section A of this 
chapter. 
In order to more closely mimic early events in neural versus non-neural ectoderm 
specification, I also examined the effect of manipulating BMP and FGF signalling on the 
differentiation fate of TERA2.sp 12 cells in the absence of RA. As treatment with BMPs or the 
FGF receptor1 inhibitor SU5402 induced not only non-neuml ectoderm marker expression, 
but markers of mesoderm and trophoblast, I subsequently attempted to characterise this 
differentiation. Figure 4.6 presents an outline of the aims, objectives and experiments carried 
out in Section B of this chapter. 
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4.2 RESULTS 
SECTION A 
In order to determine whether the observed up-regulation of neural and corresponding down-
regulation of non-neural ectoderm marker expression in TERA2.sp 12 cells cultured under 
suspension as opposed to adherent conditions was due to changes in BMP and/or FGF 
signalling, in the following section I compared and manipulated these pathways in RA treated 
cultures under these conditions. 
4.2.1 Monitoring the BMP signalling pathway in RA treated cultures 
To detect changes in BMP signalling in TERA2.spl2 cells cultured under suspension or 
adherent conditions, the level of phosphorylation of the receptor Smads 1,5 and 8 proteins that 
occurs as a direct consequence of BMP-receptor activation was assayed using Western blot 
analyses with antibodies specific for Smad 1 ,5,8 and phosphorylated Smad 1 ,5,8 (P-Smad). 
TERA2.spl2 cells were cultured with lOflM RA under either suspension or adherent culture 
conditions for 4, 5, 7 or 14 days. At each time point protein was extracted from samples in 
each culture condition, and protein was also extracted from a confluent culture of cells grown 
under maintenance conditions (EC sample). Protein samples were then subjected to Western 
blot analysis and probed with an antibody to Receptor Smads 1 ,5,8 (Santa Cruz), an antibody 
to phosphorylated Smads 1,5,8 (Santa Cruz) or with an antibody to~ actin (Sigma), following 
the procedure outlined in Section 2.4. Western blot detection of Smad 1 ,5,8 and p-Smad 1 ,5,8 
proteins was repeated over multiple experiments using cultures at different passage numbers. 
Phosphorylated Smad 1, 5 and 8 protein was detected in TERA2.sp 12 cells cultured 
under maintenance conditions in multiple experiments, and the level of P-Smad protein was 
detected to consistently increase with RA treatment in both adherent and non-adherent 
conditions. However, the level of P-Smad 1, 5 and 8 proteins over different time-points and in 
comparisons with adherent versus non-adherent conditions appeared to fluctuate in repeated 
experiments, and no positive detection with the antibody to Smad 1, 5 and 8 was achieved. As 
a consequence BMP signalling was monitored by detecting levels of transcripts from genes 
transcriptionally regulated by active receptor smads 1, 5 and 8. 
Following the protocol in Section 2. 7 and using the primers listed in Table 4.1, PCR 
detection of transcripts from genes that are reportedly transcriptionally regulated through 
Receptor smad binding, such as Id2, Id3 and Msx 1 were used to monitor the level of BMP 
signalling in TERA2.sp12 cultures, as represented in Figure 4.7. RNA degradation was 
PCR Detection Of Transcripts Regulated By BMP Signalling In TERA2.sp12 
Cells Treated With RA Under Suspension Or Adherent Culture Conditions. 
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Figure 4.7 
Figure 4.7 TERA2.sp12 cells were seeded at 20 000cells/cm2 under either suspension conditions in 
bacteriological dishes (AGG) or adherent conditions in T75 culture flasks (MON) and treated from day 
one with 10~-LM RA (+RA) or without RA for 2- 7 days. A confluent culture of TERA2.sp12 cells 
grown under maintenance conditions was used for the EC sample. At the selected time-points cultures 
were individualised with Trypsin, the RNA extracted using Tri-reagent, lllg of RNA for each PCR 
sample was reverse transcribed and amplified with specific primers using a PCR machine. As a 
negative control (-ve) no reverse transcriptase enzyme was added prior to amplification. The resultant 
samples for each transcript detection were electrophoresed in 1% agarose gels and the bands visualised 
under ultra violet light. Id2 transcripts were up-regulated in RA treated cultures after 2 days, although 
in aggregate cultures this decreased to undetectable levels after 7 days. In aggregates cultured without 
RA little difference from the low expression levels in EC cultures was observed. Id3 transcripts were 
up-regulated in all treatments compared to EC cultures, and the strongest expression was detected in 
adherent cultures. Msx 1 expession was markedly down-regulated from EC levels in aggregate cultures 
(with or without RA) after 7 days of treatment, contrasting with more sustained expression in adherent 
cultures treated with RA. Smad I transcript detection remained relatively equal in all treatments. 
Detection of~ actin transcripts demonstrated equal loading. 
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assayed by running RNA samples on a 1% agarose gel as described in Section 2.7 and to 
ensure equal loading primers for ~ actin were used. 
Table 4.1 Details of primers used for PCR analysis. 
PRIMER FOR PRIMER CODE ANNEALING TEMPERATURE 
ld2 Forward: 5-CAC CAT GGG GAG CGA AAA C-3 51.4 ·c Reverse: 5-GAA ATA AAG CAG GCA ATC AC AT-3 
ld3 Forward: 5-AGC TCG CTC CGG AAC TIG TCA TC-3 61.4 ·c Reverse: 5-CCG CCT TGG CAT AGT TIG GAG AG-3 
Smad 1 Forward: 5-AAGCGTICCATGCCTCCTC-3 54.7·c Reverse: 5-CTCCCCAGCCCTICACAAA-3 
Msx 1 Forward: 5-GTGGCGCCCGTGGGACTCTACA-3 so.2·c Reverse: 5-CACCGA TTICTCTGCGCTTICTIG-3 
13 actin Forward:ATCTGGCACCACACCTICTACAA TGAGCTGC-3 55•c Reverse: 5-CGTCATACTCCTGCTIGCTGATCCACATCTG-3 
Id2 and Msxl expression demonstrated marked regulation by RA treatment and exhibited 
differences in expression between suspension and adherent cultures ofTERA2.sp12 cells. Id2 
transcripts were up-regulated after 2 days of RA treatment in both adherent and suspension 
cultures, although in suspension cultures Id2 expression subsequently decreased to 
undetectable levels after 7 days. In cells cultured under suspension conditions without RA 
treatment, Id2 expression remained at similar levels to in EC cultures. Id3 transcripts were up-
regulated in all treatments compared to EC cultures, with the strongest expression detected in 
adherent cultures. Msxl expression was markedly down-regulated from EC levels in cells 
cultured under suspension conditions (with or without RA) after 7 days of treatment, 
contrasting with more sustained expression in adherent cultures treated with RA, and this 
observation was consistent in repeated experiments. PCR detection also confirmed that Smad 
1 expression was equal between treatments at the transcriptional level. This pattern of down-
regulation of BMP regulated genes is consistent with the hypothesis that BMP mediated 
pathway activity is markedly down-regulated in TERA2.sp 12 cells differentiated under 
suspension conditions compared to adherent conditions. 
To determine whether the changes in transcript expression of BMP regulated Id2 and 
Id3 genes were reflected by changes in protein expression, Western blot analysis was 
subsequently used to monitor changes in the levels of Id2 and Id3 protein in TERA2.sp 12 
cells cultured for 4-14 days with RA under either suspension or adherent culture conditions, 
following the procedure described in Section 2.4. Western blots were probed with antibodies 
to Id2, Id3 and~ actin, and one of the two Western Blot analyses is presented in Figure 4.8. 
Multiple bands corresponding to large molecular weights were detected in immuno-
blots probed with Id2 and Id3 over repeated experiments, although only a single band was 
present at the predicted size and this was taken as the representative protein. Id2 protein was 
detected in untreated cells and rapidly down-regulated after 4 days of RA treatment when 
cultured under suspension conditions, compared to a more gradual down-regulation in cells 
Figure 4.8 
Western Blot Detection Of Proteins Regulated By BMP Mediated Signalling In 
TERA2.Spl2 Cells Treated With RA Under Suspension Or Adherent Culture 
Conditions. 
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Figure 4.8 TERA2.sp 12 cells were seeded at 20 000cells/cm2 under either suspension conditions in 
bacteriological dishes (AGG) or adherent conditions in T75 culture flasks (MON) and treated from 
day one with 101-!M RA, (+RA) or without RA for 4, 7 or 14 days. At the se lected time-points 
protein was extracted and analysed by Western blot analysis. Blots were probed with antibodies to 
Smad 1 regulated proteins 102, 103, to phosphorylated Smad I ,5 and 8 (P-Smad), and equal loading 
was demonstrated by blotting with an antibody to 13 actin. A confluent culture of TERA2.sp 12 cells 
grown under maintenance conditions was used for the EC sample, and protein extracted from human 
FaDU cells was used as a positive control for the expression of BMP regulated proteins. ld2 protein 
levels were observed to decrease to almost undetectable levels after 14 days in RA treated 
suspension cultures, compared to sustained levels in RA treated adherent cultures. In contrast, 
detected levels of ld3 protein did not markedly change between treatments, although a stronger band 
was detected at 4 days of RA treatment under adherent conditions. Detected levels of P-Smad 1 
protein varied between treatments. In suspension cultures, initially low levels of phosphorylated 
Smadl were detected, although these increased over the 14 day period. In contrast, in RA treated 
adherent cultures phosphorylated Smad I, 5 and protein was initially detected at high levels, and 
decreased over the 14 day period. In cultures grown without RA the level of P-Smad I 5 and 8 
protein detected was markedly lower in cells grown under suspension conditions compared to 
adherent cultures. 
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cultured under adherent conditions, such that Id2 protein was still at detectable levels after 14 
days. Id2 was also down-regulated to some extent in suspension cultures grown without RA, 
whereas protein levels in corresponding adherent cultures were similar at 14 days to those of 
untreated cells. In contrast, levels of Id3 remained similar in all treatments. These 
observations were consistent over 2 repeated Western blot analyses. This data demonstrates 
that although no marked change in Id3 protein occur, the down-regulation of Id2 gene 
expression is also reflected in a down-regulation of protein activity. 
4.2.2 Manipulating BMP pathway activity in RA treated cultures 
To determine whether manipulations in BMP signalling would modify the differentiation 
behaviour of TERA2.sp12 cells cultured under adherent or suspension conditions, 
TERA2.sp 12 cells were differentiated with 1 OJ.1M RA as either suspension aggregates or 
adherent cultures with or without the addition of 25nglml BMP2 or 1 OOnglml Noggin. 
The predicted outcome was that Noggin treatment of adherent cultures would generate similar 
levels of neuml differentiation to that observed in suspension cultures, and BMP2 treatment 
would down-regulate neural differentiation in suspension cultures. 
As depicted in Figure 4.9, BMP and RA treated adherent cultures formed larger, less 
densely packed cells compared to RA treated cultures alone, and suspension cultures were 
slightly more irregular and smaller in shape than cultures treated solely with RA. In contrast, 
cultures treated with Noggin and RA combined were similar in morphology to cultures treated 
with RA alone, and showed markedly higher proliferation rates. In a flow cytometry analysis 
of adherent cultures, the down-regulation of stem cell markers TRA 160 or SSEA3 upon RA 
treatment was not markedly affected by the addition of BMP or Noggin, although cultures 
treated with BMP4 or BMP2 and RA exhibited a reduced up-regulation of neuml associated 
surface antigen A2B5 compared to cultures treated with RA alone. This indicates that the 
manipulation of BMP signalling is not affecting the mte of stem cell differentiation, and the 
up-regulation of A2B5 in BMP treated cultures is consistent with the hypothesis that neuml 
differentiation is inhibited in cultures subjected to high BMP signalling. 
Western blot comparisons of neural and non-neural ectoderm marker expression 
Western blot comparisons of Neuronal ~11 tubulin and Keratin 8 protein expression in 
cultures ofTERA2.sp12 treated with RA alone, with RA and BMP2, or with RA and Noggin 
demonstrated marked differences in the expression of these proteins in adherent cultures, in 
contrast to suspension cultures. At 5, 7 and 14 day time-points selected cultures were 
individualised and prepared for Western blot analysis as described in Section 2.4. Blots were 
probed with antibodies to ~Ill tubulin, NSE, Keratin 8, Nestin and ~ actin. This experiment 
was repeated 3 times with cells grown at different passage numbers, measuring expression at 
Figure 4.9 
Changes In Morphology In TERA2.sp12 Cells Cultured Under Adherent Or Suspension 
Conditions And Treated With Either RA Alone Or Together With BMP 2 Or Noggin. 
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Figure 4.9 Representative phase contrast images of TERA2.sp 12 cells seeded at a density of 20,000 
cells/cm2 into either adherent T25 culture flasks or non-adherent petri dishes and treated from day one with 
either lOJ.!M RA (A-B), or with I OJ.!M RA and I OOng/ml Noggin (C-D), or I OJ.!M RA and 25ng/ml BMP2 
(E-F) . Note that Noggin and RA treated cultures demonstrated similar morphologies to RA treated cultures 
alone, whereas TERA2.spl2 cells treated with BMP and RA as adherent cultures formed larger, less densely 
packed cells and under suspension conditions formed more irregular aggregates. Scale bars = 50Jlm 
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time-points ranging from 5-14 days A representative Western blot analysis is depicted in 
Figure 4.1 0. Consistent with previous observations, treatment of adherent cultures with RA 
alone up-regulated neuronal ~Ill tubulin to a lesser extent than in suspension cultures, and also 
up-regulated Keratin 8 expression as opposed to the down-regulation observed in suspension 
cultures. However, treatment of adherent cultures with Noggin and RA combined up-regulated 
neuronal ~Ill tubulin expression to levels comparable to suspension cultures, and down-
regulated Keratin 8 expression. Thus inhibition of BMP signalling in adherent cultures was 
sufficient to increase neural differentiation and suppress non-neural differentiation to the same 
levels as that observed in suspension cultures. In contrast, the expression levels of neuronal 
~Ill tubulin and Keratin 8 in suspension cultures treated with Noggin and RA combined 
remained unchanged from the levels expressed in cultures treated with RA alone. One could 
hypothesise that BMP signalling is already attenuated to such a level that exogenous inhibition 
of BMP signalling has no effect. Adherent cultures also demonstrated a marked 
responsiveness to BMP2 treatment, strongly down-regulating neuronal ~Ill tubulin and up-
regulating Keratin 8 expression in cultures treated with BMP2 and RA combined. This effect 
was visible by 7 days of treatment. Suspension cultures also down-regulated neuronal ~Ill 
tubulin expression and up-regulated Keratin 8 expression, but neuronal ~Ill tubulin expression 
remained relatively high - often comparable to levels in adherent cultures treated with RA 
alone. This effect was reproduced in 4 different Western blot analyses over time-points 
ranging from 5-14 days. The marked responsiveness of adherent cultures to exogenous up-
regulation and down-regulation of BMP signalling activity are in contrast to the more 
restricted response of suspension cultures. This could be explained by the presence of factors 
attenuating BMP pathway activity acting down-stream of BMP signalling which are active in 
suspension cultures and not in adherent cultures. 
In a pilot experiment investigating the effect of changes in foetal calf serum (FCS) on 
neural differentiation, under low serum conditions (5% FCS) an up-regulation of ~Ill tubulin 
and marked down-regulation of Keratin 8 expression in adherent cultures treated with RA was 
observed. Consistent with the hypothesis that this was due to reduced exposure to BMPs in the 
FCS, this effect was repressed in adherent cultures treated under low serum conditions with 
RA and BMP2 combined. 
4.2.3 Inhibiting FGF mediated signalling prior to RA treatment 
To investigate whether the up-regulation in neuronal markers observed in suspension cultures 
was linked to a temporary up-regulation in FGF signalling, similar to that observed in 
dissociated Xenopus explants (Kuroda et al. 2005), FGF mediated signalling was blocked in 
the first 24 hours prior to treatment with RA by exposure to SU5402, an FGF receptor 
Figure 4.10 
Western Blot Analyses Demonstrating The Effect Of Noggin Or BMP2 On Neural 
And Non-neural Ectoderm Marker Expression In TERA2.sp12 Cells Differentiated 
With RA 
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Figure 4.10 Western blot detection of neuronal ~Ill tubulin and keratin 8 in protein extracted at 5 
and 14 days from cells seeded at 20 000cells/cm2 under either adherent conditions (MON) or 
suspension conditions (AGO) and treated from day I with either 1 OJ.!M RA alone, I OJ.!M RA and 
25nglml BMP2 or IOJ.!M RA and IOOnglml ofthe BMP inhibitor noggin. For the EC sample, protein 
was extracted from confluent cultures of TERA2.sp 12 cells grown under maintenance conditions, 
and to monitor equal loading blots were also probed with an antibody to~ actin . In adherent cultures 
neuronal ~lll tubulin expression was detected to be markedly up-regulated by the addition of noggin, 
matching the levels of expression observed after 14 days of RA treatment in suspension cultures. In 
contrast, the level of ~Ill tubulin up-regulation after 14 days remained similar in suspension cultures 
treated with either RA alone or a combination of noggin and RA. Similarly, in suspension cultures 
the addition of noggin was not detected to markedly change keratin 8 expression from the minimal 
levels observed after 14 days in RA treatments alone. In contrast, the addition of Noggin to RA 
treated adherent cultures prevented the up-regulation of keratin 8 observed in cultures treated with 
RA alone. Correspondingly, the addition of BMP2 was detected to inhibit the up-regulation of 
neuronal ~Ill tubulin under both suspension and adherent conditions, although in suspension cultures 
~Ill tubulin expression remained relatively strong. In addition, keratin 8 levels were up-regulated by 
BMP2 treatment in both cultures, with adherent cultures exhibiting the strongest expression after 14 
days. 
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inhibitor. Temporary treatment with the FGF inhibitor SU5402 induced distinct changes in 
morphology and differentiation in both adherent and suspension cultures, with the most 
marked effects on neuronal marker expression observed in cells cultured in suspension. 
In adherent cultures pulsed with SU5402, plaques of large cells formed between 4-7 
days in cultures treated either with or without RA. Under suspension conditions, treatment 
with SU5402 alone generated aggregates that were generally smaller and more irregular 
compared to mock treated aggregates, whereas in RA treated suspension cultures aggregates 
that had been initially treated with or without SU5402 were similar in size, although the total 
number of aggregates present in SU5402 treated cultures was lower. 
Western blot analyses demonstrated a marked effect of SU5402 exposure on neural 
and non-neural ectoderm marker expression in all conditions (see Figure 4.11). After 14 days 
of culture, the samples were individualised and prepared for Western blot analysis as 
described in methods Section 2.4. Blots were probed with antibodies to ~lll tubulin, NSE, 
Keratin 8, Nestin and ~ actin. This experiment was repeated twice with cells grown at 
different passage numbers. In both treatments 24 hour exposure to SU5402 increased levels of 
the neural progenitor Nestin detected after 14 days. However, under adherent conditions, prior 
SU5402 exposure was observed to up-regulate ~Ill tubulin expression after 14 days, again 
with the most dramatic increase detected in adherent monolayer cultures grown without RA. 
The expression of simple epithelial keratins 8 and 18 was up-regulated by SU5402 exposure 
in all culture conditions (this effect was most marked in suspension cultures cultured without 
RA). These changes in protein expression were consistent in two repeated Western blot 
analyses, demonstrating that changes in FGF signalling generated marked effects on neural 
and non-neural ectoderm marker regulation in TERA2.sp 12 cells cultured under both 
suspension and adherent conditions, and moreover that inhibition of FGF signalling in the first 
24 hours of culture markedly inhibited neuronal ~Ill tubulin up-regulation in cells cultured 
under suspension conditions. 
Western blot mediated detection ofMAPK pathway activity 
To assess whether differences in FGF mediated MAPK pathway activity were present m 
TERA2.sp I2 cells cultured under suspension or adherent conditions, levels of phosphorylation 
regulated MAPK pathway components ERK I and ERK 2 were compared. Protein samples 
from TERA2.sp I2 cells cultured for 4-I4 days with RA under either suspension or adherent 
culture conditions were subjected to Western blot analysis and probed with antibodies to 
ERKl/2, phosphorylated ERKI/2 and~ actin following the procedure outlined in Section 2.4. 
The Western blot analysis data is presented in Figure 4.I2. Total levels ofERK I and ERK 2 
proteins increased with RA treatment in all cultures, although in suspension cultures, ERK I 
levels were very low after 4 days of treatment, and were up-regulated only after 7 days, as 
Figure 4.11 
Western Blot Comparison OfNeural And Non-Neural Ectoderm Protein Expression In 
TERA2.Spl2 Cells Pulsed With SU5402 Prior To Treatment With RA. 
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Figure 4.11 Western blot detection of neural markers (plate i) and epithelial keratins (plate ii) 
in TERA2.sp 12 cells seeded at 20 000cell s/cm2 as either adherent (MON) or suspension 
(AGO) cu ltures and pulsed for 24 hours with 20flM SU5402 (+)or without SU5402 (-),prior 
to being cultured for 14 days with (+) or without (-) RA. After 14 days cu ltures were 
subjected to Western blot analysis and probed with antibodies to either neural proteins (i) or 
epithelial keratins (ii). Positive controls for neural proteins and epithelial keratins were 
extracted from IMR32 and FaDU cells respectively. For EC samples, protein was extracted 
from confluent cultures of TERA2.spl2 cells grown under maintenance conditions. In a ll 
conditions, detected levels of keratin 8 and keratin 18 protein were up-regulated by prior 
treatment with SU5402. Correspondingly, the level of neuronal ~Ill tubulin expression was 
detected to be markedly down-regulated by prior SU5402 treatment in suspension cultures, 
(in both RA treated and untreated cultures), whereas in adherent cu ltures the level of 
neuronal ~Ill tubulin expression was detected to be higher in cultures pre-treated with 
SU5402. Under all conditions prior treatment with SU5402 generated increased detected 
levels of nestin expression . 
Figure 4.12 
Monitoring MAPK Pathway Activity In Cultures OfTERA2.Spl2 Cells Treated With 
RA Under Either Adherent Or Suspension Conditions 
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Figure 4.12 Western blot detection of active (phosphorylated) forms of MAPK pathway 
components ERK I and ERK2 compared to total levels in TERA2.sp 12 cells treated with RA 
as either adherent or suspension cultures. TERA2.sp 12 cells were seeded at 20 000cells/cm2 
under either adherent (MON) or suspension conditions (AGG) and treated from day one with 
I O).LM retinoic acid (RA). At 4, 7 and 14 day time-points culture samples were subjected to 
Western blot analysis and probed with antibodies to either the phosphorylated active forms of 
ERK 1/2 or total ERK 1/2 proteins. As a positive control for MAPK pathway activity, protein 
was extracted from human MSC cells grown on Laminin (MSC). For EC samples, protein 
was extracted from confluent cultures of TERA2.sp 12 cells grown under maintenance 
conditions. Equal loading was determined by probing with an antibody to ~ actin. Total 
levels of ERK 1 and ERK2 protein were detected to increase over 14 days of treatment in 
both suspension and adherent conditions. However, in suspension cultures a temporary 
decrease was initially detected. This pattern was mirrored to some extent in the detected 
levels of phosphorylated ERK I /2 protein (P-ERK I /2). However, no phosphorylated ERK I /2 
was detected at all at day 4 in suspension cu ltures, in marked contrast to the relatively strong 
and steady expression detected from day 4-14 of adherent cultures. 
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opposed to a rapid increase detected after 4 days of treatment in adherent cultures. 
Phosphorylated ERK I and 2 was also up-regulated in treated cultures, although a temporary 
down-regulation was initially observed in suspension cultures such that at 4 days no 
phosphorylated ERK protein was detected. Thus MAPK pathway activity (as indicated by 
monitored levels of phosphorylated ERKI/2 protein) was not detected to be up-regulated in 
suspension cultures compared to adherent cultures, in fact exhibiting a marked down-
regulation (at the earliest time-point of 4 days) in suspension cultures. 
SECTIONB 
In the following section I characterised the differentiation of TERA2.sp I2 cells generated as a 
result of direct manipulation of BMP or FGF signalling (in the absence of RA). 
4.2.4 Manipulation of BMP signalling 
To investigate the effect of manipulation of BMP signalling in the absence of a background of 
RA, TERA2.sp I2 cells were seeded at 20 000 cells/cm2 into electro-statically coated NUNC 
tissue culture flasks and cultured in DMEM media with I 0% FCS, 2mM L-glutamine and 
IJ.lM pen/strep supplemented with either 25ng/ml BMP2, 25ng/ml BMP4, I OOng/ml Noggin, 
I OJ.lM RA or vehicle treated with 0.25J.1M HCL. 
General observations 
Cells cultured under adherent conditions and treated with BMP2 or BMP4 rapidly lost their 
characteristic stem cell morphology and for a transient period 3-5 days after treatment cells 
demonstrated a shrunken and irregular morphology (depicted in plates E, G, Figure 4.I3), with 
increased debris observed within the culture. However, by 7 days of treatment distinct 
patches of large plate-like cells with large nuclei and prominent nucleoli had developed, 
(plates F, H, Figure 4.I3). After 14 days these large cells dominated the culture, occurring in 
extensive regions bordered by distinct clusters of small cells with densely packed nuclei. The 
formation of these plate-like cells was observed to occur in larger sheets and at an earlier stage 
in cultures treated with BMP4 compared to BMP2 treated cultures, such that large hexagonal 
cells were detected after approximately 7 days of treatment with BMP2 as opposed to after 4 
days of exposure to BMP4. Increased levels of cell debris were consistently observed in early 
cultures of BMP treated cells, although there was some variation in the level of debris and the 
length of the stage in which shrunken morphologies were observed. In cells cultured for more 
than I4 days, increased debris was associated with the large celled populations, and the 
number of large hexagonal cells decreased. TERA2.spi2 cells mock treated with 0.25J.1M 
HCL used as a diluent for BMP2 and BMP4 did not develop any of the morphologies 
Changes In Morphology Of TERA2.sp12 Cells Treated With RA, BMP2, 
BMP4, Or Noggin 
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Figure 4.13 Representative phase contrast images of TERA2.sp 12 cells seeded at a density of 
20,000 ce lls/cm2 and treated with either I 01-1M RA (A-B), IOOng/ml Noggin (C-D), 25ng/ml 
BMP2 (E-F) or 25ng/ml BMP4 (G-H) for 5 or 14 days. After 14 days Noggin treated cells 
formed densely packed cultures similar to RA treated cells, with rosette-like formations visible 
(arrow). After 5 days of BMP treatment cells exhibited a shrunken appearance and were 
sparsely populated. However, after 14 days of BMP treatment the culture was dominated by 
large flat plate-like cells with large nuc lei that formed large continuous sheets and were 
bordered by small areas of densely packed cells. Scale bars = 501-lm 
Figure 4.13 
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described above, and behaved similarly to cells seeded at differentiation density and cultured 
in maintenance media, demonstrating that HCL was not linked to the observed differentiation 
behaviour in BMP treatments. 
In contrast to BMP treated cells, cultures of TERA2.sp 12 cells treated with the BMP 
inhibitor Noggin initially demonstrated a similar morphology to vehicle treated cultures. 
However, they were slower to form densely packed cultures and frequently formed rosette-
like structures, similar to those observed in RA treated cultures (arrow heads in Figure 4.13). 
A cell count assay was used to gauge the effect of these treatments on cell 
proliferation. After 7 and 14 days of treatment, cells within three culture flasks for each 
condition were individualised and counted with a haemocytometer following the protocol 
described in Section 2.2. The summarised results are displayed in Table 4.2. 
Table 4.2 Mean number of cells (millions) in 3 T75 flasks harvested at 0, 7 and 14 days in 
cultures ofTERA2.sp 12 cells treated with RA, BMP2, BMP4 or Noggin. 
Days RA BMP2 BMP4 Noggin 
0 1.5 1.5 1.5 1.5 
7 18.95 18.50 21.40 18.65 
14 106.00 25.70 10.03 33.73 
As demonstrated in the histogram summarising the cell count results in Figure 4.14, 
BMP or Noggin treatment resulted in a reduction in the rate of increase in cell number 
between 7 and 14 days compared to both vehicle treated and RA treated cultures, and this was 
most marked in BMP treated cultures. Vehicle (HCL) treated cultures behaved similarly to 
mock treated cultures, initially demonstrating slow proliferation and then between 7-10 days 
demonstrating an escalating increase in cell number such that the cultures became so dense 
that they were no longer viable. In both BMP2 and BMP4 treated cultures, little or no increase 
in cell number was observed between 7 and 14 days (in BMP 4 treated cultures the mean cell 
counts were actually lower than at 14 days, although this was not statistically significant). 
This stabilisation in cell number corresponds to the stage in which distinct populations of 
large plate-like cells and clusters of densely packed cells are established, compared to the 
initial 7 days when substantial cell debris was observed. This suggests that the stabilisation in 
cell number after 7 days in BMP treated cultures is due to cells exiting from the cell cycle and 
embarking on differentiation. 
In the first 7 days of culture Noggin treated cells initially showed similar counts to 
that of vehicle or RA treated cells; however the increase in cell number remained steady 
between 7-14 days, in contrast to the exponential increases observed in RA or vehicle treated 
cultures. This suggests that Noggin treated cells are also exiting from the cell cycle and 
embarking on differentiation, albeit more slowly. 
Histogram Depicting Mean Cell Counts Of TERA2.Spl2 Cells Cultured With 
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Figure 4.14 Histogram depicting mean cell counts (from three T75 flasks) over time of 
TERA2.spl2 cells seeded at 20,000 cells/cm2 under adherent culture conditions (white bar) and 
treated with either RA, Noggin, BMP2, BMP4 or vehicle treated respectively. Cultures were 
individualised with Trypsin and counted using a haemocytometer at 7 days (patterned bars) or 
14 days (black bars). Error bars represent the standard deviation of the mean (n=3 at the same 
passage number). Over the fiTSt 7 days all treatments demonstrated similar increases in cell 
number, however in the following 7 days BMP2 and BMP4 cultures demonstrated a relative 
stabilisation in cell number compared to RA treated cultures, which continued to increase at a 
rapid rate. Mock treated cultures proliferated so rapidly after 7 days that with-out splitting and 
re-seeding they became too dense and expired. Noggin treated cultures continued to increase in 
cell number, although to a reduced degree compared to RA or mock treated cultures. 
Figure 4.14 
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Comparison of cell surface marker regulation 
To compare the expression of surface antigens associated with the stem cell phenotype, (TRA 
160, SSEA 3) or with the neural phenotype (VINIS 53, A2B5) in TERA2.sp12 cells treated 
with BMP2, BMP4, Noggin or RA, the remaining cells from the cell count assay at 7 and 14 
days were used in a flow cytometry assay following the protocol outlined in Section 2.3. A 
confluent flask of undifferentiated TERA2.sp 12 cells was used for the EC time point, and 
three replicates of cells from the same passage number were used for each treatment and 
processed in parallel. As measured by flow cytometry, BMP and Noggin treatment induced a 
down-regulation of stem cell marker expression in TERA2.sp 12 cells, although to manifestly 
differing degrees (as depicted in Figure 4.15). To summarise, in BMP treated cultures SSEA 3 
expression was rapidly down-regulated such that 20% of BMP2 treated cells and less than 
1 0% of BMP4 treated cells were positive after 7 days of treatment. TRA 160 expression was 
down-regulated more gradually, with over 80% of cells still expressing TRA 160 after 7 days 
of BMP treatment, although in corresponding flow cytometry traces the intensity of TRA 160 
expression in these cultures was markedly lower than in mock treated cells, and by 14 days 
TRA 160 was expressed in less than 20% of cells for both BMP treatments. This indicates that 
in the absence of a background of RA, exogenous activation of BMP signalling alone induces 
differentiation of TERA2.sp 12 cells under these conditions. 
Noggin treated cells also down-regulated stem cell surface marker expression to some 
extent, with less than 30% of cells positive for SSEA3 after 14 days, and although over 80% 
of cells were still positive for TRA 160 after 14 days of culture, corresponding flow cytometry 
traces (represented in plate ii of Figure 4.15) demonstrate that approximately 50% of the 
population had down-regulated the level of TRA 160 expression. Thus under these conditions, 
inhibition of BMP signalling in the absence of a background of RA signalling also induces 
differentiation of TERA2.sp 12 cells. 
The expression of the neural associated marker A2B5 was also up-regulated to a 
certain extent by BMP or Noggin treatment, such that A2B5 expression was detected in 20-
30% of cells treated with BMP2 or BMP4 and in roughly I 0% of cells treated with Noggin. 
This unexpected result implies that up-regulation ofBMP signalling in the absence of RA may 
induce some neural differentiation in TERA2.sp 12 cells. 
Comparing the differentiation fate of BMP versus Noggin treated cells: Testing for 
neural and non-neural ectoderm marker expression 
The large cells dominating BMP treated cultures demonstrated some resemblance to the large 
cells in observed in RA treated cultures, and cultures exhibited no morphological evidence of 
neural differentiation, in contrast to the neural rosette-like formations observed in Noggin 
Figure 4.15 
Down-Regulation Of Stem Cell Surface Marker Expression In TERA2.sp12 Cells 
Treated With Either RA, BMP2, BMP4 Or Noggin 
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Figure 4.15 Detection of stem cell surface markers by flow cytometry. TERA2.spl2 cells were seeded 
at a density of 20,000 cells/cm2 into T75 culture flasks and either mock treated (MOCK) or treated 
with lO!lM RA, 25ng BMP2, 25nglml BMP4 or lOOnglml Noggin. At 7 and 14 days 3 replicate 
cultures of each treatment individualised using Trypsin and immuno-labelled with antibodies to stem 
cell surface antigens SSEA3 or TRA 160 or with the control antibody P3X. The percentage of immuno-
positive cells in each sample was detected using a flow cytometer, with the mean percentage for each 
treatment generated from 3 replicates. Histograms in plate i depict the mean percentage of positive 
cells at day 7 (patterned bars) and day 14 (black bars) after live immuno-labelling with stem cell 
surface markers SSEA3 or TRA 160. The error bars represent the standard deviation of the mean. 
Mock treated cultures were split and re-seeded at a ratio of 1 :3 at 7 and 10 days of culture (only one 
flask from each original culture was maintained, the remaining cells were discarded). The percentage 
of cells immuno-positive for stem cell antigens SSEA3 and TRA 160 decreased rapidly in RA treated 
cultures and more steadily in BMP2 or BMP4 treated cultures, such that at 14 days approximately 20% 
and 15% of BMP treated cells were immuno-positive for SSEA3 and TRA 160 respectively. The 
proportion of cells immuno-positive for stem cell markers TRA 160 and SSEA3 also decreased in 
Noggin treated cultures to a certain extent, with approximately 30% and 90% of cells positive for 
SSEA3 and TRA 160 respectively after 14 days. Representative flow cytometry traces of cultures 
either mock treated or treated with Noggin and immuno-stained with either TRA 160 (grey trace) or 
with the control antibody P3X (clear trace) in plate ii, demonstrate that the fluorescence intensity for 
TRA 160 expression was markedly reduced in cells treated with Noggin. 
Figure 4.15 
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treated cultures. To assay for neural differentiation and markers of non-neural ectoderm, 
cultures treated with either BMP2/4 or the BMP inhibitor Noggin were subjected to Western 
blot analyses. TERA2.sp12 cells were seeded as adherent cultures and treated with 25ng/ml 
BMP2, 25ng/ml BMP4, 100ng/ml Noggin, lOJ.1M RA or mock treated with no additional 
supplement. After 7 and 14 days protein was extracted from cultures and used for Western 
blot analysis following the protocol in Section 2.4. Protein was extracted from confluent 
cultures of TERA2.sp12 cells grown under maintenance conditions for the EC sample, and 
protein extracted from IMR32 and FaDU cell lines was used as a positive control for neural 
and epidermal differentiation respectively. Blots were probed with antibodies to Nestin, the 
neuronal proteins pm tubulin and NSE, and Keratin 8 and 18. Equal loading was assessed by 
both ponceau staining and by probing with an antibody to p actin. These Western blot 
analyses were repeated using fresh cell samples at 7 and 14 day time points. As shown in a 
Western blot analysis in Figure 4.16 the expression of keratin 8 was markedly up-regulated in 
BMP treated cultures, with minimal up-regulation of neural proteins. In marked contrast, 
Noggin treated cultures demonstrated a strong up-regulation of the neural progenitor marker 
Nestin (even greater than in RA treated cultures), up-regulation of neuronal pm tubulin (more 
mature neural markers were not detected), and down-regulation of keratin 8 expression. These 
results are consistent with the hypothesis that an up-regulation of BMP signalling induces 
differentiation of TERA2.sp 12 cells into non-neural ectoderm, whereas the inhibition of BMP 
signalling induces differentiation ofTERA2.sp 12 cells into neural ectoderm. 
Immuno-staining analyses were subsequently used to characterise the differentiation of cells 
treated with either BMPs 2, 4 or Noggin. TERA2.sp 12 cells were seeded as adherent cultures 
and treated with 25ng/ml BMP2, 25ng/ml BMP4, I OOng/ml Noggin, I OJ.1M RA or mock 
treated with no additional supplement. After 14 days, cultures were fixed in 4% PFA and 
following the protocols outlined in Section 2.5 either immuno-labelled with the stem cell 
markers Oct4 and Nanog, or double immuno-labelled using the following combinations of 
antibodies: Nestin and Neuronal pm tubulin, MAP2 and Neuronal pm tubulin, Pan-epithelial 
keratin and Tp63, NF200 and Neuronal pm tubulin. This experiment was repeated and BMP 
treated cultures double immuno-labelled with antibodies to pm tubulin and Pan-epithelial 
keratin, Nestin and pm tubulin, Pan-epithelial keratin and Keratin 8. 
Corresponding with the Western Blot analysis data, immuno-staining analyses 
demonstrated little supporting evidence for a neural population within BMP treated cultures. 
Nestin expression was barely detected and although some pm tubulin immuno-positive cells 
were identified, the localisation was distinctly atypical: Positive pm tubulin staining was 
detected in the cytoplasm of groups of large cells (demonstrated in Figure 4.17, plates A-B), 
with stronger staining surrounding the nucleus. Some eo-localisation of pm tubulin and pan-
epithelial keratin was also demonstrated (Figure 4.17 plates C-E). No cells displaying a neural 
Figure 4.16 
Western Blot Detection Of Neural And Non-Neural Ectoderm Proteins In Cultures Of 
TERA2.spl2 Cells Treated With Either RA, BMP2, BMP4 Or Noggin 
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Figure 4.16 Western blot detection of neural and non-neural ectoderm markers from protein extracted at 7, 
11 and 14 days from cells seeded at 20 000cells/cm2 in culture flasks and treated with either IOJ.1M RA 
(A), 25nglml BMP2 (B), 25nglml BMP4 (C) or IOOnglml Noggin (D). Positive controls for neural protein 
and epidermal protein were extracted from IMR32 and FaDU (FD) cells respectively, and protein was 
extracted from confluent cultures of TERA2.spl2 cells grown under maintenance conditions for EC 
samples. 
In BMP2 treated cultures, Nestin was slightly up-regulated such that a faint band was present at day 7 and 
14, and after 7 days exposure to BMP4 Nestin was detected as a faint band at day 7 and then down-
regulated to minimal detected expression by day 14. In contrast, the level ofNestin protein detected was 
markedly up-regulated by Noggin treatment after 14 days, even to a greater extent than the level ofNestin 
detected during RA treatment Neuronal pm tubulin expression followed a similar pattern, with BMP 
treatment decreasing pm tubulin levels to a level lower than present in untreated cells. Noggin treatment 
correlated with slightly up-regulated levels of TUJ I protein, yet not to a level comparable with RA 
treatment. Levels ofNSE were detected to be temporarily up-regulated by BMP2 treatment, and this was 
mirrored to a smaller degree by BMP4 treatment. As predicted, RA treatment markedly up-regulated NSE 
levels, and Noggin treatment also appeared to up-regulate NSE levels to a small extent. Levels of the 
transcription factor NeuroDl were up-regulated by RA treatment, and also up-regulated by BMP4 and 
Noggin treatment. The neurofilament protein NF200 was detected to be up-regulated by RA treatment, 
and also detected at low levels in BMP2 treated cells. Epithelial Keratin 8 was up-regulated by BMP2 or 
BMP4 treatment, and down-regulated in Noggin treated cultures. 
Neuronal Pili Tubulin And Pan-epithelial Keratin Immune-staining Of Large Cells In 
BMP4 Treated cultures of TERA2.sp 12 Cells 
Figure 4.17 TERA2.sp 12 cells were seeded at 20,000 cells/cm2 into 12 well plates and treated with 
25nglml BMP4 for 14 days prior to fixation in 4% PFA and immuno- labelling with neurona l ~111 tubulin, 
(A-B) or double immuno-labelling with pan-epithelial keratin (green) and neuronal ~Ill tubulin (red), (C-F) 
and the nuc lei stained with hoescht (blue). Large cel ls demonstrated atypical staining for neuronal ~111 
tubulin (A wth overlay in B), with increased staining intensity surrounding the nucleus. In some cases large 
cells immuno-labelled positive for both ~111 tubulin and pan-epithelial keratin (C, D with overlay including 
hoescht in E). The large cells are clearly defined in the corresponding phase contrast image (F). Scale bars 
= IOOjlm. 
Figure 4.17 
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morphology and typical pm tubulin expression were detected. Taken together this confirms 
that neural differentiation did not occur in BMP treated cultures. Although these large cells 
showed some epithelial keratin expression, the level of expression was variable within large 
celled populations and in repeated experiments. Unlike the cells within large cell plaques 
generated by RA treatment, they did not typically express Keratin 8. Atypical Keratin 8 
staining was also detected in these cultures, with small clusters of cells sometimes 
demonstrating solely nuclear localised staining with Keratin 8 antibody. This suggests that the 
non-neural differentiation occurring in BMP treated cultures is not similar to that seen in RA 
treated cultures and may not be non-neural ectoderm. 
Noggin treated cultures demonstrated distinct and regional immuno-staining for 
Nestin, with organised orientated cells frequently forming neural rosettes that stained 
immuno-positive for Nestin, pm tubulin and MAP2, similar to those found in cultures of cells 
treated with RA (Figure 4.18). More mature markers of neural differentiation were not 
detected in these cultures, and additionally no epithelial keratin expression was detected. 
Noggin treated cultures also exhibited negative staining for the stem cell marker Nanog after 
14 days of culture. This data is consistent with the hypothesis that inhibition of BMP 
signalling promotes neural differentiation ofTERA2.spl2 cells, but suggests that inhibition of 
BMP signalling alone (under these conditions) may not be sufficient to induce widespread 
commitment to the neural lineage. 
4.2.5 Inhibition of FGF mediated signalling 
To investigate the effect of continuous inhibition of FGF mediated signalling in TERA2.sp12 
cells, individualised cells were cultured under adherent conditions and treated with either 
20J.1M SU5402 or vehicle treated with DMSO. Media was replenished every 3-4 days (or 
every 1-3 days as required for vehicle treated cultures). After 14 days cultures were fixed in 
4% PFA and double immuno-labelled (using the protocol in Section 2.5) with antibodies to 
the following: Pill tubulin and Nestin, pm tubulin and pan-epithelial keratin, Keratin 8 and 
18, Tp63 and Pan-epithelial keratin, MAP2 and pm tubulin, GFAP and pm tubulin. 
TERA2.sp12 cells cultured under adherent conditions and continuously treated with SU5402 
rapidly developed morphologies similar to those observed in cultures treated with BMP2 or 
BMP4. Sheets of large plate-like cells interspersed with clusters of densely packed nuclei 
formed between 7-10 days, and dominated the culture after 14 days. Vesicle-like dots were 
also visible surrounding the nucleus of the large cells. A pilot immuno-staining analysis also 
revealed a similar expression pattern to that of BMP2 or 4 treated cells, as pan-epithelial 
keratin was frequently expressed in these large cells and similar patterns of non-neural pm 
tubulin expression were observed. This suggested that either inhibition of FGF signalling or 
Figure 4.18 
Nestin and Pill tubulin expression in Noggin treated cultures ofTERA2.sp12 cells 
Figure 4.18 TERA2.sp 12 cells were seeded at 20,000 cells/cm2 into 12 well plates and treated with 
100ng/ml Noggin for 14 days prior to fixation in 4% PFA and double immuno-labelling with Nestin (green) 
and neuronal f3III tubu1in (red), and the nuclei stained with hoescht (blue). Distinctive aggregate-like 
structures are visible (asterix), which are also visible under phase microscopy (E). Note that radially 
orientated 13111 tubulin or Nestin positive cells project out from this aggregate-like structure (C, D or 
overlays A, B) with Nestin expression strongest towards the edge of the structure, and neuronal f3111 tubulin 
towards the centre. Note that small groups of morphologically distinct cells under phase contrast (arrow in 
E and in overlay B) exhibited weaker staining for Nestin or 13111 tubulin expression, and were typically 
surrounded by radially orientated cells strongly positive for these markers. Scale bar = IOOilm. 
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activation of BMP signalling induced the same effect on TERA2.sp 12 cells. 
4.2.6 Characterising cultures treated with BMP2, BMP4 or SU5402 
Since cultures of TERA2.sp12 cells treated with the FGF inhibitor SU5402 or BMP2 or 
BMP4 exhibited similar morphologies, and pilot immuno-staining analyses of SU5402 treated 
cells demonstrated similar expression patterns of epithelial keratins and pm tubulin, the 
differentiation of TERA2.sp 12 cell cultures in response to these treatments were together 
more comprehensively characterised and compared using both Western blot and immuno-
staining analyses. TERA2.sp 12 cells were cultured under adherent conditions and treated with 
25nglml BMP2, 25nglml BMP4, 20f.!M SU5402 or vehicle treated. Media was replaced every 
2-3 days, and after 7 and 14 days protein was extracted from cultures and used for Western 
blot analysis following the protocol in Section 2.4. Blots were probed with antibodies listed in 
Table4.3. 
Table 4.3. List of antibodies used in Western Blot analysis of samples from TERA2.sp 12 cells 
treated for 14 days with BMP2, BMP4, SU5402 or RA. 
Antigen Molecular weight Antibody Source Dilution Category (kDa) 
13 actin 42 Mouse lgG Sigma 1:4000 House keeping gene 
Nestin 220-240 Mouse lgG Chemicon 1:200 Ectoderm- neural 
13111 Tubulin 50-54 Rabbit lgG Covance 1:4000 " 
NSE 45 Mouse lgG Chemicon 1:200 " 
Vimentin 58 Mouse lgG Sigma 1: 200 " 
Keratin 18 45 Mouse lgG Sigma 1:400 Ectoderm- non neural 
Keratin 8 55,45 Rabbit lgG Abeam 1:400 . 
TP63/ TP73l 73 Goat lgG R&D systems 1:200 . 
HCG 40 mouse lgG Abeam 1:200 Trophoectoderm-Trophoblast 
a smooth muscle 
actin 42 mouse lgG Sigma 1:400 Mesoderm- smooth muscle 
Protein was extracted from confluent cultures of TERA2.sp 12 cells grown under maintenance 
conditions for the EC sample, and protein extracted from cultured IMR32, FaDU and MSC 
cells was used as positive controls for neural, epidermal and mesenchymal markers 
respectively. Protein extracted from day 19 human villous placental tissue was used as a 
positive control for the expression of HCG protein. Equal loading was assessed by staining the 
blot with Ponceau prior to blotting and also by probing with an antibody to p actin. 
In Western blot analyses, the protein expression profile of cultures treated with 
BMP2, 4 or SU5402 was very similar (representative blots in Figure 4.19). Neural proteins 
pm tubulin, Nestin and NSE were not up-regulated after 14 days of treatment (with the 
exception of BMP2 treated cells, in which Nestin and NSE protein was detected at low levels 
after 14 days of culture). Vimentin, a protein typically expressed in neural cells, (although it is 
also expressed in mesenchymal cells) was also markedly down-regulated in contrast to the up-
Figure 4.19 
Developmental Regulation Of Neural, Non-Neural Ectoderm, Trophoblast And Smooth 
Muscle Markers In TERA2.sp12 Cells Treated With Either BMP2, BMP4 Or The FGF 
Receptor Inhibitor SU5402. 
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Figure 4.19 Western blot detection of a panel of neural (i), non-neural ectoderm (ii), trophoblast and 
smooth muscle (iii) markers from protein extracted at 14 days from TERA2.sp 12 cells treated with either 
lO!lM RA, 25nglml 8MP2 (82), 25nglml 8MP4 (84), 20!lM FGF inhibitor SU5402 (SU), or untreated(-). 
As positive controls for the expression of neural proteins, epidermal proteins, the trophoblast hormone 
Human chorionic gonadotrophin (HCG) and a smooth muscle actin, protein was extracted from IMR32 
cells (IR), FaDU cells (FD), day 9 human placental tissue (PL) and human MSC cells respectively. For the 
EC sample protein was extracted from confluent cultures of TERA2.sp 12 cells grown under maintenance 
conditions. To determine equal loading blots were also probed with p actin. (i) In contrast to RA treated 
cultures, 8MP2, 8MP4 or SU5402 treated cultures down-regulated pm tubulin expression and did not up-
regulate Nestin or Vimentin with the exception of BMP2 treated cultures, which minimally up-regulated 
both of these markers. Correspondingly Keratins 8 and 18 were markedly up-regulated with 8MP or 
SU5402 treatment, with 8MP2 treated cells and SU5402 treated cells demonstrating the least and most up-
regulation respectively (ii). However, expression of the epidermal stem cell marker TP63 was not detected 
in any treatments, compared to strong detection in control FaDU cultures. 
As an indicator of trophoblast differentiation no HCG protein was detected in treated TERA2.sp 12 cells. 
However HCG was only faintly detected in the human placental tissue used as a positive control. In 
contrast, a smooth muscle actin, expressed in smooth muscle, was strongly detected in cultures treated with 
8MP4 or SU5402, with low levels also detected in 8MP2 treated cultures and trace detection in RA treated 
cells. 
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regulation observed in RA treated cultures. Simple epithelial keratins 8 and 18 were also up-
regulated, with the strongest up-regulation in SU5402 treated cultures, and weakest in BMP2 
treatments. However, the epidermal stem cell marker TP63 was negative in all treatments, 
including RA treated cultures. 
During an immuno-staining survey for markers of differentiation into non-ectodermal 
lineages, positive expression of the smooth muscle marker a smooth muscle actin and the 
trophoblast hormone HCG was detected, (as described in detail later). To compare the 
expression of these markers between cultures the level of total protein was detected in 
Western blot analyses (plate iii in Figure 4.19). Smooth muscle actin protein was detected at 
increasing levels in cultures treated with BMP2, BMP4 or SU5402 respectively and 
unexpectedly also at trace levels in RA treated cultures. The trophoblast hormone HCG was 
not detected in Western blot analyses, despite multiple attempts. However HCG protein was 
only faintly detected in the positive control tissue (day 9 human placental villous tissue), 
indicating that the negative results may be due to difficulties with this technique of detection. 
To more comprehensively characterise the differentiation of BMP or SU5402 treated 
TERA2.sp12 cells, cultures treated for 14 days with BMP2, BMP4 or SU5402 were immuno-
labelled with a range of markers indicative of different germ layers and with markers to extra-
embryonic endoderm and ectoderm. TERA2.sp12 cells were cultured under adherent 
conditions and treated with 25ng/ml BMP2, 25ng/ml BMP4, 20uM SU5402 or vehicle treated. 
Media was replaced every 2-3 days. After 14 days cultures were fixed in 4% PFA and double 
immuno-labelled using the protocol in Section 2.5 with antibody combinations listed in Table 
4.4. As a positive control for markers of differentiation into multiple germ layers and for 
trophoblast differentiation, 11 day spontaneously differentiated H7 embryonic stem cells and 
sectioned 19 day human villous tissue were used respectively (as described in Sections 2.12 
and 2.9 respectively). 
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Table 4.4 Details of the antibodies and antibody combinations used in multiple immuno-
labelling and double immuno-labelling experiments. 
Antibodies Staining notes Aim/guestion 
13111 tubulin and pan- Is 13111 tubulin and pan-epithelial keratin expression 
epithelial keratin mutually exclusive? 
Nestin and 13111 tubulin Confirm that no neuronal differentiation is 
occurring 
Gata 4 Assay for endoderm differentiation 
Brachyury Assay for mesoderm differentiation 
TP63 Assay for epidermal differentiation 
HNF313 Assay for endoderm differentiation 
AFP Pre-treat with ethanol Assay for primitive endoderm differentiation 
a smooth muscle actin Fix in methanol with Assay for smooth muscle differentiation 
5% acetic acid 
a smooth muscle actin Fix in methanol with Are the large 13111 tubulin positive cells also 
and Bill tubulin 5% acetic cid expressing smooth muscle actin? 
HCG Pre-treat with Assay for trophoblast differentiation 
BrefaldinA 
HCG + Keratin 8 Pre-treat with Do HCG positive cells also express trophoblast 
Brefeldin A marker nuclear localised Keratin 8 Ab staining? 
HCG + 13111 tubulin Pre-treat with Are cells positive for trophoblast markers also 
Brefeldin A expressing non-neurall3111 tubulin? 
HCG + Gata 4 Pre-treat with Is HCG (trophoblast marker) and Gata 4 
Brefeldin A (endoderm) marker expression mutually 
exclusive? 
102 Is 102 expressed at high levels in a 
morphologically distinct sub-population? 
Vimentin Assay for neural or mesenchymal differentiation 
As indicated in the table, the standard staining protocol was adjusted for the detection of the 
certain markers and these modifications are described as follows: 
I. To increase the detection of HCG, 4 hours prior to fixation in PFA 1.25J.lg/ml of Brefeldin 
A, (Sigma B7651) was added to the cell cultures to be immuno-stained with HCG antibody. 
2. After PF A fixation, cells to be immuno-stained for AFP were treated for I m in with 
ethanol, washed briefly in water and then PBS before continuing with the standard immuno-
staining method. 
In essence the same population profiles were observed within all treated cultures, with some 
variation in the frequency of each phenotype: Brief summaries of the immuno-staining 
phenotypes observed are described below. 
1. Sub-population (I 0-15%) Densely clustered small cells 
These clustered small cells were frequently immuno-positive for nuclear localised Keratin 8 
antigen (the nuclear staining generated from the cross-reaction of a trophoblast antigen with 
Keratin 8 antibody), and a sub-population of cells within these clusters was immuno-positive 
for the trophoblast hormone HCG, indicating that these cells were differentiating along a 
trophoblast lineage (see Figure 4.20). Some of these HCG positive cells appeared to be 
multinucleate cells, containing multiple small clustered nuclei, (often arranged as 'strings') 
and a more or less continuous membrane. These cells were negative for AFP, Neuronal pm 
tubulin, pan-epithelial keratin and Gata4. In the case of Gata4, large cells immediately 
surrounding clusters of HCG positive de~ked cells were also negative (as depicted in 
Figure 4.20 
Trophoblast Marker Expression In TERA2.Sp12 Cells Treated With An Inhibitor Of 
FGF Signalling 
Figure 4.20 TERA2.sp12 cells were seeded into 12 well plates and treated with 20J.!M of the FGF receptor 
inhibitor SU5402 for 14 days. Four hours prior to fixation in 4% PFA cultures were pulsed with 1.25Jlg/ml 
Brefaldin A. Fixed cultures were double immuno-labelled with antibodies to HCG (green) and Keratin 8 
(red), and the nuclei stained with hoescht (blue). Plates A-D depict the expression of trophoblast hormone 
HCG (green) and nuclear localised cross-reactive staining of a trophoblast antigen to Keratin 8 antibody 
(red) in a representative cluster of cells. Positive immuno-staining for HCG is outlined by white dashes in 
plate B, and the corresponding outline transposed to the hoescht stained image in D. Note that cells positive 
for HCG also exhibit nuclear localised Keratin 8 reactive antigen expression (A and overlay in C), and 
hoescht staining (D) reveals a distinctive morphology with ' strings ' of nuclei clustered together. For 
comparison a section of day 19 villous placental tissue double immuno-labelled with Keratin 8 (red) and 
HCG (green) is presented (E). Note that nuclear localisation of Keratin 8 reactive antigen and HCG 
expression is visible in cells lining the villous tissue. Scale bars = I OOJlm. 
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A-D of Figure 4.21 ). Regions containing HCG positive cells were also highly distinctive 
under phase microscopy, with prominent arrangements of densely clustered nuclei. Brefaldin 
A treatment to disrupt the Golgi apparatus and reduce the secretion of HCG into the media did 
enhance the brightness of immuno-staining for HCG. However HCG positive cells were also 
identified in un-treated cultures, indicating that Brefaldin A treatment was not necessary for 
the immuno-detection of HCG. Taken together this provides supporting evidence that a sub-
population ofBMP or SU5402 treated cells formed trophoblast cells. 
2. Remaining population: Mixture of large plate-like cells and less defined smaller cells 
forming a continuous sheet. 
As previously described, neural marker expression was minimal in all treatments, with the 
exception of neuronal ~Ill tubulin, which was often expressed in large hexagonal shaped cells. 
These large cells were also detected to weakly express pan epithelial keratin and Keratin 18, 
with eo-localisation of neuronal ~Ill tubulin and pan epithelial keratin demonstrated in some 
regions. However, unlike RA treated cultures, the expression of the epidermal stem cell 
protein TP63 was not detected in any cultures in all repeated experiments. Some very large 
cells with large nuclei were also observed, typically in close association with clusters of cells 
exhibiting similar morphologies to those positive for HCG. Taken together this suggests that 
non-neural ectoderm was not present at significant levels in these cultures. 
Through-out the culture more densely packed cells with less defined borders were 
also observed and the frequency of these cells in comparison to the large hexagonal cells 
exhibited some variation in repeated culture experiments. In general these cells were negative 
for epithelial keratins and ~Ill tubulin, and stained immuno-positive for the endoderm 
transcription factor Gata4. Nuclear localised Gata4 was detected in large patches through-out 
these cultures with the highest levels of Gata4 detected in BMP 4 treated cultures. A 
proportion of cells exhibiting negative staining for nuclear localised Gata4 was consistently 
observed in all culture treatments and in repeated experiments, with distinct patches of 
negative staining detected in cells associated with trophoblast differentiation or in larger 
hexagonal cells (see plates A-D in Figure 4.21 ). This suggests that a sub-population of BMP 
or SU5402 treated cells formed endoderm progenitors. 
The smooth muscle marker a smooth muscle actin was also detected in large regions 
through-out the culture, typically associated with the plate-like large cells, suggesting that 
some cells had differentiated into smooth muscle. These cells were not similar to positively 
stained cells in cultures of spontaneously differentiated H7 ES cells, with smooth muscle actin 
positive cells in TERA2.sp 12 cultures exhibiting a less mature differentiation morphology 
(see Figure 4.21 plates E-F), although this could be attributed to differences in cell density. 
Figure 4.21 
Expression Of Gata4, HCG And Alpha Smooth Muscle Actin In BMP2 Treated 
TERA2.Sp12 Cells 
Figure 4 .21 TERA2.sp12 cells were seeded into 12 well plates and treated with 25nglml of BMP2 or 
BMP4 for 14 days. Plates A-D depict a representative region of HCG positive and Gata4 negative cells 
in BMP2 treated cultures double immuno-Jabelled after fixation in 4% PFA with antibodies to Gata4 
(green) and HCG (red), and the nuclei stained with hoescht (blue). Negative immuno-staining for Gata4 
is outlined by white dashes in plate B, and the corresponding outline transposed to an overlay in C and 
the phase contrast image in D. Note that HCG positive cells were located within distinct regions of 
Gata4 negative expression, and Gata4 positive cells exhibited a more compact morphology than Gata4 
negative cells. Plates E and F depict representative regions of positive a smooth muscle actin expression 
in either 14 day BMP4 treated cultures of TERA2.sp 12 cells (E) or for comparison in 11 day cultures of 
H7 human embryonic stem cells grown in the absence of stem cell maintenance factors (F). Cultures 
were fixed in methanol with 5% acetic acid and immuno-stained with an antibody to a smooth muscle 
actin. Note that immuno-positive cells in BMP treated TERA2.spl2 cultures (E) exhibit a less 
differentiated morphology and remain relatively compact compared to immuno-positive cells in H7 
cultures (F). Scale bars = I OO~m. 
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Variations in levels of staining 
Although cultures treated with either BMP2, BMP4 or SU5402 exhibited very similar 
immuno-staining expression patterns, some variation was observed between these treatments. 
To more qualitatively compare this variation, for each antibody immuno-stained cultures were 
scored according to staining intensity and frequency of positive staining (see Table 4.5). The 
tabulated scores are based on the number of immuno-positive cells, ranging from -(negative), 
slight positive [(+)]and increasing levels of positive staining indicated by more[+] symbols, 
such that very high levels of staining are scored with [+++]. The tabulated score is 
representative of three sets of individual scores for each culture condition at the same passage 
number. 
Table 4.5 Scored levels of positive immuno-staining for a range of antibodies in TERA2.sp12 
cells treated with BMP2, BMP4, SU5402 or vehicle treated for 14 days. 
Cell type Antibody BMP4 BMP2 SU5402 Mock Mock SU5402 BMP 
Neural progenitor Nestin (+) (+) (+) ++(+) 
Neural 13111 tubulin (neural 
- - -
(+) 
morphology) 
-
13111 tubulin (non-
+ +(+) ++ -neural morphology) 
Non-neural Pan Epithelial Keratin + + (+) 
ectoderm - -
Non-neural keratin 18 (+) + (+) 
ectoderm - -
Keratin 8 Ab binding 
Trophoblast antigen (nuclear + + (+) - -
localisation) 
Trophoblast HCG +(+) ++ + 
- -
Smooth muscle a smooth muscle ++ + ++ 
actin - -
Endoderm GATA4 ++(+) ++(50%) ++ (+) (70%) (50%) 
Endoderm HNF3j3 (+) (+) (+) 
- -
To summarise, the level of CGB staining was variable in cultures treated with BMP2, BMP4 
or SU5402, with the highest population of HCG positive cells occurring in BMP2 treated 
cultures, in distinct large patches. Gata 4 immuno-staining was very high in BMP or SU5402 
treated cultures, with BMP4 treated cultures exhibiting the highest proportion of positive cells. 
The protein a smooth muscle actin was also detected at significant levels in BMP4 and 
SU5402 treatments, although BMP2 treated cultures exhibited slightly lower levels of smooth 
muscle actin expression. It was interesting to note that smooth muscle actin was also 
significantly present in placental villous tissue as detected by both immuno-staining and 
Western blot analyses. 
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Treatment with trophoblast stimulating hormones insulin and forskolin 
To determine whether the subpopulation of clustered small cells exhibited behaviour typical 
of trophoblast cells, cultures previously treated for 14 days with BMP2, 4 or SU5402 were 
subsequently treated for 3 days with the trophoblast differentiation inducing hormones Insulin 
(200mg/litre insulin in I OmM HCL), Forskolin (I OJ!M forskolin in ethanol), or mock treated. 
To determine whether any cells formed during RA differentiation were also responsive to 
these factors, 14 day RA treated adherent cultures were also treated with either RA alone or 
with the addition of Insulin or Forskolin for 3 days. After 17 days cultures were fixed for 15 
minutes at room temperature with ice cold PFA, blocked with blocking buffer at 4°C 
overnight and then immuno-labelled with either HCG, Keratin 8, Neuronal pm tubulin or 
Nestin, following the protocol in Section 2.5.No HCG or nuclear localised Keratin 8 reactive 
nuclear antigen was detected in any cultures pre-treated with RA, consistent with previous 
observations that RA treatment does not induce trophoblast differentiation, and demonstrating 
that treatment with trophoblast stimulating hormones alone is not sufficient to induce 
trophoblast differentiation in TERA2.spl2 cells not previously exposed to BMP or SU5402. 
However, HCG and nuclear localised Keratin 8 antigen was detected in the remaining 
treatments, and Table 4.6 presents the scores for the level of positive immuno-staining in each 
condition. The tabulated scores are based on the number of immuno-positive cells range from 
-(negative), slight positive [(+)]and increasing levels of positive staining indicated by more 
[ +] symbols, such that very high levels of staining are scored with [ +++]. The tabulated score 
is representative of three sets of individual scores for each culture condition (at the same 
passage number). N=3 for only HCG. Note that no positive control was used in this 
experiment, as trophoblast cell lines were not available. 
Table 4.6. Scored levels of positive immuno-staining for trophoblast markers in TERA2.sp12 
cells treated with BMP2, BMP4 or SU5402 for 14 days (Treatment 1), prior to continued 
treatment with or without the addition of insulin or forskolin for 3 days (Treatment 2). 
SET 1 Treatment 1 BMP4 
Treatment 2 BMP4 INSULIN FORSKOLIN 
Antibody staining HCG ++ ++ ++ 
nK8 + + + 
SET2 Treatment 1 BMP2 
Treatment 2 BMP2 INSULIN FORSKOLIN 
Antibody staining HCG ++ ++ ++ 
nK8 + + + 
SET3 Treatment 1 SU5402 
Treatment 2 SU5402 INSULIN FORSKOLIN 
Antibody staining HCG + (+) + 
nK8 + (+) + 
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These results indicate that forskolin and insulin did not affect the expression of trophoblast 
markers HCG and nuclear localised antigen reactive to Keratin 8 antibody (nKS), and that 
under these conditions these cells were not responsive to Insulin and Forskolin. However, it is 
interesting to note that compared to previous experiments where cultures were grown for 14 
days, both the expression of HCG and size of HCG positive clusters in all treatments cultured 
for 17 days (with or without Insulin or Forskolin) appeared markedly greater (Figure 4.22). 
This suggests that the trophoblast population in these cultures was still increasing and 
maturing between 14 and 17 days. 
4.2.7 Monitoring BMP and FGF mediated pathway activity 
To monitor the effect of FGF receptor inhibitor and BMP treatment on both BMP and MAPK 
pathway activity, in particular to determine whether inhibition of FGF signalling up-regulated 
the activity of the BMP pathway, the level of BMP regulated Id2 and MAPK regulated 
ERKl/2 phosphorylation were monitored using Western blot analysis. TERA2.sp12 cells were 
cultured under adherent conditions with the addition of 25ng/ml BMP2, 25ng/ml BMP4, 
20J!M SU5402 or vehicle treated. Media was replaced every 2-3 days, and after 7 and 14 days 
protein was extmcted from cultures and used for Western blot analysis following the protocol 
in Section 2.4. Protein was extmcted from confluent cultures of TERA2.spl2 cells grown 
under maintenance conditions for the EC sample, and protein extracted from cultured IMR32, 
FaDU, MSC cells or day 19 villous placental tissue was used as comparative controls for 
neural, non-neural ectoderm, mesodermal and trophoblast expression profiles. Blots were 
probed with antibodies to ld2, ERKl/2, phosphorylated ERK1/2 and equal loading was 
assessed by probing with an antibody to P actin. The results were consistent in two repeated 
Western blot analysis experiments, one of which is presented in Figure 4.23. 
Levels of phosphorylated ERKI, (upper band) did not change markedly with 
treatment, in contrast to marked differences in levels of phosphorylated ERK2. Unexpectedly, 
levels of phosphorylated ERK 2 were reduced only slightly compared to mock treated cells, 
and EC cells showed only trace levels of P ERK phosphorylation. BMP2 or RA treated cells 
demonstrated marked or some up-regulation of phosphorylated ERK respectively compared to 
mock treated cultures, with a lower up-regulation compared to mock treated cultures observed 
in BMP4 treated cells. This pattern was consistent in both Western blot analyses. Total levels 
of ERKl/2 protein were highest in SU5402 treated cultures, and all treatments induced some 
up-regulation in ERK 1/2 expression. BMP regulated levels of Id 2 protein increased in RA, 
BMP2, BMP4 and SU5402 treated cultures to similar extents (with BMP2 treated cells up-
regulating Id2 to the highest levels), indicating that BMP signalling was up-regulated in all of 
these cultures. This supports the hypothesis whereby FGF signalling in TERA2.sp 12 cells 
mediates the attenuation of BMP pathway activity, such that inhibiting FGF signalling up-
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Figure 4.22 Expression of the trophoblast hormone HCG in 17 day BMP treated cultures that were 
cultured in the last 3 days with or without Insulin. TERA2.sp 12 cells were seeded into 12 well plates 
and treated with either 25nglml of BMP2 or 25nglml BMP4 for 14 days, then cultured for a further 3 
days with or without the addition of 200flg/ml Insulin. Cultures were treated for 4 hours with 
1.25f.1g/ml Brefaldin A and then fixed in 4% PFA, prior to immuno-staining with an antibody to the 
trophoblast hormone HCG (green) and the nuclei counterstained blue with hoescht. Plates A-C depict a 
representative region of dense HCG staining in TERA2.sp 12 cells cultured with BMP2 for 14 days and 
then BMP2 and insulin for a further 3 days. Note that densely packed ' strings ' of nuclei are associated 
with bright HCG staining (overlay in B) and HCG positive cells exhibit a distinctive morphology under 
phase contrast (C). Plates (D-F), depict a representative region of dense HCG staining in TERA2.sp 12 
cells cultured with BMP4 continuously for 17 days. Note that similarly large and densely packed cells 
exhibit high staining for HCG (overlay in E) and demonstrate a distinctive morphology under phase 
contrast (F). Scale bars = I OOflm. 
Regulation Of BMP And MAPK Pathway Activity In Cultures Treated For 14 Days 
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Figure 4.23 Western blot detection of phosphorylated ERK 1/2 (P ERK 1/2) as an indicator of FGF 
mediated MAPK activity, compared with total levels of ERK 1/2, and detection of Id2 as an indicator of 
8MP mediated Smad activity. Protein was extracted at 14 days from cells treated with either 10~-tM RA, 
25nglml 8MP2 (82), 25nglml 8MP4 (84), 20~-tM FGF inhibitor SU5402 (SU) or mock treated(-). For 
comparison protein was extracted from IMR32 (IR), FaDU (FD), MSC cells and day 19 human placental 
tissue (PL) respectively. For the EC sample protein was extracted from confluent cultures ofTERA2.spl2 
cells grown under maintenance conditions. To determine equal loading blots were also probed with ~ 
actin. The expression of the Smad transcriptionally regulated protein Id2 was detected to increase in RA, 
8MP2, 8MP4 and SU5402 treated cultures to similar extents (with 8MP2 treated cells up-regulating ld2 
to the highest levels), indicating that 8MP signalling was up-regulated in all of these cultures. 
Levels of phosphorylated ERKl (upper band) did not change markedly with treatment, in contrast to 
marked differences in levels of phosphorylated ERK2 (lower band). Unexpectedly, levels of 
phosphorylated ERK 2 were reduced only slightly compared to mock treated cells, and EC cells showed 
only trace levels of P ERK phosphorylation. In contrast, 8MP2 or RA treated cells demonstrated marked 
or some up-regulation respectively compared to mock treated cultures, with a lower up-regulation 
compared to mock treated cultures observed in 8MP4 treated cells. Total levels of ERK I /2 protein were 
highest in SU5402 treated cultures, and all treatments induced some up-regulation in ERK 1/2 expression. 
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regulates BMP pathway activity regardless of changes in BMP signalling. 
4.2.8 Subsequent Noggin and FGF inhibitor treatment 
To determine whether TERA2.sp 12 cells initially treated with Noggin were committed to a 
neural fate and would respond differently to inhibition of FGF signalling (for example by 
differentiating further along a neural lineage), in a pilot study TERA2.sp12 cells were treated 
with Noggin for 14 days or mock treated and then trypsinised and reseeded at differentiation 
density prior to exposure to SU5402 for 7 days. The effect of SU5402 on Noggin treated cells 
that were not trypsinised and re-plated was also assayed. Cells pre-treated with Noggin and 
then re-seeded at low density and treated with SU5402 formed at least two distinct cell types. 
Large morphologically distinct flat cells expressing pan-epithelial keratin formed sheets of 
cells on which small numbers of highly differentiated neural pm tubulin positive cells were 
detected, exhibiting long axons and in some cases extensive branching (Figure 4.24). Cells 
treated without reseeding also formed neural cells, however these were less mature in 
morphology and extensive branching was not observed. This suggests that under these 
conditions, inhibition of BMP signalling using Noggin treatment is not sufficient to form 
committed neural progenitors from the majority of a population of TERA2.sp 12 cells. 
However, a sub-population appears to have indeed responded as committed neural progenitors 
to FGF signalling inhibition and differentiated extensively into neural lineages. 
Neural Versus Non-neural Differentiation In TERA2.Sp12 Cells After Sequential 
Inhibition Of BMP Signalling and FGF Mediated Signalling. 
Figure 4.24 Neural vs Non-neural differentiation in TERA2.sp 12 cells treated sequentially with 
inhibitors of BMP and FGF signalling. TERA2.sp 12 cells were seeded into 12 well plates and 
treated with I OOng/ml Noggin for ?days, prior to being reseeded at a low density and treatment 
with JO~M SU5402 or lOOng/ml Noggin for 7 days. Cultures were fixed in 4% PFA prior to 
immuno-staining with antibodies to ~Ill tubulin, ~Ill tubulin and MAP2, Pill tubulin and pan-
epithelial keratin and the nuclei counterstained blue with hoescht. Plate A depicts a 
representative region of positive staining for neural markers Pill tubulin and MAP2 in a culture 
treated with Noggin followed by reseeding at a low density and treatment with SU5402 (a 
corresponding image of ~Ill tubulin staining alone with hoescht overlay is presented in 8). In 
some cases highly mature and branched morphologies were observed (as depicted in the ~111 
tubulin stained cell in C), and neural cells often developed in close proximity to epithelial 
keratin positive regions (see overlays in 0 and F). In cultures which were not subject to re-
seeding at low density, extensive neuronal differentiation was also observed (a representative 
region of positive Pl!l tubulin staining is shown with hoescht overlay in G). Note that the highly 
branched morphologies observed in cultures reseeded at a low density were not observed in 
cultures maintained at a high density. Scale bars = IOO~m 
Figure 4.24 
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4.3 DISCUSSION 
4.3.1 Summary 
The initial aim of the investigations in this chapter was to determine whether the marked 
differences in neural differentiation between TERA2.sp 12 cells differentiated with RA under 
either suspension or adherent conditions (Horrocks et al. 2003) were caused by changes in 
BMP signalling, and whether RA induced neural differentiation could be inhibited or 
promoted by manipulation of the BMP signalling pathway. As described in Section A, the 
manipulation ofBMP or FGF signalling in RA treated cultures ofTERA2.sp12 cells markedly 
affected the expression of neural and non-neural ectoderm markers, although differences were 
detected in the responsiveness of cells cultured under adherent or suspension conditions. Cells 
cultured under suspension conditions were less responsive to either BMP or Noggin treatment 
compared to adherent cultures, and PCR and Western blot detection of markers 
transcriptionally regulated by BMP signalling indicate that BMP signalling was reduced in 
cells differentiated under suspension conditions compared to adherent conditions. As an initial 
increase in FGF mediated signalling was proposed in a report by Kuroda et al. (2005) to 
mediate the inhibition of BMP pathway activity and the adoption of a neural fate in 
dissociated Xenopus explant tissue, the effect of early inhibition of the FGF mediated 
signalling pathway on neural differentiation was investigated. In this study a temporary pulse 
with the FGF receptor 1 inhibitor SU5402 prior to RA treatment markedly inhibited the up-
regulation of neuronal pm tubulin in suspension cultures, whereas in adherent cultures the up-
regulation of neuronal pm tubulin was not inhibited. This provides supporting evidence for a 
mechanism by which up-regulated FGF signalling and MAPK activity as a result of 
dissociation and culture in suspension inhibits BMP pathway activity in TERA2.sp 12 cells, 
resulting in increased neural differentiation in response to RA treatment. 
In the second part of this chapter (Section B), the effect of manipulations in BMP and 
FGF mediated signalling on TERA2.sp12 cells differentiation in the absence of RA was 
investigated, in order to more closely mimic signalling events of the embryonic ectoderm. 
Continuous treatment ofTERA2.spl2 cells with either BMP2, 4 or the FGF receptor inhibitor 
SU5402 resulted in the down-regulation of stem cell marker expression and the formation of 
sheets of large cells that expressed epithelial keratins but were also detected by immune-
staining to express Gata 4, neuronal pm tubulin and a smooth muscle actin, interspersed with 
dense clusters of multinucleate cells that expressed trophoblast markers HCG and nuclear 
localised Keratin 8 antigen. This demonstrated that TERA2.sp 12 cells are not limited to 
ectodermal derivatives in vitro and are similar in their response to BMP treatment to human 
ES cells. In contrast, Noggin treated cultures formed densely packed cells which slowly down-
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regulated the expression of stem cell surface markers TRA 160 and SSEA3, and after 14 days 
exhibited marked up-regulation of the neural progenitor protein Nestin. In addition, immuno-
stained cultures contained many aggregate-like structures that were positive for Nestin and 
pm tubulin. 
In preliminary experiments which aimed to monitor BMP pathway activity in these 
treatments, both SU5402 and BMP treatment were detected to up-regulate the expression of 
Id2, a transcription factor that is transcriptionally up-regulated by BMP pathway activity. This 
provides supporting evidence that both treatments drive the differentiation of TERA2.sp12 
cells into similar fates by up-regulating BMP pathway activity. One mechanism by which 
inhibition of FGF signalling could up-regulate BMP pathway activity is through inhibiting 
MAPK mediated phosphorylation and inhibition of Smad 1. 
SECTION A 
4.3.2 BMP and FGF mediated signalling in RA treated cultures 
As RA induced neural differentiation was indeed enhanced in TERA2.sp12 cells cultured 
under suspension conditions, I postulated that changes in the activity of signalling pathways 
involved in neural induction could be occurring in differentiating TERA2.sp 12 cells cultured 
as aggregates in suspension compared to adherent cultures. As previously discussed, both FGF 
and BMP signalling are both reported to play key roles in regulating neural induction in 
vertebrates, and previous studies have demonstrated their sensitivity to changes in cell-cell 
contact. 
Monitoring BMP signalling 
Initial attempts to monitor BMP signalling in TERA2.sp12 cells were made by detecting 
levels of phosphorylated Receptor Smad 1 (p-Smad 1) and total levels of Smad 1 using 
phosphorylation specific and non-specific antibodies to this protein. Unfortunately due to 
difficulties with the antibody no data was collected on levels of Smad 1 protein expression, 
although PCR detection showed stable expression of Smad 1 transcripts in all treatments. RA 
treatment of TERA2.sp 12 cells up-regulated the level of p-Smad 1 protein in all cultures, and 
this corresponds with studies by Caracisole et al. (2000) in which they reported a 
transcriptional up-regulation in BMP production upon RA treatment in NT2D 1 cells. Levels 
of detected p-Smad 1 varied over the measured time-points during repeated Western 
experiments. This variation may be due to experimental errors or reflect marked fluctuations 
in p-Smad levels over time. Previous studies have demonstrated that receptor smads are 
susceptible to rapidly regulated negative feedback loops (such as inhibitory smad activation, 
see review Massague 2005), so the level of p-Smad detected at these time-points may reflect 
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very transient variations and not the overall level ofBMP pathway activity. 
As markers that would more stably reflect BMP pathway activity, I assessed the 
expression of Msx 1, Id2 and Id3; factors reported to be directly transcriptionally activated by 
BMP signalling activity (Hollnagel 1999, Suzuki l997b) using PCR and Western blot 
detection. The expression of these genes as detected by PCR analysis was manifestly different 
in RA treated cultures grown under adherent or suspension conditions: Msxl and Id2 
transcripts detected by PCR were both present in undifferentiated cultures, and were markedly 
down-regulated after 7 days of treatment in TERA2.sp 12 cells cultured with RA under 
suspension conditions compared to adherent cultures. Corresponding Western blot detection 
of Id2 protein also demonstrated a marked down-regulation in expression during RA treatment 
in suspension cultures compared to adherent cultures. The down-regulation of transcripts 
reported to be directly regulated by BMP signalling does imply that BMP pathway activity is 
down-regulated in RA treated suspension cultures compared to adherent cultures. 
Msxl transcript expression in undifferentiated TERA2.sp 12 cells suggests that this 
transcription factor is not solely associated with non-neural ectoderm differentiation in this 
culture system, or that a low level of epidermal differentiation may be occurring in 
maintenance cultures. However, the protein levels of Msx l were not assayed, so msxl 
transcript expression may not reflect active protein levels. Msx 1 expression has also been 
reported to inhibit epithelial progenitor differentiation through maintenance of the cell cycle 
regulators such as cyclin 0 (Hu 2001 ), and from this one could speculate that Msx I may also 
play an (as yet un-reported) role in cell cycle maintenance in other cycling populations such as 
stem cells. 
Manipulating BMP signalling 
To investigate whether the manipulation of BMP signalling could regulate RA induced neural 
differentiation of TERA2.sp12 cells cultured as suspension or adherent cultures, cells were 
cultured under these conditions and treated for 14 days with RA alone or with the addition of 
either BMP2 or the BMP signalling inhibitor Noggin, and the expression of neural and non-
neural ectoderm proteins detected by Western blot analysis. 
Combined Noggin and RA treatment up-regulated the expression of neuronal pm 
tubulin and down-regulated Keratin 8 in adherent cultures to levels comparable with 
suspension cultures, demonstrating that inhibition of BMP signalling in adherent cultures 
could generate an expression phenotype similar to that observed in suspension cultures. In 
contrast, no difference was detected in neuronal pm tubulin or Keratin 8 expression between 
treatments with RA alone or RA and Noggin combined in suspension cultures, indicating that 
the exogenous inhibition of BMP signalling in suspension cultures had no effect. This 
corresponds with similar observations in a study by Finley et. al. where Noggin was shown to 
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have no effect on the neural differentiation of aggregates of mouse ES cells when added alone 
or in combination with RA or its precursor retinyl acetate (Finley I999). These results are 
consistent with the hypothesis that BMP pathway activity is down-regulated in suspension 
cultures as opposed to adherent cultures, such that exogenous inhibition of BMP signalling in 
adherent cultures mimics the suspension culture phenotype, and has no detectable effects on 
suspension cultures. 
Exogenous BMP treatment markedly inhibited RA induced ~Ill tubulin up-regulation 
in cultures grown under either suspension or adherent conditions, although this effect was 
most marked in adherent cultures. Similar observations were made in previous studies by 
Hood less and Hemmati-Brivanlou ( I997) in both adherent and suspension cultures of mouse 
embryonal carcinoma PI9 cells, where BMP4 treatment was shown to interfere with RA 
mediated neural induction and promote the expression of epithelial keratins. Finley et al. 
( I999) also demonstrated that BMP4 exposure of aggregate cultures of mouse embryonic stem 
cells treated with RA or it's precursor retinyl acetate markedly inhibited neural and glial 
differentiation. 
As the most marked effects of BMP inhibition on neural and non-neural ectoderm 
protein expression were observed in adherent as opposed to suspension cultures of 
TERA2.sp 12 cells, this implies that either the up-regulation of neural differentiation in 
suspension cultures was not entirely due to attenuated BMP signalling or that BMP pathway 
activity was still being attenuated in suspension cultures exogenously treated with BMP2. As 
previously discussed, FGF signalling has been extensively reported to play a key role in neural 
induction, and recent studies have identified a mechanism by which FGF signalling can 
directly inhibit BMP pathway activity (Pera 2003, Sater 2003). This occurs through MAPK 
mediated phosphorylation of receptor smad I, which prevents smad I binding to smad 4 and 
subsequent localisation to the nucleus, regardless of previous BMP receptor mediated 
phosphorylation events. The importance of this phosphorylation mediated inhibition of BMP 
signalling was recently demonstrated by Kuroda et al (2005) in a fresh evaluation of the 
classic Xenopus dissociation experiments carried out by Hemmati-Brivanlou and Wilson 
(I995). In summary, they demonstrated that dissociated Xenopus explants generated neural 
ectoderm whereas intact explants generated epidermis, and this effect could be rescued by 
exogenous BMP treatment. In support of the default neural induction theory, neuralisation was 
thought to occur in dissociated explants as a result of reduced BMP signalling from a dilution 
effect of endogenous BMPs in the media. However, Kuroda et al. showed that BMP signalling 
activity and Smad I phosphorylation remained high in dissociated tissues. They also observed 
that Xenopus explant dissociation induced an up-regulation ofFGF mediated signalling, which 
resulted in inhibitory phosphorylation of Smad I via MAPK activity, and thus inhibition of 
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BMP mediated transcriptional regulation. 
Dissociation-induced up-regulation of FGF signalling and MAPK mediated inhibition 
of BMP pathway activity provides a potential mechanism by which BMP pathway activity 
could be inhibited and neural differentiation promoted in suspension cultures as opposed to 
adherent cultures of RA treated TERA2.sp 12 cells. To investigate whether an initial up-
regulation of FGF mediated signalling was necessary for the increased neural differentiation 
observed in RA treated suspension cultures, the FGF receptor inhibitor SU5402 was used to 
temporarily down-regulate FGF signalling during the first 24 hours of culture (prior to 
treatment with RA) and the expression of neuronal proteins and epithelial keratins monitored 
by Western blot analysis. 
Treatment with FGF inhibitor SUS402 
Western blot analyses demonstrated that in all treatments, early exposure to SU5402 increased 
levels of Keratin 8 and 18 proteins detected after 14 days, suggesting that temporary inhibition 
of FGF signalling was promoting non-neural ectoderm lineage acquisition. However the effect 
of SU5402 exposure on neuronal ~Ill tubulin expression differed in cells cultured under 
suspension or adherent conditions. Under suspension conditions, the RA induced up-
regulation of neuronal ~Ill tubulin expression was inhibited in SU5402 treated cells compared 
to untreated cells, and a dramatic reduction in neuronal ~Ill tubulin expression upon SU5402 
exposure was observed in cells cultured in suspension without RA, such that they expressed 
lower levels than EC cells. However, under adherent conditions, prior SU5402 exposure did 
not markedly affect the expression of ~Ill tubulin expression after 14 days, and actually 
increased the expression of ~Ill tubulin in adherent cultures treated without RA. 
In the case of suspension cultures, the sensitivity of aggregate cultures to SU5402 
mediated inhibition of FGF signalling during the first 24 hours in terms of neuronal ~Ill 
tubulin and Keratin 8 expression is supporting evidence that early FGF signalling plays a key 
role in the up-regulation of neural differentiation markers. However, in adherent cultures, one 
would expect some down-regulation or little change in the expression of neuronal ~Ill tubulin 
as a result of early inhibition of FGF mediated signalling; whereas in adherent cultures treated 
with SU5402 alone, ~Ill tubulin expression was actually up-regulated to some extent. 
However, subsequent staining analyses demonstrated atypical, non-neuronal localisation of 
~Ill tubulin in TERA2.sp12 cells pulsed with SU5402, indicating that the up-regulation of 
neuronal ~Ill tubulin detected in Western blot analyses did not reflect an up-regulation in 
neural differentiation. More extensive markers of neural differentiation besides ~Ill tubulin 
and NSE are needed to clarify the effect of SU5402 pulsed exposure on neural differentiation 
in these culture systems. 
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Detection of FGF mediated signalling 
As ERK phosphorylation has previously been utilised to measure FGF receptor mediated 
MAPK pathway activity (Christen & Slack 1999, Gotoh & Nishida 1996), antibodies to 
ERKI/2 and phosphorylated ERK 112 were used to monitor MAPK pathway in TERA2.spl2 
cultures. In summary, levels of ERK.l/2 and phosphorylated ERKl/2 proteins were up-
regulated upon RA treatment to similar levels after I4 days in both adherent and suspension 
cultures in Western blot analyses. However in suspension cultures expression of P-ERK I and 
P-ERK2 proteins was barely detectable levels after 4 days of culture, in contrast to in RA 
treated adherent cultures and EC cultures. Taken at face value this implies that although RA 
induced an up-regulation of FGF mediated MAPK pathway activity, this was temporarily 
disrupted in the initial phase of suspension cultures. 
However, one key flaw to these experiments is the time-points at which MAPK 
signalling was monitored. SU5402 treatment indicated that FGF mediated signalling was 
necessary for up-regulated neuronal differentiation in the initial 24 hours of culture. Thus the 
level of FGF signalling through detection of phosphorylated ERK should also have been 
monitored in the initial 24-48 hours of culture. The detected down-regulation of 
phosphorylated ERK in 4 day aggregates could well be a subsequent negative feed back effect 
of high levels of ERK phosphorylation. To determine whether up-regulated FGF mediated 
signalling is causing the up-regulation of neural differentiation in RA treated suspension 
cultures, several further investigations are necessary: If FGF mediated phosphorylation of 
ERKI/2 is detected to be up-regulated in the initial 24-48 hours of culture, one would also 
need to determine whether the up-regulation in FGF mediated signalling correlated with an 
inhibition of BMP signalling via inhibitory phosphorylation of Smad 1. Western blot analyses 
could be used to could compare the inhibitory phosphorylation status of Smad I under 
suspension and adherent conditions and in cultures treated with SU5402 or FGF. Additionally, 
one could assess whether inhibition of MAPK activity is able to prevent the up-regulation of 
neural differentiation in RA treated suspension cultures. However, due to time restrictions 
these experiments were not carried out in the course of this study. 
Conclusions 
In summary, BMP and FGF manipulation analyses provide some preliminary evidence 
supporting the hypothesis that FGF signalling mediated inhibition of BMP pathway activity is 
occurring in suspension cultures of TERA2.spl2, accounting for the increased neural 
differentiation observed. This draws parallels to the signalling events and behaviour of 
Xenopus animal cap explants cultured as intact or dissociated tissue. However, no conclusive 
evidence was garnered from these investigations, and further experiments are necessary to 
compare the level of FGF signalling in adherent versus suspension cultures of TERA2.spi2, 
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and to determine whether up-regulated FGF signalling is causing MAPK mediated attenuation 
of BMP pathway activity and consequentially an up-regulation in neural differentiation in 
suspension cultures. 
These preliminary experiments have demonstrated the importance of FGF and BMP 
signalling in the differentiation of TERA2.sp 12 cells, with active manipulations of these 
pathways markedly modulating the response of these cells to RA. Although these experiments 
have been used in part to model the effect of BMPs and FGF on neural induction, the use of 
RA as a differentiation inducer is a complicating factor and does not model early events in the 
developing ectoderm. RA does play key roles in the dorsaVventral patterning of the neural 
tube and later in the differentiation and specification of motor neuron subtypes, but is absent 
in the early stages of neural induction (for review see Wilson & Maden 2005). Therefore to 
more closely model the early signalling events during ectoderm development, in the remaining 
studies BMP and FGF signalling was manipulated in TERA2.sp 12 cells in the absence of RA. 
SECTIONB 
4.3.3 Manipulation of BMP signalling 
To investigate the effect of manipulating BMP signalling on TERA2.sp 12 cells, cultures were 
treated with either recombinant BMP2, BMP4 or the BMP inhibitor Noggin. 
BMP treated cells - changes in morphology and down-regulation of stem cell markers 
BMP treated cells rapidly exhibited shrunken morphologies, and the increased cell debris 
observed indicates some cell death was occurring. However the formation of large sheets of 
plate-like cells between 5-7 days of treatment was associated with a stabilisation in cell 
number and a reduction in cell debris. This suggests that in the first stage cell proliferation and 
some cell death was occurring as cells responded to BMP signalling by either beginning to 
differentiate or embark on cell death, whereas in the later stage the observed stabilisation in 
cell number was predominantly due to differentiation and exit from the cell cycle as opposed 
to increased cell death. 
No increase in propidium iodide intake was detected in BMP treated cells prepared for 
flow cytometry between 7 and 14 days. However, media changes and initial PBS washes prior 
to individualisation with Trypsin and may have removed any apoptotic cells as they detached 
from the culture surface. Recently Gambaro et al. (2005) demonstrated that the BMP4 induced 
epidermal differentiation of mouse ES cells concomittently induced apoptotic cell death in 
Soxl positive neural precursors, suggesting this functioned as an additional mechanism by 
which BMPs promote epidermal as opposed to neural differentiation. To investigate whether 
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BMP treatment is inducing apoptotic cell death in cells comittting to a neural fate in 
TERA2.sp12 cells, the expression of apoptotic marker C-JUN in BMP treated TERA2.sp12 
cells, in conjunction with early markers of neural differentiation (Sox 1, Neuro D 1) as opposed 
to non-neural ectoderm differentiation could be assayed by immuno-staining. However this 
was not undertaken in the course of this investigation. If apoptosis was induced in some 
TERA2.sp 12 cells as a result of BMP treatment, this would also imply that a sup-population 
of cells was already comitted to early stages of neural differentiation in these cultures, or that 
seeding at a low density had triggered the differentiation of a proportion of cells towards early 
stages of neural differentiation. 
The down-regulation of stem cell marker expression in BMP treated TERA2.sp 12 
cells is concordent with the observations of Andrews et al. in 1994 that BMP 7 treatment of 
NTERA2 cells induced the down-regulation of SSEA3 and SSEA4, a reduction in 
proliferation and the formation of cells that were morphologically distinct from either EC or 
RA treated cultures (Andrews et al. 1994). Caricasole et al. also described a similar pattern of 
stem cell marker down-regulation and the formation of sheets of large cells in embryonal 
carcinoma NT2D1 cells treated with either BMP2, BMP4 or BMP7 (Caricasole 2000). 
Specifically, they detected a down-regulation of stem cell markers TRA 160, SSEA3, SSEA4 
and the expression of proliferative antigen PCNA, and the formation of epithelial-like sheets 
of cells in cultures treated with 25ng/ml ofBMP 2, 4 or 7. 
It is also interesting to note that TERA2.sp 12 cells treated with RA down-regulated 
surface stem cell markers SSEA3 and TRA 160 more rapidly than BMP treated cells, yet 
demonstrated markedly high levels of proliferation even after 14 days. So although RA treated 
cultures more rapidly depart from the EC stem cell phenotype, the proliferation assay suggests 
that they subsequently remain in an earlier stage of differentiation than BMP treated cultures, 
as the data implies that BMP treated cells exit the cell cycle and embark on more advanced 
stages of differentiation, albeit in a different direction. This corresponds with the observation 
that RA treatment induces rapid differentiation into neuro-progenitors; in immuno-staining 
analyses of cultures treated for 14 days with RA treatment the majority of the cells expressed 
markers of proliferating neural progenitors such as Nestin and Musashi. 
Noggin treated cultures- stem cell marker down regulation and reduced proliferation 
Noggin treatment also appeared to reduce cell proliferation compared to untreated cells, as 
little evidence of increased cell death was observed. In addition, treated cells slowly down-
regulated surface stem cell surface antigens TRA 160 and SSEA3 and stem cell markers Oct4 
or Nanog such that after 14 days of treatment the majority of cells were negative for SSEA3, 
Oct4 and Nanog and a substantial population had down-regulated expression of TRA 160. 
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Combined with the Western blot detection and immuno-staining detection of increased Nestin 
expression, this indicates that many Noggin treated cells were differentiating into early neural 
progenitors. Pera et al. (2004) demonstrated that treatment of human HES-2 and HES-3 
embryonic stem cells with Noggin (at 100-500nglml) transcriptionally down-regulated Oct4 
expression and up-regulated Nestin and Pax6 expression. After subsequent culture under 
neural stem cell maintenance conditions these cells demonstrated increased capability of 
forming Nestin immuno-positive neurospheres compared to those initially cultured without 
Noggin treatment. 
It is possible that Noggin treatment of TERA2.sp 12 cells did not sufficiently inhibit 
BMP signalling for neural differentiation to occur throughout the culture. To determine 
whether a greater attenuation of BMP signalling is necessary for neural induction in these 
cells, one could treat TERA2.sp 12 cultures with a higher concentration of Noggin or in 
combination with other BMP inhibitors, (such as Chordin, Follistatin or with a recombinant 
BMP receptor). It would also be pertinent to determine whether FGF and Noggin treatment 
combined can induce neural differentiation, such that all cells within the culture express a 
neural progenitor phenotype. This would support the hypothesis that both FGF signalling and 
inhibition ofBMP signalling are necessary for neural induction in the human ectoderm. 
Non-neural ectoderm differentiation in BMP2 or BMP 4 treated cultures? 
As previously discussed, BMP signalling has been demonstrated to promote epidermal 
differentiation of the naive ectoderm in the Xenopus embryo (Suzuki 1997a, Suzuki 1997b ). 
Western blot and immuno-staining analyses demonstrated an up-regulation of simple 
epithelial keratins such as keratins 8 and 18, and a corresponding inhibition of neural 
differentiation in BMP treated cultures. This concurs with the characterisation of BMP2 or 4 
induced simple epithelial differentiation marked by the up-regulation of epithelial keratins and 
repression of pro-neural differentiation markers in the human embryonal carcinoma NT2D 1 
cell line by Houldsworth et al. (200 1 ), Caricasole et al. (2000) and more recently Chadalavada 
et al. (2005). Coraux et al. (2003) have also successfully derived keratinocyte progenitors 
from murine embryonic stem cells by seeding on matrix derived from human normal 
fibroblasts and treatment with BMP4. 
However, in BMP2 treated TERA2.sp 12 cells no expression of the epidermal stem 
cell marker TP63 was detected, in contrast to positive staining in RA treated 'large-celled 
plaques'. In addition, immuno-staining analyses revealed abnormal neuronal ~lll tubulin 
expression in some of these large cells, in some cases eo-localising with epithelial keratin 
expression. As the expression of keratins 8 and 18 is not restricted to that of simple epithelia, 
(as previously discussed), the expression analyses left open the possibility of other types of 
differentiation. 
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4.3.4 Similar effects of BMP or FGF inhibitor treatment 
In initial studies TERA2.sp 12 cells treated with the FGF receptor 1 inhibitor SU5402 
displayed a similar morphology to BMP4 or BMP2 treated cells and this was confirmed by 
immuno-staining analyses. Comparisons of differentiation by Western blot analysis and 
immuno-detection revealed marked similarities in marker expression between these cultures, 
with SU5402 treatment bearing the most potent effect on the up-regulation of markers of non-
neural ectoderm and inhibition of neural differentiation. In addition, large neuronal ~Ill 
tubulin positive cells similar to those identified in BMP treated cultures were observed, and 
markers of further epidermal differentiation such as TP63 were not detected. 
The detection of the mesoderm transcription factor Brachyury and endoderm 
transcription factor Gata4 in TERA2.sp12 cells cultured under suspension conditions to form 
aggregates in previous experiments indicates that unlike previously thought, TERA2.sp12 
cells retain the ability to differentiate into non-ectodermal derivatives. As previously 
discussed, BMP signalling plays multiple roles in development, and in developing vertebrates 
in addition to promoting the formation of the prospective epidermis, BMP signalling also 
plays an important role in specifying dorsal mesoderm. This corresponds with data from a 
pilot assay for the effects of 8 different growth factors on the differentiation of embryoid 
bodies cultured from the human embryonic stem cell line H9 clone 1 by Schuldiner et al. 
(2000), in which BMP 4 treatment was detected to be permissive for both ectoderm and 
mesoderm differentiation. 
However, two key studies indicate that direct treatment of human embryonic stem 
cells with BMPs appears to induce differentiation into extra-embryonic lineages, with Xu et 
al. (2002a) reporting trophoblast differentiation, and Pera et al. (2004) reporting the formation 
of extra-embryonic endoderm in ES cells treated with BMP2 or BMP4. As a consequence, 
BMP2, BMP4 or SU5402 treated cultures were screened with markers for lineages from all 
germ layers, particularly focussing on markers of mesoderm, extra-embryonic and definitive 
endoderm and trophoblast differentiation. 
In summary, after 14 days of treatment the BMP responsive endoderm transcription 
factor Gata4 was highly expressed in all cultures, as well as a smooth muscle actin. However, 
the early mesoderm transcription factor Brachyury was not detected in cultures after 14 days 
of treatment. Markers of trophoblast differentiation were detected in all cultures, whereas no 
evidence of extra-embryonic endoderm differentiation such as cyst formation or AFP 
production was observed. 
Trophoblast differentiation 
The detection of a sub-population of cells displaying trophoblast characteristics; forming 
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multi-nucleate cells, exhibiting nuclear localised Keratin 8 antigen and producing HCG, draws 
several parallels to work by Xu et al. (2002b) on BMP4 treated human embryonic stem cells. 
They described a synchronous wave of differentiation characterised by flattened enlarged cells 
and reduced proliferation, with changes obvious on day 2 for cell colonies treated with BMP4 
at 1 OOng/ml, days 3-4 for I Ong/ml and days 4-5 for 1 ng/ml. BMP2, BMP7 and GDF5 
induced similar changes. This corresponds somewhat to the observations made in BMP or 
SU5402 treated cultures of TERA2.sp12 cells, however the proportion of cells expressing 
HCG after 14 days of treatment was markedly lower than described for ES cells, as in the 
study by Xu et al. flow cytometry data demonstrate a remarkably uniform shift upon 1 OOng/ml 
of BMP4 treatment, such that the majority of the population were detected to express the HCG 
hormone after 7 days. It would be interesting to investigate whether treatment ofTERA2.sp12 
cells with higher concentrations of BMP4 (such as 1 OOng/ml) would up-regulate trophoblast 
differentiation and HCG production in TERA2.sp 12 cells. However a difference in the 
proportion of cells differentiating along a trophoblast lineage as opposed to other lineages in 
cells treated with lower concentrations of BMP4 was not reported, instead Xu et al. described 
a slower rate of differentiation. In their study ES colonies treated with BMP4 formed 
mononuclear cells, however when individualised cells were plated at low density and treated 
with BMP4, syncitial cells containing multiple nuclei formed after 2 weeks (44 in 622 cells). 
Cells bearing similarities to syncitial cells were also observed in TERA2.spl2 cultures, 
consistent with the fact that all cultures were seeded from individual cells. One possible 
method of extending this investigation would be to seed TERA2.sp 12 cells at a range of lower 
densities prior to BMP treatment, to determine whether the proportion of HCG positive cells 
or syncitial cells formed is directly correlated to the original seeding density, and subsequently 
compare the activity of key signalling pathways in these cells seeded at different densities, to 
identify candidate promoters of syncitial cell formation. 
Characterising the remainder of the population generated by BMP or SU5402 treatment 
The widespread expression of the endoderm transcription factor Gata4 corresponds with 
reports that Gata 4 is up-regulated by BMP signalling (Rojas et al. 2005). Gata4 is primarily 
expressed in developing endoderm, although it is also expressed in mesoderm derived 
myocardial cells (Arceci et al. 1993, Heikinheimo et al. 1994, Laverriere et al. 1994). 
Together with the absence of positive Brachyury expression, this data suggests that early 
endoderm differentiation may be occurring in these cultures, although this cannot be fully 
asserted until further staining analyses are carried out with more specific markers of endoderm 
and also other markers of mesoderm differentiation. 
Taken at face value, the presence of smooth muscle actin positive cells in treated 
cultures could represent a mesoderm derivative. However, it is known that during 
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development BMPs play a role in the formation of the neural crest, which subsequently has 
the potential to differentiate into multiple cell types, including smooth muscle (Luo et al. 
2003, Mizuseki et al. 2003). These results correspond somewhat with observations of smooth 
muscle differentiation in BMP2 treated NT2Dl cells (Chadalavada 2005). As well as markers 
of differentiation for prospective epidermis, Chadalavada et al. detected the expression of 
smooth muscle actin by immuno-staining and a panel of markers associated with smooth 
muscle differentiation by micro-array analysis. No significant Brachyury expression was 
detected, or other key markers of mesoderm differentiation. Since smooth muscle 
differentiation was detected to correlate with an earlier up-regulation of markers of neural 
crest, they proposed that the observed smooth muscle differentiation neural crest derived. To 
support their hypothesis they detected an early induction of SNAI2 that has been associated 
both with the epithelial to mesenchymal transition and in the diversification of neural crest 
lineage from naive ectodermal cells through BMP signalling (Hemavathy et al. 2000). It is 
interesting to note that no evidence of trophoblast differentiation was observed in their study. 
The consistent non-neural localisation of neuronal pm tubulin in these cultures and 
detection of some eo-localisation with epithelial keratins could (as previously discussed), be a 
result of unusual pm tubulin expression accrued under prolonged cell culture. However, non-
neural populations documented to express neuronal pm tubulin include mesenchymal stem 
cells (Tondreau et al. 2004), which also express Vimentin and a smooth muscle actin. Thus 
differentiation along the mesenchymal stem cell lineage is also a possible explanation for the 
expression of this panel of markers in TERA2.spl2 cells. However, the liver (endoderm) 
derived HepG2 cell line also stained immuno-positive for neuronal pm tubulin, (as well as 
Gata 4) which together suggests that early endoderm derivatives could also express pm 
tubulin. 
To summarise, in the light of other reports and previous observations, the current 
evidence suggests both endoderm differentiation and possibly neural crest derived smooth 
muscle differentiation is occurring in BMP or SU5402 treated cells. However, in order to 
more definitively characterise the differentiation of BMP or SU5402 treated cells, more 
extensive staining analyses with further markers of endoderm (both primitive and definitive), 
mesoderm and neural crest differentiation are necessary. 
BMP mediated induction of differentiation- trophoblast or extra-embryonic ectoderm? 
It is interesting to note that BMP2 or BMP4 treatment of TERA2.sp 12 cells was detected to 
induce trophoblast differentiation and the expression of markers or characteristic 
morphologies specific to extra-embryonic endoderm differentiation were not observed. This 
corresponds with the report of trophoblast differentiation in BMP2 or BMP4 treated human 
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ES cells by Xu et al. (2002), in contrast to the report by Pera et al. (2004) ofBMP2 or BMP4 
induced extra-embryonic endoderm differentiation (with minimal trophoblast differentiation) 
in HES cells. However, there are several key differences in the materials and methods used 
between these two studies, which are outlined and compared with this study in Table 4.7. 
Table 4.7 Comparison of the materials and methods used in studies by Xu et al. and Pera et al. 
with this study, in which BMP 2 or 4 treatment induces either trophoectoderm or extra 
embryonic endoderm. (Italicised markers are also expressed in other germ layers) 
- ---~-
~ -
Studies: Xu et al. 2002 Pera et al. 2004 This study 
Cells used HES cell lines H1, H7, H9 HES cell lines H2, H3 and TERA2.sp12 cells 
and H14 human EC cell line GCT27X-1. 
Serum free mouse embryonic 
Culture fibroblast conditioned media Media with 20% serum, grown DMEM media with 1 Oo/o 
conditions supplemented with 4ng/ml on mouse embryonic fibroblasts serum. 
bFGF. 
Recombinant BMP4 (1-300ng/ml) BMP2, BMP2 (25ng/ml) BMP2 (25ng/ml) BMP proteins (300ng/ml), BMP7 BMP4 (25ng/ml) BMP4 (25ng/ml) tested (300ng/ml)~ GDF5 (30ng/ml) 
Formed flat, squamous Flattened, enlarged cells 
epithelial cells with abundant formed after 7-14 days, Flattened, enlarged cells 
eosinophilic intracellular similar in appearance to 
Morphology of formed within a few days, material. Cells sometimes BMP4 treated ES cells in the 
cells cells seeded individually at formed fluid filled cysts, study by Xu et al. In approx low density formed large 
occasionally observed foci 1 0-15% of the population 
multi-nucleate cells 
resembling trophoblast cells with multiple densely 
precursors (less than 5%) packed nuclei were 
observed. 
Detection of Stained positive to combined Large cells stained positive to 
Epthelial Keratin 8, 18 and 19 antibody Pan-epithelial keratin, 
markers and to Laminin KeratinB/18 
HCG immuno-positive, also 
progesterone, estrodiol and Densely packed cells stained 
Detection of HCG production increased in positive for HCG and nuclear 
trophoblast media. Microarray and PCR Negative for HCG Keratin 8 antigen, also 
differentiation detection of up-regulated evidence of multiple 
expression of placenta nucleated cells. 
associated genes 
Detection of No up-regulation of Cyst formation and AFP No HNF3f3 detected. No AFP 
primitive endoderm markers compared production (especially at edges detected. No cyst formation 
endoderm to controls detected by of cysts) observed. 
differentiation microarray analysis Expression of HNF3a, HNF4, Gata 4 positive. Gata4 and Gata6 
Differentiation Majority of cells are Endoderm, smooth muscle, 
characterised trophoblast, no evidence of Extra-embryonic endoderm approximately 1 0-15% form 
as .. other lineages. trophoblast cells 
One possible explanation for the alternate differentiation pathways induced by BMP treatment 
in the studies by Pera et al. and Xu et al. is based on the different ES cell lines used. 
Individual variation between ES cell lines could be the cause of their differential response to 
BMP treatment. In support of this theory, Xu et al. reported that as detected by micro-array 
analysis, many trophoblast associated markers were expressed at high levels in the 
undifferentiated ES cell lines used. However an alternative explanation could be based on the 
different culture conditions used between these studies. In both studies the HES cells are 
maintained either in media conditioned from mouse fibroblasts or eo-cultured with mouse 
fibroblasts. However Xu et al. used serum free media supplemented with bFGF whereas Pera 
et al. used media supplemented with high levels of serum. One possibility is that a factor in 
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the serum could be promoting the differentiation of HES cells into primitive endoderm as 
opposed to trophoblast differentiation in response to BMP treatment. In support of this 
observation one would expect some evidence of primitive endoderm differentiation in this 
study, since TERA2.sp12 culture media is supplemented with 10% serum. However, 
observations of primitive endoderm differentiation reported by Pera et al., such as cyst 
formation or AFP production, were not detected in treated TERA2.sp12 cells. This may be 
because TERA2.sp 12 cells require treatment for longer time periods or with higher 
concentrations of serum for cyst formation or AFP production to be detectable. It would be 
interesting to investigate whether factors in the serum regulate the response of TERA2.sp 12 
cells to BMP induced differentiation (into either trophoblast or primitive endoderm lineages) 
by comparing the differentiation of cultures treated with BMPs in media supplemented with a 
range of serum concentrations. 
Niwa et al. demonstrated that differentiating mouse ES cells can undergo either 
trophoblast or primitive endoderm differentiation depending on whether Oct4 levels rise or 
fall (Niwa et al. 2000). Since rapidly lowered Oct4 is linked to trophoblast differentiation, the 
serum free conditions used by Xu et al. could theoretically have destabilised Oct4 levels such 
that BMP treatment rapidly down-regulated Oct4 expression and consequentially induced 
trophoblast differentiation under their culture conditions. To investigate this further one could 
monitor the initial expression level and rate of down-regulation of Oct4 in TERA2.sp 12 cells 
treated with BMPs under high and low serum conditions and determine whether this correlates 
with differing levels of endoderm or trophoblast differentiation. 
4.3.5 Converging FGF and BMP mediated signalling pathways 
The similar differentiation response of TERA2.sp12 cells to either an up-regulation in BMP 
signalling or inhibition of FGF signalling indicates that both treatments act on the same 
mechanism to induce differentiation. As discussed previously, FGF signalling can directly 
inhibit BMP pathway activity through MAPK mediated inhibitory phosphorylation of Smad 1, 
preventing translocation of Smad I to the nucleus (Pera 2003). Thus I hypothesised that in 
TERA2.sp12 cells cultured under maintenance conditions, either autocrine FGF signalling or 
FGFs present in the serum were playing important roles in attenuating BMP signalling to 
prevent BMP pathway mediated differentiation. According to this hypothesis, treatment of 
cultures with recombinant BMPs or with the FGF receptor inhibitor SU5402 was overcoming 
FGF mediated attenuation of BMP pathway activity, and the resultant up-regulation in activity 
driving TERA2.sp12 differentiation. To account for the effect of Noggin on TERA2.sp12 
cultures one could also hypothesise that very low levels or a complete abrogation of BMP 
pathway activity induces neural differentiation, in accordance with the default theory of neural 
induction. A schematic model of this hypothesis is presented in Figure 4.25. This theory 
Figure 4.25 
Proposed Mode Of Action For BMP And FGF Signalling On The Regulation Of BMP Pathway 
Activity And TERA2.Sp12 Differentiation 
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Figure 4.25 Model for the action ofBMP and FGF signalling on the differentiation ofTERA2.sp12 cells. 
Bone morphogenetic protein (BMP) signalling proteins such as BMP2 and BMP4 activate the BMP pathway, 
whereas fibroblast growth factor (FGF) mediated MAPK activity inhibits BMP pathway activity in 
TERA2.sp12 cells. In the presence of a balance of FGFs and BMPs present in the serum, which induces low 
levels of BMP pathway activity in TERA2.sp12 cells, cultures remain undifferentiated. However, if cultures 
are treated with BMP2 or BMP4, which activate BMP signalling, or cultured in the presence of FGF receptor 
inhibitor SU5402, which inhibits FGF signalling, BMP pathway activity is up-regulated and cells differentiate 
into a heterogeneous population of trophoblast, simple endoderm and smooth musc le cells. Conversely, 
treatment of TERA2.spl2 cells with Noggin down-regulates BMP signalling to minimal levels, which 
encourages TERA2.spl2 differentiation towards a neural fate (neural differentiation not depicted in diagram). 
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corresponds with a recent report by Xu et al. (2005). In this report they demonstrate that 
human ES cells which are normally dependent on conditioned media from mouse fibroblasts 
for undifferentiated culture, can be maintained undifferentiated in unconditioned media 
supplemented with I OOng/ml Noggin and 40ng/ml bFGF or high concentrations of bFGF 
alone, and they attribute this effect to attenuated BMP signalling. 
To investigate whether inhibition of FGF signalling by SU5402 treatment increased 
BMP pathway activity in a similar manner to exogenous BMP treatment (in support of my 
hypothesis) and also to investigate whether changes in BMP pathway activity in turn could 
regulate ERKI/2 phosphorylation, the levels of Smad I regulated Id2 and MAPK regulated 
phosphorylated ERKI/2 were assessed by Western blot analysis in protein extracted from I4 
day cultures ofTERA2.spl2 cells treated with RA, BMP2, BMP4 or SU5402. Id2 expression 
was up-regulated by BMP or SU5402 treatment. Taken together with the observed up-
regulation of Gata4 in BMP and SU5402 treated culture in immuno-staining analyses, this 
indicates that SU5402 mediated suppression of FGF signalling was indeed generating an up-
regulation of BMP pathway activity. Unexpectedly, levels of phosphorylated ERK I did not 
markedly change with any treatments, whereas levels of phosphorylated ERK2 were in 
general up-regulated from trace EC levels in all treatments, with BMP2 treatment inducing the 
highest up-regulation, and RA also inducing marked up-regulation. In addition, substantial P-
ERK 2 phosphorylation was still observed in cultures continuously treated with the FGF 
receptor I inhibitor SU5402. SU5402 treatment has been used extensively to inhibit FGF 
mediated signalling in many culture systems, and also recently in embryonic stem cells 
(Dvorak et al. 2005, Vallier et al. 2005). However this raises an important point: As a down-
stream component of the MAPK pathway, ERKI/2 is phosphorylated not only by FGF 
mediated receptor activation but also as a result of signalling via a range of other growth 
factors, including EGF, NGF, BDNF, PDGF. Thus although inhibition of FGF mediated 
signalling through inhibition of the FGF receptor may attenuate MAPK pathway activity, 
MAPK activity can also be modulated by a host of other factors. Whether all of these factors 
can also mediate BMP signalling inhibition through ERKI/2 activation is yet to be 
determined. An alternative method of measuring FGF mediated signalling such as monitoring 
the level of FGF receptor activation could provide a means of monitoring specifically FGF 
mediated MAPK pathway activity. Otherwise a more simple means of investigating whether 
FGF mediated signalling inhibits BMP pathway activity in TERA2.sp 12 cells would be 
determine whether BMP mediated differentiation is inhibited when cultures are treated with 
BMPs in the presence of high levels of FGFs (such as recombinant bFGF). If this is the case, 
to determine whether ERKI/2 is necessary for this inhibition, one could assay whether 
exposure to a specific ERI/2 phosphorylation inhibitor is able remove the inhibitory effect of 
FGF exposure on BMP induced differentiation. 
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4.3.6 Subsequent inhibition of BMP and FGF signalling 
As Noggin treated cells expressed a phenotype similar to neural progenitors after 14 days of 
treatment, in a pilot experiment I assessed whether these cells had committed to a neural 
progenitor lineage and would now respond differently to an inhibition of FGF signalling 
through SU5402 treatment. Down-regulated FGF signalling (by bFGF withdrawal) is 
frequently used to differentiate neural progenitor cells in culture, and consequentially this was 
used as an assay to determine whether Noggin treated cells were committed towards a neural 
progenitor phenotype (differentiating into neural lineages) or whether they would respond 
similarly to previously untreated TERA2.sp 12 cells. Cultures treated for 14 days with Noggin 
followed by 14 days with SU 5402 generated a heterogeneous population of cells, with a small 
population exhibiting strikingly mature neuronaVglial morphologies, and the remaining 
population differentiating into similar fates observed in cells that had not previously been 
treated (expressing markers such as HCG and epithelial keratins). This indicates that most of 
the population had not committed towards a neural progenitor phenotype and retained the 
ability to differentiate into non-neural phenotypes. However the presence of a distinctive sub-
population of cells that differentiated extensively along a neuronal/glial phenotype indicates 
that a small proportion of cells had committed towards a neural progenitor fate. Further 
investigations in which - prior to treatment with SU5402, cells are cultured for prolonged 
periods with Noggin, with higher concentrations of Noggin, or with Noggin in combination 
with FGF, would be of interest here. As a comparison it would also be valuable to investigate 
the effect of SU5402 treatment on TERA2.sp12 cells treated for 14 days with RA, as the 
majority of these cells demonstrate marked up-regulation of neural progenitor markers and 
should respond as neural progenitors. 
4.3. 7 Conclusions 
The effect of BMP and FGF signalling on TERA2.sp12 cells was initially investigated with 
the aim of characterising their role in neural and non-neural ectoderm differentiation decisions 
as an in vitro model of human ectoderm. These investigations did demonstrate the marked 
inhibitory effect of increased BMP signalling or decreased FGF signalling on neural 
differentiation. However, during these studies TERA2.sp 12 cells demonstrated their capacity 
to differentiate not only into ectoderm lineages but also into putative tropho-ectoderm, 
endoderm (and possibly mesoderm). Supporting evidence was also generated for a convergent 
effect of up-regulated BMP signalling or down-regulated FGF signalling on the pathway of 
differentiation, possibly via the regulation of BMP pathway activity through Smad I 
phosphorylation events. 
Since the findings of this study show that TERA2.sp 12 cells respond to BMP treatment 
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similarly to human ES cells, this suggests that TERA2.sp 12 cells are not restricted in their 
differentiation potential as previously thought, and further characterisation is required to 
determine their full differentiation potential. 
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5.1 INTRODUCTION 
The initial premise of the previous chapters was that TERA2.sp 12 cells were limited in their 
differentiation capacity to ectodermal lineages, thus providing a suitable in vitro model in 
which to investigate neural versus non-neural transitions in the developing human ectoderm. 
As discussed previously, this was based on both previous in vitro studies and histological 
observations that tumours derived from TERA2.sp 12 cells transplanted into immune-deficient 
mice contained only ectodermal derivatives (Przyborski et al. 2004, Stewart et al. 2003). 
The formation of tumours from transplanted stem cells 
Teratomas have fascinated clinicians and researchers for centuries, mainly by their ability to 
generate extensively differentiated and morphologically identifiable complex tissue structures 
including bone, tooth, hair and gut that very closely resemble tissues found in normal 
development, but within a grossly disorganised context, for reviews (Andrews 2002, Andrews 
et al. 200 1 ). 
As previously discussed, embryonal carcinoma cell lines were first isolated from 
teratomas and characterised as the stem cell component by their ability to form new tumours 
upon transplantation into immuno-compromised mouse hosts (for review see Andrews 2002). 
Subsequent investigations to identify an embryonic counterpart in normal development which 
also exhibited teratoma forming capability led to the first isolation of mouse embryonic stem 
cells from the inner cell mass of developing blastocysts in 1981, and subsequently the 
derivation of human embryonic stem cells from developing human blastocysts in 1998 
(Martin 1981, Thomson et al. 1998). 
Although embryonic stem cell lines can differentiate into derivatives of all three germ 
layers in vitro, complex tissue formation, pattern formation or organogenesis does not occur to 
a significant degree. In contrast, the highly differentiated tumours formed upon transplantation 
of human embryonic stem cells into immune-deficient mice frequently exhibit complex 
structure formation. In this context, many of the normal features of tissue architecture are 
reproduced. For example, epithelia exhibit polarity, are enveloped by a basement membrane 
and are surrounded by mesenchyme, and composite tissue structures such as hair follicles, 
teeth, and gut are also formed (for review see Oderico 2001). Human embryonic stem cells 
injected into immune-deficient mice form benign teratomas with advanced differentiated 
tissue types representing all three embryonic germ layers, and transplantation into immune-
deficient mice is now routinely used to demonstrate the full differentiation potential of newly 
derived embryonic stem cell lines, (Heins et al. 2004, Reubinoff et al. 2000, Stojkovic et al. 
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2004a, Thomson 1998). 
Tumour formation from TERA2.sp12 cells- a means of fully testing their developmental 
potential 
Although earlier studies of TERA2.sp 12 differentiation had only revealed evidence of 
differentiation into ectodermal derivatives (Horrocks et al. 2003, Przyborski 2004, Stewart 
2003), during investigations described in the previous two chapters I demonstrated that 
TERA2.sp 12 cells were capable of differentiating into cells expressing markers of 
trophoectoderm, endoderm and mesoderm differentiation. This led to the questioning of 
earlier observations that TERA2.sp12 cells differentiated into solely ectodermal derivatives 
after transplantation into immune-deficient mice. 
As a means to investigate the full developmental potential of TERA2.sp 12 cells, and 
examine whether these cells exhibit exclusively or predominantly ectodermal differentiation 
in vivo, in the following chapter I characterise the differentiation of TERA2.sp 12 cells within 
tumours formed from transplantation into immune-deficient mice using both histological and 
immuno-staining techniques, and compare this differentiation with a tumour derived from the 
human embryonic stem cell line NCL-1. An outline ofthe aims, objectives and experiments in 
this chapter is presented as a strategy flow chart in Figure 5.1. 
Figure 5.1 
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5.2 RESULTS 
As described in Section 2.8, batches of prepared TERA2.sp12 cells were injected 
subcutaneously on the left flank into nude (C57BLI6J-Hfhllnu) adult male mice. Tumours 
were isolated on the basis of identifying an obvious palpable growth that was not too large to 
affect the welfare of the animal (maximum dimensions up to 1.5cm in length). At this time the 
mice were sacrificed and tumours surgically removed, fixed in 4% PF A, processed and 
sectioned as described in Section 2.6.4. Although for each batch of injections 3-4 animals 
were used, I only had access to some of these tumours, the details of which are listed in Table 
5.1 . 
Table 5.1 Details of tumours derived from sub-cutaneous TERA2.sp 12 injection into immune-
deficient mice. 
Tumour Date of injection Age of tumour PFA fixation Embedded and processed in 
1. 12.04 6-7 weeks Post-dissection Wax 
ovemiaht 4"C 
2. 14.12.05 Isolated 31.3.05 Post- dissection 40- Wax 
- 14 weeks 60 mins 
3. 14.12.05 Isolated 8.3.05 Post- dissection 40- OCT 
-11 weeks 60mins 
4. 1.6.06 Isolated 20.9.05 Perfusion fixed prior OCT 
-17weeks to dissection 
Gross morphology -Histological staining 
After 11-17 weeks readily palpable, solid tumours ranging from 40-50mm3 in diameter had 
formed at the site of injection. These were surrounded by a layer of fat and in some cases hair, 
and were heavily vascularised. Fixation, sectioning and histological staining of these tumours 
revealed large regions of loosely packed disorganised cells of mixed morphology interspersed 
with some distinctive organised formations, typically composed of an organised layer or 
layers of cells surrounding a cavity such that cross-sections appeared like 'islets' or tubular-
like. Sections from tumours fixed post-extraction in PF A and embedded in OCT exhibited 
poorer morphology preservation than those from tumours embedded in wax or perfusion fixed 
prior to OCT embedding. However in all cases a similar range of phenotypes was observed in 
consecutive sections through the tumour. 
Immuno-detection of markers of germ layer derivatives 
To characterise the differentiation of cells within the TERA2.sp 12 derived tumours, serial wax 
and cryostat sections of the tumours were immuno-stained with antibodies to a panel of 
markers detailed in Table 5.2. Since several of the available antibodies were raised in mouse 
hosts (see Table 5.2), in many cases non-specific staining occurred as a result of non-specific 
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interactions between the anti-mouse secondary antibody and host antigens. In order to 
minimise these non-specific interactions, sections to be immuno-stained with primary 
antibodies that had been raised in mouse hosts were first blocked for 1 hour with a 
monovalent Fab fragment of anti-mouse IgG, (goat anti-mouse lg H+L from Jackson Labs), 
diluted to 1 :50 in blocking buffer, prior to incubation with the primary antibody overnight and 
immuno-staining following the protocols outlined in Section 2.5. 
Table 5.2 Details of antibodies used in immuno-labelling screen for markers of differentiation 
ANTIGEN ANTIBODY SOURCE DILUTION Pre-treatment CATEGORY 
Nestin Mouse lgG Chemicon 1:400 Block with mouse Ectodenn-Fab fragment neural progenitor 
13111 Tubulin Rabbit lgG Covance 1:400 Ectodenn-
neuronal 
NF160 or Mouse lgG Chemicon 1:100 Block with mouse . NFM Fab fragment 
NF200 or Rabbit lgG Chemicon 1:400 . NFH 
GFAP Mouse lgG Sigma 1:100 Block with mouse Ectodenn --gial Fab fragment 
5100 Rabbit lgG Abeam 1:200 . 
TP63/ Goat lgG R&D 1:50 Ectodenn-TP73L systems epidermal 
Keratin 8 Rabbit lgG Abeam 1:100 Epithelial 
Keratin Mouse lgG Chemicon 1:400 Block with mouse . 
epithelial Fab fragment 
Endodenn (and 
Gata4 Goat lgG R&D 1:50 mesodenn 
systems derived 
myoblasts) 
PFA then treat for 1 Endodenn and 
AFP Mouse lgG Sigma 1:100 minute with ethanol, primitive then block with 
mouse Fab fragment endodenn 
HNF313 Goat lgG R&D 1:50 Primitive streak systems and endodenn 
Brachyrury Goat lgG R&D 1:50 Mesodenn 
systems 
Mesodenn or 
A smooth 
mouse lgG Sigma 1:100 Block with mouse ectodenn 
muscle actin Fab fragment (neural crest 
derived)- muscle 
HCG mouse lgG Abeam 1:50 Trophoblast of trophoectodenn 
Non-specific staining generated from antibodies raised in a mouse host 
Of the range of primary antibodies used in immuno-staining analyses that were raised in 
mouse hosts, under the standard immuno-staining protocol most generated non-specific 
staining in negative controls of mouse tissue and in tumour explants. However for some 
antibodies (such as Nestin, ~Ill tubulin and epithelial keratin), positive immuno-staining was 
easily distinguishable from non-specific background staining because of the marked 
difference in staining intensity. In order to reduce background staining caused by host 
antigens interacting with the mouse secondary antibody, prior to the normal blocking step 
tumour sections were incubated with a mouse Fab fragment. This reduced the background 
staining intensity in many cases but not in all. Alpha-smooth muscle actin for example still 
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exhibited high levels of non-specific staining. 
Ideally it would be preferable to completely remove this background effect from 
staining analyses by using primary antibodies raised in a different host (such as rabbit or 
goat), although in several cases these were not available. 
A comment on the guality of immuno-staining, morphology and tumour processing 
technigues 
In addition to non-specific staining generated from using antibodies raised in mouse hosts, 
other difficulties with background staining were encountered. Some antibodies functioned 
poorly or not at all on sections from wax-embedded tissue, and many antibodies exhibited 
high back-ground despite extensive antigen retrieval, blocking and prolonged primary 
incubation steps. As a result the remaining tumours were embedded in OCT instead of wax. 
However, although these antibodies functioned better on sections from OCT embedded 
tumours, the preservation of tumour morphology (from tumours fixed after removal from the 
host), was reduced in those embedded in OCT compared to wax, and substantial background 
staining was still observed. However, the last tumour, which was perfusion fixed prior to 
surgical removal, exhibited a high level of morphology preservation, stained positively for the 
range of antibodies tested and exhibited much lower background staining, including in 
sections immuno-stained with primary antibodies raised in the mouse host. 
Detection of multiple germ layer derivatives 
In all TERA2.sp 12 derived tumours surveyed, section samples exhibited extensive immuno-
positive staining for the neuro-progenitor marker Nestin, and large areas were also immuno-
positive for neuronal markers ~Ill tubulin and MAP2. The expression pattern of these neural 
markers throughout the tumour was heterogeneous and associated with discrete patches of 
tissue. Neural rosette like structures displaying immuno-positive staining for Nestin and 
surrounded by ~Ill tubulin positive areas were also observed. Although Nestin and ~Ill tubulin 
expression was closely associated in these areas, cellular eo-localisation was not detected. 
Figure 5.2 depicts neural marker expression in different regions and increasing magnifications 
in a representative section of the PF A perfusion fixed tumour. Some evidence of more mature 
neuronal differentiation was also observed, demonstrated by the expression of mature 
neurofilaments and substantial staining for the early glial marker SI 00 (and in rare cases the 
astroglial marker GFAP was detected), in some instances in cells exhibiting a branched glial 
morphology (Figure 5.2 plates E-F). It is interesting to note that one of the tumours examined 
exhibited a general trend whereby regions of neural marker expression were typically detected 
closer to the outer edge of the tumour. 
Pan-epithelial keratin and simple epithelial markers Keratin 8 and 18 were also 
Neuronal and Glial Differentiation In TERA2.sp12 Derived Tumours 
Figure 5.2. Neural marker expression in representative sections from a TERA2.sp 12 
derived tumour generated from injection into an immune-deficient mouse host. 
TERA2.sp 12 cells were injected sub-cutaneously into a nude mouse and after a period of 
17 weeks the tumour was perfusion fixed in 4% PFA, embedded in OCT and I O~m 
cryosections double immuno-labelled with either Nestin (green) and ~Ill tubulin (red), 
(plates A-C and D), or double immuno-labelled with GFAP (green) and SI 00 (red), (plates 
E-F). Cells were counterstained with hoescht (blue) prior to mounting under coverslips. 
Note the extensive regions exhibiting early neural differentiation as demonstrated by 
positive expression of Nestin (A and in another region at higher magnification in D) and 
~Ill tubulin (B with overlay of Nestin, 13111 tubulin and hoescht in C). Some glial 
differentiation indicated by the expression of GFAP was detected (as depicted in E), with 
some GFAP immuno-positive cells exhibiting a branched glial morphology (arrow head) 
and demonstrating nuclear localisation of the astrocytic marker SI 00 (overlay in F). Scale 
bar for plates A-C = IOO~m. Scale bar for plates D-F = 50 Jlm 
Figure 5.2 
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expressed within tumour sections (although not at comparable levels with Nestin), and 
epithelial keratin expression was typically associated with ordered arrangements of cells that 
formed a simple epithelial or stratified cell layer around a small cavity (see Figure 5.3). No-
eo-localisation was observed between epithelial keratins and the neural antigens Nestin and 
pm tubulin. The majority (although not all) of these epithelial keratin positive structures 
exhibited nuclear localised expression of the epidermal stem cell marker TP63. In cross 
sections of predominantly single-cell lined (epithelial keratin positive) tubular structures TP63 
expression was detected in only a few adjacent cells, and this was observed in regions where 
the lining was no longer composed of single cells. Tubular epithelial keratin positive 
structures within sections that were composed of multiple cell layers exhibited the highest 
frequency ofTP63 positive nuclei, and TP63 positive cells were localised to the outer edge or 
basal layer of the structure (as shown in Figure 5.3). 
A minority of these epithelial keratin positive structures exhibited strong staining for 
the nuclear localised endoderm transcription factor HNF3~ (typically expressed in gut), and 
these were typically more complex and often branched, comprised of multiple layers of cells. 
Unlike the more restricted pattern of expression observed for the epidermal stem cell marker 
TP63, almost all of the epithelial keratin positive cells within this structure stained positive for 
HNF3~. It is important to note that other epithelial keratin positive islets within the same 
sections exhibited no positive immuno-staining for HNF3~, even when surrounding cells were 
immuno-positive. In some regions exhibiting positive HNF3~ and epithelial keratin 
expression, the pattern of epithelial keratin expression and arrangement of cells were more 
loosely organised. Figure 5.4 presents the two main patterns of HNF3~ expression observed in 
tumour sections. No positive HNF3~ staining was observed in the absence of positive staining 
for epithelial keratin. Laminin (the main extra-cellular matrix component of basement 
membranes), was detected to line both the outer edge of cells forming the organised branched 
structures and also to surround the large regions of more loosely organised HNF3P positive 
cells. 
The endoderm transcription factor Gata4 was detected in extensive regions through-
out tumour sections, (also closely associated with areas of positive epithelial keratin staining). 
Different regions within the same tumour sections exhibited marked variations in staining 
intensity (see Figure 5.5). Ordered arrangements of epithelial keratin positive cells around a 
cavity such as those exhibiting positive staining for HNF3~ or TP63 were not typically 
positive for Gata4, although cells exhibiting high Gata4 expression frequently surrounded 
these structures. 
Little expression of the mesoderm transcription factor Brachyury was detected in 
sampled tumour sections, and this was not associated with any morphologically distinct 
Non-Neural Ectoderm Differentiation In TERA2.spl2 Derived Tumours 
Figure 5.3. Epidermal antigen expression in representative sections from a TERA2.sp 12 derived 
tumour generated in an immune-deficient mouse. TERA2.sp 12 cells were injected sub-cutaneously 
into the left flank of a nude mouse. After a period of 17 weeks the tumour was perfusion fixed in 
4% PF A, embedded in OCT and IO~m cryo-sections double immuno-labelled with either epithelial 
keratin (green) and Keratin 8 (red), (A-C), or epithelial keratin (red) and TP63 (green), (D-F). 
Cells were counterstained with hoescht (blue) prior to mounting under coverslips. Plates A-B (and 
overlay with hoescht in C) depict a structure composed of relatively organised layers of cells 
expressing epithelial keratins. As depicted in (D-F) morphologically distinct islet shaped structures 
were observed, comprising of layers of cells which organised around a small central cavity and 
were immuno-positive for epithelial keratin and the epidermal stem ce ll transcription factor Tp63 . 
Note that some cells demonstrate nuclear polarity (overlay with hoescht in G). Scale bars= I 0011m. 
Figure 5.3 
Figure 5.4 
Expression OfThe Endoderm Marker HNF3f3 In TERA2.spl2 Derived Tumours 
Figure 5.4. Expression of the endoderm transcnpt1on factor HNFJI3 and epithelial keratin in a 
representative section from a TERA2.spl2 tumour generated in an immune-deficient mouse host. 
TERA2.sp 12 ce lls were injected sub-cutaneously into a nude mouse and after a period of 17 weeks 
perfusion fixed in 4% PF A, embedded in OCT and IO~m cryo-sections double immuno-labelled with 
epithelial keratin (red) and the endoderm transcription factor HNF3f3 (green). The nuclei were 
counterstained with hoescht (blue) prior to mounting under coverslips. Plates A-B (with overlay inc luding 
hoescht in C) depict a relatively organised branched structure comprised of a multi-cellular lining of cells 
immuno-positive for HNF3f3 and pan-epithelial keratin. Plates D-E (with overlay including hoescht in F) 
depict HNF3f3 positive staining in a less organised arrangement of cells that surround epithelial keratin 
positive cells organised around a cavity (arrow). Scale bars=! OO~m. 
Expression Of The Endoderm Transcription Factor Gata4 In TERA2.sp 12 Derived 
Tumours 
Figure 5.5 
Figure 5.5. Epithelial keratin and Gata4 expression in representative sections from a TERA2.sp 12 derived 
tumour. TERA2.sp 12 cells were injected sub-cutaneously into a nude mouse and after a period of 17 weeks 
perfusion fixed in 4% PFA, embedded in OCT and IO~!m cryo-sections double immuno-labelled with 
epithelial keratin (red) and the endoderm transcription factor Gata4 (green). Cells were counterstained with 
hoescht (blue) prior to mounting under covers lips. Sections A-C and D-F depict the two main patterns of 
Gata4 and epithelial keratin expression observed within the tumour. As depicted in A-B (with overlay in C), 
in morphologically distinct and organised 'eyelet ' structures immuno-positive for epithelial keratin, no Gata4 
expression was detected, such that adjacent cells exhibited distinct patterns of Gata4 or epithelial keratin 
expression. In other regions, as demonstrated in D-E (with overlay in F), eo-localisation of Gata4 and 
epithelial keratin was frequently observed, (typically in less organised areas of epithelial keratin expression). 
Note that in these images taken from the same section Gata4 expression is much higher in cells within plates 
D-F than within plates A-C. Scale bars=IOO~!m. 
Detection Of Human Nuclear Antigen Within TERA2.sp 12 Derived Tumours 
Figure 5.6. Human specific nuclear antigen expression in two representative sections from different 
TERA2.spl2 derived explants. TERA2.spl2 cells were injected sub-cutaneous ly into nude mice and after a 
period of 14-17 weeks fixed in 4% PFA, embedded in Wax (A-C) or OCT (D-F) and 10~-tm cryo-sections 
immuno- labelled with an antibody to Human nuc lear antigen (red or green) and counterstained with 
hoescht (blue) prior to mounting under coverslips. Close to the edge of a tumour section in plates A-C, a 
layer of tissue containing a hair follicle-like structure (arrow) exhibits no nuclear staining for human 
nuclear antigen, compared to adjacent tissue which exhibits bright nuclear localised staining (positive 
staining outlined in white dashes). As depicted in plates D-F nuclear localisation of human nuclear antigen 
within the tumour is exhibited in the majority of cells, although regions negative for human nuclear antigen 
are present (negative staining outlined with white dashes). These negative regions were typically tubular 
structures, containing cells with a more compact elongated nucleus (D and E) and a distinctive morphology 
under phase contrast (F) indicative of vascular tissue. Note that although relative ly high background 
staining was exhibited, non-specific staining was weaker than in surrounding tissue and did not specifically 
label the nuclei . Scale bars= I 00~-tm . 
Figure 5.6 
Figure 5.7 
Detection Of A Stem Cell Population Within TERA2.sp 12 Derived Tumours 
Figure 5.7. Nestin and Nanog expression in two representative sections (A-C and D-F) from a TERA2.sp12 
derived tumour. TERA2.sp 12 cells were injected sub-cutaneously into a nude mouse and after a period of 
17 weeks the tumour was perfusion fixed in 4% PFA, embedded in OCT and I 0~-tm cryo-sections double 
immuno-labelled with Nestin (red) and the stem cell transcription factor Nanog (green). The nuclei were 
also counterstained with hoescht (blue). Two different sections in plates A-C and D-F depict the detection 
of a sub-population of stem cells exhibiting nuclear expression of the stem cell transcription factor Nanog. 
Nanog positive cells (plates A and D) were negative for the widely expressed neuro-progenitor marker 
Nestin (plates B and E). Note that Nanog positive cells exhibited larger nuclei compared to surrounding 
cells (see overlays with hoescht in C and F). Scale bars= I 00~-tm. 
Varied Structures And Expression Of Multiple Markers Of Differentiation In Sections 
Of A Tumour Derived From Human ES Cells NCL-1 
Figure 5.8 
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structures. Positive expression occurred in small patches of cells in a similar pattern to that 
previously observed in RA treated TERA2.sp 12 cells in vitro. 
In summary, extensive regions of neural differentiation were observed in all tumours, 
displaying a range of differentiation stages and both neuronal and glial marker expression. 
Epithelial cells within the teratomas were made up of both endoderm and ectoderm as 
detected by specific markers, and formed the histologically distinctive structures observed in 
haematoxylin and eosin stained sections. No definitive evidence of differentiation into 
mesoderm derivatives was detected; very little Brachyury expression was observed, and 
although positive staining was detected with the smooth muscle marker a smooth muscle 
actin, this observation was treated with caution because of the accompanying high levels of 
non-specific staining. In addition, (as previously discussed) smooth muscle may be either 
neural crest (ectoderm) or mesoderm derived, so markers of smooth muscle do not necessarily 
represent a mesoderm derivative. 
The relative composition of different markers of germ layers was grossly consistent in 
all of the tumours tested, although one tumour contained organised tubular structures of a 
greater size and complexity compared to other tumours, and also exhibited higher levels of 
HNF3~ expression. This was observed in the tumour isolated 17 weeks after injection, 
compared to the other tumours which were isolated after 7-14 weeks. It is also important to 
note that only a sample of sections from regions through-out the tumours were observed, and 
in a relatively small sample number of tumours, so it is possible that some phenotypes were 
not detected in this study. 
Discriminating between mouse and human cells within the tumours 
As substantial tumours are extensively vascularised by the host, the tumours examined were 
likely to contain -at the least- vascular structures derived from mouse tissue. Indeed, 
structures that resembled blood vessels were observed within all tumour sections. These were 
lined with cells containing distinctive flattened nuclei (endothelium-like) and these structures 
also frequently exhibited high levels of non-specific staining. In addition, TERA2.sp 12 
derived tumours were typically surrounded in a layer of fat-like tissue and structures 
resembling hair follicles were frequently observed in this outer layer and sometimes deeper 
within the tumour tissue. These regions demonstrated relatively high levels of background 
staining even with extensive blocking treatments, and cells lining the hair follicle-like 
structures stained brightly with epithelial keratin. 
The aim of the following experiment was to discern between structures formed from 
TERA2.sp 12 cells or the mouse host and determine whether the range of phenotypes 
previously described could truly be attributed to TERA2.sp12 cell differentiation. To 
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discriminate between mouse and human cells within the tumour explants, serial sections were 
immuno-stained with mouse anti-Human nuclear antigen (Chemicon) used at a dilution of 
1:50. As this antibody was raised in mouse, sections were pre-treated with a Fab fragment of 
anti-mouse IgG as previously described. Unfortunately, as this human specific antibody was 
only available as an antibody raised in mouse, non-specific staining was observed in all 
tumours, despite extensive blocking treatments. However the background staining was low 
enough in all tumours for a difference in staining specificity and intensity to be detected, as 
the antibody only brightly stained the nuclei of human cells, compared to lower intensity non-
localised staining in mouse cells (see Figure 5.6). 
This enabled me to observe that the blood vessel-like structures, the outer layer of 
fatty tissue and hair follicles were all consistently negative for human nuclear antigen. The 
remaining cell types and structures all exhibited positive nuclear immuno-staining for human 
nuclear antigen, demonstrating that the majority of the tumour was derived from TERA2.sp12 
cells. 
Detection of stem cell populations within tumour explants 
To assess whether these tumours contained a sub-population of cells that retained their stem 
cell phenotype or determine whether the tumours increased in size solely as a result of the 
proliferation of progenitor cells, tumour sections were screened with an antibody to the stem 
cell transcription factor Nanog. Serial sections through the tumours were stained with an 
antibody to Nanog (raised in goat) following the protocol outlined in Section 2.5, with an 
initial blocking step in donkey serum and primary incubation overnight at 4°C. 
Although relatively high background was observed in all tumour sections except those from 
the tumour that was perfusion fixed, a distinctive Nanog immuno-positive population was 
observed in all tumours. In the 17 week perfusion fixed tumour, a substantial population of 
Nanog positive cells was observed and these cells were negative for the neural progenitor 
marker Nestin (Figure 5.7). In addition, Nanog positive cells were typically observed to be 
closely associated with structures resembling vascular tissue. This was consistent with the 
character of TERA2.sp 12 cells as EC cells whereby a stem cell population is retained in the 
tumour. 
Comparison with human ES cell derived tumour 
To compare the differentiation within TERA2.sp 12 derived tumours with that of a human ES 
cell line, sections of tumour explants derived from hES-NCL 1 cells injected beneath the 
capsule of the kidney of adult male severe combined immune deficient (SCID) mice were 
either stained with haematoxylin and eosin following the procedure in Section 2.6 or immuno-
labelled following the protocol in Section 2.5.3 with antibodies to germ layer markers listed in 
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Table 5.2. The tumour sections were obtained from a collaboration project between Stefan 
Przyborski (University of Durham) and Miodrag Stojkovic (University of Newcastle), 
(Stojkovic 2004). The cells were prepared in Newcastle and the tumours processed by 
Rebecca Stewart, a fellow lab member. To summarise, 3000 hES-NCL 1 cells grown on 
mouse embryonic fibroblasts were injected beneath the kidney capsule. After a palpable 
tumour had formed, the mice were sacrificed and the tissues dissected, fixed in PF A, 
embedded in wax, processed and sectioned following the protocol described in Section 2.5. 
Sections exhibited much greater variation and complexity in structure formation under gross 
examination, although some structures were very similar to those found in tumours derived 
from TERA2.sp12 cells. Unfortunately only a sub-set of antibodies worked successfully on 
the tumour sections, because the tumour was embedded in wax, so a detailed immuno-logical 
comparison with TERA2.sp12 derived tumours was not possible. Figure 5.8 depicts 
representative images from sections of the human embryonic stem cell derived tumour after 
both histological and immuno-staining. These initial results are consistent with the hypothesis 
that TERA2.sp 12 cells differentiate in vivo into a more restricted range of cell types than hES-
NCL 1 cells, although further experiments are required to support this hypothesis. 
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Figure 5.8 
Figure 5.8. Varied structures and expression of multiple markers of differentiation in sections of a tumour 
derived from human ES cells NCL-1. Cells were injected beneath the left kidney capsule of a SCID 
mouse, and upon generation of a palpable tumour the tumour was removed, fixed in 4% PFA and 
embedded in wax. 1 OJ.tm sections were either immuno-stained with pan epithelial keratin (red, A with 
overlay in B) or Nestin (green, C with overlay in D) or double immuno-labelled with epithelial keratin 
(red) and HNF3P (green), (E-F with overlay in G) and the nuclei counter stained blue with hoescht. 
Tumour sections were also stained with haematoxylin and eosin and viewed under phase contrast (H). 
Discrete patches of tissue were immuno-positive for the neural progenitor marker Nestin (C and overlay 
with hoescht D), and organised, morphologically distinct multicellular structures exhibiting epithelial 
keratin staining were observed (A-B). Plate H depicts a similar structure under phase contrast (arrow). In 
contrast, relatively simple arrangements of epithelial keratin and HNF3P positive cells around a central 
cavity were also observed in sections (E, F and overlay with hoescht in G). Scale bars = 1 OOJ.lm 
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5.3 DISCUSSION 
5.3.1 Summary 
As in the previous chapters it was demonstrated that TERA2.sp12 cells could form non-
ectodermal derivatives in vitro, in this chapter the differentiation of TERA2.sp 12 cells in vivo 
was characterised by both histological and immuno-staining analyses, in order to more fully 
explore the differentiation potential of these cells. Sub-cutaneous injection of TERA2.sp12 
cells into immune-deficient mice generated readily palpable tumours after ll-17 weeks that 
contained a range of differentiated phenotypes of predominantly TERA2.spl2 origin. Neural 
differentiation was dominant in all the tumours generated, but a substantial population of 
epithelial structures indicative of simple non-neural epithelial ectoderm was also observed. In 
addition, a stem cell population was detected in all tumours, consistent with the properties of 
TERA2.spl2 cells as an embryonal carcinoma cell line. Histological comparison with tumours 
derived from human stem cells demonstrated a markedly restricted range of structures and 
phenotypes in TERA2.sp 12 cell derived tumours compared to human ES cell derived tumours, 
supporting the hypothesis for TERA2.sp 12 cell differentiation being restricted to primarily an 
ectodermal phenotype. However, immuno-staining analyses identified some selected 
expression of endoderm markers, indicating that TERA2.sp 12 cells still retain the capacity to 
differentiate into non-ectodermal lineages in vivo. In this study the ability of TERA2.spl2 
cells to form mesoderm derivatives was not demonstrated, so they may still display a 
restricted differentiation potential. 
5.3.2 Histological analysis of TERA2.sp12 derived tumours 
Haematoxylin and eosin staining of tumour sections identified a range of phenotypes within 
the TERA2.sp 12 derived tumours, including neural rosettes and organised epithelial structures 
consisting of layers of cells surrounding a central cavity. However the majority of the tissue 
was disorganised, and compared to the extensive range of phenotypes and more complex 
structures observed in sections of a tumour derived from the human ES cell line NCL-1, 
TERA2.sp12 derived tumours exhibited a markedly reduced range of differentiation 
phenotypes. As only one tumour was examined from the human ES cell line NCL-1, and more 
importantly this tumour was derived from a different site of injection, only limited 
comparisons can be made. However multiple reports documenting the formation of tumours 
from ES cells injected into different sites in immune-deficient mice all demonstrate the 
formation of multiple tissue types representing all three germ layers. In these reports they 
present histological evidence of readily identifiable tissues such as smooth muscle, striated 
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muscle, bone, cartilage, fetal glomeruli, gut, respiratory epithelium, keratinizing squamous 
epithelium, hair, neural epithelium, ganglia and highly organised structures such as teeth, hair 
follicules and gut (Heins 2004, Reubinoff 2000, Stojkovic et al. 2004b, Thomson 1998) for 
review (Oderico 2001). 
In comparison, the markedly restricted range of phenotypes and simple epithelial 
structures observed in TERA2.sp 12 cells supports the theory that TERA2.sp 12 cells are more 
restricted in their capacity to differentiate to that of ectoderm derivatives (as we have 
previously reported (Przyborski 2004, Stewart 2005). A limited differentiation capacity has 
also been previously observed in teratomas formed from NTERA2.ci.D1 cells and other clonal 
lines derived from TERA2 by Andrews et al (Andrews et al. 1984). They reported that 
injection into immuno-compromised mice generated teratocarcinomas containing neural 
elements and simple tubular structures resembling primitive gut. 
However, experiments described in previous chapters demonstrate the ability of 
TERA2.sp12 cells to form derivatives expressing markers of endoderm (Gata4), mesoderm 
(Brachyury, a-smooth muscle actin) and trophoectoderm (HCG) in vitro, questioning the 
hypothesis that TERA2.sp12 differentiation is restricted to ectoderm derivatives. To more 
closely examine the differentiation phenotypes within TERA2.sp 12 derived tumours, cells 
were immuno-stained with a range of markers expressed in derivatives of all three germ 
layers. 
5.3.3 lmmuno-staining analysis of TERA2.sp12 derived tumours 
Characterising differentiated populations within TERA2.sp12 derived tumours 
Immuno-staining of tumour sections demonstrated that TERA2.sp 12 cells had embarked on 
extensive differentiation into ectodermal derivatives, with extensive neural marker expression 
in discrete regions of tissue and also substantial epithelial keratin expression (Stewart 2005). 
Organised arrangements of layers of cells surrounding a cavity stained positive for pan-
epithelial keratin and simple epithelial keratins 8 and 18, and a proportion of these structures 
also expressed the epidermal stem cell antigen Tp63. It was interesting to note that Tp63 
expression was restricted to the outer surrounding layer of epithelial keratin positive cells, 
similar to the pattern of normal epidermal development where basally localised epithelial stem 
cells generate overlying progenitors by asymmetric division. 
Importantly, selected regions within tumours derived from TERA2.sp 12 cells also 
immuno-stained positive for markers of other germ layers. The endoderm transcription factor 
Gata4 was detected in regions of epithelial keratin positive tissue, as was the endoderm 
transcription factor HNF3~- a member of the fork head family of proteins initially identified 
in drosophila mutants with limited gut development (Lai et al. 1993). HNF3~ is expressed in 
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visceral and definitive endoderm during early mouse embryogenesis (Ang et al. 1993, Lai 
1993, Sasaki 1993) and is required for normal primitive streak morphogenesis (Dufort et al. 
1998). Gata4 is also expressed in primitive and definitive endoderm, and later in development 
in the liver and gut epithelium (Arceci et al. 1993, Laverriere et al. 1994). Taken together this 
indicates that the Gata4 and HNF3P immuno-staining observed in regions of less organised 
tissue represents primitive or definitive endoderm. HNF3P expression was also detected in 
organised epithelial keratin positive structures that were frequently branched and structurally 
resembled primitive gut epithelia. This corresponds with observations by Andrews et al. 
(1984b) of gut-like structures in tumours derived from NTERA2.cl.dl. Through immuno-
staining analyses Gertow et al (2004) also demonstrated that the epithelial components of 
tumours derived from HS 181 human embryonic stem cells consisted of endoderm and 
ectoderm derivatives. They observed similar simple epithelial structures and gut like 
structures staining positive for simple epithelial keratins as well as the presence of more 
complex duct-like structures not observed in TERA2.sp12 derived tumours. 
Gata4 is also expressed in mesoderm derived developing and mature cardiomyocytes 
(Arceci 1993, Heikinheimo et al. 1994, Laverriere 1994 ). However, there was no 
morphological evidence of differentiation along this lineage, and the similar pattern of 
immuno-staining to HNF3p suggests that Gata4 expression was linked to endoderm lineages 
in these tumours. No evidence of the primitive endoderm marker AFP was detected in these 
tumours, implying that the differentiation observed was primarily definitive endoderm. 
However technical problems with using the antibody on wax sections may have hindered 
observations of AFP expression, and thus primitive endoderm differentiation cannot be 
excluded. To further characterise these endoderm derivatives including the primitive gut-like 
structures and also effectively discriminate between visceral or primitive endoderm, more 
extensive immuno-staining analyses including eo-staining with a greater range of markers are 
necessary. 
The early mesoderm transcription factor Brachyury was also detected in tumour 
sections, but not in association with organised tissue and in relatively few cells, following a 
similar pattern to that observed in adherent cultures of RA treated cells. Together with the 
report that the embryonal carcinoma cell line TERA2 expresses Brachyury with no obvious 
mesoderm differentiation (Gokhale et al. 2000), this does not conclusively provide evidence 
of mesoderm differentiation in vivo. Expression of the general marker of smooth muscle, a 
smooth muscle actin, was detected within these tumours, which could provide supporting 
evidence for mesoderm differentiation. However, as previously discussed in chapter 4, smooth 
muscle can also be derived from neural crest cells of the ectoderm. Together with the absence 
of histological evidence of mesoderm derivatives such as bone or striated muscle, this 
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indicates that mesoderm differentiation was limited or absent in these tumours. Staining with 
further markers of mesoderm (for example with desmin) would clarifY whether mesoderm 
derivatives are present. 
In summary, immuno-staining evidence of predominantly ectoderm differentiation, 
(both neural and non-neural simple epithelial) and some endoderm differentiation, (putative 
simple gut epithelia) was detected in TERA2.sp 12 cell derived tumours, whereas no solid 
evidence of mesoderm differentiation was detected. This is in contrast to reports by Heins et 
al. (2004) and Gertow et al. (2004) demonstrating the expression of markers of all three germ 
layers in immuno-staining analyses of tumours generated from human ES cell lines. 
Identification of a stem cell population within TERA2.sp12 derived tumours- the EC 
phenotype 
A sub-population of cells expressing the stem cell transcription factor Nanog was identified in 
all of the TERA2.sp 12 derived tumours surveyed, in contrast to a report by Gertow et al. 
(2004) in which they demonstrated the absence of a stem cell population in tumours derived 
from human ES cells, attributing tumour growth solely to progenitor proliferation. This is 
consistent with the inherent tumourigenic nature of embryonal carcinoma cells, as embryonal 
carcinoma cell lines were originally derived from the undifferentiated stem cell component 
(embryonal carcinoma) of teratomas. Correspondingly, embryonal carcinoma cells are 
typically easily maintained to exhibit a stem cell phenotype in vitro, in contrast to embryonic 
stem cells, which spontaneously differentiate unless they are cultured on feeder layers or 
together with a host of growth factors. This may reflect the transient nature of their 
counterparts in development, as a pluripotent stem cell population only exists in the 
developing blastocyst prior to gastrulation (for review Andrews 2002). 
It is also interesting to note that in a recent report, the human embryonic stem cell 
sub-line H7-s6, which after prolonged culture had accumulating karyotypic abnormalities and 
displayed enhanced growth characteristics, was demonstrated to form a tumour containing a 
stem cell-like sub-population upon injection into immune-deficient mice, and that this stem 
cell population could be explanted and sub-cultured in vitro (Andrews et al. 2005). This 
demonstrates a link between malignant EC cells and their non-malignant ES cell counterparts. 
Together with the observation that the karyotypic abnormalities accumulated in ES cultures 
are typical of those found in EC cell lines (Draper et al. 2004, Liu et al. 1997, Skotheim et al. 
2002), this also suggests that 'culture adaptation' of ES cells mirrors to some extent the 
progress towards malignancy in the formation of germ cell tumours and their EC components. 
It was also interesting to note that the stem cell population in TERA2.sp12 derived 
tumours was frequently observed to be closely associated with host blood vessels. This may 
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reflect the influence of growth factors and more optimal growth conditions on stem cell 
maintenance but is also likely to be a result of the angiogenic properties of embryonal 
carcinoma stem cells as tumour cells. 
Contribution of host cells versus implanted TERA2.sp12 cells in tumour formation 
lmmuno-staining analyses clearly demonstrated that over 90% of each tumour consisted of 
TERA2.spl2 cells, whilst surrounding outer layers containing fatty tissue and hair follicles 
were host derived, as well as blood vessel-like structures through-out the tumours. Similar 
results were generated by Gertow et al. (2004) who analysed human ES derived tumours using 
FISH screening to detect human DNA, and reported that the contribution of mouse cells was 
largely restricted to endothelial cells of the nutriating vessels. However, they also reported 
evidence of some interactions between human and mouse cells, such as observations of blood 
vessel linings consisting of both mouse and human derived endothelial cells. They confirmed 
these observations with immuno-staining for anti-human endothelial markers CD31 and 
CD34, indicating that some co-oporation in tumour vascularisation between the host and 
transplanted cells was occurring. 
The data generated in my study using an antibody to anti-human nuclei alone 
indicates that blood vessels in TERA2.sp 12 cells were solely host derived. However in the 
light of the report by Gertow et al. this requires more detailed examination. Additional 
immuno-staining with an antibody to human endothelial markers CD3 I and CD34 may serve 
to more definitively determine whether or not blood vessels were entirely host derived. 
However, the absence of evidence for mesoderm differentiation in tumours from this study is 
in marked contrast to the presence of extensive mesoderm derivatives in the ES derived 
tumours analysed by Gertow et al., which increases the likely-hood that the vasculature in 
TERA2.sp 12 derived tumours may be indeed entirely host-derived. 
5.3.4 A restricted differentiation potential for TERA2.sp12 cells? 
Support for a restricted differentiation potential for TERA2.sp12 cells 
The immuno-staining and histological results from this study indicate that although tumours 
do contain endoderm derivatives and are therefore not restricted to ectoderm in their 
differentiation, no solid evidence was obtained for mesoderm differentiation and extensive 
differentiation similar to embryonic stem cells was not displayed. Theoretically, TERA2.spl2 
cells could easily exhibit a restricted differentiation potential compared to ES cells as a result 
of their tumourogenic nature. EC cells including TERA2.sp 12 are highly aneuploid and have 
generally adapted over many generations to growth either in culture or as a tumour in a host 
mouse. As their differentiated derivatives typically have a limited lifespan and are non-
malignant, the accumulation of mutations that inhibit differentiation could provide EC cells 
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with a selective advantage. As previously described, the cell line from which TERA2.spl2 
cells were cloned was itself derived from embryonal carcinoma cells isolated from a teratoma 
generated from injection of TERA cells into immuno-compromised mice, and of course the 
TERA cell line was initially established from the embryonal carcinoma cells of a teratoma. So 
as well as being subjected to selection pressure under pro-longed culture conditions, 
TERA2.sp 12 cells and it's parent cells were also subjected to in vivo selection through 
multiple steps of tumour formation and isolation of undifferentiated cells. Thus there are 
multiple windows of opportunity in which TERA2.sp 12 cells could have acquired a reduced 
differentiation potential. Along these lines, it would be interesting to directly compare the 
differentiation of tumours derived from the parent cell lines TERA and TERA2 with 
TERA2.sp12 to determine whether an increasingly restricted differentiation phenotype is 
observed in tumour explants from these cells respectively. 
If for example TERA2.spl2 cells have lost the ability to differentiate along 
mesodermal lineages, this would in part explain the reduced complexity of structures observed 
within these tumours compared to ES cells. Complex epithelial-mesenchymal interactions 
control the formation of organized tissue structures during normal embryogenesis, and the 
absence of mesoderm lineages would prevent these interactions from occurring and therefore 
the establishment of organised tissue structures. 
An alternative explanation for the restricted differentiation observed in TERA2.sp12 
derived tumours 
The presence of a stem cell population and the reduced variety of differentiation and 
complexity in TERA2.sp12 derived tumours compared to ES derived tumours is likely to be 
inherently linked. This suggests an alternative means of explanation for the more restricted 
range of phenotypes manifested in TERA2.sp 12 derived tumours than the hypothesis that 
TERA2.sp12 cells possess a restricted differentiation potential. In this alternate hypothesis, I 
suggest that TERA2.sp12 cells injected into immuno-compromised mice are slower to embark 
on differentiation compared to ES cells, with the majority of cells initially proliferating as 
stem cells, such that by the time the tumour has become large enough to be palpable and is 
removed, only early forms of differentiation, (such as ectoderm and some simple endoderm) 
are observed. In essence this hypothesis proposes that embryonal carcinoma cells do not form 
such a range of differentiated structures and germ layer derivatives compared to embryonal 
stem cells because they are in less advanced phases of differentiation. To investigate this 
hypothesis, very young tumours derived from TERA2.sp 12 cells and ES cells could be 
examined. If such TERA2.sp12 derived tumours consisted mainly of stem cells and early ES 
derived tumours demonstrated a more restricted range of phenotypes (due to less time for 
differentiation to occur), this would provide supporting evidence for this hypothesis. 
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Alternately, older tumours from TERA2.spl2 cells could be examined to investigate whether 
the increased time allowed for more advanced differentiation and the generation of derivatives 
of all three germ layers. However, this is not practically possible when the welfare of the host 
is taken into consideration, because the tumour would become very large and consequently 
place unacceptable levels of stress on the host. 
As previously discussed, a recent report documents the ability of a 'culture adapted' 
human embryonic stem cell sub-line to form a tumour containing a small stem cell component 
after injection into immune-deficient mice. No accompanying restriction in differentiation was 
reported. However, this may reflect the low incidence of stem cells generated within these 
tumours (only one population in one tumour was detected), in the tumours generated from 
transplantation 
5.3.5 Conclusion 
Although initial histological examination indicated TERA2.spl2 cells exhibited restricted 
differentiation to ectodermal derivatives during tumour formation in vivo, subsequent 
immuno-staining analyses identified derivatives of endoderm as well as ectoderm. No solid 
evidence for mesoderm differentiation was generated, suggesting that TERA2.spl2 cells may 
still show a more restricted differentiation potential compared to human ES cells in their 
ability to form all three germ layers. A sub-population of stem cells was identified in every 
tumour examined, reflecting the malignant nature of TERA2.spl2 cells. Two alternative 
hypotheses for the restricted differentiation of TERA2.sp 12 cells were presented: The first 
hypothesis proposes that the accumulation of mutations in embryonal carcinoma cells under 
selection pressure to maintain a malignant phenotype has led to a loss of functional genes that 
confer the ability to differentiate along certain lineages, and this is reflected in the restricted 
differentiation phenotypes observed in vivo. The second hypothesis proposes that the reduced 
complexity and range of differentiation observed in TERA2.sp 12 derived tumours is a result 
of a delay in differentiation of injected TERA2.spl2 cells, such that only early stages of in 
vivo differentiation are observed in harvested tumours. This hypothesis implies that 
TERA2.sp 12 cells are not restricted in their developmental potential and under suitable 
conditions are able to differentiate into all three germ layers. Although the observations of 
predominantly ectodermal differentiation in vitro previously reported in studies of 
TERA2.sp12 cells support the first hypothesis, this may reflect the limited range of culture 
conditions and growth factors used. In the previous experimental chapters I have demonstrated 
that TERA2.sp12 cells have the ability to differentiate into endoderm and trophoectoderm and 
express early markers of mesoderm differentiation. It is also likely that TERA2.spl2 cells 
exhibit a restricted differentiated phenotype in vivo as a result of the combined effects 
described in both hypotheses, or that TERA2.sp 12 cells are not restricted to ectodermal 
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differentiation but exhibit an increased preference for differentiation along this lineage due to 
the accumulation of mutations in a few key genes. 
In summary, taken together with experiments in earlier chapters this data suggests that 
TERA2.sp12 cells are not restricted to ectodermal differentiation in vitro or in vivo. The 
tumours derived from TERA2.sp12 injection into immune-deficient mice do not demonstrate 
the formation of all three germ layers, although the strong malignant component within these 
tumours may have limited the extent of time for differentiation resulting in less advanced 
phenotypes. In future experiments I suggest a more comprehensive survey in vitro using a 
range of growth factors to more exhaustively determine the differentiation potential of 
TERA2.spl2 cells. Most importantly future experiments should specifically test whether 
TERA2.spl2 cells can form mesoderm derivatives by treating cultures with previously 
described mesoderm inducers (such as the TGF~ ligand Activin). Determining whether 
TERA2.sp12 cells can form complex mesodermal derivatives after prolonged incubation in 
vivo would be difficult as previously discussed. One suggestion to overcome this problem is to 
subject TERA2.sp 12 cells to mesoderm inducing treatment prior to transplantation into 
immuno-compromised mice. lfTERA2.sp12 cells are subsequently demonstrated not to retain 
the ability to differentiate into mesodermal derivatives, it would be interesting to test whether 
eo-transplantation with mesoderm progenitors would allow for the formation of more complex 
structures similar to the those observed in ES cell derived tumours. 
CHAPTER6 
GENERAL DISCUSSION 
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6.1 SUMMARY OF THE FINDINGS FROM THIS STUDY 
The central aim of this study was to investigate the mechanisms governing the transition of 
developing human ectoderm into neural or non-neural progenitors using TERA2.sp 12 cells as 
an experimental model, with focus on determining whether the role of BMP signalling in this 
event is conserved in human development. A flow chart in Figure 6.1 summarises the main 
routes of investigation in this study. 
To begin with, the RA induced differentiation of TERA2.sp 12 cells under two 
alternative culture conditions was characterised, in which the level of neural differentiation 
was markedly different. TERA2.sp 12 cells treated with RA under suspension culture 
conditions to form aggregates demonstrated more rapid and extensive differentiation into 
neural derivatives compared to adherent cultures. In contrast to cultures treated under 
suspension conditions, RA treated adherent cultures also displayed both neural and non-neural 
differentiation, (which was characterised as early non-neural ectoderm in this study). The 
dissociation and culture of TERA2.sp12 cells under suspension conditions draws parallels 
with dissociation experiments in Xenopus ectoderm explants (Grunz & Tacke 1989, Hemmati-
Brivanlou & Melton 1997) and changes in BMP signalling as a result of dissociation and 
culture in suspension were hypothesised to be influencing neural versus non-neural ectoderm 
fate decisions in TERA2.sp 12 cultures. 
Molecular analysis of components reported to be transcriptionally up-regulated by 
BMP signalling (Hollnagel et al. 1999, Suzuki et al. 1997) supported the hypothesis that BMP 
signalling is up-regulated in TERA2.sp12 cells cultured under suspension conditions 
compared to adherent cultures, and the manipulation of the BMP signalling pathway was 
demonstrated to markedly influence the level of neural differentiation in TERA2.sp 12 cells. 
This indicates that a key role for BMP signalling in inhibiting neural induction in the early 
ectoderm is conserved in human development. However, under the conditions used in this 
study, the manipulation of BMP signalling in the absence of the differentiation inducer RA 
was not sufficient to induce differentiation into either non-neural ectoderm or committed 
neural progenitors in TERA2.sp12 cells. In response to BMP treatment TERA2.sp12 cells 
formed non-ectodermal derivatives, (trophoblast, endoderm and smooth muscle lineages), 
similar to the reported differentiation of human ES cells into either endoderm or trophoblast 
derivatives in response to BMP treatment (Pera et al. 2004, Xu et al. 2002). In mouse ES 
cells, BMP treatment has been demonstrated to induce differentiation into non-neural 
ectoderm, however only under certain conditions, such as in cells that have been previously 
been treated with the neural differentiation inducing factor SCID (Kawasaki et al. 2000). The 
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presence of growth factors in the serum may have influenced the effects of BMP treatment on 
the differentiation of these cells, and further investigations with manipulations of the BMP 
pathway and culture conditions are necessary to determine whether, under conducive 
conditions, BMP pathway up-regulation is able to induce the differentiation of TERA2.sp 12 
cells towards a non-neural ectoderm progenitor phenotype, or whether other signalling cues 
are also required. 
Correspondingly, treatment ofTERA2.sp12 cells with the BMP inhibitor Noggin was 
not sufficient to differentiate the population of TERA2.sp 12 cells towards a committed neural 
progenitor phenotype, although some neural progenitor markers such as Nestin were up-
regulated in a proportion of the culture. This may reflect an insufficient level of BMP 
signalling inhibition, or alternatively suggests that other signalling cues are required before 
TERA2.sp12 cells are competent to respond to an inhibition of BMP signalling by 
differentiating into neural precursors. Pera et al. (2004) had also reported that treatment of 
human ES cells with Noggin generated cells which under subsequent neural progenitor 
inducing conditions, were able to generate greater numbers of neural derivatives than 
untreated cells. However the generation of neural progenitors from human ES or EC cells 
from inhibition ofBMP signalling alone has not yet been demonstrated. 
Treatment of TERA2.spl2 cells with the FGF receptor 1 inhibitor SU5402 was 
demonstrated to induce a markedly similar response to BMP treatment. As FGF mediated 
signalling has been reported to inhibit BMP pathway activity through inhibitory 
phosphorylation of Smadl (Pera et al. 2003), this mechanism may explain the similar 
response ofTERA2.sp12 cells to either BMP pathway stimulation or FGF pathway inhibition. 
Further experiments are required to determine whether this is indeed the mechanism by which 
FGF mediated signalling inhibits the BMP pathway in TERA2.sp12 cells, and also to fully 
characterise the differentiation of these cells in response to changes in BMP pathway activity. 
Culture of TERA2.sp 12 cells under suspension conditions in the absence of RA was 
also demonstrated to induce differentiation, with a proportion of cells expressing markers of 
endoderm and mesoderm progenitors. The aggregates formed shared similarities with early 
embryoid bodies derived from ES cells, further indicating that TERA2.sp 12 cells are more 
similar to human ES cells than previously thought. However, TERA2.sp 12 cells cultured to 
form aggregates differentiated even though they were subjected to the same media conditions 
which are routinely used to maintain self-renewal. In contrast embryoid bodies are formed 
from ES cells cultured under suspension conditions and in the absence of factors necessary for 
stem cell maintenance, (such as fibroblast feeders or growth factors). The results from this 
study identifY the potent effects of aggregation alone on differentiation, which warrants 
further investigation as this may more closely reflect the signalling environment of the early 
6.2 Discussion 145 
embryo and also of cells within teratomas. 
As TERA2.sp12 cells had demonstrated their capability of differentiating into non-
ectodermal lineages during these investigations in vitro, in the last chapter of this study the 
differentiation potential of TERA2.sp 12 cells was more fully explored by further 
characterising the derivatives formed in tumours derived from transplanting TERA2.sp 12 cells 
into immune-deficient mice. This investigation demonstrated that TERA2.sp12 cells have a 
greater differentiation potential than previously thought, and are capable of forming non-
ectodermal derivatives in vivo, although the range and complexity of differentiation is still 
markedly reduced compared to tumours derived from human ES cells. Further characterisation 
of these derivatives with a range of lineage markers is necessary to determine the full range of 
differentiation in these tumours. 
6.2 DISCUSSION 
In characterising the effect of BMP signalling on neural differentiation of TERA2.sp 12 cells, 
this investigation has touched on key aspects that relate to both human development and the 
field of embryonic stem cell research, which are reviewed in the following discussion. 
6.2.1 The effects of dissociation and aggregate formation 
In this study, the remarkable effects of dissociation and culture under suspension conditions 
on both up-regulated neural differentiation (RA treated cultures) and also differentiation into 
early derivatives of all three germ layers (untreated cultures) has been characterised in 
TERA2.sp12 cells. As previously discussed, temporary dissociation and culture under 
suspension conditions has been used in many systems to induce differentiation. However, the 
key signalling events that underpin these changes in behaviour have not yet been addressed. 
As previously suggested, one such event may be a down-regulation in BMP pathway activity 
mediated by an up-regulation in MAPK activity associated with dissociation (Kuroda et al. 
2005). However the cells are then exposed to more complex and 3-dimensional interactions 
with increased cell-cell contacts as they form aggregates in suspension, mediating more 
localised signalling pathways. This may more closely mimic the environment of cells in a 
developing embryo, and that also that of cells within teratomas, in which more extensive 
differentiation is observed (as shown in Chapter 5). 
Evidence of a community effect in the down-regulation of stem cell marker 
expression was observed in TERA2.sp 12 cells grown to form aggregates under suspension 
conditions without RA, suggesting that localised signalling to down-regulate stem cell marker 
expression was occurring: Characterisation of these signalling events would be pertinent to 
several aspects of development-particularly in the down-regulation of stem cell markers in the 
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developing blastocyst. 
The results of this study do not clearly distinguish whether the changes in behaviour 
of TERA2.sp 12 cells treated with RA under suspension culture conditions (as opposed to 
adherent cultures) are from the initial state of dissociated single cells in suspension or the 
effects of growth in a more three dimensional context as aggregates form, although it is likely 
that the results of this study were generated from a combination of these effects. However, 
preliminary experiments where suspension cultures were treated with RA immediately after 
dissociation and culture in suspension, (compared to 24 hours later) exhibited a less marked 
up-regulation of neural differentiation markers, indicating that this initial stage is key to 
promoting neural differentiation. This correlates with the proposed mechanism by which 
MAPK mediated BMP pathway down-regulation occurs as a direct result of dissociation. 
Careful analysis ofMAPK and BMP pathway activity is needed to confirm this. 
6.2.2 Investigating the default model of neural induction in humans 
Mimicking Xenopus ectoderm explant dissociation experiments in mammalian cells 
Early in this study, parallels were drawn between aggregate formation and the dissociation 
experiments in Xenopus na'ive ectoderm explants which induced neural differentiation. 
Although there were several similarities, namely the initial dissociation step and its effects on 
neural differentiation, there were also inherent differences between these experiments (such as 
the presence of serum and/or RA in TERA2.pl2 cultures) and it would be interesting to more 
closely model the early Xenopus explant dissociation experiments with TERA2.spl2 cells: For 
example, one could investigate whether culture of dissociated TERA2.sp 12 cells under 
suspension conditions (without RA) in either very low serum conditions or with no serum 
generates entirely neural differentiation, and whether this effect can be rescued by the addition 
of either FGFs or BMPs. However, difficulties may be encountered in maintaining cell 
survival under low serum conditions. Shulz et al. (2004) report that transfer of colonies of 
human embryonic stem cells into suspension conditions and culture in media with serum 
replacer promotes neural differentiation, including into dopaminergic neurons, and that this is 
blocked by early exposure to BMP4. This indicates that simply removing serum and culturing 
in suspension (without the dissociation step) encourages neural differentiation, corresponding 
somewhat with the default theory in that a reduced signalling environment is conducive to 
increased neural induction. 
Other approaches to investigate the default model of neural induction 
In the course of this investigation adherent cultures of TERA2.sp 12 cells were treated with 
Noggin to actively inhibit BMP signalling. This induced an up-regulation of some neural 
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progenitor markers such as Nestin, but only in a proportion of the population, and was not 
sufficient to induce neural differentiation. This may reflect the requirement for a greater 
inhibition or complete abrogation of BMP pathway activity, which could be generated by 
using a cocktail of BMP inhibitors at high concentrations (or using BMP receptor inhibitors). 
Alternatively, this may reflect a requirement for other instructive signals for neural induction 
to occur in TERA.sp12 cells (contrary to the default model of neural induction). Again the use 
of serum in the culture media provides an undefined source of a host of growth factors that 
could be influencing differentiation in TERA2.spl2, so ideally experiments should be carried 
out using either low serum conditions or with no serum to minimise this effect. 
Another aspect that hasn't been addressed is the effect of the initial low seeding 
density on the results of these experiments: Seeding at a low density may encourage 
TERA2.spl2 cells to differentiate and also influence differentiation fates. Within the first few 
days of seeding at a low density a proportion of the population was observed to down-regulate 
the stem cell marker SSEA3, and Andrews et al. ( 1984b) reported an increased expression of 
Fibronectin and changes in morphology in TERA2 derived clonal lines cultured under low 
densities. Changes in seeding density have also been demonstrated to modify the 
differentiation fate of human embryonic stem cells in response to BMP signalling (Xu 2002). 
It would therefore be highly relevant to investigate whether similar results are generated in 
experiments where TERA2.sp 12 cells are treated under maintenance density conditions, or 
even as confluent cultures, although the subsequent passaging required would introduce 
another variable to these experiments. This would determine whether signalling cues 
generated or eliminated as a result of seeding at low density have modulated the response of 
TERA2.sp12 cells to these treatments. Conversely, one could determine whether maintaining 
cells at very low densities (by constant reseeding), results in robust differentiation along a 
characterised lineage. 
A very recent study by Smukler et al. (2006) has markedly demonstrated the effects of 
seeding density and the absence of serum on differentiation behaviour in mouse embryonic 
stem cells, and also generated evidence strongly supporting the default model of neural 
induction: They reported that mouse embryonic stem cells differentiate into primitive neural 
stem cells in the absence of any extrinsic cues (although a large proportion of cells do not 
survive) and proposed that neural differentiation may indeed be the default state of cells that 
are not exposed to extrinsic cues. In their investigation, single mouse embryonic stem cells 
seeded at very low density (to abrogate intercellular signalling) in the absence of serum or 
feeder layers (to remove extrinsic factors) displayed neural stem cell marker expression, 
although subsequently the majority of cells died. Furthermore, they demonstrated that 
treatments to increase viability- such as the addition of exogenous survival factors, activation 
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of the endogenous cAMP pathway, or genetic interference with apoptosis generated 
increased numbers of primitive neural stem cells, without any non-neural differentiation being 
detected. They also demonstrated that FGFs were important for the proliferation and 
subsequent survival but not the generation of the default pathway derived primitive neural 
stem cells. It is interesting to note that ES cells seeded under these conditions in minimal 
media and treated with SU5402 at the same concentrations used in this study, were not 
inhibited from differentiating into primitive neural stem cells, and in marked contrast to 
TERA2.sp 12 cells exhibited no evidence of trophoblast or endoderm differentiation. This 
suggests that the presence of other factors in the serum of cultures in which TERA2 .sp 12 cells 
were treated, or generated as a result of the higher seeding density in which they were 
cultured, may have influenced the affect of SU5402 on TERA2.sp12 cell fate. It would be 
highly valuable to mimic these experiments in a human model such as TERA2.sp 12 cells, and 
determine if they exhibit a similar 'neural induction' response. 
6.2.3 Maintenance of the stem cell phenotype 
A thorough understanding of the pathways regulating stem cell maintenance and self-renewal 
in stem cells is necessary not only for efficient propagation of human embryonic stem cells in 
the absence of animal derived products, but is also important in understanding and minimising 
tumour formation in transplanted grafts. From a developmental perspective, stem cell 
regulation is inherently linked with differentiation and cell fate - as many of the pathways 
involved maintain the stem cell phenotype at least in part by inhibiting specific routes of 
differentiation, such as the inhibition of pro-neural transcription factors by BMP pathway 
components such as Id hlh factors (as described in Ying et al. 1993). Accordingly, gaining an 
understanding of the mechanisms controlling stem cell maintenance will have direct relevance 
to elucidating the mechanisms controlling early induction events and cell fate in the embryo. 
Xu et al. (2005) recently demonstrated that human embryonic stem cells could be 
maintained undifferentiated in culture without serum, feeder layers or conditioned medium 
when exposed to both high levels of FGF and the BMP inhibitor Noggin. Thus they proposed 
that through antagonising the BMP signalling pathway the stem cell phenotype was 
maintained in these cells. However, human embryonic stem cells could not be clonally 
propagated using this method, suggesting that other signalling pathways are also necessary to 
maintain the stem cell phenotype. In support of this observation, TERA2.sp 12 cells seeded at 
low densities and then treated with Noggin did not maintain the expression of stem cell 
markers, indicating that inhibition of BMP signalling alone was not sufficient to maintain 
undifferentiated TERA2.sp 12 cells. 
In the last two years several studies have rapidly advanced our understanding of the 
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pathways involved in maintenance of human stem cells, and a key point that emerges is the 
marked differences in the pathways involved compared to mouse embryonic stem cells. In 
summary, activation of the Wnt signalling pathway has also been demonstrated to maintain 
the stem cell phenotype in human embryonic stem cells cultured without feeder layers or 
conditioned medium (Sato et al. 2004}, and two recent reports by Vallier et al. (2005) and 
James et al. (2005) have demonstrated that activation of another branch of the TGFPsignalling 
pathway through Nodai/Activin signalling is necessary for stem cell maintenance in human 
ES cultures. They also demonstrate that both FGF and Wnt mediated maintenance of stem cell 
pluripotency requires an active Nodai/Activin signalling pathway, and Vallier et al. report that 
human embryonic stem cells can be maintained long-term in unconditioned, serum free media 
without serum replacer or growth on feeder layers, when cultured in the presence of FGF2 and 
either Nodal or Activin. However, in all cases these cells were cultured on matrigel and 
maintained in colonies or at high densities, so more factors may be necessary to maintain 
human embryonic stem cells as single cells in the absence of matrigel or feeder layers. Figure 
6.2 outlines the pathways reportedly involved in maintenance of the pluripotent stem cell 
phenotype in human embryonic stem cells. 
It could prove highly constructive to directly compare the expression of these 
signalling pathway components between human embryonic stem cells and a feeder 
independent embryonal carcinoma cell line such as TERA2.sp 12, as it is likely that these 
pathways also play key roles in maintaining the stem cell phenotype of TERA2.sp 12 cells. A 
key step is to establish whether TERA2.sp 12 cells can also be maintained in serum free media 
with the addition of Activin/Nodal and FGF, and whether these components are necessary, or 
whether TERA2.sp 12 cells have acquired activating mutations in these pathways or exhibit 
strong autonomous signalling loops. 
The signalling conditions required to maintain human embryonic stem cells as single 
cells or at very low seeding densities in the absence of a feeder layer or matrigel have not yet 
been elucidated: As seeding at low density also induces TERA2.sp 12 cells to down-regulate 
stem cell markers, TERA2.sp 12 cells could provide a simpler experimental system in which to 
investigate the roles of a range of factors in maintaining the stem cell phenotype in single 
cells. For example, one could investigate the ability of exogenous addition of a range or 
combination of signalling ligands to maintain levels of SSEA3 expression in TERA2.spl2 
cells seeded at a very low density. 
6.2.4 Manipulation of the BMP and FGF mediated signalling pathways 
Considering temporal regulation ofBMP signalling 
A key issue that emerged from the study ofBMP signalling in TERA2.sp12 cells (see Chapter 
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Figure 6.2. An outline of the signalling pathways thought to be important in maintaining the stem cell phenotype 
in human embryonic stem cells. Xu et al. (2005) reported that FGF and Noggin treatment can maintain 
undifferentiated colonies of human embryonic stem cells in the absence of feeder conditioned medium when 
cultured on matrigel in the presence of serum replacer. Sato et al. (2004) reported that activation of the Wnt 
signalling pathway was sufficient to maintain human ES cells in the absence of feeder conditioned medium or 
serum, although cells were cultured as colonies on matrigel. James et al. (2005) and Vallier et al. (2005) 
demonstrated that Activin/Nodal signalling was necessary to maintain human stem cell maintenance, and Wnt 
mediated stem cell maintenance required an active Activin/Nodal signalling pathway. Vallier et al. also report 
that FGF mediated stem cell maintenance requires an active NodaVActivin signalling pathway, and that culture 
with FGF2 and either Activin or Nodal is sufficient to maintain human embryonic stem cells in the absence of 
feeder layers, conditioned medium, serum or serum replacer. No reports have yet demonstrated the sustained 
maintenance ofhuman embryonic stem cells as single cells and in the absence ofmatrigel and serum replacer. 
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4) was the wide-ranging effects that manipulations in BMP signalling can generate, such that 
in TERA2.sp 12 cells induced to differentiate down ectodermal lineages by RA, BMP 
treatment markedly inhibited neural differentiation and promoted non-neural ectoderm-like 
differentiation, whereas BMP treatment of TERA2.spl2 cells alone induced differentiation 
into derivatives that were previously uncharacterised in this cell line - such as trophoblast, 
endoderm and smooth muscle. It is also important to consider embryonic stem cells in the 
context of their ability to form all the tissues of the body, and note that many of these 
derivatives are temporally and differentially modulated by BMP signalling. Consequently ES 
cells provide the opportunity to explore the effects of modulating BMP signalling in different 
embryonic cell types. For example, stem cells of the central nervous system (CNS) respond to 
BMPs by differentiating into a wide variety of dorsal CNS and neural crest cell types: BMP 2, 
4 and 7 are reported to inhibit neurogenesis and induce astrocytogenesis of mouse fetal 
neuroepithelial cells, and reduce oligodendrocyte differentiation (Games et al. 2003, 
Yanagisawa et al. 2001). It is interesting to note that BMP4 mediated glial differentiation has 
been reported to occur via the FRAP/STAT pathway, (Rajan et al. 2003), for review see (Hall 
& Miller 2004). In addition, BMP signalling has been reported to induce dendritic growth in 
cultured sympathetic neurons (Lein et al. 2002), induce differentiation of mesencephalic 
precursors into dopaminergic neurons (Brederlau et al. 2002) and modulate the differentiation 
of post-natal cells of the rat cerebellum (Angley et al. 2003). Thus the effects of BMP 
modulation on the differentiation and specification of these types could also be investigated in 
human TERA2.sp 12 cells that have been previously differentiated to form neural sub-types. 
Modulating BMP pathway activity in the context of other signalling cues 
Another promising avenue of investigation is to determine whether various concentrations or 
combinations of BMPs induce differentiation of TERA2.sp 12 cells towards different lineages, 
in order to more fully elucidate the graded effects of BMP signalling on differentiation: BMP 
treatment has been demonstrated to induce both trophoectoderm and primitive endoderm 
differentiation in human ES cells (Pera 2004, Xu 2002) and it is plausible that low levels of 
BMP signalling may instead promote differentiation into non-neural ectoderm. In addition, it 
would be highly constructive to investigate the effect of BMP treatment in embryonic cells 
subjected to different signalling cues - such as in cells cultured with or without serum and/or 
at very low densities, in the presence ofNodaVActivin signalling or Wnt signalling, and in the 
presence/absence of FGF mediated signalling. Evidently control experiments that characterise 
the individual effects of these signalling cues on TERA2.sp 12 cells would be essential. This 
would generate a better understanding of both the ability of other signalling pathways to block 
BMP mediated behaviour (such as inhibiting differentiation), and also their ability to perhaps 
modify the effects of BMP pathway activity on differentiation (for example in the presence of 
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high FGF signalling BMP treatment may induce trophoectoderm as opposed to endoderm 
differentiation (Pera 2004, Xu 2002). 
Results from this study indicate that in TERA2.sp12 cells, a principle function ofFGF 
signalling is to antagonise BMP pathway activity, as treatment with the FGF receptor inhibitor 
SU5402 results in differentiation analogous to treatment with BMP2 or BMP4. As discussed 
previously, in the developing Xenopus embryo FGF mediated inhibition of BMP pathway 
activity through Smad 1 phosphorylation has been proposed to play a key role in promoting 
neural induction (for review see Pera 2003). This hypothesis remains to be substantiated in 
TERA2.sp12 cells- and future investigations should determine whether high FGF signalling 
can block BMP mediated pathway activity and whether this is indeed mediated through 
ERK 1/2 phosphorylation of Smad I. 
However, other signalling cues may function independently of their activity on the 
BMP pathway, such as by changing the competence ofthe cell to respond to BMP signalling, 
or changing the state of the cell such that it will respond differently to BMP pathway activity. 
If future studies demonstrate that TERA2.sp 12 cells dramatically modify their differentiation 
response to BMP treatment when subjected to different signalling cues, by comparing the 
results with data demonstrating the effects of various concentrations of recombinant BMPs on 
differentiation fate, you could also gauge whether these effects are generated simply through 
attenuating BMP pathway activity or whether the resulting differentiation is unique to that 
induced by changes in BMP signalling alone. The results from these experiments would have 
direct relevance to embryonic development, increasing our understanding of how different 
combinations of signalling cues act on identical cells from the blastocyst to generate the 
complex and wide ranging derivatives required in a developing embryo. 
6.2.5 Working with TERA2.sp12 cells- a useful experimental tool in which to 
study human development? 
With regard to the rapid advances in the last few years in the characterisation and 
establishment of multiple human embryonic stem cell lines, together with recent technological 
advances that have greatly reduced their extensive culture requirements, the question naturally 
arises as to whether TERA2.sp 12 cells - as an EC cell line - are no longer a compelling 
system in which to study human development. As previously discussed, TERA2.spl2 cells 
provide a robust and simple culture system for manipulation experiments. However, as cancer 
cells they are malignant and display genetic instability, and like all human EC cell lines 
typically have undergone extensive culture in vitro, an opportunity in which to accumulate 
further mutations, some of which may reflect a reduced capacity for differentiation. In fact 
recent reports also document the accumulation of mutations and the formation of aneupoid 
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karoytypes in human embryonic stem cell lines that have undergone prolonged culture, 
(specifically the recurrent gain of chromosomes 12 and 17q) demonstrating that culture 
conditions are selective for mutations (Draper et al. 2004). It is interesting to note that the 
accumulated chromosomal abnormalities in human ES cells are typically similar to those 
observed in human EC cells, and are associated with sites of stem cell maintenance. 
Significantly, these mutations have not been reported to reduce the pluripotency of these 
embryonic stem cell lines in vitro or in vivo (Andrews et al. 2005, Draper 2004, Liu et al. 
1997). 
As malignant cells, EC cell lines are unlikely to be used preferentially for 
transplantation therapies. However, in one sense their greater tumourogenic tendencies can be 
exploited: If human EC cell derivatives are manipulated such that they demonstrate 
integration and differentiation upon transplantation into animal hosts without tumour 
formation, this provides a highly rigorous test of the ability of a technique to prevent tumour 
formation upon transplantation, which could then be safely applied to human ES cells. The 
current approach for transplantation therapies is to differentiate embryonic stem cells 
extensively in vitro prior to transplantation, although this also can have a negative impact on 
survival after transplantation. The potential of extensive in vitro differentiation prior to 
transplantation to prevent tumour formation has been successfully demonstrated with a sub-
clone of the NTERA2 embryonal carcinoma line. Differentiated neurons derived from RA 
treated NT2Dl cells have been reported to generate significant behavioural recovery upon 
injection into ischemic rats in the absence of tumour formation, and in current clinical trials 
with patients suffering from stroke or cerebral (basal ganglionic) infarction, abnormal tissue 
masses or tumour formation from NT2Dl neuron cell grafts have not been detected. These 
transplantation studies and the current progress of clinical trials are extensively reviewed by 
Newman et al. (2005). 
Despite their malignant character, as demonstrated in this study, in many aspects 
embryonal carcinoma cell lines may exhibit very similar differentiation behaviour to human 
ES cells and as a simple culture tool, provide a means in which to investigate key questions in 
human embryonic development that could subsequently be confirmed in human stem cell 
lines. In order to truly validate observations of human development derived from studies of 
human TERA2.sp12 cells, it would be necessary to test these results in not one but multiple 
other human embryonic stem cell lines, to demonstrate that the results generated are not due to 
the variant behaviour of an individual cell line. With the increasing availability of embryonic 
stem cell lines, this is becoming easier. 
In summary, although the emphasis of human stem cell research has undoubtedly 
shifted to human embryonic stem cell lines, robust and well characterised embryonal 
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carcinoma cell lines such as TERA2.sp12 cells remain a useful tool if they are studied- not in 
isolation - but together with embryonic stem cells, as a simple and robust culture model in 
which to carry out investigations. 
6.2.6 The future of embryonic stem cell research 
Models in which to study human embryogenesis 
Embryonic stem cells provide a highly accessible model in which to study events such as 
germ layer induction and lineage specification. However, this requires the development of 
defined protocols for lineage specification which do not require serum or other animal derived 
products, and the development of further markers of specific lineages. Additionally, the 
functions of specific genes in early development could be explored using gene knock out 
techniques, such as RNAi mediated inhibition of specific genes. 
As with all culture models, it is also important to take into consideration the 
limitations of in vitro experiments, and try to test any results in an in vivo system. In the case 
of humans this is not possible, but other mammalian developmental models are well 
characterised, and human ES cell derived neural progenitors transplanted into the ventricles of 
newborn mice and adult rats exhibit migration and neural differentiation (Reubinoff et al. 
2001, Tabar et al. 2005, Zhang et al. 2001). In addition, chimeric embryos have recently been 
successfully generated from human embryonic stem cells injected into either a developing 
chick or mouse embryo (Goldstein et al. 2002, Muotri et al. 2005). 
These reports of successful differentiation and integration of human ES cells and their 
derivatives with host murine and chick embryonic tissues have important implications. The 
study of chimeric embryos provides a means of exploring the differentiation potential of 
human embryonic stem cells in the context of early development in vivo and importantly, 
suggests that fundamental developmental pathways are indeed conserved between these 
species. Future studies utilising the manipulation of embryonic stem cells both in vitro and in 
vivo will allow researchers to unravel the mechanisms of human embryonic development and 
also possibly reconcile differing developmental theories between species - such as the 
conflicting theories for the mechanism of neural induction. 
Clinicalffherapeutic applications 
As discussed, significant advances have been made in characterising human embryonic stem 
cells and unravelling various aspects of human development. In addition, significant steps 
have been taken towards the use of embryonic stem cells in medical applications. These 
include providing differentiated derivatives for drug testing and for transplantation therapies 
in diseases generated by the loss of specific cell types, such as diabetes, heart disease, liver 
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disease and Parkinsons disease. Since Parkinsons disease is caused by loss of a specific neural 
sub-type (dopaminergic neurons), extensive research has been invested towards using 
embryonic stem cell derived dopaminergic neurons in transplantation therapies and 
subsequently will be discussed here as a specific example. The key requirements for the 
clinical application of stem cells include the ability to direct cells along a specific lineage in 
defined conditions and isolate large numbers of these cells for transplantation, ensuring that 
the transplant is not contaminated with other differentiated phenotypes or with 
undifferentiated (potentially tumour forming) cells. 
Using a rat model for Parkinson's disease, Kim et al. (2002) demonstrated that mouse 
ES cell-derived dopamine neurons survived, developed functional synapses and displayed 
electrophysiological properties characteristic of midbrain neurons following transplantation 
into these animals. In addition, the animals showed some recovery, suggesting that the 
transplanted cells were functional. In 2004, Perrier et al. reported the directed differentiation 
of human embryonic stem cell lines (using eo-culture techniques) to generate high-yields of 
dopaminergic neurons (Perrier et al. 2004). In addition, recent transplantation experiments 
with neural progenitors and dopaminergic neurons derived from primate ES cells into the rat 
model for Parkinsons disease have also demonstrated that a small proportion of dopaminergic 
neurons survive in the host, but significant functional recovery as a result of improved 
dopaminergic neuron function has not been generated (Ben-Hur et al. 2004, Sanchez-Pernaute 
et al. 2005). Thus to meet the requirements for a pre-clinical trial, researchers need to generate 
grafts which exhibit extensive survival and integration of the transplanted cells, retain the 
required dopaminergic phenotype, and furthermore are able to mediate functional recovery. A 
final obstacle to be overcome is donor/recipient compatibility and graft rejection, although a 
recent report indicates that human embryonic stem cells are less susceptible to immune 
rejection than adult cells (Drukker et al. 2006). 
Another important avenue of investigation with enormous potential is the generation 
and characterisation of human ES cell lines with genotypes characteristic of different diseases. 
Human ES cell lines from patients suffering from a variety of different diseases could be 
generated through the use of somatic cell nuclear transfer (Hochedlinger & Jaenisch 2003). 
These lines could then be used as in vitro models in which to study and further characterise 
these diseases, and as a model for testing new approaches to treat diseases (see review Keller 
2005). To summarise, in order to safely utilise embryonic stem cells and their derivatives in 
transplantation therapies we need to further characterise the mechanisms governing stem cell 
maintenance and the specification and differentiation of specific lineages. Currently our 
understanding is restricted. We have yet to unleash and- more importantly- control the full 
differentiation potential of human ES cells. 
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6.2. 7 Conclusions 
Research using human embryonic stem cells has potent implications for both clinical 
applications and for the study of human embryogenesis and development. The results of this 
study have contributed to the elucidation of the role of the BMP pathway in neural versus non-
neural transitions of the developing ectoderm in humans. An increased understanding of 
human embryogenesis and the basic molecular mechanisms that control the specification of 
lineages will be in turn highly applicable to the manipulation of stem cells towards specific 
cell lineages for medical applications such as drug development and transplantation therapies. 
APPENDIX 
7.1 RECIPES FOR CELL CULTURE 
ACID WASHED GLASS BEADS 
Cover beads with concentrated HCL leave o/night in fume-hood. Pour off HCL. Wash beads 
three times in distilled water. Drain, autoclave. Leave to dry in vacuum oven. Aliquot 20 
beads per test tube. Re-autoclave beads in tubes. 
7.2 RECIPES FOR WESTERN BLOT ANALYSIS 
LYSIS BUFFER 
In IO mls: 
I OOJ!I lgepai, (detergent) 
500Jll IM TrisCL (ph 8) 
500Jll 3M NaCI 
IOJll IM MgCI 
8960J!I mqH20 
Add proteinase inhibitors at a ratio of I :7 
PROTEINASE INHIBITORS 
Complete MINI protease inhibitor cocktail tablets (Roche Biosciences) 
(Dissolve I tablet in I.5ml MQH20. 
5X SOS REDUCING BUFFER (PROTEIN SAMPLE BUFFER) 
2.5ml I M Tris pH 6.8 
5ml Glycerol 
Ig SOS 
0.05g bromophenol blue 
2.5ml 2 beta-mercaptoethanol 
I OX TRIS-BUFFERED SALINE 
6.1 g Tris Base 
43.8gNaCI 
500mls H20, adjust pH to 7.5 
I 56 
Appendix 
10% GEL (RESOLVING GEL) 
4.9mlsdH20 
2.5mls Tris HCL (pH 8.8) 
1 OOul 10% SOS stock 
2.5mls 40% Acrylamide Bis Phosphate, (37 .5:1) 
Just before pouring into mould add the following setting agents 
50J!I I 0% Ammonium persulfate 
5J!ITEMEO 
4% GEL (STACKING GEL) 
6.4mls dH20 
2.5mls Tris HCL (pH 8.8) 
1 OOul 10% SOS stock 
1ml40% Acrylamide Bis Phosphate, (37.5:1) 
Just before pouring into mould over the set resolving gel add the following setting agents 
50J!I 10% Ammonium persulfate 
IOJ!ITEMEO 
10x RUNNING BUFFER 
9g Tris Base 
43.2g Glycine 
3gSOS 
dH20 to 600mls. 
2x TRANSFER BUFFER 
3g Tris Base 
28.8g Glycine 
400mls Methanol 
600mls dH20 
PONCEAU STAIN 
0.2% Ponceau, 3% trichloro-acetic acid in dH20 
PONCEAU OESTAIN 
5% Acetic acid in dH20 
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BLOCKING BUFFER 
5% milk powder, (Marvel) 
0.2% Tween 20 (Sigma) in TBS. 
DEVELOPING SOLUTION 1 
I OOul Luminal (Sigma), (250mM in DMSO) 
44ul P Coumaric Acid, (Sigma), (90mM in DMSO) 
lml1M TrisCl ph 8.5 
9ml H20 
DEVELOPING SOLUTION 2 
6.4,.tl H202 
I ml 1 M TrisCI ph 8.5 
9ml H20 
7.3 RECIPES FOR IMMUNO-STAINING 
4%PFA 
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Add 4g of PF A powder (Sigma) to I OOmls of PBS. Add a few drops of 0.5M NaOH and 
agitate at 40°C until solution clears, then filter through filter paper. 
7.4 RECIPES FOR PCR ANALYSIS 
5X TBE BUFFER 
27g Tris Base 
13.75g Boric Acid 
I Oml 0.5M EDT A (pH8), (or 1.861 g) 
Make up to 500ml with H20 
RUNNING BUFFER 
25mls 5x TBE 
225mls H20 
Appendix 
AGAROSEGEL 
5 m15XTBE 
45 ml H20 
I% (0.5g) agarose 
Microwave in plastic beaker for lmin (High) 
Cool beaker under running water (l-2mins). 
Add 2.5ul ethidium bromide, (TOXIC) 
Pour into gel cast and leave to set. (Takes 20-40mins, turns opaque when set). 
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After gel is set, remove casting ends and well casts, place gel in electrophoresis tank. Add 
running buffer until surface of gel is just covered. 
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